TW200413503A - Method of inhibiting oxidation, water capable of inhibiting oxidation and use thereof - Google Patents
Method of inhibiting oxidation, water capable of inhibiting oxidation and use thereof Download PDFInfo
- Publication number
- TW200413503A TW200413503A TW092128817A TW92128817A TW200413503A TW 200413503 A TW200413503 A TW 200413503A TW 092128817 A TW092128817 A TW 092128817A TW 92128817 A TW92128817 A TW 92128817A TW 200413503 A TW200413503 A TW 200413503A
- Authority
- TW
- Taiwan
- Prior art keywords
- water
- hydrogen
- concentration
- pigment
- test
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
五、發明說明〇) [發明所屬之技術領域] 本發明係關於一種抗氧化方法 途,係利用使屬於催化劑2请ί氣化機能水及其用 除去生體内存在者Μ逷原酵素(惟,為預先 程,促…:ΐ;存二金含屬有膠, 成物活性氨之分解反應,作為基質形成生 態或欲防止氧化之抗氧化“::;;::造成之氧化狀 態。 豕艾成W電子充足的還原狀 [先前技術] 對於生體來說氧氣是把雙 營養素氧化以獲得能量之目的或3 面用在將 各種氧加成反應中,但一方;#於生體所必須之 種組織障害所伴隨之危險而被指摘因其氧化力所產生之各 特別是在因代謝所生成 自由基是具有不安定性不對稱電子一氧化氮(Ν0)等 保持安定。-·,超么(反:…個電子以 ⑽.)、過氧化氫叫)、—重離項m)、經基 氧基 '另外,氫過氧基⑽2 ·)、過^)44種被稱為活性 (L〇 .)等廣義上也可被認為 ^ 2 、烷氧基 會將該等活性氧基總稱為”活性氧類乳游:基右:下,有時 之化氮⑽等自由基總稱為游2將此處 …性乳類在鐵離子或銅離子存在下,會J帶生成 第4頁 2030-5943.PF(Nl);Chiume〇w.ptd 200413503 五、發明說明(2) 新的活性氧類。這些加速形成之活性氧類已知會損害細胞 或去氧核糖核酸鏈,並透過生成老化促進因子過氧化脂質 氧而與許多疾病相關。其中又以羥基(H0 ·)反應性最高, 已知為一種對細胞損傷等傷害作用大的活性氧類。而且, 因紫外線(UV)造成之皮膚發炎也已確認與羥基(H0 ·)之生 成有關。又,已知病毒感染時因感染者過度免疫反應使生 體内產生超過維持平衡所需必要量之活性氧類,會對生體 造成毒性作用。 帶有該種對生體有毒性之活性氧通常在生體内係藉稱 為S0D(氧化物歧化酶,Superoxide Dismutase)之酵素而 去除。 但,如因壓力或飲酒、吸煙、劇烈運動、高齡化等諸 要因使生體内失去平衡,則S〇D會減少,使因活性氧造成 之過氧化脂質增加,引發心肌梗塞、動脈硬化、糖尿病、 癌症、腦中風、白内障、肩凝症、怕冷、高血壓及老人痴 呆症等各種疾病,使生體的生理機能低落,而帶來產生^ 人斑、雀斑、皺紋等問題。 另外,含有活性氧類之 敗、污濁、消臭及鮮度下降 性化之重大要因之一。其結 造成商品價值降低、生產性 重傷害的問題被指摘。 游離基與氧化、品質裂化、腐 之關連也被指摘為其表現及惡 果是,含有活性氧類游離基會 下降、增加生活自然負荷等嚴V. Description of the invention 0) [Technical field to which the invention belongs] The present invention relates to an anti-oxidation method, which uses a catalyst 2 to vaporize functional water and use it to remove a person's existing enzyme in the living body (but only As a pre-procedure, it promotes…: 存; the existence of two metals containing a gel, the decomposition reaction of the active ammonia, as a matrix to form an ecological or anti-oxidation to prevent oxidation ":: ;; :: the state of oxidation caused. 豕Aicheng W electron-reduced reduction state [prior art] For living organisms, oxygen is used for the purpose of oxidizing binutrients to obtain energy, or 3 sides are used in various oxygen addition reactions, but one side; # 于 生 所 requisite The dangers associated with this kind of tissue disorders have been accused of maintaining stability due to their oxidizing power, especially when the free radicals generated by metabolism are unstable, asymmetric electron nitric oxide (NO), etc. -..., super? (Reverse: ... electrons are called ⑽.), Hydrogen peroxide is called),-re-separation term m), via the alkoxy group 'In addition, hydroperoxy group ⑽ 2 ·), per ^) 44 kinds are called active (L 〇.) Can also be considered in a broad sense such as ^ 2, alkoxy will Isoactive oxygen is collectively referred to as "active oxygen type milk swim: base right: bottom, sometimes free radicals such as nitrogen hafnium are collectively referred to as swim 2. Here ... sex milk in the presence of iron ions or copper ions, will be J band Generate page 4 2030-5943.PF (Nl); Chiume〇w.ptd 200413503 V. Description of the invention (2) New reactive oxygen species. These accelerated reactive oxygen species are known to damage cells or DNA strands and are associated with many diseases by generating aging-promoting factors, lipid peroxides. Among them, the hydroxyl group (H0 ·) has the highest reactivity, and it is known as a reactive oxygen species that has a great harmful effect on cell damage and the like. In addition, skin inflammation caused by ultraviolet (UV) has been confirmed to be related to the generation of hydroxyl (H0 ·). In addition, it is known that an excessive immune response of an infected person at the time of viral infection causes the body to produce more than necessary amounts of reactive oxygen species necessary for maintaining balance, which may cause a toxic effect on the body. The reactive oxygen species with this toxic body is usually removed in vivo by an enzyme called SOD (Superoxide Dismutase). However, if the living body is out of balance due to stress or drinking, smoking, strenuous exercise, aging, etc., SOD will decrease, and the peroxide lipids caused by reactive oxygen species will increase, leading to myocardial infarction, arteriosclerosis, Various diseases such as diabetes, cancer, stroke, cataract, shoulder coagulation, cold, hypertension, and Alzheimer's disease reduce the physiological function of the living body, and cause problems such as human spots, freckles, and wrinkles. In addition, it is one of the major factors that cause degradation, turbidity, deodorization, and degradation of freshness of active oxygen species. As a result, the problems of causing a decrease in the value of the product and serious damage to productivity were blamed. The relationship between free radicals and oxidation, quality cracking, and decay has also been accused of manifestations and negative consequences. The fact that free radicals containing active oxygen species will decrease and increase the natural load of living is severe.
200413503 五、發明說明(3) (ubiquinone ) An i so 1e)、BHT 專抗氧化劑或活 但是,因該 體等抗氧化對象 慮。且,該等抗 化,因而所產生 全性的顧慮問題 因此,期待 與先前之抗氧化 能力,且對於抗 準者。 BHA(丁基备基甲氧苯jjydroxy (二叔 丁基羥基甲苯 dibutyl toluene)、 性氧消去劑等。 等抗氧化劑為化學合成品,多量使用於生 時對於抗氧化對象會有安全性問題的顧 氧化劑在將對方還原的過程中本身會被氧 之副生成化合物對於抗氧化對象亦會有安 〇 能開發一種革新技術,其係能夠一面發 劑同等或更好之抗氧化能或消去活性氧 氧化對象之安全性或環境負荷減低為高水 [發明内容] 的為提供一種抗氧 化劑氫氧化還原酵 金屬膠體作用於氫 含有之分子狀氫作 將由於缺乏電子所 對象能夠變成電子 安全性或環境負荷 目的為提供—種 含有催化劑氫氧化 本發明係為解決該課題所形成,目 化方法及抗氧化機能水,其係透過使催 素(惟,除去預先存在於生體内者)或貴 溶存水中之過程,促進以該氫溶存水中 為基質形成生成物活性氫之分解反應, 造成之氧化狀態或欲防止氧化之抗氧化 充足的還原狀態,藉此可期待對人體之 低減之高水準。 又,本發明係為解決該課題所形成 具有抗氧化機能之抗氧化機能水,一種 第6頁 2030-5943-PF(Nl);Chiumeow.ptd 200413503200413503 V. Description of the invention (3) (ubiquinone) An i so 1e), BHT special antioxidant or active. Moreover, these resistances, and the general concerns that arise, therefore, look forward to the previous antioxidant capacity, and to those who resist. BHA (butyl butyl methoxybenzene jjydroxy (di-tert-butyl hydroxytoluene dibutyl toluene), sexual oxygen scavenger, etc .. Antioxidants are chemical synthetic products, a large amount of use in the raw materials will have safety issues for the antioxidant object Gu oxidants in the process of reducing the other side will be by-produced by oxygen compounds will also be safe for anti-oxidants. Can develop an innovative technology, which can be equivalent to or better than the antioxidant power or eliminate active oxygen. The safety of the oxidized object or the reduction of the environmental load is high [contents of the invention] To provide an antioxidant, hydroxide reduction enzymes, metal colloids act on molecular hydrogen contained in hydrogen, and the object can become electronic safety or environment due to lack of electrons. The purpose of the load is to provide a kind of catalyst containing hydroxide. The present invention is to solve the problem, the method of visualization and the antioxidant function water, which is made by dissolving the oxytocin (except for those who are pre-existing in the body) or noble solution. The process in water promotes the decomposition reaction of the active hydrogen formed by the formation of the product in the hydrogen-soluble water as the matrix, resulting in the oxidation state It is desired to prevent the oxidation from being in a sufficiently reduced state, so that a high level of reduction to the human body can be expected. In addition, the present invention is to form an antioxidant function water with an antioxidant function in order to solve this problem, page 6 2030- 5943-PF (Nl); Chiumeow.ptd 200413503
,,酵素(惟,除去預先存在於生體内者)或貴金屬膠體於 氫,存水所形成之水,可促進以該氫溶存水中含有之分子 狀氫作為基質形成生成物活性氫之分解反應,利用前述催 化劑所催化的分解反應,可將由於缺乏電子所造成之氧化 狀^或欲防止氧化之抗氧化對象能夠變成電子充足的還原 狀態。本發明之目的亦為提供含有該抗氧化機能水之抗氧 化劑、抗老化劑、品質劣化阻止劑、防腐劑、污濁防止 劑、消臭劑及鮮度保持劑。 先對本發明人等對於本發明 在本發明之概要說明前 之思考方向作說明。 (1)本發明之思考方向 本案申請人在先前已申請並已公開,將其記載内容取 材引用在本申請案之再公開專利w〇99/1〇286號中,揭示氯 離子指數(以下稱「pH」)與氧化還原電位(以下稱 ^里 「0RP」)可彼此獨立控制之電解槽及電解水生成裝置。該 申請案之概要如以下所示。即,係電解槽及還原電位水= 成裝置,其具備導入原水之電解室、區隔前述電解室内外 之一個以上隔膜,及分別設於電解室内外以夾住隔膜之至 少一個以上的電極板對,及以電解室内所設電極板為陰 極、以電解室外所設電極板為陽極,於兩極間加給電壓之 電源電路’並且前述電解室外之電極板係接觸前述隔膜或 透過極小縫隙被設置。在同裝置中陰極側上原水tpH值不 會改變报多,但可生成0RP值大幅下降之電解還原電位水 (以下,有時稱「還原電位水」)。以下,只要不特別限, Enzymes (except for those pre-existing in the living body) or precious metal colloids in hydrogen, and the water formed by storing water can promote the decomposition reaction of the active hydrogen produced by the molecular hydrogen contained in the hydrogen-soluble water as a matrix. By using the decomposition reaction catalyzed by the aforementioned catalyst, the oxidation state due to lack of electrons or the oxidation-resistant object to be prevented from being oxidized can be reduced to a state with sufficient electrons. It is also an object of the present invention to provide an antioxidant, an anti-aging agent, a quality deterioration preventing agent, a preservative, a fouling preventing agent, a deodorant and a freshness maintaining agent containing the antioxidant function water. First, the present inventors will explain the thinking direction of the present invention before the outline of the present invention. (1) Thinking direction of the present invention The applicant of this case has previously applied for and has published it. The content of its content is cited in the re-published patent No. w099 / 0286 of this application to disclose the chloride ion index (hereinafter referred to as "PH") and oxidation-reduction potential (hereinafter referred to as "0RP") can be controlled independently of each other and the electrolyzer and electrolyzed water generator. The summary of the application is shown below. That is, it is an electrolytic cell and a reduction potential water = forming device, which includes an electrolysis chamber for introducing raw water, one or more separators for separating the aforementioned electrolysis chamber and the outside, and at least one or more electrode plates which are respectively provided inside and outside the electrolysis chamber to sandwich the membrane. Right, and the electrode plate provided in the electrolytic room is used as the cathode, and the electrode plate provided in the electrolytic room is used as the anode, and a voltage supply circuit is provided between the two electrodes, and the electrode plate in the electrolytic room is arranged in contact with the diaphragm or through a small gap. In the same device, the tpH value of raw water on the cathode side does not change much, but it can generate electrolytic reduction potential water (hereinafter, sometimes referred to as "reduction potential water") with a significantly reduced ORP value. Below, as long as it is not particularly limited
200413503200413503
定,「電解處理」係指使用上述之 通水式電解處理。 〜逆只 本發明人等透過以卜^ ^ ΠΤ — ^ Λ ^ Φ , 上过之還原電位水生成裝置進行對 斤生十:原電位水之性能評價試驗,而啟發了本發明。 此處,還原電位水係表示帶有負值之〇Rp pH之0RP值超過既定值者。叩p佶9 μ 兀疋值考。〇RP值疋否超過既定值係依以下 之尼倫司特式(近似式)判斷。 〇RP = -59pH-80UV)···(尼倫司特式)。 該式如第1圖所示,顯示pH與〇Rp具有比例關係⑽愈 偏鹼性側時0RP愈偏負值)。因此,對應於pH之·值超過 既定值係指0RP值比上述尼倫司特式所對應之值為小。滿 足此條件之水就稱為還原電位水。若將pH7代入上述尼倫 司特式,則0RP為-493 (mV)左右。即,ph7時0RP在 j9 3 (mV)左右以下之水相當於還原電位水。惟,在此處所 定義下屬於還原電位水範圍内之水中仍存在有溶存氫濃舟 之些微差異,對於此點,將與該溶存氫濃度之定量分析 法一併於後詳述。 首先’還原電位水中含有相當量的高能量電子。此點 若以0RP計測定即可知。〇Rp為顯示被測定液中所含有氣化 物質及還原物質存在比率之指標,其單位一般使用毫伏 (mV)。一般’ 0RP計若測定用之電極帶負電則會觀測到負 的0RP值’反之’若測定用之電極帶正電則會觀測到正的 0RP值。為使測定用之電極帶負電必須使被測定液中含有"Electrolytic treatment" refers to the use of the above-mentioned through-water electrolytic treatment. ~ Inverse Only The present inventors inspired the present invention by performing a performance evaluation test on Jinsheng X: original potential water by using a reduction potential water generating device that has been passed ^ ^ ΠΤ — ^ Λ ^ Φ. Here, the reduction potential water system means a person whose ORP pH with a negative value of 0 Rp exceeds a predetermined value. The value of 叩 p 9 μ is considered. 〇 Whether the RP value exceeds a predetermined value is judged according to the following Nylenstein formula (approximate formula). 〇RP = -59pH-80UV) (Nilensted). As shown in Fig. 1, this equation shows that pH has a proportional relationship with ORP (the more the ORP becomes more negative the more the alkaline side). Therefore, a value corresponding to a pH value exceeding a predetermined value means that the value of the ORP is smaller than the value corresponding to the above-mentioned Neilstein formula. Water that meets this condition is called reducing potential water. When pH7 is substituted into the above-mentioned Nylenstein formula, the ORP is about -493 (mV). That is, water having an ORP of about j9 3 (mV) or less at ph7 corresponds to reducing potential water. However, there is still a slight difference in the concentration of dissolved hydrogen in the water that falls within the range of the reduction potential water as defined here. For this point, this point will be described in detail with the quantitative analysis method of the dissolved hydrogen concentration. First, the 'reduction potential water contains a considerable amount of high-energy electrons. This point can be known if it is measured by an 0RP meter. 〇Rp is an index showing the existence ratio of gasified substances and reduced substances contained in the liquid to be measured, and its unit is generally millivolt (mV). Generally, a '0RP meter will observe a negative 0RP value if the electrode used for the measurement is negatively charged', and a 'positive 0RP' value will be observed if the electrode used for the measurement is positively charged. In order to negatively charge the electrode for measurement, the test solution must contain
第8頁 2030-5943-PF(Nl);Chiumeow.ptd 200413503 五、發明說明(6) 高能電子。因此’若0RP值呈現負的大的 必然被測定液中含有能量高之電子。 寸 了為 此處,為對還原電位水中含有多少程度之古& 行性能評價,使用發光二極體(以下,略稱為ϋ 仃焭燈試驗。此係利用電池的原理。具體上,^ 之白金等電極201與隔膜203,及各有3個昤故^ / 宕9Π7 士士入有個陰極至205及陽極 至207左右之试驗用電池209中,於陰極室中 為- 600(mV)左右之還原電位水、於陽極 又Page 8 2030-5943-PF (Nl); Chiumeow.ptd 200413503 V. Description of the invention (6) High-energy electrons. Therefore, if the ORP value is negative, the measured liquid must contain high-energy electrons. In order to evaluate the performance of the reduction potential contained in the water, a light-emitting diode (hereinafter, referred to as the 仃 焭 lamp test) is used. This is based on the principle of the battery. Specifically, ^ Platinum and other electrodes 201 and diaphragm 203, and each of them have 3 ^ ^ / 79Π7 taxi into a test battery 209 with a cathode to 205 and anode to 207, in the cathode chamber -600 (mV The reduction potential of the water
盔丄π、丄r 味極至中各別投入ORP 為+ 4〇〇(mV)左右之自來水,再將與陰極室2〇5接觸之電極 上連接LED211之負極側端子、與陽極室連接led2u之正極 側端子,並觀察LED2U之持續亮燈狀態。此表示透過 LED211,有電流由電池2〇9之陽極往陰極流動,進一步的 說,有電流流動就代表有電子在流動。此 電子為自電池209之陰極流向陽極,則還考原慮電位、 水中確貫含有能量高之電子群的事實就可以被實驗性的定 性評價。 在上述電池209中,於陰極室内分別投入市售之電解 水生成裝置所生成之鹼性電解水(例如〇Rp為—5〇mV左右)或 天然之礦泉水等、陽極室内分別投入自來水以作為參考 7 ’與上述同樣在陰極室之電極上連接LED之負側端子, 陽極室連接LED之正側端子,並未觀察到LED亮燈。此可被 認為 >是因既存之驗性電解水或天然之礦泉水中不含有可使 LED亮燈程度之高能電子群的原故。 又’在市售之電解水生成裝置中,雖然將流量集中可 2030-5943-PF(Nl);Chiumeow.ptd 第9頁 200413503 五、發明說明(7) 使0RP值往偏負的方向移動,但依上述尼倫司特式,若此 時之PH值下0RP值之絕對值變小,仍觀察不到LED亮燈。例 如’在市售之電解水生成裝置中,提高流量之結果,即使 在PH為10左右下0RP值為-50 0〜-60 0 (mV),但因減去pH值之 ORP值變小’故電子能量上為弱的,推測在上述尼倫司特 式中,若pH為10左右時ORP值無法下降到—67〇(mV)左右以 下,則可能無法使LED亮燈。 二 一又,LED雖也有好幾種,但使用如上述各室交錯配置 為三層構造之電池20 9時,可觀察到呈色為藍或綠等要求 3V左右高端子間電壓之二極體在還原電位水有持續亮燈。 因此,在對於還原電位水中含有高能電子之產業利用 性進行專意研究下,發現還原電位水或許具有「潛在還原 力」之暗示特別疋,因為要使LED亮燈則〇rp必須傾向為 有相當負值,故還原電位水具有相當強之還原力,若能順 =的引出其f原力,則確信應能在包含醫療、工業、食、 品、農業、汽車、能源等廣泛產業領域被利用。 明。此處’對所謂「潛在性還原力」是何種狀態加以說 例如,在自來水等普通的水中加入維生素 酸削原劑後,再添加氧化劑,則還原 裘 化劑也不會馬上被還原。此狀態可認為是還 值大的ORP值和氧化南I比χ ν -貝 Μ狀能下。A @ 白保持原來狀恶,兩者是處在共存 的狀恶下此時,尚未發揮還原力。 第10頁 2030-5943-PF(Nl);Chiumeow.ptd 五、發明說明(8) 即’無論還原電位水中 將氧化劑還原之反應。推 之電子並不會馬上發生放電 大小與電子放電之容县择“疋還原電位水中所含電子能量 題。 又,即還原力之發揮,為不同的問 那麼’要如何 題,本發明人等進一位水能發揮還原力?對於此命 作用之念頭。雖說催i “2:,#到應用何種催化劑 生體為前提時,想到應可用特別是以適用於 屬叢集之微粒子)作為催化劑之H後述貝金屬㈣(貴金 此處特別提到酵素,醆参心 劑且酵素活性係以催化反應之】:::為:學反應之催化 應時’A為基質B為生成物以:纟二::化A-B之反 則氫溶存水中所含之八工,以此套用於本發明之個案, 於生成物。且,該種二:相當於基質’而活性氫則相當 明。 該種酵素作用之機轉可想成為如下之說 化劑相遇並以中:::帶高能量電子群與氧 壁。該能量障壁-妒稱^子群存在必需超越之能量障 此能量愈高,則須越過之壁::”活化此」荨。 表示之昝旦璧回度也愈兩。且,以壁的高度 b里因為較電子群所帶 ,,g ^ 無法越過該壁,结果是益、、^f之月b里還同’故通常電子 應無法使氧化劑還原一去移動到氧化劑處十可想成 第11頁 2〇3(M943-PF(N1);Chiu_.ptd 200413503 五、發明說明(9) 但’若有如酵素之催化劑 活化能可降低,結果 ,則因相當於壁高度之 催化劑之情形下比較了可往氧化=位水中之電子群與沒有 移動完成的時點, 蜊相當順利的移動且在其 如此,在酵幸ί; 可將氧化劑還原。 南能量電子群變得容士二1還原電位水中之 若換個方式表示還盾:Τ 、,:果為可發揮還原力。即, 說是「還原電位水所且右盾;;有潛在性還原力」,可 思考,最後終於得到:解、周破封印了」。經過各種 為催化劑」之想法。 开 < 原電位水還原力其封印之鑰 明。在了解本發明思考之方向之後,對本發明之概要作說 (2)本發明之概要 2 · 1抗氧化方法 本發明係提供一種抗氧化方法,其特徵 劑氫氧化還元酵素(惟,卜麥顆务在.為透k使催化 ,八准除去預先存在於生體者)或貴金屬 二體作用於虱溶存水之過程,促進以該氫溶存水中含有之 1子狀虱作為基質形成生成物活性氫之分解反應,將由於 ^乏電子所造成之氧化狀態或欲防止氧化之抗氧化對象能 夠還原到電子充足的狀態下。 本發明人4涊為電解處理水或氫氣泡水等氫溶存水之 0RP值呈現負值之本質為同水中所溶存之氫。氫為最基本 之還原物質且在電解處理中陰極側會產生氫之事實支持了 上述之論點。 'Helmets 丄 π and 丄 r are respectively fed with tap water with an ORP of about +400 (mV), and then the electrode in contact with the cathode chamber 205 is connected to the negative terminal of LED211 and connected to the anode chamber led2u. The positive side terminal, and observe the continuous lighting state of LED2U. This means that through the LED 211, there is a current flowing from the anode of the battery 209 to the cathode. Further, the current flowing means that the electrons are flowing. This electron flows from the cathode to the anode of the battery 209, and the fact that the electron group with high energy is definitely contained in the water can also be considered experimentally qualitatively based on the consideration of the potential. In the above battery 209, alkaline electrolytic water (for example, 〇Rp is about -50 mV) or natural mineral water generated by a commercially available electrolytic water generating device is respectively put into the cathode chamber, and tap water is separately put into the anode chamber as the Reference 7 'Same as above, the negative terminal of the LED is connected to the electrode of the cathode chamber, and the positive terminal of the LED is connected to the anode chamber. No LED lighting is observed. This can be considered to be due to the fact that the existing experimental electrolyzed water or natural mineral water does not contain a high-energy electron group capable of lighting the LED. Also, in a commercially available electrolyzed water generating device, although the flow rate can be concentrated, 2030-5943-PF (Nl); Chiumeow.ptd Page 9 200413503 V. Description of the invention (7) Move the 0RP value to a negative direction. However, according to the above-mentioned Nylenstein formula, if the absolute value of the 0RP value at the PH value becomes smaller at this time, the LED is still not observed. For example, "In a commercially available electrolyzed water generator, as a result of increasing the flow rate, even if the 0RP value is -50 0 to -60 0 (mV) at a pH of about 10, the ORP value becomes smaller by subtracting the pH value" Therefore, the electron energy is weak. It is presumed that in the above-mentioned Nylenstein formula, if the ORP value cannot drop below about -67 (mV) when the pH is about 10, the LED may not be turned on. Although there are several types of LEDs, when using a battery with a three-layer structure such as the above-mentioned cells staggered, it can be observed that the color is blue or green, which requires a diode with a high voltage between the terminals of about 3V. There is continuous light at the reducing potential. Therefore, under the intensive research on the industrial applicability of high-potential electrons in reducing potential water, the suggestion that reducing potential water may have "potential reducing power" is particularly rampant, because in order for LEDs to light, Orp must tend to be quite Negative value, so the reducing potential water has a fairly strong reducing power. If the f-force can be derived, it is believed that it can be used in a wide range of industries including medical, industrial, food, agricultural, automotive, and energy. . Bright. Here 'is what is the state of the so-called "potential reducing power". For example, if vitamin acid degener is added to ordinary water such as tap water and then an oxidant is added, the reducing agent is not immediately reduced. This state can be considered as the value of the large ORP value and the oxidized south I ratio χ ν-bay M-shaped energy. A @ 白 remains the same as the evil, and the two are in the state of coexistence. At this time, the reducing power has not yet been exerted. Page 10 2030-5943-PF (Nl); Chiumeow.ptd V. Description of the invention (8) That is, the reaction of reducing the oxidant in water regardless of the reduction potential. The magnitude of the discharge and the discharge of the electron will not immediately occur. Rong County chose the question of "the energy of the electron contained in the reduction potential water." That is, the reduction force is exerted. For different questions, the question "how to do it, the inventor, etc." Can a bit of water play a reducing power? The idea of this life effect. Although the premise of "2:, #" is the premise of the application of a catalyst organism, it is thought that it should be used as a catalyst, especially for particles belonging to clusters. H. Shellfish metal ㈣ mentioned later (Gold Gold specifically mentions enzymes, ginseng heart agents, and enzyme activity to catalyze the reaction] ::: is: the catalysis of the academic reaction 'A is the substrate B is the product: 纟2: The reverse of chemical AB is the eight workers contained in hydrogen-dissolved water. This set is used in the case of the present invention in the product. And, the second: equivalent to the substrate, and the active hydrogen is quite clear. The effect of this enzyme The turn of the machine can be thought of as the encounter of the chemical agent and the middle: :: with a high-energy electron group and the oxygen wall. The energy barrier-envy ^ Subgroups have energy barriers that must be surpassed. The higher the energy, the higher the energy must be crossed Wall :: " "This" Xun. It means that the degree of reversion is also more and more. And the height b of the wall can not cross the wall because it is more than that of the electron group. As a result, the month b of Yi, ^ f It is also the same as 'Therefore, usually the electron should not be able to reduce the oxidant and move to the oxidant. You can think of it on page 11 203 (M943-PF (N1); Chiu_.ptd 200413503 V. Description of the invention (9) But' if there is The activation energy of the catalyst of the enzyme can be reduced. As a result, because the electron group in the oxidizable water is compared with the time when the movement is not completed in the case of a catalyst corresponding to the wall height, the clam moves quite smoothly and in this way, in Enzyme can reduce the oxidant. The South Energy Electron Group becomes Yung Shi II. The reduction potential of the water in another way means that the shield can be restored: T,,: If the reducing power can be exerted. And right shield; there is a potential reducing power ", you can think about it, and finally get: solution, Zhou break the seal". After various thoughts as a catalyst "open the key to the seal of the original potential water reducing power. After understanding the thinking direction of the present invention, Brief summary (2) Summary of the present invention 2.1 Antioxidant method The present invention provides an antioxidant method, the characteristic agent of which is a redox enzyme (however, bumai granules are in order to make catalysis through permeation) The process of removing the pre-existing organisms) or the noble metal dimers in the lice-soluble water promotes the decomposition reaction of the active hydrogen produced by the 1-like lice in the hydrogen-soluble water as a substrate, which will be caused by the lack of electrons. The oxidized state or the anti-oxidation object to be prevented from being oxidized can be reduced to a state with sufficient electrons. The inventors of the present invention are that the 0RP value of hydrogen-soluble water, such as electrolytically treated water or hydrogen bubble water, is negative. The fact that hydrogen is the most basic reducing substance and that hydrogen is generated on the cathode side during electrolytic treatment supports the above argument. '
200413503200413503
但,如本發明之田I 氫溶存水在原樣 π <心考方向中可明白 下其還原力係被封印的。 之使催化 還原力其 因此’發現如本發明 劑作用於氫溶存水之過程 封印解開,是極重要的。 相關抗氧化方法所定義 對於將氫溶存水所具有 另外 象不存在 即, 化劑而第 合,氫潛 在内之廣 氧化機能 欲防止氧 此處之還 或與上述 可依後面 溶存氫濃 其次 之技術範 一重要之要 ,則本發明 本發明中重 三為抗氧化 在所具有之 義抗氧化作 之展現是指 化之抗氧化 原力大小係 尼偷司特式 詳述使用還 度DH之實效 ’對於該等 圍〇 素為抗氧化對象之存在。若抗氧化對 相關抗氧化作用就沒有發揮的空間。 2要素第—為氫溶存水,第二為摧 ^象。將該等三要素予以有機性結 田原力其封印被釋放,包含還原機 用便可彰顯。又,本發明中所說之 將由於缺乏電子所造成之氧化狀態或 對象能夠還原到電子充足的狀態下。 以0RP值之狀態(〇Rp計測值之安定性 之關係等)概略推定,但若要講究, 原色素之溶存氫濃度定量方法求得之 值來決定。 —要素’提及本發明所屬於及所推定 Z · 1 · 1虱浴孖水 氫溶存水可總括所為 (有時亦稱為原水)係於: 虱之水。又,此處所稱之 活性碳處理水、離子=來水、純水、蒸餾水、天然水 瓶水、後述的生體水t在t中純水、超純水、市售之寶 在水中以化學反應產生分子氫之However, as in the field I hydrogen-dissolved water of the present invention, it can be understood that the reducing power is sealed in the original π < heart test direction. Therefore, it is very important to find that the process of removing the seal when the agent of the present invention acts on hydrogen-dissolved water. Related anti-oxidation methods are defined to have the hydrogen hydrogen dissolving water in addition to the absence of the chemical agent, the extensive oxidation function within the hydrogen potential is to prevent the return of oxygen here or with the above can be dissolved hydrogen concentration followed by the second An important point of the technical paradigm, then in the present invention, the third important aspect of the present invention is the meaning of anti-oxidation. The expression of the anti-oxidative force refers to the magnitude of the antioxidant force. "Effective" for the existence of these antioxidants. There is no room for antioxidants to play a role in related antioxidants. The first two elements are hydrogen dissolved water, and the second is destruction. When these three elements are organically bound, the original force of their seals is released, and the reduction mechanism can be used to highlight them. In the present invention, it is said that the oxidized state due to lack of electrons or the object can be reduced to a state where electrons are sufficient. It is roughly estimated based on the state of the 0RP value (such as the stability of the measured value of RPp). However, if you want to pay attention to the value, determine the value obtained by the quantitative method of the dissolved hydrogen concentration of the original pigment. —Element 'mentions that the present invention belongs to and is estimated to be Z · 1 · 1 lice bath water. Hydrogen-soluble water can be collectively referred to (sometimes also referred to as raw water) in the water of lice. In addition, the activated carbon-treated water, ion = come water, pure water, distilled water, natural water bottle water, and biological water (to be described later) are pure water, ultrapure water, and commercially available treasure. Of molecular hydrogen
200413503 五、發明說明(11) 等,包括所有的水。再者,在該水中添加電解助 還原劑之水也全部都在本發明技術範圍内。 =" 氯之水的條件,不論其液性為酸性?中性Ϊ ,欢性,且原則上也不論其溶存濃度高低。惟, 用 發明所展現之抗氧化機能係透 狀^ ”活性氯之過程所放出之電子所產生= 存;辰度愈高可期待展現較大之抗氧化機能。 虱之洛 水進:ί解ϊίΐ水亦包含透過隔膜在陽極與陰極間將原 水内將氫起^#在陰極側所生成之鹼性電解水,或將原 計f 氣)乃至進行加壓充填處理過之水。以相 式或批式電解水生】m圍亦包含以既存之連續通水 含有氫所生成之氫溶存水。此處所舉例之 僅為最起碼之例示,並不限定於此1此:即: 除於本發明技術ί圍:…,則很明顯的該水並非被排 # u 例如生體之血液或淋巴液等體液(有時也稱為生 可推疚古ν腸内微〃生物,特別是生成具有氫激酶之微生物 爽,二刀子狀氫溶存,本發明所說之氫溶存水不論其由 體中t子有ί子狀氯之生體水也在該技術範圍内。又,生 到血二t狀氫所在不僅限於腸内,推測可由腸管吸收分布 肝_ = π,而流動在血液中之分子狀氫,特別是會被送到 =^腎臟等各内臟器官等,並貯存在生體内之各部位。 月7下,為利用生體内所貯存之分子狀氫作為還原劑,200413503 V. Description of invention (11) etc., including all water. In addition, all the water in which an electrolytic co-reducing agent is added is within the technical scope of the present invention. = " The condition of chlorine water, regardless of its liquidity is acidic? Neutral slugs are pleasant, and in principle it does not matter whether they are dissolved or not. However, the anti-oxidation function exhibited by the invention is transparent ^ "produced by the electrons emitted by the process of active chlorine = existence; the higher the degree, the greater the anti-oxidation function can be expected to display. The water also includes alkaline electrolyzed water (or the original gas) that is generated by lifting hydrogen in the raw water between the anode and the cathode between the anode and the cathode through the diaphragm, or water that has been subjected to pressure filling treatment. Or batch electrolysis aquatic] m circle also includes hydrogen-dissolved water generated by the existing continuous continuous water containing hydrogen. The examples given here are only the minimum examples, and are not limited to this 1: that is: except in the present invention Techniques encircle: ..., it is clear that the water is not being drained # u For example, body fluids such as blood or lymph fluids (sometimes called bio-intestinal micro-organisms in the intestine, especially those with hydrogen Kinase microorganisms are refreshing, two-knife-shaped hydrogen is dissolved, and the hydrogen-dissolved water according to the present invention is also within the scope of this technology regardless of the biological water in which the t-shaped chlorine is contained in the seed. Furthermore, blood-t-shaped The location of hydrogen is not limited to the intestine, and it is estimated that it can be absorbed and distributed by the intestine. Liver _ = π The molecular hydrogen flowing in the blood is sent to various internal organs, such as the kidney, and stored in various parts of the living body. On the 7th, the molecular form stored in the living body is used. Hydrogen as reducing agent,
200413503 五、發明說明(12) 只要藉將氫激酶等酸音#;^、+、主& 使分子狀氯可活後迷貝金屬膠體投予至生體内’ n i ^ 水包含0RP為負•及對_之0rp值較依尼 :司=P—--59pH_80(fflV)所得到之值為低之還原電位 ΐ還原電位水當然包含以本案申請人所開發 、十、蕾立7生成裝置(具備導入原水之電解室、區隔前 =;至内外之一個以上隔膜,及分別設於電解室内外以 一個以上的電極板對,及以電解室内所; 解極板為陽極,於兩極間 二 心电原電路,並且前述電解室外之電極板係接網 μ述隔膜或透過極小縫隙被設置)所生成之水,_不排^ 以其他裝置所生成且其滿足上述還原電位示 又,附帶一提,採用使還原電位水生成裝置卜U成 至!解槽,m將以既定時間反覆循環電解 ^ 一 1逛流工程的技術時,如後述表1等所示,可得 到溶存氫濃度高且0RP值更低之還原電位 位水可發揮良好之還原力(抗氧化力)。 3還原電 4介Ϊ者^ f溶存水以溶存有大氣壓下飽和濃度(以利用 杏崎佶、^、色素之·溶存氫濃度定量分析方法換算溶存氫濃声 =j U上的氫的水為佳。因為這樣可以期待本發明又 乳化機能水可展現高度還原活性、抗氧化活性。 几 ,處,對本發明人等所推想之氫溶存水的參考例與 令子虱之水的比較例其各別相關各物性值作舉例。^ 較用之對象水係以將藤澤市自來水通過活性碳管柱200413503 V. Explanation of the invention (12) As long as the acid kinase #, ^, +, main & • And the value of 0rp of _ is lower than that of Eni: Division = P --- 59pH_80 (fflV) The value obtained by the reduction potential is low. Of course, the reduction potential water includes the device developed by the applicant of this case. (Equipped with raw water electrolysis room, before separation = one or more diaphragms to the inside and outside, and one or more electrode plate pairs located inside and outside the electrolysis room, and the electrolysis room; depolarization plate as the anode, between the two poles Two ECG circuit, and the electrode plate outside the electrolytic cell is connected to the network or the diaphragm is set up through a very small gap), the water generated is not discharged ^ generated by other devices and it meets the reduction potential shown above, attached A mention is made of a device for generating water at a reduced potential! When the tank is decomposed, m will repeatedly cycle the electrolysis in a predetermined time. ^ 1 When the technology of flow-through project is shown in Table 1 below, etc., a reduction potential water with a high dissolved hydrogen concentration and a lower 0RP value can play a good reduction. Force (antioxidant power). 3 reduced electricity 4 mediators ^ f dissolved water at a saturated concentration at atmospheric pressure (using the quantitative analysis method of apricot sloppy, ^, pigment, and dissolved hydrogen concentration to convert the dissolved hydrogen concentration sound = hydrogen on j U is This is because the emulsified functional water of the present invention can be expected to exhibit high reducing activity and antioxidant activity. The reference examples of the hydrogen-dissolved water and the comparative example of water caused by the louse are different from each other. The relevant physical property values are used as examples. ^ The target water system is to pass Fujisawa city water through activated carbon tubing.
200413503 五、發明說明(13) 理過之活性碳處理水、將藤澤市 "" 之離子交換管柱處理過之 、過臥魯加奴社製 思依藤忠礦泉水(株)對曰本國供:J ·,使用由可爾必200413503 V. Description of the invention (13) Treated activated carbon treated water, treated with Fujisawa's ion-exchange tubing, passed through Sugatochu mineral water manufactured by Wolukanoo Co., Ltd. For: J ·, used by Calbee
Eaux Mineales d, Evi 二evian 」(S·A·des 例來作為例示。在=為寶特瓶水之一 種處理後之氫溶存水係以索 a過為使氳溶存之各 生成裝置,用每分!公升之、、:速:人所開發之還原電位水 進行連續式電解處理後之第還5 A固,流之電解條件 用同樣電解條件(循環水量為2:、原,::卜,以同裝置使 30分鐘後之第2還原電位水:及"j仃連績式電解處理 氣起泡處理30分鐘後之氫對各種比較對象水進行氫 水生成裝置「迷你密兹(股)公司製電解 「4」之電解條件進行 ^1水置下使用電解範圍 為例示。 ^電解處理後之鹼性電解水作Eaux Mineales d, Evi di evian "(S · A · des is taken as an example. In = is a kind of treated water-soluble hydrogen water, which is a kind of hydrogen-soluble water, which is used as a generator to dissolve plutonium. Min !, liters, speed: The 5 A solid after the continuous electrolysis treatment of the reduction potential water developed by the human, the same electrolysis conditions are used for the current electrolysis conditions (the circulating water volume is 2 :, the original, ::: bu, Use the same device to make the second reduction potential water after 30 minutes: and "j 仃 continuous-type electrolytic treatment gas foaming treatment 30 minutes after hydrogen treatment" Hydrogen water generation device for various comparison target water "Mini Mitz (stock) The electrolysis conditions of the company-made electrolysis "4" are ^ 1. The range of electrolysis under water is used as an example. ^ The alkaline electrolyzed water after electrolysis is used as
又,該水所具有$久Μ A 〇mmv)、電傳導度阶^物、氧化還原電位 存氫濃度DH(mg/L)、水溫/合存乳》辰度D〇(mg/L)、溶 種物性時所使用之各種f 為例。又,在計測該等各 (股)掘場製作所製之仰計,:類,仰計(含溫度計)係使用 式為「9620-l〇D」,〇RPf+K體形式為「卜13」,探針形 本體形式為「D-25」,〆斜5股)、掘場製作所製之0RP計, (股)掘場製作所製之ECf;,2為「930 0- 1 0D」,EC計為 式為「9382-l〇D」,D〇^+a本體形式為「D —24」,探針形 體形式為「D —25」,探針掘場製作所製之D0計,本 〜式為「9520- 1 0D」,DH計(溶 2030-5943-PF(Nl);Chiumeow, ptd 第16頁 200413503 五、發明說明(14) 存氫計)為東亞DKK(股)製,本體形式為「DHDI-1」,電極 (探針)形式為「HE-532 1」,中繼器形式為「DHM-F2」, 使用該等各種計器類,分別計測比較對象水所具有之各種 物性值。 表1各種水之基礎動據 不含氫之各種水的物彳生値 pH ORP[mV] EC[mS/m] DO[mgyL] DH[mg/L] TfC] 活1生碳處理水 7.31 308 16.15 8.65 0.000 22.2 欧魯加奴純水 6.00 395 0.11 4.52 0.000 23.3 Evian(冷藏保阁 7.30 407 56.30 9.76 0.000 12.5 _ 1涵解時之物性値 pH ORPfmVl EC[mS/ml DO[mfl/Ll DHfmq/Ll T[t] 活性碳處理水 9.54 -735 22.30 3.22 0.900 27.5 歐魯加奴純水(非5A) 1048 -760 5.60 4.45 0.425 24.2 Evian(冷藏^存) 7_48 -530 56.10 5.25 0.460 15.7 循?8«(30分)時之物性値 pH 0RP[mV] EC[mS/m] D0[mgyL] DH[mg/L] T[t] 活1生碳處理水 11.00 -850 42.80 1.76 1.332 25.8 歐魯施純水(非5A) 11.15 -850 52.30 0.94 1.374 31.9 Evian(冷藏保存) 7.72 -635 45.10 1.46 1.157 24.2 氫起泡(30分)時之物性値 pH ORP[mV] EC[mS/m] D〇[mg[] DH[mg/L] TO •黼财 8.30 585 17.97 1.67 1.070 23.6 歐魯ΛΠδί純水 6.40 -550 0.22 1.75 1.090 23.4 Evian(冷藏保存) 8.25 -765 50.7 2.59 0.89 21.3 活性碳處理水(以氫氧化納) 11.00 -836 33.50 1.55 0.910 20.9 以電解水生成器電解時之物&1® pH ORP[mV] EC[mS/m] DO[mgyL] DH[mg/L] T[t] 鹼性匍跑R膊_備理) 9.34 60 14.78 8.00 0.163 20.7In addition, the water has a long time (Amm), an electrical conductivity step, a redox potential hydrogen storage concentration DH (mg / L), a water temperature / combined milk, and a degree D0 (mg / L). The various types of f used in seed solubilizing properties are taken as examples. In addition, when measuring the gauges manufactured by each excavation company, the gauges (including thermometers) use the formula "9620-l0D", and the form of RPf + K is "Bu 13" , The probe-shaped body form is "D-25", oblique 5 shares), 0RP meter manufactured by excavation factory, ECf manufactured by excavation factory; 2 is "930 0-1 0D", EC meter The formula is "9382-l0D", the body form of D〇 ^ + a is "D-24", the form of the probe body is "D-25", and the D0 meter manufactured by Probe Digging Co., Ltd. is ~ "9520- 1 0D", DH meter (soluble 2030-5943-PF (Nl); Chiumeow, ptd page 16 200413503 V. Description of the invention (14) Hydrogen storage meter) is made by the DKK (shares) system of East Asia, and the body form is " "DHDI-1", the electrode (probe) format is "HE-532 1", and the repeater format is "DHM-F2". Using these various types of instruments, measure various physical property values of the water to be compared. Table 1 The basics of various waters According to the properties of various waters that do not contain hydrogen, the pH value is ORP [mV] EC [mS / m] DO [mgyL] DH [mg / L] TfC] Live 1 carbon-treated water 7.31 308 16.15 8.65 0.000 22.2 Ouluganu pure water 6.00 395 0.11 4.52 0.000 23.3 Evian T [t] Activated carbon treated water 9.54 -735 22.30 3.22 0.900 27.5 Orugano pure water (not 5A) 1048 -760 5.60 4.45 0.425 24.2 Evian (refrigerated storage) 7_48 -530 56.10 5.25 0.460 15.7 30 minutes) Properties: pH 0RP [mV] EC [mS / m] D0 [mgyL] DH [mg / L] T [t] Live 1 carbon-treated water 11.00 -850 42.80 1.76 1.332 25.8 Oulu Shi pure water (non- 5A) 11.15 -850 52.30 0.94 1.374 31.9 Evian (refrigerated storage) 7.72 -635 45.10 1.46 1.157 24.2 Physical properties at the time of hydrogen foaming (30 minutes) P pH ORP [mV] EC [mS / m] D〇 [mg [] DH [mg / L] TO • Wealth 8.30 585 17.97 1.67 1.070 23.6 Oulu ΛΠδί pure water 6.40 -550 0.22 1.75 1.090 23.4 Evian (refrigerated storage) 8.25 -765 50.7 2.59 0.89 21.3 activated carbon treated water (sodium hydroxide) 11 . 00 -836 33.50 1.55 0.910 20.9 When electrolyzed with an electrolyzed water generator & 1® pH ORP [mV] EC [mS / m] DO [mgyL] DH [mg / L] T [t] Alkaline run R (Shoulders) 9.34 60 14.78 8.00 0.163 20.7
依表1,可了解注目於以溶存氫計所計測之溶存氫濃 度(DH)時,使用還原電位水生成裝置進行1次電解處理後 之第1還原電位水不僅可將電解處理後之水即時取出,亦 可使達0.425〜0.900(mg/L)之高濃度氫溶存在其中。 又,可了解處理時間設定為3 0分時,比較原還原電位 水生成裝置中循環電解還原電位水(第2還原電位水)與氫 氣體氣泡水之溶存氫濃度,相對於後者為 0.89〜1.0 90 (mg/L),前者可溶存達 1.157〜1.374(mg/L)之According to Table 1, it can be understood that when the dissolved hydrogen concentration (DH) measured by the dissolved hydrogen meter is used, the first reduced potential water after the electrolytic treatment using the reduced potential water generating device for one time can not only immediately effect the electrolytic treated water. It can also be dissolved in high concentration hydrogen up to 0.425 ~ 0.900 (mg / L). In addition, it can be understood that when the processing time is set to 30 minutes, the dissolved hydrogen concentration of the circulating electrolytic reduction potential water (second reduction potential water) and the hydrogen gas bubble water in the original reduction potential water generating device is compared with 0.89 to 1.0 relative to the latter. 90 (mg / L), the former can be dissolved up to 1.157 ~ 1.374 (mg / L)
2030-5943-PF(Nl);Chiumeow.ptd 第17頁 200413503 五、發明說明(15) 南激度氫。 但,氫溶存水中較佳為依需要添加擇自 鹽、硫代硫酸鹽、抗壞血酸、抗壞血酸鹽之群中至小L ^ 還原劑。其原因為欲預防催化劑所產生 二:種 而快速氧化時,以儘量使氯溶存水中之溶存㈡:存: (氫溶存水中之溶存氧濃度為2mg/i以下,丨.5 ^較佳 l^y/1以下,〇· 5mg/l以下,0mg/1以下,依序以愈少愈 若對此進-步說明,若使催化劑作用之氫溶存 加:不到恰使溶存氧可還原之化學當量之還原劑時走 溶存氧濃度(D0)(mg/L)下降到幾乎為〇(mg/L)。 吏 在未使催化劑作用之氫溶存水中加入同樣量之 作為比較例者不會使溶存氧濃度D0(mg/L)下多’。、此 推測是因封印被解放之氫溶存水原本具有之夕= 劑具有之還原力更被強力引出的原故。 還原 附帶提出’若將本發明之抗氧化機能水與還原劑或2030-5943-PF (Nl); Chiumeow.ptd p. 17 200413503 V. Description of the invention (15) South-excited hydrogen. However, it is preferable to add a medium-to-small L ^ reducing agent selected from the group consisting of salt, thiosulfate, ascorbic acid, and ascorbate in hydrogen-soluble water as needed. The reason for this is to prevent the catalyst from producing two kinds: rapid oxidation, so as to make the dissolved chlorine in water as much as possible. Storage: (The dissolved oxygen concentration in hydrogen-soluble water is less than 2mg / i, 丨. 5 ^ preferably l ^ y / 1 or less, 0.5 mg / l or less, 0 mg / 1 or less, in order, the less the more the more, if this is further explained, if the hydrogen function of the catalyst is added: less than the chemistry that just reduces the dissolved oxygen When the equivalent amount of reducing agent is removed, the dissolved oxygen concentration (D0) (mg / L) drops to almost 0 (mg / L). Adding the same amount of hydrogen dissolved water that has not acted on the catalyst as a comparative example will not cause dissolution. The oxygen concentration D0 (mg / L) is much lower. ”This is speculated to be due to the fact that the sealed liberated hydrogen dissolved water originally had = the reducing power possessed by the agent was more powerfully drawn out. The reduction was accompanied by the statement 'If the present invention Antioxidant water and reducing agent or
共存狀態下裝在瓶中時,添加物在 ;抗巩化衣兄下之、纟σ果,可將添加物原本所具有之抗 η用更強?丨出。意#,若將本發明抗氧 原,t壞血酸於共存狀態裝在瓶中時,抗壞血酸因在抗氧 匕::::可持續其還原態’故還原型抗壞血酸 ,化作用可被更強力引出。此情形下,添加量以僅UWhen co-existing in the bottle, the additive is under the anti-sclerosis agent, can the additive η have a stronger resistance?丨 Out. Yi #, if the ascorbic acid and t-ascorbic acid of the present invention are packed in a bottle in a coexisting state, the ascorbic acid can be reduced in the anti-oxidant :::: to sustain its reduced state, so the reductive ascorbic acid can be changed Pull out forcefully. In this case, the amount added is only U
Si等還原劑將共存系内之溶存氧等氧化物進 ’、σ為彳。惟,抗壞血酸之添加量以考慮抗氧化機 第18頁 2030-5943-PF(Nl);Chiumeow.ptd 200413503 五、發明說明(16) 能水所呈現之pH或每日建議攝取之下限量等 2 · 1 · 2催化劑 催化劑總括為具有對前述氯溶存水中所含 ^子狀氫進行分解為生成物活性氳反應之催化 I7本毛明之催化機能本質為圓滑的促進分子 =,該機能包含由分子氫取得電子(藉使i個分 =,得到2個電子;h2—2e-詹)及將所取得之 =後(包含吸附或吸藏於催化劑之概念),或者 提供,抗氧化對象。又,供給抗氧化對象電子 使在氧化態之抗氧化對象本身還原的情形,以 抗氧化之抗氧化對象氧化,而將活性氧類等氧 還原的情形兩者。 本發明催化劑之技術範圍包括例如氫氧化 進一步言之,有含氫激酶、次述貴金屬膠體, 可見光、紫外線、電子線之群中至少一種電磁 本發明中所推想之貴金屬膠體概念包含鉑、鈀 釕、金、銀、銖及該等貴金屬元素之鹽、合金 化合物等之膠體粒子本身及該等之混合物。在 相關貴金屬膠體時,可參照記載内容取材在本 之,難波征太郎、大倉一郎兩人所作「鉑膠體 用法」、表面ν〇1· 21Νο· 8 ( 1 983 )記載之内容即 發明所說之膠體係一般本質舉動顯示為膠體, 度添加為 ‘作為基質之 *機能者。 狀氫之活 子狀氯活 電子暫時偶 不偶合,以 之概念包含 及為使用於 化物質本身 還原酵素, 或擇自包含 波等。又, 、铑、銥、 化合物、錯 製造或使用 申請發明 之作法與使 可。又,本 推測係直徑 為貴金屬膠 1 nm〜0 · 5 “ m範圍之粒子者。惟,採用鉑膠體作Reducing agents such as Si add oxides such as dissolved oxygen in the coexisting system, and σ is 彳. However, the amount of ascorbic acid is added in consideration of the antioxidant machine. Page 18 2030-5943-PF (Nl); Chiumeow.ptd 200413503 V. Description of the invention (16) The pH value of the water or the lower limit of the recommended daily intake, etc. 2 · 1 · 2 catalyst The catalyst is a catalyst that has the activity to decompose the ^ -like hydrogen contained in the chlorine-soluble water into the product. The catalyst's catalytic function is essentially a smooth promoting molecule =. This function contains molecular hydrogen. Obtain electrons (if i points =, get 2 electrons; h2-2e-Zhan) and after the obtained = (including the concept of adsorption or storage in the catalyst), or provide, anti-oxidation object. In addition, in the case where the oxidation target electron is supplied to reduce the oxidation target itself in the oxidation state, the oxidation target is oxidized and the oxygen such as active oxygen is reduced. The technical scope of the catalyst of the present invention includes, for example, hydroxide. In addition, there are at least one kind of electromagnetism including hydrogen-containing kinase, secondary precious metal colloids, visible light, ultraviolet rays, and electron beams. The concept of precious metal colloids conceived in the present invention includes platinum, palladium and ruthenium. , Colloidal particles of gold, silver, baht, and salts of these precious metal elements, alloy compounds, etc., and mixtures of these. Regarding colloids of precious metals, you can refer to the contents of the record for the original materials. The contents of "Platinum Colloid Usage" and the surface ν〇1 · 21Νο · 8 (1 983) made by Namba Seitaro and Okura Ichiro are the gels mentioned in the invention. The general nature of the system is shown as a colloid, and the degree of addition is regarded as the function of the matrix. The hydrogen-like activity, the child-like chlorine activity, and the electrons are temporarily uncoupled. The concept is to include and reduce enzymes used in the chemical substance itself, or to choose self-contained waves. In addition, Rhodium, Rhodium, Iridium, Compounds, and other methods and applications for making or using the invention. In addition, it is estimated that the diameter is a particle in the range of 1 nm to 0. 5 "m of precious metal colloid. However, platinum colloid is used as the particle.
2030-5943-PF(Nl);Chiume〇w.ptd 第19頁 200413503 五、發明說明(17) 體日:’為使該鉬谬體之催化活性提高,粒子 在論文「Kit 如上述難波等 盾女糾衍,> 體作法與使用法」中記載,為發捏主厶居 所導出之粒:催m高以爭取表面積,在取捨;係下 ..仏。且’本發明所說之膠體德國之殊挞丁故士 ^出。 。再者,本發明之貴金屬膠體為爭取表面積,盆位^ m為佳。此係因貴金屬膠體表面積大_,與:: 機i展i之f虱接觸機會會增加,對以貴金屬膠體之催化 機此展現之觀點看來是有利的。 益機催化劑範圍包含輔助其自身作用之輔酶、 …、 口物、有機化合物等電子傳遞物質在内。 2 · 1 · 2 · 1電子傳遞物質之候選者 尸〆3電子傳遞物質較佳為例如為電子提供者,可由氫、 氫^化還原酵素氫激酶、或貴金屬膠體圓滑的接受電子, :ΐ ΐ有將收到之電子對作為電子受容體之抗氧化對象圓 /月、’之性質。簡單的說,電子傳遞物質之 子)之運送屋。 ~ % 以下’列舉電子傳遞物質之候選者。又,雖不論電子 傳遞物質為氧化型或還原型,但還原型之電子傳遞物質因 為預先帶有多餘電子,故在更容易放出電子這一點可說是 有利的。 (a)亞甲藍(methyiene biue,通常為氧化型) 甲基硫僅氯化物、四甲基硫僅氯化物2030-5943-PF (Nl); Chiume〇w.ptd Page 19 200413503 V. Description of the invention (17) Body day: 'In order to improve the catalytic activity of the molybdenum molybdenum body, the particles in the paper "Kit such as the above Namba and other shields Female Entanglement, > Physical Practice and Use Method, "records the grains derived from the main residence of the hairpin: urge m high to fight for surface area, in the choice; And ‘the colloidal German special tarts’ as referred to in the present invention. . Furthermore, the precious metal colloid of the present invention strives for surface area, and the basin position is better. This is because the precious metal colloid has a large surface area, and the chances of contact with the lice will increase, which is beneficial to the view expressed by the precious metal colloid catalyst. The range of beneficial organic catalysts includes electron transfer substances such as coenzymes, ..., substances, organic compounds that assist its own function. 2 · 1 · 2 · 1 Candidate for electron transfer material 3 Electron transfer material is preferably, for example, an electron provider, and can smoothly accept electrons by hydrogen, hydrogen reduction enzyme hydrogen kinase, or noble metal colloids: ΐ ΐ The received electron pair has the properties of a circle / month and an oxidation target of the electron acceptor. Simply put, the transport house of the son of an electron-transporting substance. ~% Below 'lists the candidates for electron-transporting substances. In addition, although the electron-transporting substance is oxidized or reduced, the reduced-type electron-transporting substance is advantageous because it has extra electrons in advance, so that it is easier to emit electrons. (a) Methylene blue (methyiene biue (usually oxidized)) methyl sulfur chloride only, tetramethyl sulfur chloride only
2030-5943-PF(Nl);Chiumeow.ptd 第20頁 200413503 五、發明說明(18) 化學式= C16H18C1N3S · 3(H20) 還原型亞甲藍指無色亞甲藍。 (b) 綠膿菌素(Pyocyanin) 化學式= C13H1QN2。。 為綠膿菌(Pseudomonas aeruginosa)所產4抗生物皙 之-種。綠膿菌素可進行可逆性的氧化還= 有驗性下呈現藍色及酸性下呈現紅色2種。又,其還原型 和還原型亞甲藍(無色亞甲藍)均為無色。 〃 (c) 硫酸吩嚷甲醋(phenazine methosulfate) 略稱·· PMS。 化學式= C14H14N2G04S。 硫酸吩嗪甲酯有易光分解之傾向。2030-5943-PF (Nl); Chiumeow.ptd Page 20 200413503 V. Description of the invention (18) Chemical formula = C16H18C1N3S · 3 (H20) Reduced methylene blue refers to colorless methylene blue. (b) Pyocyanin chemical formula = C13H1QN2. . It is a 4-antibiotic-species produced by Pseudomonas aeruginosa. Pyocyanin can be reversibly oxidized = two colors are blue under test and red under acid. The reduced and reduced methylene blue (colorless methylene blue) are both colorless. (C) Phenazine methosulfate is abbreviated as PMS. Chemical formula = C14H14N2G04S. Phenazine methyl sulfate has a tendency to be easily photodecomposed.
(d)l-甲氧基PMS 被開發作為上述光不安定性PMS之代替品,對光為安 定的。 — (e )含鐵(I I I )離子化合物 /例如,有FeCl3、Fe2(S04)3、Fe(0H)3等多種。原本目 的係作為使鐵(III)離子Fe( + 3)離子化之試藥。在生體中 被認為存在於紅血球血紅素之血基質鐵。又,血基⑽愈 獨立之鐵離子性質不同。 、' ^、 特別疋在體外下若與抗壞血酸共軛化,會生成氧化力 強之羥基游離基(· 〇H),故並不是只要是鐵離子就可以。 但,在體内,若鐵離子與一氧化氮(N〇)共存,則 會生成羥基游離基(· 0H)。 、π f亚不(d) l-methoxy PMS was developed as a substitute for the photo-labile PMS described above and is stable to light. — (E) Iron-containing (I I I) ionic compounds / For example, there are various kinds of FeCl3, Fe2 (S04) 3, Fe (0H) 3 and the like. The original system was used as a reagent for ionizing Fe (+3) ion. Blood matrix iron that is thought to be present in red blood cells in heme. In addition, the properties of the iron ions that are different from each other in the blood-based group are different. In particular, if conjugated with ascorbic acid in vitro and in vitro, hydroxyl radicals (· OH) with strong oxidizing power will be generated, so it is not necessary only to be iron ions. However, in the body, if iron ions coexist with nitric oxide (NO), hydroxyl radicals (· 0H) are formed. F
200413503 五、發明說明(19) 甘 特別是2價鐵Fe(2 + )為3價鐵Fe(3 + )之還原型,但雖然 疋還原型仍時常會使氧化作用亢進。特別是過氧化脂質存 在時’很容易產生游離基連封印反應。鐵(丨j丨)Fe(3 + )因 k壞血酸被還原時,是過氧化脂質存在時,會產生游離基 生成連封印反應。即,會生成多數脂質游離基,推測對生 體會造成不利影響。 (Ο還原型抗壞血酸(化學式=(:6118〇6) 存在於生體中’但是是由體外吸收的,人體不會合 成。 (g) 麵胱甘肽(化學式ciqHi7N3〇6S) 為生體内存在很多之SH化合物,推測人類亦具有合成 此物I之基因。為3個胺基酸(谷胺酸—半胱胺酸—甘胺酸 = Glu-Cys-Gly)所構成之多肽,為乙二醛酵素之輔酶,且 土知有作為細胞内還原劑、抗老化劑等機能…麵胱甘 肽具有使氧(〇2 )直接(非酵素性)還原之機 (h) 半胱胺酸(Cys) 八解ί Γ ί ί :種’為SH化合物,是攝取蛋白質並消化 為上述穀胱甘肽之構成要素,且為具 八別i t:馱盾其如同穀胱甘肽,當兩個半胱胺酸Cys 刀另】放出一個虱原子以雙硫鍵(一s—s—)結合 型半胱胺酸。 卞㈢办风虱化 (i) 苯甲酸(C7H6 02 ) A太不存在,但草莓類中含有約〇.05%左右。 基本上為還原具有將經基游離基以非酵素性且有效消200413503 V. Description of the invention (19) Gan In particular, the divalent iron Fe (2+) is a reduced form of the trivalent iron Fe (3+), but although the tritium reduced form still often causes oxidation to be excessive. Especially in the presence of a lipid peroxide, a radical-linked seal reaction is liable to occur. When iron (丨 j 丨) Fe (3 +) is reduced due to k ascorbic acid, it is the presence of a peroxidized lipid that generates radicals and forms a continuous seal reaction. That is, many lipid free radicals are generated, which is presumed to have an adverse effect on the body. (〇 reduced ascorbic acid (chemical formula = (: 6118〇6) exists in the living body 'but is absorbed in vitro, the human body does not synthesize.) (G) glutathione (chemical formula ciqHi7N306) is present in vivo Many SH compounds, it is speculated that humans also have a gene to synthesize this substance I. It is a polypeptide composed of 3 amino acids (glutamine-cysteine-glycine = Glu-Cys-Gly), which is ethylene glycol. Coenzyme of aldehyde enzyme, and it is known to function as intracellular reducing agent, anti-aging agent, etc. Facial glutathione has a mechanism for direct (non-enzymatic) reduction of oxygen (〇2) (h) Cysteine (Cys ) Eight solutions Γ Γ ί: Species are SH compounds, which are components that ingest protein and digest into the above-mentioned glutathione, and have eight distinct it: it is like glutathione, when two cysteine Cys knife also releases a lice atom with a disulfide bond (one s—s—) binding type cysteine. How to deal with wind lice (i) Benzoic acid (C7H6 02) A is too absent, but strawberry It contains about 0.05%. Basically, it has a non-enzymatic and effective digestion of free radicals.
200413503 五、發明說明(20) 去轉變為水的機能。 (j)對胺基苯曱酸(C7H7N〇2) (1〇沒食子酸((:7116〇5)(3,4,5一三羥基苯甲酸) 廣泛存在於植物之葉、莖、根等,一般作 食品用抗氧化劑(食品添加物)使用。其鹼性水 特別強。易與氧反應的傾向。 又,此處所舉例之催化劑僅為起碼之例示 於此。故應了解,本發明所假設之催化反應並 以/JEL度、超音波或授拌等物理性外力等其他參 又,附帶一提,生成物活性氫之概念包含 (H·)及氫化物離子(Hydride,η-)在内。 再者,如此處所述之催化劑可個別單獨使 :二’適度的組合複數使用。基本上,係 二匕劑:抗氧化對象之順序進行電子傳達,但除 又以虱溶存水—酵素(氯激酶)—抗氧化 水—電子傳遞物質—抗氧化 、 酶)-電子傳遞物質對象,、虱溶存水- Γ抗“對象,或氫溶存水= =了抗軋化對象等之順序進行電 ,又 達糸,亦可將擇自包含可見朵此專遞 至少一種電磁波組合以使用。、外線、電子 2 · 1 · 3抗氧化對象 抗氧化對象總括為可防 態’或欲防止氧化之對象物、:二乏所引 又,此處所說之 為止血劑或 溶液還原力 ,並非限定 未排除例如 數。 原子狀氫 用,亦可依 溶存水^催 此之外,亦 象、氫溶存 酵素(氫激 *貴金屬膠 電子傳遞物 對該電子傳 射線之群中 起之氧化狀 氣化係指因 200413503 五、發明說明(21) 為氧、熱、光、pH、離子等直接或間接作用使從對象物取 走電子之現象。且,本發明技術範圍内之抗氧化對象具體 上,例如,有生體細胞,或在工業用洗淨、食品洗淨/乃至 精密洗淨等各產業領域中之被洗淨對象物,及維生素等抗 氧化物質、食品、準醫藥品、醫藥品、化粧品 '、飼料、^ 述氧化還原色素、及水本身等。又,在此所列舉之抗 對象僅為最起碼之例示,應先了解並非限定於此。 少其次,由催化劑之觀點討論催化劑與抗氧化對象之關 係。 荆 本發明係催化氫溶存水中所含之分子狀氫基質分 生成物活性氫之反應,催化劑例如有氫氧化 二 激酶,或貴金屬膠體。 疋眾醉常、虱 尸現在,考慮在還原電位水中添加氫氧化還原 如虱激,者(即’添加氫激酶之抗氧化機能:、例如二 用添加虱激酶於弱鹼性之還原電位水時,若 在飲 系統生體細胞(抗氧化對象)有共存活性氧等化器 上該等氧化劑就會被還原。又,丘 剑時,馬 加物(抗氧化對象)時,還原電位水 _之條,下,會作為該等添加物之抗 在有風激 推測為還原電位水中所溶存 乍用機轉 ,用會解離為2個原子狀二之; 狀風(H .)在水之存在下分成質子與電子,生成之原子 子會提供給抗氧化對象。此處,電子 生之電 之概念包含使氧化態之抗氧化對象本身還:以化=200413503 V. Description of invention (20) The function of turning into water. (j) p-aminobenzoic acid (C7H7NO2) (10 gallic acid ((: 7116605) (3,4,5-trihydroxybenzoic acid) is widely present in the leaves, stems and roots of plants It is generally used as a food antioxidant (food additive). Its alkaline water is particularly strong. It tends to react with oxygen. Moreover, the catalysts exemplified here are only a few examples. Therefore, it should be understood that the present invention The hypothetical catalytic reaction includes other parameters such as physical external forces such as / JEL degree, ultrasound, or mixing. In addition, the concept of the product active hydrogen includes (H ·) and hydride ion (Hydride, η-). In addition, the catalysts described herein can be used individually and individually: a moderate combination of two or more. Basically, they are two daggers: the order of antioxidant objects is electronically communicated, but in addition to lice dissolved water— Enzyme (chlorokinase) -antioxidant water-electron transfer substance-antioxidant, enzyme) -electron transfer substance object, lice soluble water-Γ anti "object, or hydrogen soluble water = = anti-rolling object, etc. Electricity, up to 糸, can also choose to self-contain visible flowers at least one Use of electromagnetic waves in combination. External lines, electronics 2 · 1 · 3 Anti-oxidation objects Anti-oxidation objects are collectively anti-oxidants or anti-oxidation objects. The reducing power is not limited but is not excluded. For example, atomic hydrogen can also be used to dissolve it in addition to water. It is also similar to hydrogen-dissolving enzymes (hydrogen-stimulated * noble metal colloid electron transporters that start from the group of electron-transmitting rays). Oxidation-like gasification refers to the phenomenon in which electrons are removed from an object due to direct or indirect effects of oxygen, heat, light, pH, ions, etc. due to 200413503 V. Invention Description (21). Specifically, the oxidation target includes, for example, biological cells, objects to be cleaned in various industrial fields such as industrial cleaning, food cleaning, and even precision cleaning, and antioxidants such as vitamins, foods, and quasi-medicines. Products, pharmaceuticals, cosmetics, feeds, redox pigments, and water itself, etc. The resistance objects listed here are only the minimum examples, and it should be understood that they are not limited to this. Less second From the viewpoint of catalysts, the relationship between catalysts and antioxidants is discussed. The present invention is a catalyst that catalyzes the reaction of active hydrogen in the molecular hydrogen matrix product contained in hydrogen-dissolved water. Examples of the catalyst include hydroxide dikinase or precious metal colloids. Drunk often, corpses now consider adding hydroxide reduction to reducing potential water such as lice, (ie, the antioxidant function of adding hydrogen kinase: for example, when using lice kinase in weakly alkaline reducing potential water, These oxidants will be reduced on the co-survival oxygen equalizers of the drinking cells (antioxidants). When Qiu Jian, Ma Jiawu (antioxidants), the reduction potential water is reduced, In the presence of water, it will be used as the resistance of these additives to be dissolved in water which is estimated to be a reduction potential. It will dissociate into two atomic two; the wind (H.) is divided into protons in the presence of water. With electrons, the generated atomic atoms will be provided to the antioxidant object. Here, the concept of electron-generated electricity includes making the oxidation-resistant object itself:
2030-5943-PF(Nl);Chiumeow.ptd ίη "ϊ 24 頁'"-------2030-5943-PF (Nl); Chiumeow.ptd ίη " ϊ page 24 '" -------
SL 赞明說明(22) 為使用於抗氧化之於& 物質本身還原的情形:^對象氧化,而將活性氧類等氧化 mί二t慮還原電位水中添加貴金屬狀辦m人士 (Pt)或鈀(Pd)之膠體粒 金屬膠體,例如含有鉑 之抗氧化機能水)。例 1 p,添加貴金屬膠體催化劑 體之弱驗性還原電位水°時飲用含有翻(⑴或把⑽膠 (抗氧化對象)若有共存活性以;器ί統生體細胞 就會被還原。又,丑在古I^,虱化4,馬上該等氧化劑 (抗氧化對象)時,還原水二類等之其他添加物 測為還原電位水中所溶存之分化劑。作用機轉推 並活化同時解離為2個原子狀氫(H .) 成質子與電之原子狀氫(Η.)在水之存在下會分 處,電子被提供时,生之電子會提供給抗氧化對象。此 =本身還原的情形’以及為使用於抗氧化之抗氧化對 象乳:二,將活性氧類等氧化物質本身還原的情形兩者。 催化;:乳1匕機能是綜合如還原電位水之氫溶存水及作為 催化Μ之風虱化還原酵素氫激酶或貴金屬膠體,及消化器 t體細胞等抗氧化對象三者才展現的。換言之,僅在必要 時j現還原力,在不需要時則不會發揮任何作用。且,在 注意其化學成分組成時’例如’還原電位水只不過是將原 水電解所得到之普通水。故,可強調即使在展現還原力之 後,也仍然是普通水,對生體不會有任何不利影變。換古SL clarified that (22) is used for the case where the antioxidant itself is reduced: ^ the target is oxidized, and the active oxygen is oxidized and the reduction potential water is added with a precious metal (Pt) or Colloidal metal colloids of palladium (Pd), such as antioxidant-containing water containing platinum). Example 1 p, the weakly demonstrative reduction potential water of the noble metal colloid catalyst body is added when drinking water containing peptone (or pectin (antioxidant object) if there is co-viability; the whole body cells will be reduced. Ugly in ancient times, lice 4, immediately when the oxidants (antioxidants), other additives such as reduced water and so on were measured as differentiating agents dissolved in the reduction potential water. The action mechanism was reversed and activated while dissociating It is 2 atomic hydrogens (H.). Protons and electricity are separated into atomic hydrogens (Η.) In the presence of water. When electrons are provided, the generated electrons are provided to the antioxidant object. This = itself reduction The situation 'and the antioxidant milk used for antioxidation: two, the case of reducing oxidizing substances such as active oxygen itself. Catalysis ;: Milk 1 can function as a hydrogen-soluble water such as reducing potential water and as Antioxidant objects such as catalase-reducing enzyme hydrogen kinase or noble metal colloid that catalyzes M, and digestive organ somatic cells are exhibited. In other words, the reducing power is only displayed when necessary, and it will not exert any effect when it is not needed. Role, and pay attention to its When studying the composition of ingredients, for example, reducing potential water is just ordinary water obtained by electrolysis of raw water. Therefore, it can be emphasized that even after showing reducing power, it is still ordinary water, and it will not have any adverse effect on the living body. Change the old
2030-5943-PF(Nl);Chiumeow.ptd 第25頁 2004135032030-5943-PF (Nl); Chiumeow.ptd p. 25 200413503
之,可知到目標之正作用,但是負的作用,即所謂副作用 元全不存在14 一點,是與先前之抗氧化劑或活性氧消去 之關鍵性差異。 此處’ ^丨用京都大學研究所理學研究科副教授樋口芳 樹之論文「氫氧化還原酵素之X線構造化學」(Spring — 8In other words, it can be seen that the positive effect of the target, but the negative effect, that is, the so-called side effect element does not exist at all, is a key difference from the elimination of previous antioxidants or active oxygen. Here ’s ^ ^ The paper "The X-ray Structural Chemistry of Hydroxyl Reductive Enzymes" (Spring — 8
Information/ V〇l,4 Νο·4 JULY 1999)。該學者發表了Information / Vol. 4 No. 4 JULY 1999). The scholar published
氫氧化還原酵素被稱為氳激酶,為一種廣泛見於細菌之 蛋白質。一般為具有鐵、鎳等金屬之蛋白質,但最近發現 70全不具有該等金屬之新穎氫激酶。該分子被用於使氫分 解所生成之電子圓滑的進行菌體内之各種氧化還原反應。 又’因直接支配細胞膜表層上膜内外之質子濃度比例,被 認為擔當與ATP合成分解酵素有關之細菌内代謝系之重要 作用」之研究成果。該學者又在別的論文r使用放射光以 多波長異常分散法進行氫激酶之X線結晶構造解析」中, 發表「生物為得到能量所進行一連串反應系之中心酵素為 ATP合成分解酵素。為使該酵素活化已知需控制細胞膜内 外之質子濃度比例。氫激酶具有使細胞膜表層存在之膜蛋 白質上膜周邊分子狀氫之氧化還原催化之作用。即,該氫 激酶直接支配膜内外之質子濃度比例,並控制ATP合成分 解酵素之作用。因此,氫激酶具有使生物能量代謝系圓滑 進行之重要功能之可能性。了解氫激酶立體結構具有解明 生命維持機制中最重要之能量代謝其相關部分構造與機能 關係之重大意義」之研究成果。 本發明人等對於「氫激酶直接支配膜内外之質子濃度Hydrogen-reducing enzymes are called prion kinases and are a protein widely found in bacteria. Generally it is a protein with metals such as iron and nickel, but it has recently been discovered that 70 of these novel hydrogen kinases do not have these metals. This molecule is used to make the electrons generated by the hydrogen decomposition smoothly perform various redox reactions in the bacteria. And because it directly controls the ratio of the proton concentration inside and outside the cell membrane surface, it is considered to play an important role in the metabolic system of bacteria related to ATP synthesis and degradation enzymes ". In another thesis, the scholar also used radiation to analyze the X-ray crystal structure of hydrogen kinase using a multi-wavelength anomalous dispersion method, and published "The central enzyme in a series of reaction systems for biological energy to obtain energy is the ATP synthesis and degradation enzyme." To activate this enzyme, it is known that the ratio of proton concentration inside and outside the cell membrane needs to be controlled. Hydrogen kinase has the role of redox catalysis of the molecular hydrogen around the membrane protein existing on the surface of the cell membrane. That is, the hydrogen kinase directly controls the concentration of protons inside and outside the membrane. Ratio, and control the role of ATP synthesis and degradation enzymes. Therefore, the hydrogen kinase has the possibility to make the biological energy metabolism smooth and important function. Understanding the three-dimensional structure of the hydrogen kinase has the structure of the most important energy metabolism in the life maintenance mechanism to understand the relevant parts of the structure The significance of the relationship with function ". The inventors have stated that "hydrogen kinase directly controls the proton concentration inside and outside the membrane.
2030-5943-PF(Nl);Chiumeow.ptd 第26頁 200413503 五、發明說明(24) 比例,並控制ATP合成分解酵素之 卜 特Γί意。因為氫激酶對生物期待有效果可“因 广合細胞級所展現之抗氧化機能體 質子漠度比例改善而使能量代謝系圓滑促進的佐^待攸 ^此’本發明之氳氧化還原酵素、氫激酶或貴 =„為對與單球/巨噬細胞機能相關或引起之疾患屬,> ί 幾能宄進或低下有關或引起之: ;之醫藥:::二::障害或病態之預…善或治療 可也t,| ?藥品之具體例如下。#,-般而言,水因具有 :速到達脂質膜:細胞膜或血腦障壁等生體所有部位之 貝可活性氧而損傷之生體部位,透過注射、點 1巧等操作將氫氧化還原酵素氫激酶或貴金屬膠體傲 j…-起或分別送入,以期待該損傷部位之治癒效一 此,,氫氧化還原酵素氫激酶為蛋白質,假設將其對 合恭=Γ傷"卩位以注射、點滴、透析等操作送入時,可能 i 1 ^ ,之免疫機構辨識該酵素非自我而引發抗原抗體 六μ,問題。為解決此問題,只要將生體所具有之經口寬 奋^原理應用於臨床即可。經口寬容係指對於以經口 /經 =仏^之外來抗原所誘導之抗原特異性τ/Β細胞不具反應 性。簡單的說,由口所攝取之物質即使是可成為抗原之蛋 第27頁 2030-5943-PF(Nl);Chiumeow.ptd 200413503 五、發明說明(25) 白質,只要是由小腸吸收則對該物質會成立免疫寬容,此 現象稱為經口寬容,此原理已嘗試應用於治療。透過將經 口寬容之原理作臨床應用,推測應可開啟抗氧化之新治療 戰略。 ^ 2 · 2抗氧化機能水及其用途 依本發明,提供一種抗氧化機能水,其特徵為:一種 含有催化劑氫氧化還原酵素(惟,除去預先存在於生體内 者)或貴金屬膠體於氫溶存水所形成之水,可促進以該氫 溶存水中含有之分子狀氫作為基質形成生成物活性氫X之里分 解反應,利用前觸催化劑所催化的分解反應,可將由於缺 i:::ί成之氧化狀態或欲防止氧化之抗氧化對象能夠 运原到電子充足的狀態。 採,該組成之抗氧化機能水因含有本發明中重 ’争,虱溶存水及催化劑,故之後只要可遇到抗氧化對 象,氫潛在具有之還原力其封印 J <匕對 特有之抗4仆據& & +玎p j被解放,並展現本發明 = Γ 處,電子被提供給抗氧化對象之概 念包含使氧化態之抗氧化對象 =化對象之概 用於抗氧化之抗氧化4 還原㈤it形’以及為使 本身遏原的情形兩者。,乳頰寻虱化物質 以士 ί二若將採用上述組成之抗氧化機能水供μ田廿 以大腸設為抗氧化對象時 ::上供於飲用,並 力已幾乎被釋放,則合右11=大腸以則右虱潛在之還原 因此,對於作為;f法達成原本目標的問題。 貴金屬膠體,較佳為要劑之氫氧化還原酵素、氫激酶或 為要進行調整該催化劑反應時間之處理 第28頁 2030.5943-PF(Nl);Chlumeow.ptd 200413503 五、發明說明(26) 或操作。 此處,調整該催化劑反應時間之處理或操作例如第3 圖或第4圖所示,包含以氫激酶或貴金屬膠體到達小腸或 大腸等對象部位時使原本催化劑開始作用為目標,將氫 酶或貴金屬膠體封入腸溶性膠囊等之處理,或將含氫激酶 化機能水之溫度或pH調整在可抑制使酵素氫激酶失活 章巳圍内之操作。又’氫激酶被認為最適 :显度左右…所有對氯激酶等或;9周左邊右^ 技整催化劑反應時間之處理或操作皆屬於本發明 本發明為一種為一種含有屬於催化劑之氫氧化還 、容存水’中之預广除去生體内存在者)或貴金屬膠體作用於氫 =^水中之水,可促進該氫溶存水中含有之分子 = 基質形成生成物活性氫之分解,人 飞作為 化劑促進前述反應,將由於缺乏;子所‘成用前$催 欲防止氧化之抗氧化對象能夠;:二狀態或 括飲用、注射用、點滴用、透析;:化為調製包 生體用途之生體適用液。斤用 粧用專各種使用於 滴用即透之J氧化機能水使用於注射用 '點 用於生體時,t要將本d直二液的態樣施 血液為等張滲透壓之生理t u抗虱化機此水pH s周製為約與 _.Η·8 較佳,以 例:二 • 5更佳)。此日守,滲透壓調製 200413503 五、發明說明(27) ' ---- 物質只要是生理可容許者即可,不特別限定,例如,可使 用各種電解質(例如納、鉀、的、鎮、辞、鐵、鋼、猛、 2、磷等無機成分的水溶性鹽類等)、葡萄糖、透明質酸 f :類、白蛋白等蛋白質、胺基酸等。又,pH調整劑只要 2理可容許者即τ ’不特別限^,例如,可使用各種有 =^、無機酸、有機驗、無機料,特別是以使用有機酸 =佳。有機酸例如可使用檸檬酸、乙酸、琥珀酸、葡萄糖 乳酸、蘋果酸mm無機酸可使 :例如鹽酸、磷酸等。另外,有機鹼可使用例如擰檬酸 、&、葡萄糖酸鈉、乳酸鈉、蘋果酸鈉、乙酸鈉、順丁烯二 酸鈉、丙二酸鈉等,無機鹼例如可使用氫氧化鉀金屬等。 再者,以改善生體,具體而言為患者症狀為目的時, ί添加各種電解質、胺基酸、高熱量成分、經腸營養 ^ 4藥液成分、維生素或抗生物質等藥劑成分以調製本發 明之抗氧化機能水,並作為輸液使用。又,各種電解質可 使用例如^、卸、辦、鎂、辞、鐵、銅、猛、峨、碟等無 $成分的水溶性鹽類等。又,胺基酸可使用例如必需胺基 酉欠、非必需胺基酸及/或該等胺基酸之鹽、酯或Ν—醯基 體。再者,高熱量成分例如可使用葡萄糖、果糖等單糖 或麥芽糖等雙糖類。 、 而’於本發明之抗氧化機能水中添加例如維生素c等 維生素類及胺基酸(良質蛋白質)之生體適用液被認為可期 待因具有如下的作用機轉而使生體免疫力活化。即,例如 維生素c等維生素類一方面與本發明之抗氧化機能水同樣2030-5943-PF (Nl); Chiumeow.ptd Page 26 200413503 V. Description of the invention (24) Proportion and control of ATP synthesis and decomposition enzymes. Because hydrogen kinase is expected to have an effect on organisms, it can be treated as "the proton indifference ratio of the antioxidant function body exhibited by the cognate cell level is improved, and the energy metabolism system is smoothly promoted." The 'redox enzyme of the present invention, Hydrokinase or expensive = "is a genus associated with or caused by the function of unispheres / macrophages, > ί is related to or caused by the invasion or inferiority of: ??? Medicine ::: two :: barrier or pathological Pre-treatment or treatment can also be t, |? Specific examples of drugs are as follows. # ,-In general, water has the following functions: quickly reach lipid membranes: cell membranes or blood-brain barriers and other parts of living organisms, which can be damaged by shellfish active oxygen. Hydrogen reduction can be achieved by injection, point counting, etc. Enzyme hydrogen kinase or precious metal colloids are sent separately or separately, in order to expect the healing effect of the damaged site. The hydrogen-reducing enzyme hydrogen kinase is a protein, and it is assumed that it is paired with Gong = Γ 伤 " When feeding by injection, drip, dialysis, etc., the immune mechanism of i 1 ^ may recognize that the enzyme is non-self and cause antigen and antibody six μ, which is a problem. In order to solve this problem, it is only necessary to apply the principle of leniency of the living body to the clinic. Oral tolerance refers to the non-reactivity to antigen-specific τ / B cells induced by oral / traumatic foreign antigens. To put it simply, even if the substance ingested by the mouth is an egg that can become an antigen. Page 27 2030-5943-PF (Nl); Chiumeow.ptd 200413503 V. Description of the invention (25) White matter, as long as it is absorbed by the small intestine Substances can establish immune tolerance. This phenomenon is called oral tolerance, and this principle has been tried to apply to treatment. Through the clinical application of the principle of oral tolerance, it is speculated that a new treatment strategy for antioxidants should be opened. ^ 2 · Antioxidant Functional Water and Uses According to the present invention, an antioxidant functional water is provided, which is characterized in that it contains a catalyst hydroxide reduction enzyme (except for those pre-existing in the body) or noble metal colloid in hydrogen The water formed by the dissolved water can promote the decomposition reaction of the active hydrogen X formed by using the molecular hydrogen contained in the hydrogen-dissolved water as a substrate, and the decomposition reaction catalyzed by the front-contact catalyst can reduce the lack of i ::: The oxidized state or the anti-oxidation object to be prevented from being oxidized can be transported to a state with sufficient electrons. The anti-oxidant water of this composition contains the heavy water content of the present invention, lice dissolves water and catalyst, so as long as the antioxidant object can be encountered later, the hydrogen has the reducing power of its seal J < (4) According to & & + 玎 pj is liberated and the present invention = Γ, the concept that electrons are provided to the anti-oxidation object includes the oxidation state of the anti-oxidation object = the transformation object, which is used for anti-oxidation and anti-oxidation 4 Reduction of the ㈤it shape 'and the situation in order to keep itself in check. If you use the antioxidant function water of the above composition to supply μ field salamander with the large intestine as the object of oxidation: use it for drinking, and the force has almost been released, then close the right 11 = The large intestine is the potential reduction of the right lice. Therefore, for the problem of achieving the original goal as the f method. Precious metal colloids are preferably hydroxide reducing enzymes, hydrogen kinases, or treatments to adjust the reaction time of the catalyst. Page 28 2030.5943-PF (Nl); Chlumeow.ptd 200413503 V. Description of the invention (26) or operation . Here, the treatment or operation for adjusting the reaction time of the catalyst is shown in FIG. 3 or 4. For example, when a hydrogen kinase or a noble metal colloid reaches a target site such as a small intestine or a large intestine, the target of the original catalyst is started. Precious metal colloids are sealed in enteric capsules, or the temperature or pH of hydrogen-kinase-containing functional water is adjusted to prevent the enzyme hydrogen kinase from being deactivated. Also 'hydrokinase is considered to be the most suitable: about the degree of visibility ... all about chlorokinase, etc .; 9 weeks left and right ^ The treatment or operation of the catalyst reaction time belongs to the present invention. The present invention is a kind of Preservation of 'water in water' removes those present in the body) or the action of noble metal colloids on hydrogen = ^ water in water, which can promote the decomposition of molecules contained in the hydrogen-soluble water = matrix-forming products of active hydrogen. The chemical agent promotes the aforementioned reaction due to lack; the child's body can be used to prevent oxidation and prevent oxidation; the object can be used in two states, including drinking, injection, drip, and dialysis; Living body applicable fluid. Kind of make-up and makeup are specially used for dripping and transparent J-oxidizing function water for injection. When the point is used for a living body, t is to apply the blood of the straight two liquid state to the physiology of isotonic osmotic pressure. The anti-lice machine's pH s week system is about _.Η · 8 is better, for example: two • 5 is better). This day, osmotic pressure modulation 200413503 V. Description of the invention (27) '---- The substance is not particularly limited as long as it is physiologically tolerable. For example, various electrolytes (such as sodium, potassium, sodium, potassium, Water-soluble salts of inorganic components such as iron, steel, ferrite, phosphorus, etc.), glucose, hyaluronic acid f: class, proteins such as albumin, amino acids, etc. In addition, as long as the pH adjuster is tolerable, τ 'is not particularly limited. For example, various kinds of organic acids, inorganic acids, organic solvents, and inorganic materials can be used, and especially organic acids are preferred. As the organic acid, for example, citric acid, acetic acid, succinic acid, glucose, lactic acid, and malic acid can be used. For example, hydrochloric acid, phosphoric acid, and the like can be used. In addition, as the organic base, for example, citric acid, &, sodium gluconate, sodium lactate, sodium malate, sodium acetate, sodium maleate, sodium malonate, etc., and as the inorganic base, potassium hydroxide metal can be used. . In addition, for the purpose of improving the living body, specifically the symptoms of patients, add various electrolytes, amino acids, high-calorie ingredients, enteral nutrition ^ 4 medicinal solution ingredients, vitamins or antibiotics and other pharmaceutical ingredients to prepare this Invented the antioxidant function water, and used as an infusion. For the various electrolytes, for example, water-soluble salts such as 等, 卸, 办, 镁, 辞, 铁, 猛, 铜, 、, 峨, and 碟 can be used. Further, as the amino acid, for example, an essential amino acid, an optional amino acid, and / or a salt, an ester, or an N-fluorene group of the amino acid can be used. As the high-calorie component, for example, monosaccharides such as glucose and fructose, and disaccharides such as maltose can be used. It is considered that a biologically suitable liquid containing vitamins such as vitamin c and amino acids (good proteins) in the antioxidant function water of the present invention can be expected to activate biological immunity due to the following functions. That is, vitamins such as vitamin c are the same as the antioxidant functional water of the present invention.
200413503 五、發明說明(28) 具有游離基消去的活性,且具有負責生體代謝之生體酵素 (例如S0D、催化酶、麩胱甘肽過氧化酶、干擾素合成酶” 等)或干擾素(為一種糖與蛋白質構成的物質,具有免疫 力)合成或發揮原本機能之辅酶的作用。又,胺基酸(良質 蛋白質)具有作為生體酵素或干擾素原料的重要功能。、 在生體中若有某部位產生了多餘的(· 〇2_),此時,維 ,素C或維生素e等維生素類及s〇D、催化酶、麩胱甘肽過 乳化酶等生體酵素就會彼此合作,將(· 〇2_)消去。維生 C或^維生素E等維生素類在將(·〇2_)還原消去的過程中本身 會虱化,就不能發揮其包括作為輔酶之原來的功能。社果 會造成生體内生體酵素或干擾素等合成或原本的機能^ 退’而使免疫力降低。 c算維相Λ於本發明之抗氧化機能水’例如添加維生素 化機Λ Λ丄胺基酸(良質蛋白質)之生體適用液因抗氧 :1ίΐ::;(.〇2—),使維生素類其原本的作用包括輔 干擾幸可促進供應胺基酸來源之生體酵素或 :擾素專之&成或及原本機能,故可期待生體免疫力之活 機能::維生素類及胺基酸類之本發明抗氧化 之本i明本發明生體適用;夜、或含胺基酸類 給注二+生體、用液也因為可以抑制原本存在於生體内之 f生素類妁消耗,使維生素類可以專用於作用在其包人輔 = 功能,故可依此處所例示之作用機轉而使 第31頁 2030-5943-PF(Nl);Chiumeow.ptd 200413503 五、發明說明(29) -- 士 另一方面’使用貴金屬膠體作為催化劑適用於生體 =須擔保安全性。具體上,必須考慮包含貴金屬本身 =、f生毋丨生在内之生體親和性。對此,人即使攝取鉑或把也 幾乎可經由腎臟以尿的形式迅速排出,且其得到衛生署認 可為食品添加物(無添加量的規定),被認為不會產生生體 親=11的問題。另一須考慮之問題是,為使貴金屬膠體在 =氧化機能水中會安定且均—分散,彳能要添加某種分散 训。對此,例如,在飲用或化粧用時,可從有得到衛生署 可作為食品添加物者中適當選擇具有分散劑機能者。此 月:肪二:丄ί用於化粧品或醫藥品用途且低刺激性之蔗糖 曰ti乙烯基吡洛秦ρ)等為適用的。又,於抗 以作有薦糖脂肪酸酯或聚乙烯基吡嘻酮(pvp) 調整作^之广/志之、分散劑或保護膜(負有催化劑活性之 正用)之形成成分,係包含於申古主 # 整催化劑活柹》/ + c處士 σ月專利乾圍中用於調 性及/或反應時間的處理或操作的範圍内。 用發展。 ^愿在从下之產業領域中作應 第1為應用在醫學·藥學領域。 造以外之藥劑製程中之基水。又,亦U如’可作為輸液製 劑、腹膜灌流液劑、藥劑。再者,亦、y用在人工透析液 時移殖臟器之保存液(此時,較佳為、可作為生體臟器移殖 整)。藉此,可期待有對由活性氧弓丨私外進行滲透壓之調 防·治療、醫藥品副作用減輕、老a之各種疾病的預 保存性之效果。 防止、提高移殖臟器200413503 V. Description of the invention (28) It has the activity of eliminating radicals, and has the enzymes responsible for metabolism (such as SOD, catalytic enzyme, glutathione peroxidase, interferon synthase, etc.) or interferon (It is a substance composed of sugar and protein, which has immunity.) It synthesizes or exerts its original function as a coenzyme. In addition, amino acids (good proteins) have important functions as raw materials for enzymes or interferons in living organisms. If there is excess (· 〇2_) in a certain part of the body, at this time, vitamins such as vitamin C or vitamin e and biological enzymes such as soD, catalytic enzymes, and glutathione superemulsifying enzymes will mutually Cooperate to eliminate (· 〇2_). Vitamins such as vitamin C or vitamin E will lice themselves during the reduction and elimination of (· 〇2_), so they cannot perform their original functions including coenzyme. It will cause the synthesis or original function of organism enzymes or interferon in the living body or decrease its immunity and reduce the immunity. C Calculate the vitamin phase Λ in the antioxidant function water of the present invention, for example, add a vitaminizing machine Λ Λ amine Base acid White matter) is suitable for living organisms due to anti-oxidation: 1ίΐ :: ;; (.〇2—), so that the original role of vitamins includes co-interference, which can promote the supply of amino acid-derived biological enzymes or: interferon-specific & The original function can be expected, so you can expect the living function of biological immunity :: vitamins and amino acids of the present invention, the anti-oxidation of the present invention is applicable to the body of the present invention; night, or amino acid-containing injections The two + organisms and fluids can also suppress the consumption of f-biotin 妁 that originally existed in the body, so that the vitamins can be dedicated to its function of enclosing people, so it can be turned according to the action illustrated here. On the 31st page, 2030-5943-PF (Nl); Chiumeow.ptd 200413503 V. Description of the invention (29)-On the other hand, 'the use of precious metal colloids as catalysts is applicable to living bodies = safety must be guaranteed. Specifically, It is necessary to consider the biocompatibility of the precious metal itself, including the precious metal itself. For this reason, even if platinum is ingested or taken, it can be quickly excreted in the form of urine through the kidney, and it is approved by the Department of Health as a food supplement. (No requirement for added amount), considered not to The problem of biological affinity = 11. Another problem to be considered is that in order to make the noble metal colloid stable and uniform-dispersed in the oxidation function water, some dispersive training should be added. For this, for example, in drinking or For cosmetic use, those who have the function of a dispersant can be appropriately selected from those who can obtain food additives from the Department of Health. This month: Fat II: 丄 sucrose, which is used for cosmetics or pharmaceuticals, and has low irritation Pirocine ρ), etc. are applicable. In addition, it is recommended to be used as a recommended sugar fatty acid ester or polyvinylpyrrolidone (pvp), which can be adjusted as ^ Zhishi, dispersant or protective film (with a catalyst The constituents of the active use) are included in the scope of the treatment or operation of tonality and / or reaction time in the Shen Gu Zhu # catalyst activator "/ + c sigma patent month. Use development. ^ Want to respond to the following industrial fields The first is application in the field of medicine and pharmacy. Base water in non-pharmaceutical processes. In addition, as such, it can be used as an infusion preparation, a peritoneal perfusion solution, or a medicament. Furthermore, y is also used as a preservation solution for transplanting organs when it is used as an artificial dialysate (at this time, preferably, it can be transplanted as a living organ). Thereby, it is expected that the osmotic pressure can be controlled and treated privately by the active oxygen bow, the side effects of the medicine can be reduced, and the effects of pre-preservation of various diseases such as old age can be expected. Prevent and improve transplantation of organs
200413503200413503
防· 製程 為應用在皮膚組織 治療劑。例如,可用化所帶末之老化·退化之預 在製造化粧水之外其他化粧品之 中 機能食品之應用。例如 便 3為作為抗氧化食品 用在食材製造製程中。 料水Μ it::)水使用加工:料水外之應用。例〜,作為飲 瓶水楚:膏涼飲料等加工飲料水之基水使用。非寶特 染·劣化改盖、鮮产伴拉 示卓蜊·殺蟲劑引起之污 貨前之洗淨;。 例如,可作為蔬菜.水果在出 劣化Γ止可:用作/加工食品製造製程中抗氧化劑、品質 劑、污濁防止劑1臭劑、鮮度保持劑 叫之言,推測例如可作為347種食品添加 剤之代替劑使用。 若對含活性氧類游離基與氧化、老化、品質劣化、腐 貝=污濁、消臭及鮮度下降間的關連加以說明,活性氧類 游離基之表現被指摘為劣化機轉之重要因素之一。其結果 疋,含有活性氧類游離基會造成健康障害、發生疾病、生 理機能下降、美容外觀退化、商品價值降低、生產性下 降、增加生活自然負荷等嚴重傷害的問題。也為容易生病 不易治療使醫療成本增加、造成生產或流通等機會損失之 更高成本負擔之產業損失的,個原因之一。活性氧類有關 之車父佳例僅限於殺菌、消毒、漂白等例,在大部分的例子Anti-treatment process It is a therapeutic agent applied to skin tissue. For example, it can be used for the application of functional foods in the manufacture of cosmetics other than toners. For example, Ben 3 is used as an antioxidant food in the manufacturing process of food ingredients. Material water M it: :) Water processing: Application outside material water. Example ~, used as the base water of processed beverage water such as bottled water. Non-special dyeing, degrading and re-covering, fresh-producing contamination caused by clams, insecticides, washing before goods ;. For example, it can be used as a vegetable and a fruit to be degraded. It can be used as an antioxidant, quality agent, antifouling agent, odorant, and freshness-preserving agent in the manufacturing process of processed food. Use as a substitute for 剤. If the relationship between active oxygen-containing free radicals and oxidation, aging, quality deterioration, rot shellfish = fouling, deodorization and decline in freshness is explained, the performance of active oxygen-based radicals is cited as one of the important factors for the deterioration mechanism . As a result, the inclusion of active oxygen-based radicals can cause serious injuries such as health disorders, diseases, decreased physiological functions, degradation of cosmetic appearance, decreased product value, decreased productivity, and increased natural life load. It is also one of the reasons for the industrial loss caused by the susceptibility to illness, the difficulty of treatment, the increase of medical costs, and the loss of higher cost burdens such as opportunities for production or distribution. The best examples of car owners related to active oxygen are limited to sterilization, disinfection, bleaching, etc. In most cases
200413503 五、發明說明(31) 中活性氧類只會 性氧類之游離基 且低成本且應用 生體會曝露 之緊急jk液再循 上浮之肺氣腫等 活性氧類作為引 當生體在新 露於紫外線或放 屬接觸時、燒傷 正常狀態或不活 進一步游離化之 物或飼 不僅直 引發或 低且在 成生成 度增加 換 一點與 酵素反 生會使 而產生 若 料、煙之 接從該等 誘發生成 局部,但 後無法除 ’而產生 言之,活 氧化還原 應之損害 潛在生理 急速且大 以人類疾 帶來不 造成之 範圍廣 於急性 環、臟 較侷限 子,而 陳代謝 射線下 或被病 化狀態 許多機 霧、煤 物質直 活性氧 若生成 去之殘 上述例 性氧類 反應等 方式是 機能下 的損傷 病之個 好的影響。 各種產業上 泛的解決方 或多量活性 器移殖時、 的例子,在 造成廣範圍 過程或舊廢 時、與致癌 毒感染時、 之氧或含氧 會。又,曝 煙排氣氣體 接受到游離 類。即使初 超過了正常 留狀態時, 中之不好影 之生成與影 通常的化學 不同的。也 降或退化, 本發明係針對該等含活 的課題,提供最有效率 法。 氧類之例僅限於手術時 全身燒傷、潛水時I 大部分情形僅有少3 的危害。 物堆積、直射日光及曝 性及致變性物質或重金 切傷或細胞被破壞時, 化合物會活化,且存在 露於帶有活性氧類之食 、氯系有機溶劑等時, 基作用,在生體内也會 期活性氧量之生長量極 區域而持續進行,或形 活性氧類會逐漸以加 響。 響力會連鎖性增大,這 反f (非游離基反應)或 就是說,活性氧類之發 而在某天突然明顯化, 案為例,活柯氧#,, 氣類造成之慢性氧200413503 V. Description of the invention (31) Active oxygen species can only be free radicals of sexual oxygen species and are low-cost and use the emergency jk solution that the body will expose and then follow the floating emphysema and other active oxygen species as a guide when the organism is new When exposed to ultraviolet rays or radiation, when the burn is in a normal state or inactive and further dissociated, the feed or feed will not only be triggered or low, but it will increase when the formation is increased. These induced localized, but can not be removed later, and in other words, the potential physiological damage caused by live redox is rapid, and the range caused by human diseases is broader than that of the acute ring, the internal organs, and the metabolic rays. Many methods such as the above-mentioned exemplary oxygen reactions, which are caused by many organic fogs and residual active oxygen produced by coal materials, are left in a diseased state, which is a good effect of functional injury. Various industrial solutions or examples of a large number of active organs when transplanted, when causing a wide range of processes or old waste, and carcinogenic infection, oxygen or oxygen will be. In addition, the exhaust gas was exposed to the free type. Even when the initial retention state is exceeded, the formation of the bad shadow is different from the normal chemistry of the shadow. It also degrades or degrades. The present invention aims to provide the most efficient method for these living problems. Oxygen examples are limited to systemic burns during surgery, and only 3 times less in most cases during diving. When the material is accumulated, direct sunlight and exposed and denaturing substances or heavy metal cuts or cells are damaged, the compound will be activated, and when exposed to food with reactive oxygen species, chlorine organic solvents, etc., the role of the base, in the living body The growth of the amount of active oxygen during the end of the period also continues, or the active oxygen species will gradually reverberate. The response will increase in a chain, which is the opposite of f (non-radical reaction) or that the occurrence of reactive oxygen species suddenly became apparent on a certain day. For example, the live oxygen #, chronic oxygen caused by gas
200413503 、發明說明(32) 壓力負荷被認為是嬙P 一 / 化(特別是脂肪肝型)(特別是胰島素非依存型)、肝硬 脈硬化型)、痴呆神r牡狹心症等循環器官疾病(特別是動 化學致癌)等各種疾(广特:]是腦梗塞型)、惡性腫瘤(主要是 因年齡增加(高齡以的體發二,轉有關的^ ^ 因連續激烈動作造# i,力消耗所產生之生理機能低落、 衡或攝取量工”謝或呼吸之異常充進、營養平 勞等現象而產生活性:f眠或運動不足等老化及退化或疲 物容易堆積,•細胞= 現i推測是因為代謝舊廢 復延遲之一大主因成或殘存堆積量增加,為症狀促進或恢 生忐::2:外之動物及植物之個案為W,活性氧類之 插储t 2 S殘存堆積或曝露不僅與人類之例一樣合帶來各 種健康障害吱峰吉P立企 U 保曰V术各 水產養殖赤始札i早害,而且亦與家畜飼育、寵物繁殖、 下降產培產業中,搾乳率下降、肉質及肥育率 :病率=等毛r…繁殖育成效率低 產量及該等品質低",導致生產性= 值低落的結果有關。 低洛次两。口 j貝 致生=ί,飼料本身的個案為’㈣露於紫外線等導 活性氣魅®虱類、混入帶有活性氧類之原料等、因在製造 維生辛毒及漂白使用之過氧化氫殘留,使 s 分或食效成分氧化分解、因含油脂或使用 曰/月曰分解或乳化物崩壞、因含色素或使用色素者褪200413503 、 Explanation of the invention (32) Pressure load is considered to be circulatory organs such as 嫱 P- / (specific fatty liver type) (especially insulin-independent type), liver cirrhosis type), dementia and stenosis Diseases (especially carcinogenicity) and other diseases (Guangte:] is a cerebral infarction type), malignant tumors (mainly due to increasing age (older and younger body hair, the second turn, related ^ ^ because of continuous fierce movements made # i , Physical exertion caused by physical exertion, balance, or ingestion of labor, such as abnormal breathing, nutritional flatness, and other activities, produce activity: aging and degradation such as insomnia or lack of exercise, or fatigue accumulation easily, cells = It is presumed that one of the major causes of the delay of the metabolism and the resumption of the old waste or the increase of the residual accumulation is the promotion or recovery of symptoms. 2: 2: The case of outside animals and plants is W, and the insertion and storage of reactive oxygen species t 2 Residual accumulation or exposure not only brings about various health hazards like the example of humans, but it also causes various health problems, such as premature damage, hazards, damages, and aquaculture, and aquaculture. In the milk industry Decrease, meat quality and fattening rate: disease rate = equivalent hair… low breeding efficiency and low yield and these low quality " results in productivity = low value. Low-low two. Mouth j shell caused by ==, The case of the feed itself is' exposed to ultraviolet rays and other active qi charm® lice, mixed with raw materials with active oxygen, etc., because of the residual hydrogen peroxide used in the production of vitamins and bleaching, it makes s or food The active ingredients are oxidatively decomposed, decomposed due to oil or fat, or decomposed or emulsified, and faded due to pigments or pigments
五、發明說明(33) 味食品’或伴隨之不快臭味或食 以環境的個;為:造:;=:質惡化。 帶有活性氧類之浮游物存在容類之游離基或容易 有不快臭味或過敏或發炎之環境作業工間 如該等個案之損宝 曰促進水貝的改變。 發生’但因為活性氧類會;;ί進二氧;t關的情形也會 錯的。 八進仃大幅促進這一點是不畚 含活性氧類之游離基與損宝辦 的抗氧化劑、老化防 a “ 1目關的情形要以先前 濁防止劑、消臭劑及鮮度保防止劑、防腐劑、污 困難的,本發明者強烈確信唯—的解^ ^貝傷或抑制是有 抗氧化方法、抗氧化機能 。方法只有本發明之 本發明盥弁箭夕> β ^用途。 比,除可以發揮抗氧::2:::性氧類清除者之使用相 隨的副作用,故可在高水平^因完全不會發生伴 效率兩者,可解決先前品报難解游離基消去 等許多課題。 感木專不好使用或限定用途 發明之作用與效果 如前述,本發明中重 為催化劑而第二a p7 素第一為氫溶存水,第 1丨隹亿釗rt〇弟一為杬虱化對象。 弟 結合,氫潛在所具有之還焉 、〜荨二要素予以有機 返原力其封印被釋放,抗氧化作 200413503 五、發明說明(3^ ' ---— 便可彰顯。 ^ ^依本發明之抗氧化方法及抗氧化機能水,透過使催化 ^用,氫溶存水中之過程,促進以該氫溶存水中含有之 =狀氫作為基質形成生成物活性氫之分解反應,可將由 子所造成之氧化狀態或欲防止氧化之抗氧化對象 ΐ f: j! I子充足的狀態下,並藉此可期待達到人體安全性 或壞忧負荷低減之高水準。 在本發明之抗氧化方法、抗氧化機能水及其用途可 在從酸性到鹼性之廣泛仰範圍,且 用途了 基消去機能。 在至μ發揮良好的游離 故,本發明期待可在人類、人類以 酵微生物、培養細胞等生命體之生理/物、發 等障害,並特別期待利用於飼育性壓力或老化 二、加工、保存等生產物或υ;程;培、、發酵:培 貝、分解、腐敗、污濁、異臭化、谇要求防止變 能率下降等品質劣化或活性降之領降、效力減退、 再者,在食品、飼料、醫藥 田 粧品、洗淨劑、消臭劑、衛生用品療::口、準醫藥品、香 材或包裝容器、動物飼育、水產:^料用品、鮮度保持 培養等各產業領域中亦可期待有用性。、植物栽培、發酵或 又,若對利用者提供本發 易活用之具體態樣,可以將該以容易發揮又容 如下。 商品群中選出幾例 第37頁 2030.5943-PF(Nl);Chiunieow.ptdV. Description of the invention (33) Taste foods' or the unpleasant odors or foods that are accompanied by the environment; Floats with active oxygen species have free radicals in the content or are prone to unpleasant odors or allergies or inflammations. Environmental workshops such as damage to these cases promote the change of water shellfish. It ’s happening, but because the reactive oxygen species will ;; into the dioxin; t off the situation will be wrong. Bajin has greatly promoted this. It does not include free radicals containing active oxygen and antioxidants and aging and anti-aging agents of the Baobao Office. In the case of 1 mesh, the former turbidity preventive agent, deodorant and freshness preventive agent, Preservatives and stains are difficult, and the inventors are strongly convinced that the only solution is to have an antioxidant method and antioxidant function. The method has only the use of the present invention > β ^. In addition, it can exert anti-oxidant :: 2 ::: Sexual oxygen scavengers' side effects that accompany the use, so it can be at a high level ^ because the efficiency will not occur at all, and it can solve the difficulty of eliminating free radicals in previous reports. Many problems. The effects and effects of the invention are difficult to use or limit the use. As mentioned above, the invention is mainly a catalyst and the second a p7 element is hydrogen-soluble water. The first one is The object of ticking. Combined with the younger brother, the potential of hydrogen can be restored, and the two elements of the net are organically returned to its original force. The seal is released. Antioxidant action 200413503 V. Description of the invention (3 ^ '----- can be displayed. ^ ^ Antioxidation method and antioxidant according to the present invention Functional water promotes the decomposition reaction of active hydrogen formed by the formation of active hydrogen in the hydrogen-soluble water through the process of catalysis and hydrogen-dissolved water, which can change the state of oxidation caused by the child or prevent oxidation. Antioxidant target ΐ f: j! I is in a sufficient state, and it can be expected to reach a high level of human safety or reduction of bad load. The antioxidation method, antioxidative functional water and its application of the present invention can be used in It has a wide range from acidic to alkaline, and uses a basic elimination function. Therefore, the present invention is expected to exhibit good release to μ. Therefore, the present invention is expected to be used in humans, human beings to ferment microorganisms, culture cells, and other living organisms. Obstacles, and especially look forward to the use of fertility pressure or aging Second, processing, preservation and other products or processes; cultivation, fermentation: cultivation, decomposition, corruption, fouling, odorization, 谇 quality requirements to prevent decline in variable energy rate Degradation or decrease in activity, decrease in effectiveness, and further, in food, feed, pharmaceutical field cosmetics, detergents, deodorants, sanitary products treatment: mouth, quasi-drugs, fragrance It can also be expected to be useful in various industrial fields such as wood or packaging containers, animal breeding, aquatic products: food supplies, freshness maintenance culture, etc., plant cultivation, fermentation, or if the user is provided with specific aspects of the present invention, This can be easily played and described below. Select a few cases from the product group. Page 37 2030.5943-PF (Nl); Chiunieow.ptd
- I 五、發明說明(35) 例如’食品領域, 八 類機能之食品添加4勿::用:?備有除去高度活性氧 延長並保持生鮮食品之鮮σ = &品品質提高或保存曰數 水作為有效成分之特定伴二用^提供本發明之抗氧化機能 持健康及預防疾:以】食:或健康食品,以用於維 食品以作為健康管理及提Im飼料用添加物或寵物 协s里及徒回飼料效率或生產性。 於柰事法(日本)第2條規定醫、 粧品及醫療用具領域不僅 -'口:丰醫樂品、化 加物以使製劑品質提升, 二00、4、加物或化粧品添 改善、美容维持及摇4 a 了作為疾病治療與預防、體質 成分。1中,t筚。生狀態或快適環境確保之有效 病發生刪;K =待利用於與活性氧類相關之疾 壯保健樂、胃腸藥、感冒藥、口腔鼻炎用藥等外 ^ π I ®田十/、、在柰用牙S 、口中清涼劑、藥用化 Γ二,” 用齊卜腋臭防止劑及生理用品領域的 ί:ί ?,再者’化粧品則在頭髮用化粧品類、洗髮 ;土 類化粧水類、乳霜乳液類、面膜類、粉底類、 口紅類、洗臉劑類、肥皂類、牙膏類領域之有用性高。、 除以上之例以外,本發明亦可提供各種抗氧化方法及 几氧化機能之具體態樣,且本發明之實施形態與有用性 限定於上述例。 [實施方式] 據以實施發明之最佳形態 2030-5943-PF(Nl);Chiumeow.ptd 第38頁 200413503 五、發明說明(36) ΐ:對ίίΐ5之圖實2態依圖式詳細說明。 能水之基水(氫溶存水)所明使„用於生成本發明抗氧化機 本構造。 巧所用之运原電位水生成裝411之基 本例之還原電位水生成裳 水之導入口 111盥將所4 A + w 上形成有導入純水等原 i 2 ’在:亥導入口⑴與導出口112間形成有電解2出口 特別限疋,但本例之還原電 3不 底面,在番亩於闰水生成裝置11在外箱之 底面在垂直於圖不紙面之方向形成有可導入原 口 111 ’在外相114之頂面,在垂直於 之 有可取電解水之導出口112。 囬(方向形成 一又,在還原電位水生成裝置丨丨之左右側壁上設有多孔 性隔=1。15, ’在該隔膜115之室外,電極板各被設置為接觸 之大悲對側之電極板11 7其主面被設在分別面對本側電 極板116之電解室113内。 該等兩對電極板1 16、117上連接有直流電源(電 路)12,且夾著隔膜115且相對之一對電極板116、117之一 側被加以陽極電壓,而另一侧之電極板被加以陰極電壓。 例如’在電解室113生成還原電位水時,如第5圖所示,設 於電解室113内之電極板117連接直流電源12之陰極,而設 於電解室11 3外之電極板11 6連接陽極。 又’在電解室113生成電解氧化水時,設於電解室U3 内之電極板11 7連接直流電源1 2之陽極,而設於電解室11 3 外之電極板11 6連接陰極。 Μ 2030-5943-PF(Nl);Chiumeow.ptd 第39頁 200413503-I V. Description of the invention (35) For example, in the field of food, eight types of functional foods are added 4 Do not use :: use :? It is provided with the removal of highly active oxygen to prolong and maintain the freshness of fresh foods. Σ = & quality improvement or preservation of water as a specific companion for the use of water as an active ingredient ^ provides the antioxidant function of the present invention to maintain health and prevent diseases: : Or health foods, used for vitamins for health management and to improve the feed efficiency or productivity of Im feed additives or pet associations. Article 2 of the Ministry of Health Law (Japan) stipulates that the fields of medicine, cosmetics and medical appliances not only-'kou: Fengyi Music Products, adding additives to improve the quality of preparations, 2000, 4, adding additives or cosmetics to improve, beauty Maintain and shake for 4 years as a disease treatment and prevention, constitution component. 1, t 筚. Effective diseases ensured by health status or rapid environment; K = to be used for active health-related health-related oxygen, gastrointestinal medicine, cold medicine, oral rhinitis, etc. ^ I ® 田 十 / 、、 在 柰Use tooth S, mouth cooling agent, medicinal chemical Γ, "Use Zibu underarm odor preventive agent and physiological products in the field of ί: ί? Also, 'cosmetics are used in hair cosmetics, shampoos; soil lotions , Cream, lotion, mask, foundation, lipstick, face wash, soap, toothpaste, etc. High usefulness. In addition to the above examples, the present invention can also provide various anti-oxidation methods and oxidative functions The specific aspect, and the implementation form and usefulness of the present invention are limited to the above examples. [Embodiment] The best form to implement the invention is 2030-5943-PF (Nl); Chiumeow.ptd Page 38 200413503 V. Invention Explanation (36) ΐ: Detailed description of the figure 2 of ίΐ5 according to the diagram. The basic water (hydrogen-soluble water) of water can be used to generate the structure of the antioxidant machine of the present invention. The original potential water generating device 411, which is a basic example of the reduction potential, is used as the introduction port for the reduction potential water generating device 111, and the original i 2 is formed on the 4 A + w to introduce pure water. Electrolyte 2 is formed between the outlets 112. The outlet is particularly restricted, but the reduction power 3 in this example is not on the bottom. The bottom surface of the outer box on the Fanmu water generation device 11 is formed in a direction perpendicular to the paper surface. On the top surface of the external phase 114, there is a lead-out port 112 which is perpendicular to the preferable electrolyzed water. Back (directions are formed one after another, porous porosity partitions are provided on the left and right side walls of the reduction potential water generating device 丨 丨 = 1.15, 'Outside the membrane 115, the electrode plates are each set as the electrode on the opposite side of the contact. The main surface of the plate 11 7 is provided in the electrolytic chamber 113 respectively facing the electrode plate 116 on the side. The two pairs of electrode plates 1 16 and 117 are connected to a DC power source (circuit) 12 and are opposed to each other with a diaphragm 115 sandwiched therebetween. One of the pair of electrode plates 116 and 117 is applied with an anode voltage and the other electrode plate is applied with a cathodic voltage. For example, when the reduction potential water is generated in the electrolytic cell 113, as shown in FIG. The electrode plate 117 in the chamber 113 is connected to the cathode of the DC power source 12, and the electrode plate 116 provided outside the electrolytic chamber 113 is connected to the anode. When the electrolytic oxidation water is generated in the electrolytic chamber 113, the electrode provided in the electrolytic chamber U3 The plate 11 7 is connected to the anode of the DC power source 12 and the electrode plate 11 6 provided outside the electrolytic chamber 11 3 is connected to the cathode. Μ 2030-5943-PF (Nl); Chiumeow.ptd Page 39 200413503
錮 覆 孔 本例使用之電極板116、117整面為鈦,並以擇自全、 而構成之群中1或2種以上組合之貴金屬進行燒成被 而構成。又,電極板116、117上如後述,挖有複數之針 本例所使用隔膜115以具有使流動在電解室丨13内之水 可容易滲入,且流入之水難以滴流性質者為佳。即本 之逛原電位水生成裝置丨丨係在電解中於隔膜115本身及 膜115與電極板116之極小間隙s中形成水膜,並透過該水 膜使電流在兩電極116、117間流動。因此,使構成水膜之 水可依序進入更替是使電解效率提高之重要問題。又,、因 ^入隔膜115之水若由隔膜丨15與電極板丨16間漏出則必須 处理,故以具有使所滲入之水不會滴下程度之含水性較、 ,。惟,在採用固體電解質膜作為隔膜時,因該固體電 質膜本身具有電傳導性,故可省略於隔膜115本身及隔膜 1 1 5與電極板Π 6間形成極小之間隙s。 、 ^隔膜11 5之一例,例如其骨材為聚酯不織布或聚乙稀 膜材質為氯化乙烯或聚偏氟乙烯及氧化鈦或聚氯乙 =等、厚度為0·卜〇· 3mm、平均孔徑為〇· 〇5〜丨· 〇 、透水 量為l.Occ/cm2 .min以下之多孔膜,或為固體電解質膜。 以陽離子交換膜作為隔膜丨丨5使用時,例如可使用如杜邦 么司製之那非恩(NAF ION)膜之以聚四氟代乙烯為基礎材 之,離子交換基全氟代磺酸膜,或如旭化成製之福來明暝 之陽離子交換基乙烯醚與四氟乙烯的共聚物等。 、 另一方面,夾著隔膜1 1 5相對向配置之一對電極板锢 Covering holes The electrode plates 116 and 117 used in this example are made of titanium on the whole surface, and are formed by firing a precious metal consisting of one or more combinations of two or more selected groups. As described later, the electrode plates 116 and 117 are dug with a plurality of needles. It is preferable that the diaphragm 115 used in this example has the property that the water flowing in the electrolytic chamber 13 can easily penetrate and the flowing water is difficult to drip. That is, the original potential water generating device is formed in the electrolysis in the diaphragm 115 itself and in the very small gap s between the membrane 115 and the electrode plate 116, and the current is caused to flow between the two electrodes 116 and 117 through the water film. . Therefore, it is an important issue to improve the efficiency of electrolysis by sequentially entering and replacing the water constituting the water film. In addition, since water leaking into the diaphragm 115 must be treated if it leaks between the diaphragm 15 and the electrode plate 16, the water content is relatively low so as to prevent the infiltrated water from dripping. However, when a solid electrolyte membrane is used as the separator, since the solid electrolyte membrane itself has electrical conductivity, it can be omitted to form a very small gap s between the separator 115 itself and the separator 1 15 and the electrode plate Π 6. ^ Diaphragm 11 is an example, for example, the aggregate material is polyester non-woven fabric or polyethylene film material is vinyl chloride or polyvinylidene fluoride, titanium oxide or polyvinyl chloride, etc., and the thickness is 0 · 03. Porous membranes with an average pore size of 0.05 to 5 〇 and a water permeability of 1.0 C / cm 2 .min or less, or solid electrolyte membranes. When a cation exchange membrane is used as the membrane, such as NAF ION membrane made by DuPont, based on polytetrafluoroethylene, and an ion exchange perfluorosulfonic acid membrane can be used. , Or a copolymer of cation-exchange vinyl ether and tetrafluoroethylene, such as Flemings, manufactured by Asahi Kasei. On the other hand, one pair of electrode plates facing each other with the diaphragm 1 1 5 facing each other
200413503 五、發明說明(38) 116、117板間距離為0mm〜5 〇mm,較佳為15_。此處,電 極板1 1 6、11 7板間距離為〇_係指例如,在隔膜丨丨5之兩主 面使用各別直接形成無溝電極之電極膜,且實質上具有隔 膜115之厚度分。無溝電極僅在隔膜115 一側之主面上上形 成電極即可。又,採用該種無溝電極時希望將從電極表面 發生之氣體往與隔膜丨15相反之背側散逸用之孔或間隙設 在電極板116、117上。又,設在電極板116、117上之孔或 間隙組成亦可採用在如第5圖所示設於電解槽上之電極 板0200413503 V. Description of the invention (38) The distance between plates 116 and 117 is 0mm ~ 50mm, preferably 15mm. Here, the distance between the electrode plates 1 1 6 and 11 7 is 0. This means, for example, that the electrode films directly forming the groove-free electrodes are used on the two main surfaces of the separator 5 and substantially have the thickness of the separator 115 Minute. The non-grooved electrode may be formed only on the main surface on the side of the separator 115. In the case of using such a grooveless electrode, it is desirable to provide holes or gaps for the gas generated from the surface of the electrode to escape to the back side opposite to the diaphragm 15 on the electrode plates 116 and 117. In addition, the composition of the holes or gaps provided on the electrode plates 116 and 117 can also be adopted in the electrode plate provided on the electrolytic cell as shown in FIG. 5.
又,設於電解室113内之電極板116、117之板間距離 不特別限定,但以〇· 5mm〜5· Omm,較佳為1_。 使用該組成之還原電位水生成裝置丨丨生成還原電位水 時,首先要將設於電解室113内之兩片電極板116、117連 接直流電源12之負極(-),同時將設於電解室1 13外之兩片 電極板11 6、11 7連接直流電源丨2之正極(+ ),並對於隔著 隔膜115分別相對之兩對電極板116、117加電壓。並且由 導入口 111導入純水,使電解室進行水之電解作用,在電 極板117之表面及其附近產生 2H20 + 2e--20H- + H2 fThe distance between the electrode plates 116 and 117 provided in the electrolytic chamber 113 is not particularly limited, but it is preferably 0.5 mm to 5.0 mm, and preferably 1 mm. When using the reduced potential water generating device of this composition to generate reduced potential water, firstly, two electrode plates 116 and 117 provided in the electrolytic chamber 113 are connected to the negative electrode (-) of the DC power source 12 and will be provided in the electrolytic chamber The two electrode plates 11 6 and 11 7 outside 1 13 are connected to the positive electrode (+) of the DC power source 2 and voltage is applied to the two pairs of electrode plates 116 and 117 through the diaphragm 115 respectively. In addition, pure water is introduced through the inlet 111 to cause the electrolysis chamber to perform water electrolysis, and 2H20 + 2e--20H- + H2 f is generated on the surface of the electrode plate 117 and its vicinity.
之反應。又,在隔著隔膜115之電解室113外之電極板 11 6表面,即,該電極板i i 6與隔膜丨丨5之間產生 H20-2e —2ΗΗ 1 / 202 个 之反應。 該H+離子一面被含蓄在隔膜115中一面通過其一部分從Response. In addition, on the surface of the electrode plate 116 outside the electrolysis chamber 113 across the diaphragm 115, that is, between the electrode plate i i 6 and the diaphragm 丨 5, a reaction of H20-2e-2ΗΗ 1/202 is generated. The H + ions are contained in the separator 115 while passing through a part of the H + ions.
五、發明說明(39) =極板117收容電子6.,變成氫氣溶人陰 — 中。藉此’陰極側(即,電解室113 ^電解水 ;成比起先前使用有隔膜技術所生成之電解水更 原電位(ORP)之還原電位水。 《電解水更低乳化還 0H—二變膜11 5後多餘之H+因為會和電解室11 3中之 此二生成之含有氫氧化物離子之還原電位水係 信昧又^望依該電解處理所得到之還原電位水在所欲PH 田睡i歹1 :,可使用酞酸鹽、磷酸鹽、硼酸鹽等PH緩衝作 ==等:先調整原水之pH值即可。因本還原電位= 成袭置11不會使原水之pH有很大變化。具體上,例如,若 因為要作為石夕基板之洗淨或飲料用途而欲使pH偏驗,只要 將原水之pH值調整在鹼性附近進行管理調製即可,又,若 因^作為飲料、注射液、點滴液或透析液,欲使pH在約中 陡日守,/、要將原水之pH值調整在中性附近進行管理調製即 可,再者,若因要作為化粧料,欲使pH在弱酸性時,只要 將原水之pH值調整在弱酸性附近進行管理調製即可。 順帶一提’上述實施形態係對第5圖所示之還原電位 水生成裝置作說明,但該裝置丨丨亦適用於生成氧化電位水 之情形。該情形下,將設於電解室丨丨3内之兩片電極板 11 7、11 7連接直流電源1 2之陽極( + ),同時,將設於電解 至11 3外之兩片電極板11 6、11 6連接直流電源1 2之陰極V. Description of the invention (39) = The polar plate 117 contains electrons 6. It becomes hydrogen and dissolves in the human yin. By this, the cathode side (ie, the electrolysis chamber 113 ^ electrolyzed water; reduced potential water with a more original potential (ORP) than the electrolyzed water previously produced with the diaphragm technology. "Electrolyzed water has lower emulsification and 0H-two changes The excess H + after the membrane 115 is because the reduction potential water containing hydroxide ions generated by the two in the electrolytic chamber 11 3 is reliable and hopeful that the reduction potential water obtained by the electrolytic treatment is in the desired pH field. Sleep i 歹 1: PH buffers such as phthalates, phosphates, and borate can be used as ==, etc .: The pH value of the raw water can be adjusted first. Because the reduction potential of the raw water = the setting of 11 will not make the pH of the raw water It ’s changed a lot. Specifically, for example, if you want to deviate the pH because you want to use it as a substrate for washing or drinking, you only need to adjust the pH of the raw water near alkaline to manage and adjust it. ^ As a beverage, injection, drip solution or dialysate, if you want to keep the pH at about the middle of the day, you can adjust the pH of the raw water near neutral for management and modulation. Moreover, if you want to use it as makeup Material, if you want to make the pH weakly acidic, just adjust the pH value of the raw water near the weakly acidic Management modulation is sufficient. Incidentally, the above-mentioned embodiment describes the reduction potential water generating device shown in FIG. 5, but the device is also applicable to the case of generating oxidation potential water. In this case, the device Connect the two electrode plates 11 7 and 11 7 in the electrolytic cell 3 to the anode (+) of the DC power supply 1 2. At the same time, connect the two electrode plates 11 6 and 11 6 located outside the electrolysis 11 3 to DC. Cathode of power supply 1 2
2030-5943-PF(Nl);Chiumeow.ptd 第42頁 200413503 五、發明說明(40) (-),並對於隔著隔膜丨丨5分別相 加電壓即可。 別相對之兩對電極板116、117 並且,由導入口111導入純水等,則在 被電解,在電極板117之表面及其附近產生解至 H20-2e_->2HHl/2 · 02 个 之反應。又,在隔著隔膜115之電解室113外之電極板 116表面,即,該電極板116與隔臈115間之水膜產生 2H20 + 2e-—20H-+ H2 t 、 之反應。 該OH—離子一面被含蓄在隔膜115中一面通過,其一部 分從陰極板11 7受讓電子e_,變成氧氣溶入陽極側之生成電 解水中。藉此,陽極侧(即,電解室丨丨3内)所生成之電解 水可變成比起先前使用有隔膜技術所生成之電解水更高氧 化還原電位(0RP)之氧化電位水。 又’通過隔膜115後多餘之〇H-離子因為會和電解室jig 中之H+反應變回水,故電解室1丨3中所生成之氧化電位水其 pH會略接近中性。即,可得到pH不是很低,但〇Rp高的氧八 化電位水。依此所生成之含有氫離子之氧化電位水係由導 出口 112供給。 順帶一提,使用第5圖所示之還原電位水生成裝置i j 將設於電解室11 3内之兩片電極板1 1 7、11 7連接直流電源 12之陰極(-),同時,將設於電解室113外之兩片電極板 11 6、11 6連接直流電源1 2之陽極( + )(電極板之有效面積 ldm2),並以pH為7· 9、0RP + 4 7 3mV之藤澤市自來水以每分鐘2030-5943-PF (Nl); Chiumeow.ptd page 42 200413503 V. Description of the invention (40) (-), and the voltages can be added separately through the diaphragm 5. Two pairs of electrode plates 116 and 117 opposite to each other, and pure water or the like is introduced through the inlet 111, and is electrolyzed to generate a solution on the surface of the electrode plate 117 and its vicinity to H20-2e _- &2; 2HHl / 2 · 02 Response. In addition, on the surface of the electrode plate 116 outside the electrolysis chamber 113 with the diaphragm 115 interposed therebetween, a water film between the electrode plate 116 and the diaphragm 115 generates a reaction of 2H20 + 2e-20H-+ H2 t. The OH ion is passed through while being contained in the separator 115, and part of it receives electrons e_ from the cathode plate 116, and becomes oxygen dissolved into the anode side to generate electrolytic water. As a result, the electrolytic water generated on the anode side (ie, in the electrolytic cell 3) can become oxidation potential water having a higher oxidation reduction potential (0RP) than the electrolytic water generated using the diaphragm technology. Since the excess OH- ions after passing through the diaphragm 115 will react with the H + in the electrolysis chamber jig to return to water, the pH of the oxidation potential water generated in the electrolysis chamber 1 丨 3 will be slightly close to neutral. That is, it is possible to obtain oxygen octave water having a low pH but a high ORP. The oxidation potential water containing hydrogen ions thus generated is supplied from the outlet 112. Incidentally, using the reduced potential water generating device ij shown in FIG. 5, two electrode plates 1 1 7 and 11 7 provided in the electrolytic cell 11 3 are connected to the cathode (-) of the DC power source 12 and at the same time, the device The two electrode plates 11 6 and 11 6 outside the electrolytic chamber 113 are connected to the anode (+) of the DC power supply 1 2 (effective area of the electrode plate ldm2), and the pH is 7.9, 0RP + 4 7 3mV in Fujisawa. Tap water per minute
2030-5943-PF(Nl);Chiumeow.ptd 第43頁 200413503 五、發明說明(41) 1公升之流速以5 A固定電流之電解條件,進行連續通水式 電解處理。此時以杜邦公司製之那非恩膜陽離子交換膜作 為隔膜115 ’電極板116、117之距離為,電解室113 中電極板117、117間之距離為1· 4mm。其結果,在電解處 理後瞬間,可得到ΡΗ = 9·03、ORP^ 720mV之還原電位水处 又’將該還原電位水靜置,5分鐘後、1 〇分鐘後及3 〇分鐘 後測定pH及0RP之結果,5分後pH = 8, 〇RP = -70 6mV、1〇分後 PH二8.11,〇RP = -7l〇mV、30 分後pH = 8 〇2,〇Rp = —7〇7mV。即, 電解處理後瞬間之時點該處理水之pH雖超過9,但很快抑 就下降並安定在PH8附近。此可認為是因在隔膜115盥陽極 116間之水膜附近產生之H+離子通過隔膜115往電解室ιΐ3 動後,與同電解室113内之OH-離子進行中和反應變回水, 而中和反應在即使將電解處理後之還原電位水靜置下 隨時促進直到在濃度上之化學平衡成立。 曰 添加貴金屬膠體催化劑氫溶存水之還原活性/游離美 活性評價試驗 土 β f2030-5943-PF (Nl); Chiumeow.ptd Page 43 200413503 V. Description of the invention (41) The electrolysis condition of continuous flow-through electrolysis is carried out at a flow rate of 1 liter and a fixed current of 5 A. At this time, the distance between the electrode plates 116 and 117 of the diaphragm cation exchange membrane manufactured by DuPont Co., Ltd. as the separator 115 is set to be 1.4 mm, and the distance between the electrode plates 117 and 117 in the electrolytic chamber 113 is 1.4 mm. As a result, immediately after the electrolytic treatment, a reduction potential water having PΗ = 9.03 and ORP ^ 720 mV was obtained, and the reduction potential water was left to stand still, and the pH was measured after 5 minutes, 10 minutes, and 30 minutes. As a result of 0RP, pH = 8, 〇RP = -70 6mV after 5 minutes, pH 8.11 after 10 minutes, 〇RP = -7110mV, and pH = 8 〇2, 〇Rp = -7 after 30 minutes. 7mV. In other words, although the pH of the treated water exceeded 9 at a point in time immediately after the electrolytic treatment, the pH of the treated water soon decreased and stabilized near pH8. It can be considered that the H + ions generated in the vicinity of the water film between the diaphragm 115 and the anode 116 passed through the diaphragm 115 to the electrolytic chamber, and then neutralized with the OH-ions in the same electrolytic chamber 113 to return to water. The sum reaction is promoted at any time even when the reduction potential water after the electrolytic treatment is left standing until the chemical equilibrium in concentration is established. Reduction activity / free beauty activity evaluation test of hydrogen-soluble water added with noble metal colloid catalyst soil β f
以下,對在本發明之氫溶存水加入貴金屬膠 (翻膠體/把膠體)時,藉活化同氫溶存水中所含之化1隹風化 不活性分子狀氫展現之還原活性或游離基消去活予^ 價試驗,分別舉實施例與參考例。 < 合 夺在上述兩項評價試驗中,還原活性評價試驗係以亞 ^四甲基硫僅氯化物;Ci6h18C1N3S ·3(Η2〇))作為抗氧,匕 象,而游離基消去活性之評價試驗係使用在水 定之游離基DPM游離基(1,卜二苯基_2_三硝&苯基In the following, when the noble metal gum (colloid / colloid) is added to the hydrogen-soluble water of the present invention, the reducing activity or free radical deactivation exhibited by activation of the weathered inactive molecular hydrogen contained in the hydrogen-soluble water is activated. ^ Valuation test, examples and reference examples. < Conjugation In the above two evaluation tests, the reduction activity evaluation test was based on the evaluation of chlorotetramethylsulfuryl chloride only; Ci6h18C1N3S · 3 (Η2〇)) as the antioxidant, dagger, and free radical elimination activity. The test uses the free radical DPM (1,2-diphenyl_2-trinitr & phenyl
200413503 五、發明說明(42) 作為抗氧化對象200413503 V. Description of the invention (42) As an antioxidant
在此,對以屬於氧化還原色素範疇之亞甲梦 化對象時之還原活性評價原理作說明,氧化型$ =抗氧 液(吸收極大波長;6 6 5 n m左右,以下右日卑 「M 威权/各 βτΜΜβ」稱啤 甲藍)呈現藍色’但變成還原型亞甲藍(無色亞甲藍)亞 會由藍色轉為無色。以藍色消失之程度來評價還^、、舌0、’ 即還原力。又,還原型亞曱藍因溶解度低會產生白色二人 物,但若被再氧化則變成原本之氧化型亞甲藍,變u 色。即,亞曱藍水溶液之呈色反應為可逆性二。文°成Here, the principle of evaluation of reduction activity when using methylene dreaming objects that belong to the category of redox pigments will be explained. The oxidation type $ = antioxidant liquid (absorption maximum wavelength; about 6 6 5 nm, the following right is "M Authoritarianism" "Each βτMMMβ" is called beer blue) and it appears blue, but it becomes a reduced methylene blue (colorless methylene blue), and the color will change from blue to colorless. The degree of reduction of the blue color was evaluated, and the tongue 0, ′ was the reducing power. In addition, the reduced form of osmium blue will produce white dimers due to its low solubility, but if reoxidized, it will become the original oxidized form of methylene blue with a u color. That is, the color reaction of the aqueous solution of osmium blue is reversible. Wen Cheng
另外,對以DPPH游離基作為抗氧化對象時之還原活性 評價原理作說明,D Ρ Ρ Η游離基水溶液(吸收極大波長' · 520nm左右,以下有時以「DPPH」稱呼)呈現深紅色,’當 DPPH被還原游離基消失時’深紅色會褪色。以褪色之^度 來評價游離基消去活性’即抗氧化力。又,DPPH游離芙水 溶液之呈色反應為不玎逆性的。 &In addition, the principle of reduction activity evaluation when DPPH free radicals are used as antioxidant targets will be explained. D P P Η free radical aqueous solution (absorption maximum wavelength '· about 520 nm, hereinafter sometimes referred to as "DPPH") appears deep red, When DPPH is reduced by the reduction of free radicals, 'dark red will fade. The degree of discoloration was used to evaluate the radical elimination activity ', that is, the antioxidant power. In addition, the color reaction of DPPH free water solution is irreversible. &
對評價試驗之說明擬以(1 )以亞甲藍之呈色變化作添 加鉑膠體催化劑電解處理水之還原活性評價、(2 )以亞甲 藍之呈色變化作添加鉑膠體/鈀膠體催化劑之氫溶存水(脫 氣處理+氫氣封入處理)之還原活性評價、(3 )以亞甲藍之 呈色變化作添加鉑膠體催化劑電解處理水(電解處理前添 加/電解處理後添加)之還原活性評價、(4 )以DPPH游離基 之呈色變化作添加鉑膠體催化劑電解處理水之抗氧化活性 評價、(5 )以D Ρ Ρ Η游離基之呈色變化作添加催化劑氫溶存 水(脫氣處理+氫氣封入處理)之抗氧化活性評價之順序進The description of the evaluation test intends to (1) evaluate the reduction activity of electrolytically treated water with the addition of methylene blue as the addition of platinum colloidal catalyst, and (2) use the coloration of methylene blue as the addition of platinum colloid / palladium colloidal catalyst. Evaluation of reducing activity of hydrogen-soluble water (degassing treatment + hydrogen sealing treatment), (3) Reduction of electrolysis-treated water (addition before electrolysis treatment / addition after electrolysis treatment) by adding a platinum colloid catalyst to the color change of methylene blue Activity evaluation, (4) Evaluation of the color change of DPPH free radicals as the antioxidant activity of electrolytically treated water with added platinum colloidal catalyst, (5) Evaluation of the color change of DPP free radicals as the addition of hydrogen dissolved water Gas treatment + hydrogen sealing treatment)
2030-5943-PF(Nl);Chiumeow.ptd 第45頁 200413503 五、發明說明(43) 行。 (1 )以亞甲藍之呈色變化作添加鉑膠體催化 之還原活性評價 ㈠電解處理水 (1 - A ),還原力評價試驗步驟 將和光純藥工業(股)公司製之標準緩 鹽水溶液)及9.丨8(硼酸鹽水溶液)分別以純夜磷酸 製成pH緩衝水溶液。以下將該2種類之稀釋=調 「基本水6_86」、「基本水9.18」。再,將田刀^為 之鉑膠體4%溶液0.6g溶於和光純藥工業(股 :,屬製 500mL·之溶液稱為「鉑基準液又,鉑美 ° 泛餾水 C(Pt)係由計异式C(Pt) = (K6x 0.04/500mL得到,為 又 48mg/mL·。並,使用上述兩種基本水6 86與918與”翻基 液,各調製4種類共8種之樣本水溶液。如以下所示。土 > i.基本水(6. 86) ’、。 ^•基本水(6.86 ) 1 4941^中加入鈾基準液61^之含鉑膠體 溶液 i i i ·將基本水(6 · 8 6 )進行電解處理後之水溶液 iv·基本水(6· 86 ) 1 494mL中加入翻基準液6mL製成含鉑膠體 水溶液,再將該水溶液進行電解處理後之水溶液 v ·基本水(9. 1 8) vi·基本水(9.18)1494 mL中加入鉑基準液6mL之含鉑膠體水 溶液 v i i ·將基本水(9 · 1 8 )進行電解處理後之水溶液 vi i i ·基本水(9· 1 8) 1 494mL中加入鉑基準液6mL製成含鉑膠2030-5943-PF (Nl); Chiumeow.ptd Page 45 200413503 V. Description of Invention (43). (1) Evaluation of the reduction activity of methylene blue with the addition of platinum colloid catalysis㈠ Electrolytically treated water (1-A), the test procedure for the evaluation of reducing power will be a standard slow saline solution made by Wako Pure Chemical Industries, Ltd. ) And 9. 丨 8 (aqueous borate solution) are made of pH buffered aqueous solution with pure night phosphoric acid, respectively. The following two types of dilutions = "basic water 6_86", "basic water 9.18". Furthermore, 0.6 g of a 4% platinum colloid solution of Tian Dao ^ was dissolved in Wako Pure Chemical Industries (stock: 500mL · made solution is called "platinum reference solution, and platinum US ° pan-distilled water C (Pt) system Calculated from the formula C (Pt) = (K6x 0.04 / 500mL, which is another 48mg / mL ·. And, using the above two basic waters 6 86 and 918 and “turn base solution”, each of 4 kinds and 8 kinds of samples were prepared. Aqueous solution as shown below. Soil> i. Basic water (6. 86) ', ^ • Basic water (6.86) 1 4941 ^ Add uranium reference solution 61 ^ to platinum-containing colloidal solution iii • Basic water ( 6 · 8 6) Aqueous solution iv · basic water (6 · 86) after electrolysis treatment was added to 1 494mL to turn the reference solution 6mL into a platinum colloid-containing aqueous solution, and the aqueous solution was electrolytically treated v · basic water ( 9. 1 8) vi · 1494 mL of basic water (9.18) platinum standard colloid solution containing 6 mL of platinum-containing colloidal aqueous solution vii · basic water (9 · 1 8) aqueous solution vi ii · basic water (9 · 1 8) Add 1 mL of platinum reference solution to 1 494 mL to make platinum gel
2030-5943-PF(Nl);Chiumeow.ptd 第46頁 2004135032030-5943-PF (Nl); Chiumeow.ptd p. 46 200413503
體水溶液,再將該水溶液進行電解處理後之水溶液 又 上述丨〜viii總共8種之各樣本水溶液之pH、 ORP(mV)、溫度t(°c)、鉑膠體濃度整理表示於下表2。 表2 樣本編號 基本7j ^ 6.86 基本7j C 9.18 1 ii iii iv V vi vii viii PH 7.0 7.0 7.1 7.1 9.1 9.1 9.5 9.5 ORP(mV) 186 186 -625 -624 130 130 -745 -745 鉑濃度U g/L) 0 192 0 192 0 192 0 192 溫商。C) 20 20 20 20 20 20 20 20 為檢查上述i〜v i i i總共8種之各樣本水溶液還原活 性,在各水溶液350mL·中加入亞曱藍(lg/L濃度)溶液 IjmL ’將亞甲藍濃度調製為74· 4 # μ,並以分光光度計測 定各樣本水溶液之亞甲藍吸光度(Α589 ;在波長589nm之吸 光度)。 (1 - B);參考例及實施例之揭示 (參考例1) 以樣本水i之無添加催化劑水溶液(基本水6. 86)中加 入亞甲藍後水溶液其亞甲藍吸光度(A589 )作為參考例1, 結果表示於第6圖。 (參考例2 ) 以樣本水i i之添加催化劑水溶液(基本水6. 86+鉑美 液)中加入亞甲藍後水溶液其亞甲藍吸光度(A589)作\ 考例2,結果表示於第6圖。 馬冬 (參考例3 )The aqueous solution, and the aqueous solution after the electrolytic treatment of the aqueous solution are shown in Table 2 below. Table 2 Sample number Basic 7j ^ 6.86 Basic 7j C 9.18 1 ii iii iv V vi vii viii PH 7.0 7.0 7.1 7.1 9.1 9.1 9.1 9.5 9.5 ORP (mV) 186 186 -625 -624 130 130 -745 -745 Platinum concentration U g / L) 0 192 0 192 0 192 0 192 Temperature quotient. C) 20 20 20 20 20 20 20 20 20 In order to check the reducing activity of the aqueous solution of each sample of a total of 8 kinds from i to viii above, 350 mL of each aqueous solution was added with methylene blue (lg / L concentration) solution IjmL It was adjusted to 74 · 4 # μ, and the methylene blue absorbance (A589; absorbance at a wavelength of 589 nm) of each sample aqueous solution was measured with a spectrophotometer. (1-B); Disclosure of Reference Examples and Examples (Reference Example 1) The methylene blue absorbance (A589) of the aqueous solution obtained by adding methylene blue to the sample water i without added catalyst solution (basic water 6.86) was used as Refer to Example 1, and the results are shown in FIG. 6. (Reference Example 2) The sample solution ii was added with an aqueous catalyst solution (basic water 6.86 + platinum solution), and the methylene blue absorbance (A589) of the aqueous solution after adding methylene blue was used as Example 2 in the test. Illustration. Ma Dong (Reference Example 3)
200413503 五、發明說明(45) 6. 8二樣解本處水 (A589 )作為參考例3,/里甲藍後水溶液其亞甲藍吸光度 (實施例υ 例結果表示於第6圖。 解卢3+樣-本其水二,添加催化劑電解處理水(基本水6. 86+電 (Α5^9 )作為"本:文中加入亞曱藍後水溶液其亞甲藍吸光度 C A 5 8 9 )作為貫施例1 ,脸 第6圖。 將…果與參考例1〜3作對比,表示於 (參考例4) 以樣本水v之無添加催化劑水溶液(基本水9 · 1 8)中 其亞甲藍吸™則參考,, (參考例5) 以樣本水^之添加催化劑水溶液(基本水9·】8+鉑基 2加入亞曱藍後水溶液其亞甲藍吸光度(A589 )作為參 考例5 ’結果表示於第7圖。 乂 (參考例6) 以樣本水V 1 1之無添加催化劑電解處理水(基本水 6.86+電解處理)中加入亞曱藍後水溶液其亞曱藍吸光声 (A589)作為參考例6,結果表示於第7圖。 又 (實施例2) 以樣本水vi i i之添加催化劑前電解處理水(基本水 18+電解處理+鉑基準液)中加入亞曱藍後水溶液其亞 藍吸光度(A589 )作為實施例2,將結果與參考例4〜6作對200413503 V. Description of the invention (45) 6. 8 Sample solution of this place (A589) as reference example 3, / methylene blue absorbance of the aqueous solution after methylene blue (Example υ The results are shown in Figure 6. Xie Lu 3+ sample-this water, add catalyst electrolyzed water (basic water 6. 86 + electricity (Α5 ^ 9) as "quot: this: after adding methylene blue aqueous solution and its methylene blue absorbance CA 5 8 9) as Example 1 is applied, and the face is shown in Fig. 6. The comparison between the fruit and the reference examples 1 to 3 is shown in (Reference Example 4) The sample water v has no added catalyst aqueous solution (basic water 9.18) and its methylene For Blue Absorption ™, refer to (Reference Example 5) Add the catalyst aqueous solution (basic water 9 ·) 8 + platinum 2 to the sample water ^ and add the methylene blue absorbance (A589) of the aqueous solution after adding methylene blue as the reference example 5 ' The results are shown in Figure 7. 乂 (Reference Example 6) Sample water V 1 1 was added to the electrolessly treated water (basic water 6.86 + electrolytic treatment) without added catalyst. The aqueous solution of arylene blue absorbs the sound of arylene blue (A589) As a reference example 6, the results are shown in Fig. 7. (Example 2) Sample water vi ii was electrolyzed before the catalyst was added. + 18+ substantially water electrolysis platinum reference solution) were added an aqueous solution after its alkylene Yue blue blue absorbance (A589) as the embodiment 2, the results in Reference Example against Example 4 ~ 6
200413503 五、發明說明(46) 比,表示於第7圖。 (1 - C );實施例之考察 將實施例1、2之沾m 以說實施例1、2之$ ^ #與參考例1〜6作對比並考察,可 較起來,不論其PH: =化劑電解處理水與參考例 僅有添加催化劑電解處理::^專:性的還原’且 對亞甲藍水溶液是否1 :不八 的還原活性。又, 1、2之添加催化劑電解處理水為益色透明,例 甲藍之藍色消失。又,Α 4 β &\透月且可辨認出亞 之藍色消失。又,實r;M考合卜6無法以目視看出亞甲藍 具%例1、2之添加催化劑翁、、六 用目視確認有多量之白色 虱/合存水可以 α吒田鉍今g a曰巳/儿歲物(還原型亞甲藍)。 ()亞甲玉之呈色變化作添加鉑膠體/鈀膠體 溶存水(脫氣處理+氫氣封入處理)之還原活^催化劑之氫 (2-A);還原力評價試驗步驟 貝 將日本基因(股)公司製造、和光純藥工 t^#^lMTris-HCl(PH7.4)^mMTris-HCHpH;i〇V^ 以和光純樂工業(股)公司製造之蒸餾水稀釋2〇倍 ^200413503 V. Description of the invention (46) The ratio is shown in Figure 7. (1-C); Examination of the Examples The comparison of Example 1 and 2 to $ ^ # of Examples 1 and 2 is compared with that of Reference Examples 1 to 6, and it can be compared, regardless of its PH: = The chemically treated water and the reference example only have the addition of a catalyst for electrolytic treatment: ^ Special: sexual reduction 'and whether it has a reducing activity of 1: 1 for methylene blue aqueous solution. In addition, the electrolytically treated water added with the catalysts 1 and 2 is transparent and bright. For example, the blue color of methyl blue disappears. In addition, Α 4 β & \ penetrates the moon and it can be seen that the blue color of Asia disappears. In addition, it is impossible to visually recognize methylene blue with the addition of catalysts such as 1, 2 and 6; visually confirming that a large amount of white lice / synthetic water can be used. Said 巳 / children (reduced methylene blue). () The color change of methylene jade is used to reduce the activity of hydrogen (2-A) by adding platinum colloid / palladium colloidal soluble water (degassing treatment + hydrogen sealing treatment) to the catalyst (2-A); )) Manufactured by Wako Pure Chemical Industries, Ltd. t ^ # ^ lMTris-HCl (PH7.4) ^ mMTris-HCHpH; i〇V ^ Diluted by 20 times with distilled water manufactured by Wako Pure Chemical Industries, Ltd. ^
Tris-HCl之50mM濃度水溶液。以下將該2種類之稀摆八 別稱為「基本水7.4」、「基本水9.〇」。再將田稀釋水刀Tris-HCl in 50 mM strength. These two types of sparse pendulums are hereinafter referred to as "basic water 7.4" and "basic water 9.0". Tian dilute the water knife
製之鈀膠體4%溶液〇.6g溶於和光純藥工業(股)公:=餾 水500mL之溶液稱為「把基準液」。又,鈀基準液之衣把濃 度C(Pd)係以與翻膠體相同之計算方式以?(1) = 〇. 6 X 0.04/500mL得到,為48mg/mL。 其次,採取基本水7· 4及基本水9〇各84mL,並分別加A solution of 0.6% of the prepared palladium colloid solution, 0.6 g, dissolved in Wako Pure Chemical Industries, Ltd. == 500mL of distilled water is called "reference solution". In addition, the concentration C (Pd) of the palladium reference solution is calculated in the same way as the colloid. (1) = 0.6 × 0.04 / 500mL, which is 48mg / mL. Next, take 84mL of basic water 7.4 and 90.
2030-5943-PF(Nl);Chiumeow.ptd 第49頁 2004135032030-5943-PF (Nl); Chiumeow.ptd p. 49 200413503
二ΪΛ之Γ/Λ液—’調製為含有121.7"濃度MB ,,本水7.4及基本水9.0。再將含有〇之基本水7 4及美 分別從其各別之脫氣瓶中各取5〇mL,以直 ς 覆進行3:欠封入氫氣的操作。此操作之:: 糸為去除虱/谷存水中氫氣以外之氣體成分。 t別採去依此所得到完成封入氫氣之細基本水7 4 :水9.0各3mL,ϋ將其於密閉系下投入事先已進行4 2 =石英比色管’再測定當銘基準液、鈀基準液、森 基準,與鈀基準液莫耳比約丨之混合溶液分別加入該石英The Γ / Λ solution of the two ΪΛ is prepared to contain 121.7 " concentration MB, 7.4 for water and 9.0 for basic water. Then take 50 mL of the basic water 74 containing 0 and each of them from their respective degassing bottles, and repeat the operation of 3: undersealing hydrogen in a straight line. This operation: 糸 is to remove gaseous components other than hydrogen in lice / valley water. Do not collect the fine basic water 7 4: Hydrogen 9.0 3mL each, and then put them in a closed system. 4 2 = Quartz colorimeter tube, and then measure the Dangming reference liquid and palladium reference. Liquid, Mori reference, mixed solution with Moore ratio of palladium reference solution
時之亞甲藍吸光度變化(ΔΑ572 ;波長572nm之吸夫 度變化)。 (2 - B );實施例之揭示 (實施例3 ) 以含MB氫溶存水(含MB基本水7· 4+脫氣處理+氫氣封入 處理)中鉑基準液之加入量僅為使鉑膠體濃度為19〇 之水溶液其亞甲藍吸光度變化(A57 2 )作為實施例3,結果 分別表示於第8圖、第9圖。 (實施例4)Change in absorbance of methylene blue at time (ΔΑ572; change in absorbance at wavelength 572nm). (2-B); Disclosure of Examples (Example 3) The amount of platinum reference solution added in MB-containing hydrogenated water (including MB basic water 7.4 + degassing treatment + hydrogen sealing treatment) is only to make the platinum colloid The change in absorbance (A57 2) of methylene blue in an aqueous solution at a concentration of 190 was taken as Example 3, and the results are shown in FIG. 8 and FIG. 9 respectively. (Example 4)
以含MB氫溶存水(含MB基本水9 · 〇+脫氣處理+氫氣封入 處理)中鉑基準液之加入量僅為使鉑膠體濃度為丨9〇 # g/L 之水溶液其亞甲藍吸光度變化(A572)作為實施例4,其結 果與實施例3對比表示於第8圖。又,實施例3與實施例4之 各樣本水其相異點在於pH。 (實施例5 )The amount of platinum reference solution in MB-containing hydrogen-containing dissolved water (MB-based basic water 9 · 0 + degassing treatment + hydrogen sealing treatment) is only the amount of platinum colloid solution whose concentration of platinum colloid is 丨 90 # g / L and its methylene blue The change in absorbance (A572) was taken as Example 4, and the results are shown in FIG. 8 in comparison with Example 3. The difference between each sample water in Examples 3 and 4 lies in pH. (Example 5)
200413503 五、發明說明(48) 以含MB氫溶存水(含MB基本水7. 4+脫氣處理+氫氣封入 處理)中翻基準液之加入量僅為使鉑膠體濃度為95 Vg/L之 水溶液其亞曱藍吸光度變化(A572 )作為實施例5,其結果 與實施例3對比表示於第9圖。又,實施例3與實施例5之各 樣本水其相異點在於鉑膠體濃度。 (實施例6 ) 以含MB氫溶存水(含MB基本水7· 4+脫氣處理+氫氣封入 處理)中把基準液之加入量僅為使鈀膠體濃度為444 “g/L 之水溶液其亞甲藍吸光度變化(A57 2 )作為實施例6,結果 分別表示於第1 〇圖、第11圖。 (實施例7) 以含MB氫溶存水(含mb基本水9.0 +脫氣處理+氫氣封入 處理)中鈀基準液之加入量僅為使鈀膠體濃度為444 # g/L 之水溶液其亞甲藍吸光度變化(A57 2 )作為實施例7,其結 果與實施例6對比表示於第1〇圖。又,實施例6與實施例7 之各樣本水其相異點在於pH。 (實施例8 ) 以含MB氫溶存水(含MB基本水7· 4+脫氣處理+氫氣封入 處理)中鈀基準液之加入量僅為使鈀膠體濃度為丨丨i # g/L 之水,液其亞甲藍吸光度變化(A57 2 )作為實施例8,其結 果與貝施例6對比表示於第1 1圖。又,實施例6與實施例8 之各樣本水其相異點在於鈀膠體濃度。 (實施例9 ) 於含MB氫溶存水(含MB基本水74 +脫氣處理+氫氣封入200413503 V. Description of the invention (48) The amount of the reference solution in the MB-containing hydrogenated water (including MB basic water 7.4 + degassing treatment + hydrogen sealing treatment) is only used to make the platinum colloid concentration 95 Vg / L The change in absorbance (A572) of the osmium blue solution of the aqueous solution was taken as Example 5, and the results are shown in FIG. 9 in comparison with Example 3. The difference between the sample waters of Examples 3 and 5 lies in the platinum colloid concentration. (Example 6) In MB-containing hydrogen-containing water (MB-containing basic water 7.4 + degassing treatment + hydrogen sealing treatment), the amount of the reference solution was added only to make the palladium colloidal concentration of 444 "g / L of the aqueous solution The change in absorbance of methylene blue (A57 2) was taken as Example 6, and the results are shown in Fig. 10 and Fig. 11. (Example 7) Hydrogen-containing water containing MB (basic water containing mb 9.0 + degassing treatment + hydrogen) Sealing treatment) The amount of palladium reference solution added was only the solution with an palladium colloid concentration of 444 # g / L, and its methylene blue absorbance change (A57 2) was taken as Example 7. The results are compared with Example 6 and shown in the first 〇. In addition, the difference between each sample water of Example 6 and Example 7 lies in the pH. (Example 8) MB-containing hydrogenated water (MB-containing basic water 7.4 + degassing treatment + hydrogen sealing treatment) The amount of palladium reference solution added is only water that makes the palladium colloid concentration 丨 丨 i # g / L, and its methylene blue absorbance change (A57 2) is taken as Example 8, and the result is compared with that of Example 6 Fig. 11 shows the difference between the sample waters of Example 6 and Example 8 in the palladium colloid concentration. (Example 9) In MB containing hydrogen Dissolved water (including MB basic water 74 + degassing treatment + hydrogen sealing
2030-5943-PF(Nl);Chiumeow.ptd 第51頁 200413503 五、發明說明(49) ί ί)水中:广翻上準:與把基準液莫耳比約為1的混合溶液 ϊϋ谷ϋΓ溶液加入量僅為使貴金屬、混合⑷ $二體〉辰度為160 “g/L,該水溶液亞甲藍 A57 )作為實施例9,矣吉果分別表示於第 (實施例 1 0 ) ^ 10 121 於氫溶存水(含MB基本水9〇 + 中加入與實施例9相同的混合溶液使成水2 = 夜Λ入Λ僅為使責金屬混合(舶+把)膠體濃度為丄 U,: 藍吸光度變化(Α572)作為實施例10, 果與貝施例9對比表示於第12圖。又,實施例9與實施 例1 0之各樣本水其相異點在於pH。 (實施例11) 於含MB氫溶存水(含MB基本水7 · 4+脫氣處理+氫氣封入 處,)中加入與實施例9相同的混合溶液使成水溶液,使混 合溶液加入量僅為使貴金屬混合(鉑+鈀)膠體濃度為8〇 # g/L ’該水溶液亞甲藍吸光度變化(A572 )作為實施例η, 其結果與實施例9對比表示於第丨3圖。又,實施例6與實施 例8之各樣本水其相異點在於貴金屬(鉑+鈀)膠體濃度。 (2-C);實施例之考察 對比實施例3、4之第8圖在ΡΗ7· 4及ρΗ9· 0之添加鉑膠 體之氫溶存水顯示有MB還原活性。依同圖,看不出因ρΗ不 同所產生之MB還原活性有很大差異,兩者都顯示有高的Μβ 還原活性。 對比實施例3、5之第9圖在鉑膠體濃度95 //g/L及95//2030-5943-PF (Nl); Chiumeow.ptd Page 51 200413503 V. Description of the invention (49) ί) Water: wide turn to the upper standard: a mixed solution with a reference solution with a molar ratio of about 1 ϊϋ 谷 ϋΓ solution The amount of addition is only to make the precious metal, mixed ⑷ $ 二 体> Chen degree is 160 "g / L, and the aqueous solution of methylene blue A57) is used as Example 9, and 矣 吉 果 is shown in (Example 1 0) ^ 10 121 The same mixed solution as in Example 9 was added to hydrogen-dissolved water (MB-containing basic water 90+) to make water 2 = night Λ into Λ only to make the metal mixed (ship + handle) colloidal concentration 丄 U ,: blue The change in absorbance (A572) was taken as Example 10, and the comparison between Example 9 and Example 10 is shown in Fig. 12. In addition, the difference between each sample water of Example 9 and Example 10 lies in pH. (Example 11) in The same mixed solution as in Example 9 was added to the MB-containing hydrogen-dissolved water (containing MB basic water 7.4 + degassing treatment + hydrogen sealing place) to make it into an aqueous solution, and the amount of the mixed solution was added only to mix the precious metals (platinum + The palladium) colloid concentration was 80 # g / L 'The absorbance change of methylene blue in the aqueous solution (A572) was taken as Example η, and the results were compared with Example 9 It is shown in Fig. 3. In addition, the difference between each sample water of Example 6 and Example 8 lies in the colloidal concentration of precious metal (platinum + palladium). (2-C); Examination of Examples Comparative Examples 3 and 4 Figure 8 shows MB reduction activity in hydrogen-soluble water with added platinum colloid at pH 7 · 4 and ρΗ9 · 0. According to the same figure, there is no significant difference in MB reduction activity due to different ρΗ, both of which Shows high Mβ reduction activity. The ninth graphs of Comparative Examples 3 and 5 show platinum colloidal concentrations of 95 // g / L and 95 //
2030-5943-PF(Nl);Chiumeow.ptd 2004135032030-5943-PF (Nl); Chiumeow.ptd 200413503
g/L之^加翻膠體之氫溶存水顯示有龍還原活性。依該 圖’當銷膠體濃度高時MB還原活性也變高。此可被認為要 使MB還原活性提高的話,將鉑膠體濃度提高是有效的。 一,比實施例6、7之第10圖在ΡΗ7· 4及ρΗ9· 0之添加鉑膠 體之氫溶存水顯示有MB還原活性。依同圖,看不出因ρΗ不 ,所產生之MB還原活性有很大差異,兩者都顯示有高的Μβ 還原活性。 對比實施例6、8之第11圖在鉑膠體濃度丨丨} 及G / L ^ plus colloidal hydrogen-dissolved water showed dragon reducing activity. According to this figure, when the pin colloid concentration is high, the MB reducing activity also becomes high. It can be considered that it is effective to increase the concentration of the platinum colloid in order to increase the MB reducing activity. First, compared with the tenth diagrams of Examples 6 and 7, MB-reducing activity was exhibited in hydrogen-soluble water in which Pl 7 · 4 and ρ 9 · 0 were added with platinum colloid. According to the same figure, it is not seen that there is a large difference in MB reduction activity due to ρΗ not, and both show high Mβ reduction activity. The eleventh graphs of Comparative Examples 6, 8 are shown in the platinum colloid concentration.
444 # g/L之添加鈀膠體之氫溶存水顯示有MB還原活性。依 該圖’當把膠體濃度高時MB還原活性也變高。此可被認為 要使MB還原活性提高的話,將鈀膠體濃度提高是有效的。 ,比實施例9、10之第11圖在ρΗ7· 4及ρΗ9· 〇之添加貴 金屬此合(鉑+鈀)膠體之氫溶存水顯示有Μβ還原活性。依 同圖,看不出因pH不同所產生之ΜΒ還原活性有很大差異, 兩者都顯示有高的ΜΒ還原活性。 〃 曲對比實施例9、11之第13圖在貴金屬混合(鉑+鈀)膠 =二"g/L及16〇 "g/L之添加貴金屬混合(鉑+鈀)膠體 搬子水顯不有MB還原活性。依該圖,當貴金屬混合(翻Hydrogen-soluble water with 444 # g / L added palladium colloid showed MB reduction activity. According to this figure, when the colloidal concentration is high, the MB reducing activity also becomes high. This is considered to be effective in increasing the palladium colloid concentration in order to increase the MB reducing activity. Compared with the eleventh figures of Examples 9, 10, the hydrogen-soluble water containing the noble metal (platinum + palladium) colloid added to ρΗ7 · 4 and ρΗ9 · 〇 showed Mβ reducing activity. According to the same figure, it is not seen that there is a great difference in the reducing activity of MB due to different pH, and both show high reducing activity of MB. Fig. 13 of Comparative Example 9, 11 in the precious metal mixed (platinum + palladium) glue = two " g / L and 16〇 " g / L No MB reducing activity. According to the figure, when precious metals are mixed (turned
二)膠體濃度高時MB還原活性也變高。此可被認為要使MB) MB reducing activity becomes higher when the colloidal concentration is high. This can be thought of as making M
,二活性提高的話,將貴金屬混合(鉑+鈀)膠體濃度提高 疋有效的。 夕MR ί者:若將第8圖(實施例3、4 ; $加鉑膠體氫溶存水 逛舌性)與第1 0圖(實施例6、7 ;添加鈀膠體氫溶存 7之Β還原活性)對比’可了解雖然實施例3、4之濃度較If the two activities are increased, it is effective to increase the colloidal concentration of the precious metal (platinum + palladium) 疋. Evening MR: If Figure 8 (Examples 3 and 4; Tongue addition of platinum colloidal hydrogen-soluble water) and Figure 10 (Examples 6 and 7; Addition of palladium colloidal hydrogen to dissolve 7B) ) Comparison 'can understand that although the concentration of Examples 3 and 4
200413503200413503
低,但顯示與實施例6、7有同等之MB還原活性。再者,若. 將兩者之莫耳濃度(#M)對比,鉑膠體為〇·98 而鈀膠體·· 為4· 1 7 // Μ,以鉑膠體較低。由此,對本發明之貴金屬催 化劑所期待之MB還原活性以得到同等ΜΒ還原活性且使用量 較少便可的含意看來,可以說鉑膠體優於鈀膠體。 另一方面,若將第8圖(實施例3、4 ;添加鉑膠體氫溶 存水之MB還原活性)與第丨2圖(實施例9、;[ 〇 ;添加貴金屬 混合(鉑+鈀)膠體氫溶存水之〇還原活性)對比,可了解兩 者皆顯示良好之MB還原活性。將兩者之莫耳濃度(#M)對 比’翻膠體為0.98//M而貴金屬混合(翻+把)膠體為1〇 了# _ Μ,兩者大約相同。由此,對本發明之貴金屬催化劑所期 待之MB還原活性,可以說鉑膠體與貴金屬混合(鉑+鈀)膠 體大約同等。 ^ (3 )以亞甲藍之呈色變化作添加鉑膠體催化劑電解處理水 (電解處理前添加/電解處理後添加)之還原活性評價 (3 - A);還原力評價試驗步驟 調製與上述(1—A)中同樣之基本水6. 86 20 0 0mL,並於 其中的1 OOOmL中加入鉑基準液4mL,以調製含鉑膠體之基 本水6· 86約1公升。另外100OmL先不要加鉑膠體。依此, 調製不含翻膠體之基本水686約1公升,及含鉑膠體之基 t 本水6 · 8 6約1公升。 其次’對兩樣本各別進行電解處理,得到電解處理水 (氩溶存水),分別僅採取2· 8 6mL,並投入事先已進行氫氣 置換之石英比色管,再測定當鉑基準液、鈀基準液、鉑基It is low, but shows the same MB reducing activity as that of Examples 6 and 7. Furthermore, if the molar concentration (#M) of the two is compared, the platinum colloid is 0.98 and the palladium colloid is 4.17 // M, which is lower for platinum colloid. Therefore, it can be said that the platinum colloid is superior to the palladium colloid in the meaning that the MB reduction activity expected for the precious metal catalyst of the present invention can obtain the same MB reduction activity with a small amount of use. On the other hand, if Figure 8 (Examples 3 and 4; MB reduction activity of platinum colloidal hydrogen-soluble water) is added and Figure 丨 2 (Example 9; [〇; adding precious metal mixed (platinum + palladium) colloids Compared with hydrogen-soluble water (reduction activity of 0), it can be understood that both show good MB reduction activity. Comparing the molar ratio (#M) of the two to the colloidal colloid is 0.98 // M and the precious metal mixed (transposed + colloidal) colloid is 10 μM, which is about the same. Therefore, it can be said that the platinum colloid and the precious metal mixed (platinum + palladium) colloid are expected to have the MB reduction activity expected from the precious metal catalyst of the present invention. ^ (3) Evaluation of reduction activity of electrolyzed water (added before electrolysis treatment / added after electrolysis treatment) by adding a color change of methylene blue to a platinum colloidal catalyst (3-A); The test procedure of the reduction power evaluation was prepared in accordance with the above ( 1—A) 6.86 200 0 mL of the same basic water, and 4 mL of platinum reference solution was added to 1 000 mL of it to prepare about 1 liter of platinum colloid-containing basic water 6.86. Another 100OmL do not add platinum colloid. Based on this, about 1 liter of base water containing no colloid is prepared, and about 1 liter of base water containing platinum colloid t 6 6 8 6 is prepared. Secondly, two samples were subjected to electrolytic treatment to obtain electrolytically treated water (argon-dissolved water). Only 2.8 mL of each was taken and put into a quartz colorimetric tube that had been replaced with hydrogen in advance. Then the platinum reference solution and palladium were measured. Reference solution, platinum
2030-5943-PF(Nl);Chiumeow.ptd 第54頁 200413503 五、發明說明(52) 準液與鈀基準液莫耳比約1之混合溶液分別加入該石英比 色管時之亞曱藍吸光度變化(ΛΑ5 7 2 ;波長572nra之吸光度 變化)。 然後,於無鉑膠體之比色管中將僅添加已封入事先經 脫氣過氫氣之亞甲藍水溶液lg/LO· 14mL。再將兩個比色管 安放在分光光度計中並待機。 接著,在無鉑膠體之比色管中添加濃度為48mg/L之鉑 膠體溶液2 // L ’另在含始膠體之比色管中添加已封入事先 經脫氣過氫氣之亞甲藍水溶液lg/LO· 14mL,並開始用分光 光度計測定兩比色管溶液。又,添加在兩比色管内之翻膠 體濃度分別約調製為約182 //g/L。 (3-B);實施例之揭示 (實施例1 2 ) 以先添加催化劑電解處理水(含Μ B基本水6 · 8 6 +電解前 添加鉑膠體)在測定開始到30分為止之亞甲藍吸光度 (Α5 72 ;波長572nm之吸光度)最小值作為實施例12,結果 表示於第14圖。 (實施例1 3 ) 以後添加催化劑電解處理水(含MB基本水6.86+電解後 添加翻膠體)在測定開始到30分為止之亞甲藍吸光度 (A5 72 )最小值作為實施例13,並將結果與實施例12作 表示於第14圖。 (3 - C);實施例之考察 對比貝軛例1 2、1 3之第1 4圖顯示鉑膠體添加時期(電2030-5943-PF (Nl); Chiumeow.ptd Page 54 200413503 V. Description of the invention (52) The mixed solution of the quasi-liquid and palladium reference solution with a molar ratio of about 1 was added to the quartz cuvette when the absorbent was blue Change (ΛΑ5 7 2; absorbance change at wavelength 572nra). Then, only a methylene blue aqueous solution lg / LO · 14mL which had been sealed with hydrogen gas previously degassed was added to the cuvette without platinum colloid. Place two more cuvettes in the spectrophotometer and wait. Next, add a platinum colloid solution with a concentration of 48 mg / L to a platinum colloid-free colorimetric tube 2 // L 'Add another methylene blue aqueous solution that has been degassed with hydrogen beforehand to the colorimetric tube containing the original colloid lg / LO · 14mL, and started to measure the two cuvette solutions with a spectrophotometer. In addition, the colloidal concentrations added to the two colorimetric tubes were respectively adjusted to about 182 // g / L. (3-B); Disclosure of Examples (Example 1 2) The catalyst was electrolyzed by adding a catalyst (containing BM basic water 6. 8 6 + platinum colloid before electrolysis) before the measurement. The minimum value of the blue absorbance (A5 72; absorbance at a wavelength of 572 nm) was taken as Example 12, and the results are shown in FIG. 14. (Example 1 3) The minimum value of the methylene blue absorbance (A5 72) from the beginning of the measurement to 30 minutes after the addition of a catalyst electrolytically treated water (including MB basic water 6.86 + addition of colloid after electrolysis) was taken as Example 13, and The results are shown in Fig. 14 as in Example 12. (3-C); Examination of the Examples Comparative Figures 14 and 14 of Example 1 show the period of platinum colloid addition (electrical
200413503200413503
解處理前或後)不同時之電解還原水其MB還原活性。依 =,可了解在電解處理前添加鉑膠體得到較高之0還原°活 '。理由目前正在追蹤調查,但推測是來自作為MB還活 性根本之活性化氫會使電解處理水中之氧等氧化物所且有 化物無效化的原故。這是將含鉑膠體之活性碳處理 =為原水,施以電解處理後,於電解處理後瞬間計測 ^理水之溶存氧濃度,由該電解處理水之溶存氧濃度幾 為〇之結果所推導出的推論。依此,不僅限於電解處理 例子,可認為在氫氣封入處理或氫氣氣泡處理時,處理二 添加催化劑(鉑膠體)在可得到較高MB還原活性之觀點别 將氧等氧化物質所帶有之氧化力無效化而來)上是較佳< 的。再者,藉對原水進行添加還原劑之處理以得到氫1容 水之情形中,亦可認為先添加鉑膠體於原水中與上述同 樣’由得到較高MB還原活性之觀點上,是較佳的。又, 化劑不僅限於鉑膠體,鈀膠體,或鉑膠體與鈀膠體等之浐 合膠體也同樣的,在處理前添加催化劑由得到較高 : 活性之觀點上,是較佳的。 # U)以DPPH游離基之呈色變化作添加鉑膠體催化 理水之抗氧化活性評價 解處 (4 - A);抗氧化活性評價試驗步驟 與上述(1-A)中調製物質同樣,為分別檢查表2所示樣 本i〜viii共8種之各樣本水所具有之抗氧化活性,在各水 溶液16mL中,加入DPPH(0.l6g/L濃度)溶液4mL,使DppH莫 耳濃度調製為81.15( //M),並在添加DppH3分後,以分光、Before or after solution treatment) the MB reduction activity of the electrolytically reduced water at different times. According to =, it can be understood that adding a platinum colloid before electrolytic treatment results in a higher 0 reduction ° activity. The reason is currently under investigation, but it is presumed to be caused by the fact that activated hydrogen, which is fundamental to the reactivation of MB, invalidates the oxides and other oxides in the electrolytically treated water. This is the treatment of activated carbon containing platinum colloid = raw water, and after electrolytic treatment, the dissolved oxygen concentration of the treated water is measured immediately after the electrolytic treatment, and it is derived from the result that the dissolved oxygen concentration of the electrolytically treated water is almost zero. Inference. Based on this, it is not limited to the example of electrolytic treatment, and it can be considered that during the hydrogen sealing treatment or the hydrogen bubble treatment, the treatment 2 addition catalyst (platinum colloid) does not oxidize the oxidizing substances such as oxygen from the viewpoint of obtaining a high MB reduction activity Force is invalidated) is better. In addition, in the case of adding reducing agent to the raw water to obtain hydrogen 1 water-holding capacity, it can also be considered that it is better to add platinum colloid to the raw water as described above from the viewpoint of obtaining a higher MB reducing activity. of. In addition, the chemical agent is not limited to platinum colloid, palladium colloid, or a colloid of colloids such as platinum colloid and palladium colloid. The addition of a catalyst before the treatment is preferred from the viewpoint of higher activity. # U) Use the color change of DPPH free radicals as the solution to evaluate the antioxidant activity of adding platinum colloid to catalyze water treatment (4-A); the test procedure for evaluating the antioxidant activity is the same as the preparation of the substance in (1-A) above, as Check the antioxidant activity of each of the eight sample water samples i to viii shown in Table 2. In 16 mL of each aqueous solution, add 4 mL of DPPH (0.16 g / L concentration) solution to adjust the DppH molar concentration to 81.15 (// M), and after adding DppH3 points,
200413503 五、發明說明(54) 光度計測定各樣本水溶液之DPPH吸光度變化(△ΑδΜ ;波 長540ηηι之吸光度變化)。 (4-Β);參考例及實施例之揭示 (參考例7 ) 以樣本水1之無添加催化劑水溶液(基本水6 · 8 6 )中加 入DPPH後之水溶液其DPPH吸光度差(△Μ")作為參考例 7,結果表不於第15圖。又,同圖tDppH吸光度變化(△ A540 )係表不相對於樣本丨(背景值)之吸光度,與樣本 1〜viii之吸光度差異(AA540 )。故,參考例了之⑽”吸光 度變化(△A540 )為〇。 (參考例8 ) 以樣本水ii之添加催化劑水溶液(基本水6· 86+鉑基準 中加入DPPH後之水溶液其DPPH吸光度變化(△““)作 為參考例8,結果表示於第丨5圖。 (參考例9 ) 以樣本水iu之無添加催化劑電解處理水(基本水 6·86 +電解處理)中加入Dppjj始夕I, f i 後水浴液其DPPH吸光度變化 (4 0 )作為參考例9,結果表示於第丨5圖。 (實施例1 4 ) 解卢1樣@本其水Γ之添加催化劑電解處理水(基本水6. 86+電 40) ^ i f ^DPPH ^ ^ ^ ^ ^ ^DPPH ^ ^ ^ « (參考例1 0 ) 2030-5943-PF(Nl);Chiunieow. ptd 第57頁 200413503 五、發明說明(55) 以樣本水v之無添加催化劑電解處理水(基本水9. 18) 中加入DPPH後之水溶液其DPPH吸光度變化(作為參 考例1 0,結果表示於第1 6圖。又,同圖中dpph吸光度變化 (△A540)係表示對樣本v(背景值)之吸光度,與樣本 i〜viii之吸光度差異(^4540 )。故,參考例1〇之DPPH吸光 度變化(△A540 )為0。 (參考例1 1 ) 以樣本水vi之添加催化劑電解處理水(基本水9. ι8+鉑 基準液)中加入DPPH後之水溶液其dpph吸光度變化(△200413503 V. Description of the invention (54) The photometer measures the DPPH absorbance change of each sample aqueous solution (ΔΑδΜ; absorbance change of wavelength 540ηη). (4-B); Disclosure of Reference Examples and Examples (Reference Example 7) The DPPH absorbance of the aqueous solution after adding DPPH to sample water 1 without added catalyst solution (basic water 6 · 8 6) has poor DPPH absorbance (△ M ") As a reference example 7, the results are shown in FIG. 15. In addition, the tDppH absorbance change (ΔA540) in the same figure indicates the difference between the absorbance of the sample (background value) and the absorbance of samples 1 to viii (AA540). Therefore, the change in absorbance (ΔA540) of the reference example is 0. (Reference Example 8) The sample solution ii was added with an aqueous catalyst solution (basic water 6.86 + platinum), and the DPPH absorbance change of the aqueous solution after adding DPPH ( △ "" is used as Reference Example 8 and the results are shown in Fig. 5 (Reference Example 9) Dppjj 初 夕 I was added to the sample water iu without added catalyst electrolytically treated water (basic water 6.86 + electrolytic treatment), The change in DPPH absorbance (40) of the water bath after fi is used as Reference Example 9 and the results are shown in Figure 5 (Example 1 4) Xie Lu 1 sample @ 本 其 水 Γ with a catalyst electrolyzed water (basic water 6 86+ D40) ^ if ^ DPPH ^ ^ ^ ^ ^ ^ DPPH ^ ^ ^ «(Reference Example 1 0) 2030-5943-PF (Nl); Chiunieow. Ptd Page 57 200413503 V. Description of the Invention (55) The DPPH absorbance of the aqueous solution after adding DPPH to sample-free water (with basic catalyst 9.18) was treated with sample water v (as reference example 10, the results are shown in Figure 16). Also, the dpph absorbance in the same figure The change (△ A540) indicates the absorbance of sample v (background value), which is different from the absorbance of samples i to viii. (^ 4540). Therefore, the DPPH absorbance change (△ A540) of Reference Example 10 is 0. (Reference Example 1 1) In the sample water vi, the catalyst is electrolyzed with water (basic water 9. 8 + platinum reference solution). Dpph absorbance change of aqueous solution after adding DPPH (△
A 5 4 0 )作為參考例11,其結果表示於第1 6圖。 (參考例1 2 ) 以樣本水v i i之無添加催化劑電解處理水(基本水 9.18+電解處理)中加入DPPH後之水溶液其DPPH吸光度變化 (ΛΑδΑΟ )作為參考例1 2,結果表示於第μ圖。 (實施例1 5 ) 以樣本水ν i i i之添加催化劑電解處理水(基本水9. 1 8 + 電解處理+鉑基準液)中加入DPPH後之水溶液其DPPH吸光度 變化(△ A 5 4 0 )作為實施例1 5,其結果與參考例1 〇〜1 2對 比,表示於第16圖。A 5 4 0) is referred to Reference Example 11, and the results are shown in FIG. 16. (Reference Example 1 2) The DPPH absorbance change (ΛΑδΑΟ) of the aqueous solution after adding DPPH to the sample water vii without added catalyst electrolysis-treated water (basic water 9.18+ electrolytic treatment) was taken as Reference Example 12 and the results are shown in Figure μ . (Example 1 5) The DPPH absorbance change (△ A 5 4 0) of the aqueous solution after adding DPPH to the sample electrolyzed water (basic water 9. 1 8 + electrolytic treatment + platinum reference solution) added with sample water ν iii was used as The results of Example 15 are compared with those of Reference Examples 10 to 12 and shown in FIG. 16.
(4 - C );實施例之考察 將實施例1 4、1 5之結果與參考例7〜1 2對比並考察,在 基本水6. 86與基本水9· 18兩者中實施例14、15之添加催化 劑電解處理水與參考例7〜1 2比較,顯示DPPH游離基特異性 的消去且顯示高抗氧化活性或游離基消去活性。順帶一(4-C); Examination of the Examples The results of Examples 14 and 15 were compared with Reference Examples 7 to 12 and examined. Example 14, Compared with Reference Examples 7 to 12, the electrolytically treated water with the added catalyst of 15 showed specific elimination of the free radicals of DPPH and showed high antioxidant activity or free radical elimination activity. By the way
2030-5943-PF(Nl);Chiumeow.ptd 第58頁 200413503 五、發明說明(56) — 提,鉑膠體催化劑係在電解處理前添加。又,如第丨5圖所 不,參考例9雖為無添加催化劑電解處理水,仍可認為有 DPPH游離基消去活性。此可認為暗示在有高濃度氫溶存之 電解處理水中,依其pH等條件,即使沒有催化劑之幫助也 可期待展現抗氧化活性。 (5)以DPPH游離基之呈色變化作添加催化劑氫溶存水(脫氣 處理+鼠氣封入處理)之抗氧化活性評價 、 (5 - A )’抗氧化活性評價試驗步驟 與上述(2-A)同樣,準備「基本水7· 4」、「基本水9· 〇」,接著,採取40 6 //M DPPH溶液與基本水7. 4及基本水 9. 0各5OmL ’以真空幫浦脫氣1〇分後反複進行3次封入氫氣 1 0分之操作。又,此操作之目的係去除氫溶存水中除氫氣 以外之氣體成分。 ' 採取依此所得到之完成封入氫氣之DPPH溶液〇· 3mL與 基本水7.4與基本水9·〇各2.7 mL,並在密閉系下投入事先 以氫氣置換的石英比色管,以分光光度計於跨越3 〇分鐘内 分別測定前者與在相同比色管中不添加鉑基準液者此兩者 在DPPH之吸光度變化(^4540 ;波長540nm時之波長變 化)。 (5 - B ),實施例之揭示 (參考例1 3 ) 以氫溶存水(基本水7· 4 +脫氣處理+氫氣封入處理)中 不加鉑基準液之水溶液其DPPH之吸光度變化(A54〇)作為參 考例1 3,結果表示於第1 7圖。2030-5943-PF (Nl); Chiumeow.ptd page 58 200413503 V. Description of the invention (56) — mention that the platinum colloidal catalyst is added before electrolytic treatment. In addition, as shown in FIG. 5, although Reference Example 9 is electrolysis-treated water without the addition of a catalyst, it is still considered to have DPPH radical elimination activity. This is considered to imply that, in the electrolytically-treated water in which a high concentration of hydrogen is dissolved, depending on conditions such as pH, an antioxidant activity can be expected to be exhibited without the help of a catalyst. (5) Evaluation of the antioxidant activity of the hydrogenated water (degassing treatment + rat gas sealing treatment) with the addition of the color change of the DPPH radical as the catalyst, (5-A) 'Antioxidant activity evaluation test steps and the above (2- A) Similarly, prepare "basic water 7.4" and "basic water 9.0", and then take 40 6 // M DPPH solution and basic water 7.4 and basic water 9.0 each 5OmL 'to vacuum pump After degassing for 10 minutes, the operation of sealing with hydrogen for 10 minutes was repeated 3 times. The purpose of this operation is to remove gaseous components other than hydrogen from the hydrogen-soluble water. '' Take the DPPH solution sealed with hydrogen, 0.3 mL, 7.4 mL of basic water, 2.7 mL of basic water, and 2.7 mL of basic water each, and put a quartz colorimetric tube replaced with hydrogen in a closed system in a spectrophotometer. The change in DPPH absorbance (^ 4540; wavelength change at wavelength 540nm) of the former and those without the addition of a platinum reference solution in the same colorimetric tube were measured within 30 minutes. (5-B), the disclosure of the examples (Reference Example 1 3) The DPPH absorbance change of an aqueous solution containing no platinum reference solution in hydrogen-soluble water (basic water 7.4 + degassing treatment + hydrogen sealing treatment) (A54 〇) As Reference Example 13, the results are shown in Fig. 17.
2030-5943-PF(Nl);Chiumeow.ptd 第59頁 2004135032030-5943-PF (Nl); Chiumeow.ptd p. 59 200413503
(實施例1 6) 以氫/合存水(基本水7.4 +脫氣處理+氫氣封入處理)中 祐基準液之加人量僅為使麵膠體濃度為i9()#g/L之水溶液 其DPPH之吸光度變化(A540 )作為實施例16 ’其結果與實施 例13對比表示於第17圖。又,參考例13與實施例16之相显 點在於有無添加鉑膠體。 〃 (參考例1 4) 以氫溶存水(基本水9. 0+脫氣處理+氫氣封入處理)中 不加鉑基準液之水溶液其DPPH之吸光度變化(A54〇)作為來 考例1 4 ’結果表不於第1 8圖。 (實施例1 7) 以氫溶存水(基本水9· 0 +脫氣處理+氫氣封入處理)中 鉑基準液之加入量僅為使鉑膠體濃度為19〇 #g/L之水溶液 其DPPH之吸光度變化(A540 )作為實施例17,其結果與參考 例1 4對比表示於第1 8圖。又,參考例丨4與實施例丨7之相異 點在於有無添加鉑膠體。 (5-C);實施例之考察 將參考例13與實施例16對比之第17圖顯示在以有無添 加翻膠體為相異點之p Η 7 · 4中,氫溶存水有d ρ ρ η游離美消 去活性。依該圖,沒有鉑膠體之參考例1 3、;[ 4只能看&到在 測定時間(30分)内自然褪色程度之吸光度變化,但含有翻 膠體之貫施例1 6、1 7可觀察到超過自然複色程度之明顯 D P P Η游離基消去活性。又’未觀察到因p Η不同產生在j) ρ ρ η 游離基消去活性上之級差。(Example 1 6) The addition amount of Zhongyou reference solution with hydrogen / combined water (basic water 7.4 + degassing treatment + hydrogen sealing treatment) is only an aqueous solution with a colloidal concentration of i9 () # g / L. The change in absorbance (A540) of DPPH is shown in FIG. 17 as the result of Example 16 ′ compared with Example 13. The significant difference between Reference Example 13 and Example 16 is the presence or absence of the addition of a platinum colloid.参考 (Reference Example 1 4) Taking the DPPH absorbance change (A54〇) of an aqueous solution without adding a platinum reference solution in hydrogen-soluble water (basic water 9.0 + degassing treatment + hydrogen sealing treatment) as a case study example 1 The results are shown in Figure 18. (Example 17) The amount of platinum reference solution in hydrogen-dissolved water (basic water 9.0 + degassing treatment + hydrogen sealing treatment) is only the DPPH of an aqueous solution with a platinum colloid concentration of 19 # g / L. The change in absorbance (A540) was taken as Example 17, and the results are shown in FIG. 18 in comparison with Reference Example 14. The difference between Reference Example 4 and Example 7 is the presence or absence of the addition of a platinum colloid. (5-C); Examination of Examples The 17th figure comparing Reference Example 13 with Example 16 shows that in p Η 7 · 4 with or without the addition of colloids, the hydrogen-soluble water has d ρ ρ η Free beauty eliminates activity. According to the figure, there is no reference example 1 of platinum colloid 3; [4 can only see the change in absorbance to the degree of natural discoloration within the measurement time (30 minutes), but the conventional examples 1 and 1 7 containing colloid Obvious DPP (R) free radical elimination activity exceeding the degree of natural complexion was observed. No difference was observed in the radical elimination activity of j) ρ ρ η due to the difference in p Η.
2030-5943-PF(Nl);Chiumeow.ptd2030-5943-PF (Nl); Chiumeow.ptd
200413503 五、發明說明(58) 添加催化劑酵素氫激酶之氫溶存 其次,分別以實施例與參考例j還原活性評價試驗 存水中加入催化劑氫激酶時^ =對於在本發明氫溶 不活性分子狀氫活化所展現之‘原活'::容f水:所含化學 價試驗中與添加貴金屬膠體氫溶存水。還原活性評 同樣,使用還原氧化色素亞甲藍 原活性評價試驗 還原活性評價原理因為和前述在貴二二,化對象。此時之 者相同,故省略重複說明。 、屬勝體催化劑已說明 (6 )以亞甲藍之呈色變化作添加催化劑斤— 水(脫氣處理+氫氣封入處理)之還原活性評=激酉母幻谷存 (6-A);還原活性評價試驗步驟 貝 與上述(2-A)同樣,準備「基本水7 4」、「美 0」,並採取基本水7.4及基本水9〇各84社,並各1加入濃. ΐίϋ之ΓΛ溶液4mL,各調製成濃度i2i.?mM之含Μ基本 水7·4及基本水9·〇。其次,採取含〇基本水7彳及美本水 9·0各5〇mL,以真空幫浦脫氣1〇分後反複進行3次封i入氫氣 1 0分之操作。又,此操作之目的係去除氫溶存水中除氫氣 以外之氣體成分。#外,將濃度! 2 5 "之氫激酶以蒸顧水 稀釋4倍後投入lmL用之微膠囊,並在同膠囊内封入氮氣 (不活性氣體)以除去氧氣。 " 採取依此所得到之完成氫氣封入之含心基本水7· 4及 基本水9· 0各3mL,將該等於密閉系下投入已事先進行氫氣 置換之石英比色管,測定與如上述調製好之氫激酶溶液加 入同石英比色管時其亞曱藍之吸光度變化(ΑΜΚ)。 2030-5943-PF(Nl);Chiumeow.ptd 第61頁 200413503 五、發明說明(59) (6 - B );參考例及實施例之揭示 (實施例1 8 ) 以在含MB氫溶存水(含mb基本水7· 4+脫氣處理+氫氣封 入處理)中加入如上述調製之氫激酶溶液丨〇 # L後之水溶液 其亞甲藍吸光度變化(A 5 7 2 )作為實施例1 8,結果表示於第 1 9圖。 (參考例1 5 ) 以在含MB氫溶存水(含mb基本水7· 4+脫氣處理+氫氣封 入處理)中不添加氫激酶溶液之水溶液其亞甲藍吸光度變 化(A 5 7 2 )作為參考例1 5,其結果與實施例丨8對比表示於第 1 9圖。又’貫施例1 8與參考例丨5之各樣本水其相異點在於 有無添加氫激酶酵素。 (實施例1 9 ) 以在含MB氫溶存水(含mb基本水9·〇 +脫氣處理+氫氣封 入處理)中加入如上述調製之氫激酶溶液1〇 後之水溶液 其亞曱藍吸光度變化(A5 72 )作為實施例丨9,結果表示於第 20圖。 (參考例1 6 ) 以在含MB氫溶存水(含mb基本水9· 〇+脫氣處理+氫氣封 入處理)中不添加氫激酶溶液之水溶液其亞曱藍吸光度變 化(A 5 7 2 )作為參考例1 6,其結果與實施例丨9對比表示於第 20圖。又,實施例19與參考例16之各樣本水其相異點在於 有無添加氫激酶酵素。 (6-C);實施例之考察200413503 V. Description of the invention (58) Hydrogen dissolution followed by the addition of the catalyst enzyme hydrogen kinase, and the reduction activity of the examples and reference examples were evaluated respectively. When the catalyst hydrogen kinase was added to the storage water, ^ = For the insoluble molecular hydrogen that is hydrogen-soluble in the present invention Activation of the "original activity" :: capacity f water: contained in the valence test with the addition of precious metal colloid hydrogen dissolved water. Reduction activity evaluation Similarly, the reduction activity of methylene blue was evaluated using the original oxidative pigment. The principle of reduction activity evaluation is the same as that described above in Guigui. This is the same at this time, and duplicate descriptions are omitted. The catalyst that belongs to the catalyst has been explained (6) The reduction activity of methylene blue is used as an additive catalyst — the reduction activity of water (degassing treatment + hydrogen sealing treatment) = stimulating mother magic valley deposit (6-A); The reduction activity evaluation test procedure is the same as the above (2-A). Prepare "basic water 7 4" and "beauty 0", and take basic water 7.4 and basic water 90 each from 84 companies, and add 1 each. Ϊ́ίϋ 之4 mL of ΓΛ solution, each prepared to a concentration of i2i.?mM of M-containing basic water 7.4 and basic water 9.0. Next, 50 mL each of 0% of basic water and 90% of US water were used. After degassing by vacuum pump for 10 minutes, the operation of sealing and filling with hydrogen for 10 minutes was repeated 3 times. The purpose of this operation is to remove gaseous components other than hydrogen from the hydrogen-soluble water. # 外 , 将 浓 !! 2 5 " Hydrogen kinase was diluted 4 times with distilled water and put into 1 mL of microcapsules for use, and nitrogen (inert gas) was sealed in the same capsule to remove oxygen. " Take 3mL each of the heart-containing basic water 7.4 and basic water 9.0 that have been sealed with hydrogen obtained in this way, and put this into a closed system into a quartz colorimetric tube that has been replaced with hydrogen in advance. When the prepared hydrogen kinase solution is added to the quartz cuvette, the absorbance change of the osmium blue (AMK). 2030-5943-PF (Nl); Chiumeow.ptd Page 61 200413503 V. Description of the Invention (59) (6-B); Reference Examples and Disclosure of Examples (Example 18) to dissolve water in MB containing hydrogen ( 7. 4 + basic water containing mb + degassing treatment + hydrogen sealing treatment) After adding the hydrogen kinase solution prepared as described above to the ## L aqueous solution, its methylene blue absorbance change (A 5 7 2) was taken as Example 18, The results are shown in Figure 19. (Reference Example 15) The methylene blue absorbance change of an aqueous solution containing no hydrogen kinase solution in MB-containing hydrogenated water (including mb basic water 7.4 + degassing treatment + hydrogen sealing treatment) (A 5 7 2) As a reference example 15, the results are shown in FIG. 19 in comparison with the examples in Example 8. In addition, the difference between each sample water of Example 18 and Reference Example 5 lies in the presence or absence of the addition of a hydrogen kinase enzyme. (Example 1 9) The absorbance change of the osmium blue of the aqueous solution after adding the hydrogen kinase solution 10 prepared as described above to MB-containing hydrogen-containing water (containing mb basic water 9.0 + degassing treatment + hydrogen sealing treatment) (A5 72) is Example 9 and the results are shown in FIG. 20. (Reference Example 16) The absorbance change of osmium blue in an aqueous solution containing no hydrogen kinase solution in MB-containing hydrogenated water (including mb basic water 9.0 + degassing treatment + hydrogen sealing treatment) (A 5 7 2) As a reference example 16, the results are shown in FIG. 20 in comparison with the examples 9-9. The difference between the sample waters of Example 19 and Reference Example 16 is the presence or absence of the addition of a hydrogen kinase enzyme. (6-C); Examination of Examples
2030-5943-PF(Nl);Chiumeow.ptd 第62頁 200413503 五、發明說明(60) 察,可列1^1果與參考例15、16作對比並考 15、16比較起來,不二化劑氫溶存水與參考例 還原,且僅有添知: 異’可將亞甲藍專-性的 性。又,對亞甲駐^劑氮溶存水顯示具有高的還原活 有實施例丨: ι9ϊ;Γ:是否呈現藍色以目視確認時,只 辨認出亞甲藍之藍:m子水為無色透明,且可 看出亞甲藍之藍失又又4=151916無法以目視 =)存水可…視確認有 利用氧化還原色夸 > 条7 , ⑴構想之經、緯 乳化還原滴定之溶存氫濃度定量方法 理過Ϊ ΪIΪ人所開發之還原電位水生成裝置11所電解處 = = 氫氣:在電解處理水中丄 測:-俨因用'合存氫计總括測定。但此處之總括 理旦以杏1 ί ^虱計係利用在電解反應中將電化學之物 里一表方式轉換為溶存氫濃度的計測原理,依存於被 測定水液性等外部要因,計測值有變純大的^存於被 電解==上述實施例所作說明,在未添加催化劑於 劑電解處理7卜即使加入氧化型 抗氧化對象)該色素也不會呈現還 ,、^之呈色變化,但在添加催化劑於電解處理水之 添加催化劑電解處理水若加入色素,則可顯示該色素在還 第63頁 2030-5943-PF(Nl);Chiumeow.ptd 200413503 五、發明說明(61) _β SI有:呈色變化。即,氧化還原反應之氧化還原反 應可透過嬈“添加催化劑之電解處理素 溶液之呈色變化來視認。 早疋原邑素) 在反複進行試誤試驗中,本發明 劑之電解處理水所保持還原力愈大化;m化 藍從藍色到透明之呈色變化及 定原色素亞甲 發現,添加催化劑之電解产11仃的乂快的傾向。即 加入之氧化還原保持還原力與要將所 心了匕系兑ψ藍全部還原所消耗之 色πϊϊ者高時其差距即還原力相差之大小^ ;:還原色素亞曱藍之呈色變化反應速度間似有某種相r 由此見解肖在相關產業利用性 咅 發明人等想到透過氧化##主片 寻^研九後,本 定量分析添加催化劑之電解,搜f虱化還原反應,是否可 (溶存氫濃度)。 電解處理水所具有之顯在抗氧化力 關於將構想具體化,發現可提供一種氯 析方法’利用於隔離外都w 子又疋里分 金屬催化劑下將定操作,於存在貴 既定量與前述滴下量中之氫溶存量’並依前述 於該氫溶存水濃被檢定水氫溶存濃度。用 放之筒狀容器與從前述A:、置可由一端封閉另-端開 作活塞式移動之;=放;插入前述筒狀容器内可自由 狎子構成,為攪拌器用攪拌子可操作之隔 i 國 2030-5943-PF(Nl);Chiumeow.ptd 第64頁 200413503 五、發明說明(62) 離外部環境的不透氣试驗器,且為使在與外部隔離之狀態 下能夠對被以前述筒狀容器封閉端、内側壁及押子所隔出 之被檢定水收容室注入液體,以在前述筒狀容器封閉端、 内側壁及押子之任一者具有液體注入部。又,定量分析方 法可變形為於存在貴金屬催化劑下將既定濃度氧化還原色 素溶液滴入定量被檢定水中,由貴金屬催化劑使前述氧化 還原色素產生還原反應之邊色素達呈色變化速度取代以氧 化還原色素產生還原反應之該色素達呈色變化終點之滴下2030-5943-PF (Nl); Chiumeow.ptd Page 62 200413503 V. Description of the invention (60) Check, the results can be listed as 1 ^ 1 and compared with reference examples 15, 16 and compared with 15, 16 The agent hydrogen-soluble water was reduced with the reference example, and only the addition was known: iso 'can make methylene blue specific. In addition, there are examples of methylene chloride-containing nitrogen-soluble water showing high reducing activity. Examples: ι9ϊ; Γ: When blue is visually confirmed, only the blue of methylene blue is recognized: m-water is colorless and transparent And it can be seen that the blue loss of methylene blue is 4 = 151916 and it is impossible to store water visually ... visually confirms the use of redox color exaggeration > Article 7, the longitude and latitude emulsification reduction titration of dissolved hydrogen The concentration quantification method has been analyzed. The reduction potential of the electrolyzed water generating device 11 developed by the people = = Hydrogen: In the electrolytically treated water, the measurement is performed:-The factor is determined by using a total hydrogen meter. However, the summary here is based on the measuring principle of converting the electrochemical substance into a dissolved hydrogen concentration in a table manner in the electrolytic reaction using the apricot 1 虱 lice meter, which depends on external factors such as the water liquidity to be measured. If the value becomes pure, it will be stored in the electrolyzed == explained in the above example, the electrolysis treatment without adding a catalyst to the agent (even if an oxidation-type antioxidant object is added), the pigment will not appear. Changes, but if the catalyst is added to the electrolytically treated water, if the pigment is added to the electrolytically treated water, the pigment can be displayed on page 63. 2030-5943-PF (Nl); Chiumeow.ptd 200413503 V. Description of the invention (61) _β SI includes: color change. That is, the redox reaction of the redox reaction can be visually recognized by the "color change of the electrolytically treated element solution with the addition of a catalyst. Asahara Haramotosu") During repeated trial and error tests, the electrolytically treated water of the agent of the present invention is maintained. The greater the reducing power; the color change of m-blue from blue to transparent and the methylene blue dye found that the catalyst tends to produce 11% of the rapid reaction. That is, the added redox maintains the reducing power and the I understand that when the color of the dipper system is reduced to the full color of ψ blue, the difference is the difference in reducing power when the color πϊϊ is high ^ ;: there is a certain phase between the reaction speed of the color change of the reduced pigment methylene blue Xiao in the related industry, the inventors, etc. thought that after the research # 9 through the oxidation ## main film, this quantitative analysis of the addition of catalyst electrolysis, the feasibility of the reduction reaction (solubilized hydrogen concentration). It has obvious antioxidative power. Regarding the realization of the concept, it was found that it can provide a method for chlorination. It can be used to isolate the external catalyst and the metal catalyst. The amount of hydrogen dissolved in the dripping amount 'is determined according to the concentration of the hydrogen dissolved water in the hydrogen dissolved water. The cylindrical container and the A: can be closed by one end and the other can be opened for piston movement. ; = Put; inserted into the above-mentioned cylindrical container, can be freely made of dumplings, and is a partition that can be operated by a stirrer with a stirrer. Country 2030-5943-PF (Nl); Chiumeow.ptd Page 64 200413503 V. Description of the invention (62) An air-tight test device that is isolated from the external environment, and in order to be able to inject liquid into the test water storage room separated by the closed end of the cylindrical container, the inner side wall and the pier in a state of being isolated from the outside, Any one of the closed end, the inner wall, and the plunger of the cylindrical container has a liquid injection portion. The quantitative analysis method may be modified to drop a predetermined concentration of a redox pigment solution into a quantitative test water in the presence of a precious metal catalyst, and the precious metal The catalyst replaces the drop of the coloring change end point where the redox pigment produces a reduction reaction and the coloring change end point of the color reduction reaction with the redox pigment produces a reduction reaction
量為依據之定量分析,以作為定量被檢定水中氫溶存濃度 之方法。 X (B )實驗目的 卜利用以下實驗確認,對含有添加催化劑電解卢理k♦ 虱溶存水滴入既定濃度之氧化還原色处水之 溶液不再顯示還原呈色反應為止('以下右、’直到所滴入之 所添加之亞甲藍合計滴下量為溶 (:等價點」) 定量分析之尺度。 仔11 /辰度(潛在抗氧化力) (〇實效 ^ 容存氫濃度定量分析方法之概要 為疋S分析將催化劑加入本 水中所含化學不活性分子狀氣^ 時該氫溶存 氧化力)之實效量,即,定量八 斤展現之還原力(抗 DH(mg/L),使用翻膠體作為催\ /,效^溶存氫濃度 =原色素,對添加催化劑 气=甲藍作為氧 藍之氧化還原滴定。 )之虱洛存水進行亞甲 (D )實驗步驟 2030-5943-PF(Nl);Chiumeow.ptd 第65頁 200413503 五、發明說明(63) 基本實驗步驟係事先準備若干樣本水(已測過溶存氫 濃度等各特性值),將該等樣本水添加催化劑(鉑膠體)之 同時’進行亞甲藍之滴下處理。並且,對由各亞甲藍合計 滴下量等求得之溶存氫濃度實效值與以溶存氫計所得到之 實效值有無相關性進行比較評價。 兩者間如果有相關,則可認為以亞甲藍氧化還原滴定 定量分析溶存氫之濃度,及展現顯在抗氧化機能之關鍵物 質為溶存氫之事實,可以被客觀妥當的驗證。 依該基本考量,首先,準備調製為已述鉑基準液4〇倍 濃度之40倍濃度鉑基準液。該40倍濃度鉑基準液之鉑成分 漢度C(Pt)由計算式c(pt) = 24gx 0.04/500 mL求出為 192mg/L 〇 接著’準備lg/L濃度(體積莫耳濃度;2677.4 //M)之 亞曱藍水溶液與10 g/L濃度(體積莫耳濃度;26773.8 //M) 之亞曱藍水溶液。此處準備兩種不同濃度之亞甲藍是因為 依被假想之測定水中溶存之氫濃度添加不同亞曱藍濃度之 溶,I以減少該溶液之添加量,其結果,可期待實驗精密 度提咼。惟,鉑基準液之鉑濃度與亞甲藍水溶液之MB濃度 並不限定於此,可依被測定水中假想溶存之氫濃度作適當 調整。 其次,將如上述調製之4〇倍濃度鉑基準液5〇mL與濃度 不同之2種亞曱藍水溶液各50mL,分別採取到分開之脫氣 升瓦内,以真空泵脫氣1 〇分後,反複進行氮氣封入丨〇分之操 作,以調製氮氣置換後之40倍濃度麵基準液與亞甲藍水溶Quantitative analysis based on quantity as a method to quantify the hydrogen concentration in the test water. X (B) The purpose of the experiment is to use the following experiments to confirm that the solution containing the added catalyst electrolysis solution is no longer showing a reducing color reaction solution ('the following right,' until The total dropping amount of the added methylene blue added is dissolved (: equivalent point). It is the standard for quantitative analysis. Aberdeen 11 / Chen (potential antioxidant power) (0 Actual effect ^ Quantitative analysis method of stored hydrogen concentration The summary is the actual effective amount of the hydrogen-dissolving oxidizing power when the catalyst is added to the chemically inactive molecular gas contained in the water for 定量 S analysis, that is, the reducing power (anti-DH (mg / L)) exhibited by quantified eight pounds. The colloid acts as a catalyst, the effective concentration of dissolved hydrogen = the original pigment, and the redox titration of the addition of catalyst gas = methyl blue as the oxygen blue.) Lice store water is subjected to methylene (D) experimental steps 2030-5943-PF ( Nl); Chiumeow.ptd Page 65 200413503 V. Description of the invention (63) The basic experimental procedure is to prepare a number of sample water (the measured values of the dissolved hydrogen concentration and other characteristics), and add the sample water to the catalyst (platinum colloid) At the same time The methylene blue drop treatment is performed, and whether there is a correlation between the actual value of the dissolved hydrogen concentration obtained from the total dropping amount of each methylene blue, etc., and the actual value obtained in terms of the dissolved hydrogen is compared and evaluated. If there is any Related, it can be considered that the quantitative analysis of the dissolved hydrogen concentration by methylene blue redox titration, and the fact that the key substance exhibiting significant antioxidant function is dissolved hydrogen can be objectively and properly verified. According to this basic consideration, first, prepare A 40-fold concentration platinum reference solution having a 40-fold concentration of the previously described platinum reference solution was prepared. The platinum content of the 40-fold-concentration platinum reference solution, the degree C (Pt) of the platinum, was calculated from the formula c (pt) = 24gx 0.04 / 500 mL. 192mg / L 〇 Then 'prepared an aqueous solution of osmium blue at a concentration of lg / L (volume concentration; 2677.4 // M) and an aqueous solution of osmium blue at a concentration of 10 g / L (volume mol concentration; 26773.8 // M) The preparation of two different concentrations of methylene blue is based on the hypothetical determination of the concentration of hydrogen dissolved in water and the addition of different concentrations of methylene blue to reduce the amount of this solution. As a result, the experimental precision can be expected.提 咼。 However, platinum reference solution The platinum concentration and the MB concentration of the methylene blue aqueous solution are not limited to this, and can be appropriately adjusted according to the imaginary hydrogen concentration in the water to be measured. Secondly, a 50-fold concentration platinum reference solution 50 mL prepared as described above is different from the concentration 50mL each of two kinds of aqueous solutions of osmium blue were taken into separate degassing watts, degassed by a vacuum pump for 10 minutes, and then the operation of nitrogen sealing was repeatedly performed to adjust the 40-fold concentration surface after nitrogen replacement. The reference solution is soluble in methylene blue
第66頁 200413503 五、發明說明(64) 液。該操作目的 氣體成分。 接著,將被 起投入壓克力製 驗所製作,其構 狀中空管之長軸 部以形成底面, 小徑圓形板形成 側壁係為使由該 測定水收容室中 鉑基準液或MB溶 克力製圓筒形狀 液注入部被設計 將被測定水投入 於將押子由試驗 押子在不使被測 驗器之被測定水 態。又,當將40 器之被測定水收 入採取溶液,將 後,藉押針筒之 試驗器僅為最起 被測定水收容室 變、被測定水收 為去除各溶液中氮氣(不活性氣體)以外之 測定水20OmL與磁性攪拌器用之攪拌子一 之不透氣性試驗器内。該試驗器是為本實 造為活塞式封閉構造,係在壓克力製圓筒 方向上將壓克力製圓形板接著於一端之端 门寸其開放側利用較該管内握小之的極微 ^押子於長軸方向自由移動。該試驗器之 w式驗器之底面、内側壁及押子所區隔之被 可由外部環境在隔離狀態下注入40倍濃度 液’於該試驗器以放射方向往外設有由壓 之中空管所形成之溶液注入部。且,該溶 為針筒針插入用之橡皮塞可自由插拔。在 ,此組成之試驗器的被測定水收容室時係 器取下之狀態使被測定水安靜注入後,將 定水收容室内產生氣相下裝著。藉此,試 收f室内可以封閉在隔離外部環境之狀 ,,度麵基準液與亞甲藍水溶液投入試驗 容室$ ’儘量不要在針筒内產生氣相來吸 邊針筒針插入裝著在溶液注入部之橡皮塞 活塞輕輕的注入溶液。又,本處所揭示之 馬之 例’只要可滿足原料為不透氣性、 Y隔離外部環境、被測定水收容室體積可 谷室可保持氣密及液密、4 0倍濃度鉑基準Page 66 200413503 V. Description of the invention (64) fluid. The purpose of this operation is gas composition. Next, the jack was put into an acrylic laboratory. The long axis of the hollow tube was configured to form the bottom surface, and the small-diameter circular plate formed the side wall so that the platinum reference solution or MB in the measurement water storage chamber was formed. The cylindrical liquid injecting part made of Solco is designed to put the measured water into the test bait without putting the tester in the water state to be measured. In addition, when the measured water of 40 devices was collected into a solution, after that, the test device borrowing a syringe was changed only to the measured water storage room, and the measured water was collected to remove nitrogen (inert gas) from each solution. In addition to the airtightness tester of 20OmL of measuring water and a stirrer for magnetic stirrer. This tester is a piston-type closed structure, which is made by placing an acrylic circular plate in the direction of an acrylic cylinder at the end of one end. The open side is smaller than the grip inside the tube. Extremely small movers move freely in the long axis direction. The tester's w-type tester is separated from the bottom surface, the inner side wall and the quilt by an external environment and can be injected with 40 times the concentration of liquid in an isolated state. The formed solution injection portion. In addition, the rubber stopper for the syringe needle insertion can be inserted and removed freely. At this time, when the test water containing chamber of the tester with this composition is removed, the test water is quietly injected into the test water storage chamber, and then the fixed water storage chamber generates a gas phase. In this way, the test room can be closed to isolate the external environment. The surface reference solution and methylene blue aqueous solution are put into the test chamber. 'Try not to generate a gas phase in the syringe to suck the needle. The rubber stopper plunger of the solution injection part gently injects the solution. In addition, the example of the horse disclosed in this section ’as long as it can meet the requirements of raw materials being gas-tight, isolated from the external environment, and the volume of the water storage chamber can be measured.
200413503 五、發明說明(65) 液等可由外部環境以隔離狀態投 二!拌器用授拌子可操作等各種條件,亦可適當採用: 他的谷器。 /、 槌从二人、在上述放入被測定水之試驗器底面下放置磁性 見半口丄並以攪拌子開始攪拌。200413503 V. Description of the invention (65) Liquids can be cast in an isolated state from the external environment. The blender used in the mixer can be operated under various conditions, and it can also be appropriately used: His rice maker. / 、 From two people, put the magnet under the bottom surface of the tester in which the water to be measured is placed.
以朴ί : 5 5述已氮氣置換過之40倍濃度鉑基準液lmL 針请,入被測定水收容室並充分攪拌混合。 $著’將上述已氮氣置換過之既定濃度亞曱藍水 在-面以目視觀察呈色變化下用針筒少量逐次注入。若被 度較亞甲藍投入量多時,亞甲藍會還原 為…、t ’但亞曱血水溶液之投入量慢慢增加時,所加入之 ]亞曱皿由玉色艾到無色之呈色變化。若以 點,則由亞曱藍水溶液之亞甲获1寸邗馬寺饧 κ亞甲監/辰度與所加入亞曱藍水溶 液之a计I,可求出被測定水之溶存氫濃度讪。 (E )實效性溶存氫濃度之求法 “以:’由在被測定水中加入亞甲藍水溶液之濃度與合Take Pl: 5 and 5 mL of a 40-fold-concentration platinum reference solution with 1 mL of nitrogen that has been replaced with nitrogen, and then insert it into the water chamber to be measured and mix thoroughly. "着" The above-mentioned methylene blue water of a predetermined concentration which has been replaced with nitrogen gas is injected in a small amount successively with a syringe under the visual observation of the color change on the -side. If the amount of methylene blue is more than the amount of methylene blue, the methylene blue will be reduced to ..., t 'But when the amount of magenta blood solution is gradually increased, it is added] The magenta dish is from jade color to colorless Color change. If you use points, you can get 1-inch 邗 饧 寺 from the methylene solution of the aqueous solution of methylene blue. 饧 Methylene monitor / Chen degree and a meter I of the added methylene solution of blue water can be used to determine the dissolved hydrogen concentration of the measured water. . (E) Method for finding the effective concentration of dissolved hydrogen
s t ί ί,一 ΐ表不求出被測定水中實效性溶存氫濃度DH 5 計异式之導出過程,一面對實效性溶存氫濃度 DH之意義作說明。 首先,以下之說明中被測定水體積定為2_L,加入 被測定水之亞甲μ水溶液其亞甲M基體為 W—/L)。再者’以達到等價點為止所加入之亞甲藍水 浴液其總1為A(mL)則所加入亞甲藍分子其總量B(m〇i)變s t ί, once the table does not calculate the derivation process of the effective dissolved hydrogen concentration DH 5 in the measured water, the meaning of the effective dissolved hydrogen concentration DH will be explained. First, in the following description, the volume of the water to be measured is set to 2 L, and the methylene-M aqueous solution in which the water to be measured is added has a methylene M matrix of W- / L). Furthermore, in order to reach the equivalent point of the methylene blue water bath, if the total 1 is A (mL), the total amount of methylene blue molecules added (B (m〇i)) will change.
2030-5943-PF(Nl);Chiumeow.ptd 第68頁 200413503 五、發明說明(66) 成 B = N · A( //mol/Lx mL) =N · A(m // mo 1 )…(式 1 ) 若將亞甲藍分子之化學式定*MBC1,氫分子之化學式 定為札’則以翻膠體活化之氫分子與亞甲藍基分子在水溶 液中之反應可以用以下之反應式1表現。抓 H2+MBC1 —HC1+MBH ···(反應式1) 此處,HC1為鹽酸,MBH為還原型亞甲藍。依反應式 1 ’1莫耳氫分子與1莫耳亞甲藍分子反應,會生成1莫耳之 還原型亞甲藍分子。為說明電子授受,將反應式以半反應 式分離為兩式來寫,為如下。 H2 — H++ ( HH 2 e-)…(半反應式 1 ) MB+ + (H+ + 2e_) —MBH …(半反應式2) 半反應式1之意義為氫分子1莫耳放出2莫耳電子,半 反應式2之思義為亞曱藍陽離子1莫耳,即,亞甲藍1莫 耳,接受2莫耳電子。此處,氫分子1莫耳因為放出2莫耳 電子,故為2克當量,而,亞甲藍陽離子1莫耳,即,亞曱 藍1莫耳,因接受2莫耳電子,故為2克當量。結果是,氫 分子,與亞甲藍陽離子,即,亞甲藍之克當量數因為兩者 同為2 ’故氫分子與亞甲藍分子以莫耳比來說是1對1之反 應。 依此’加入上述被測定水之亞甲藍總量B也是所消耗 之氫分子總量。 因此’將待測氫分子總量(m # mol)定為C,則由上述2030-5943-PF (Nl); Chiumeow.ptd Page 68 200413503 V. Description of the invention (66) becomes B = N · A (// mol / Lx mL) = N · A (m // mo 1) ... ( Formula 1) If the chemical formula of the methylene blue molecule is set to * MBC1, and the chemical formula of the hydrogen molecule is set to Z ', the reaction of the colloid-activated hydrogen molecule and the methylene blue-based molecule in the aqueous solution can be expressed by the following reaction formula . H2 + MBC1 —HC1 + MBH (Reaction formula 1) Here, HC1 is hydrochloric acid, and MBH is reduced methylene blue. According to the reaction formula 1'1 Mole hydrogen molecule and 1 Mole methylene blue molecule react, will produce 1 Mole reduced methylene blue molecule. In order to explain the electron transfer, the reaction equation is divided into two equations as a semi-reaction equation and written as follows. H2 — H ++ (HH 2 e-) ... (half reaction formula 1) MB + + (H + + 2e_) —MBH… (half reaction formula 2) The meaning of half reaction formula 1 is that one mole of hydrogen molecule emits two moles of electrons, The meaning of semi-reaction formula 2 is 1 mole of methylene blue cation, that is, 1 mole of methylene blue, which accepts 2 moles of electrons. Here, 1 mole of hydrogen molecule is 2 gram equivalents because it emits 2 mole electrons, and 1 mole of methylene blue cation, that is, 1 mole of methylene blue, is 2 because it receives 2 moles of electrons. Gram equivalent. As a result, the hydrogen molecule and the methylene blue cation, that is, the number of gram equivalents of methylene blue are both 2 ', so the hydrogen molecule and the methylene blue molecule have a 1-to-1 reaction in terms of mole ratio. Based on this, the total amount of methylene blue B added to the water to be measured is also the total amount of hydrogen molecules consumed. Therefore, ‘set the total amount of hydrogen molecules to be measured (m # mol) to C, then
第69頁 200413503Page 69 200413503
式1得到 C = B = N · A(m // mol )…(式2) 再者’被測定水體積為2 〇 〇 mL,被測定水其實效氯分 子之體積莫耳濃度I (mol/L)為莫耳數C (mol)除以體^(1) 之值得到。 ' H2(mol/L) = C/ 200(m //mol/mL) = C/20 0 ( /zm〇l/L)…(式3) 進一步,將單位轉換為質量濃度(g/L)時若以相當之 氫分子質量濃度作為D,則關於氫分子h2為以下比例^ lmol/2g 二 H2( //mol/L)/D …(式4) 將式3代入式4則 D:2C/20 0 ( //g/L) =C / 1 0 0 ( # g / L )…(式 5 ) 此為,被測定水200 mL中所含之實效氫分子質量濃 度。又,上述實效氫分子之質量濃度為微克級,但若變換 為毫克級時,只要將分子及分母各乘1 〇 〇 〇即可。 D二C · 1 0 0 0/ 1 0 0 · 1 0 0 0 (mg/L) =C · 1 0-5 (mg/L )…(式 6 ) 如此,因從式2之關係,式6之氫分子莫耳數C可代換 為亞曱藍之總量B,故式7會成立。 D = N · A(m #mol)10_5(mg/L) ···(式7) 由式7,可了解在被測定水中所含實效氫分子之質量 濃度D(mg/L)可由將亞曱藍體積莫耳濃度N(mmol/L)乘以達 到等價點所要加入之亞曱藍水溶液總量(mL )求得。Equation 1 gives C = B = N · A (m // mol) ... (Equation 2) Furthermore, the volume of the measured water is 2000 mL, and the measured water is actually the volumetric mole concentration I of the chlorine molecule I (mol / L) is obtained by dividing the mole number C (mol) by the volume ^ (1). 'H2 (mol / L) = C / 200 (m // mol / mL) = C / 20 0 (/ zm〇l / L) ... (Equation 3) Further, the unit is converted to mass concentration (g / L) If the equivalent hydrogen molecule concentration is used as D, the following ratio of hydrogen molecule h2 is ^ lmol / 2g two H2 (// mol / L) / D… (Equation 4) Substituting Equation 3 into Equation 4 then D: 2C / 20 0 (// g / L) = C / 1 0 0 (# g / L) ... (Equation 5) This is the effective concentration of the hydrogen molecule in 200 mL of the measured water. The mass concentration of the above-mentioned effective hydrogen molecule is in the microgram order, but when converting to the milligram order, it is only necessary to multiply the numerator and the denominator by 1,000 each. D 2 C · 1 0 0 0/1 0 0 · 1 0 0 0 (mg / L) = C · 1 0-5 (mg / L) ... (Equation 6) So, from the relationship of Equation 2, Equation 6 The mole number C of the hydrogen molecule can be replaced by the total amount B of the arylene blue, so Equation 7 will hold. D = N · A (m #mol) 10_5 (mg / L) ··· (Equation 7) From Equation 7, we can know that the mass concentration D (mg / L) of the effective hydrogen molecules contained in the water to be measured can be determined by The volumetric mole concentration N (mmol / L) of Isatis indigotica multiplied by the total amount (mL) of the solution of Isatis indigotica to be added to reach the equivalent point.
2030-5943-PF(Nl);Chiumeow.ptd 第 70 頁 2U0413503 五、發明說明(68) 八子(不皮測定水中不僅溶存有在此嘗試定量分折之产 刀子(虱乳),亦溶存有各 》八工,斤里刀析之氣 碳(碳酸氣體)等。各乳分子(氧氣)或二氧化 關之物質名例示的話,氳分 =虱化還原反應相 酸鹽及次亞氯酸等。該卜彳σ有虱分子、次亞氯 要作為氧化劑,除了 1;八:::在氧化還原反應中通常主 λα 1+ 片』于、了口ρ分特殊情形下,是不合祚盔、四広 的。特別是,如此處所述 h㈢作為遇原劑 在田炎Θ 、亞甲血运原之試驗中,备J21 係用為虱化劑,不會使亞 虱原子 藍氧化變成氧化型亞甲籃^還原,反而曰將還原型亞甲 沉澱之原;亞甲藍…,或是以白色 亞甲藍再次氧化變回原來之專共广會將還原型 不透過亞甲藍,活性^夕>、^亞甲i °又’因為即使 奪去相當2氯:二=:分:也會與氧氣等直接反應, 藍還原。B第21圖=能=當量之亞甲 有氧分子等氧化物時,相告量之i t,合存水中共存 加到等量點之亞甲㈣量::$虱刀子置會被消費,且添 ^ Τ I π心里也會隨氧化物量而變少。 若考慮此,則用亞甲g之宁旦 氫濃度可說是減去被溶存[箄蓋=析T所測定之溶存 後之實效溶存氫濃; 所消f部分之氣濃度 (F)參考例與實施例之揭示 (參考例1 7) 以密兹(股)公司製電解水生成裝置「迷你 配活性奴濾益)以標準水量下使用電解範圍「4」之電解°條2030-5943-PF (Nl); Chiumeow.ptd Page 70 2U0413503 V. Description of the invention (68) Eight seeds (not measured in the skin, not only the knife (lice milk) produced in this test, but also the various 》 Baggong, the carbon of carbon dioxide (carbonic acid gas), etc. If the name of each milk molecule (oxygen) or dioxide is exemplified, it is divided into lice reduction reaction phase acid salt and hypochlorous acid. This 虱 σ has lice molecules, and hypochlorous must be used as an oxidant, except for 1; 8 ::: In the redox reaction, the main λα 1+ tablets are usually used. In the special case, it is not suitable for the helmet. In particular, as described here, h㈢ is used as an encounter agent in the test of Tian Yan Θ and methylene blood transporter. The preparation of J21 is used as a lice agent, which will not oxidize the sub-atomic blue into an oxidized sub-type. A basket ^ reduction, but said that the original type of methylene blue precipitation; methylene blue ..., or white methylene blue oxidized and changed back to the original CCP, the reduced type does not pass through methylene blue, active ^ Xi >, ^ Methylene i ° and 'because even if it takes quite 2 chlorine: two =: points: it will directly react with oxygen, etc. Blue reduction. B Figure 21 = Energy = equivalent of methylene aerobic molecules and other oxides, the amount of it, the coexistence of coexistent water to the equivalent amount of methylene halide :: $ lice knife set will be Consumption, and ^ Τ I π will also decrease with the amount of oxides. If this is considered, the hydrogen concentration of methylene g can be said to be subtracted from the dissolved [measured by dissolved T] Effective dissolved hydrogen concentration; Revised reference examples and examples of the gas concentration (F) in part f (Reference Example 17) The electrolyzed water generation device "mini with active slave filtration benefits" manufactured by Mitz Corporation Electrolytic ° bar with electrolysis range "4" at standard water volume
200413503200413503
t =連續ί電解處理後之鹼性電解水作為被測定水,將 =換之4〇倍翻基準液1社用針筒注入被測定水 Ύ 刀攪拌並混合後,在一面以目視觀察被測定水 之 變化下,將1S/L濃度(體積莫耳濃度;2677. 4 //M) 之亞甲藍水溶液以針筒少量注入該被測定水内。達到等價 點為止之同亞甲藍水溶液其總注入量為lmL,並且將各值、 代入上式7所求出之溶存氫濃度DH之實測值為 0.03(mg/L)。本參考例17被測定水相關之一、氧化還原電 位0RPUV)、電傳導、水溫τ(〇、溶存氧濃度 D0(mg/L)、溶存氫濃度DH之實測值化以。、將各值代入上 式7中所求得之溶存氫濃度讪之實測值(mg/L)表示於表3, 且DH之貫測值與實效值表示於第2 3圖。又,在計測各種物 性值日守所使用之各種計器類係使用與前述相同者。 (參考例1 8) 將以藤澤市自來水通過歐魯加奴社製之離子交換管柱 處理過之精製水彿騰後,一面進行氫氣之起泡處理並將其 溫度冷卻到2 0 t:以作為被測定水,並在該被測定水2 〇 〇mL 中’將上述經氛氣置換過之4〇倍濃度鉑膠體基準液lmL用 針筒注入被測定水收容室並充分攪拌混合後,在一面以目 視觀察被測定水之呈色變化下,將1〇g/L濃度(體積莫耳濃 度;2 6 7 7 3 · 8 μ Μ )之亞曱藍水溶液以針筒少量注入該被測 定水内。達到等價點為止之同亞曱藍水溶液其總注入量為 6· 2mL ’並且將各值代入上式7所求出之溶存氫濃度dh之實 測值為1. 66(mg/L)。本參考例19被測定水相關之各種物性t = alkaline electrolyzed water after continuous electrolysis treatment is used as the measured water, and = = 40 times the standard solution is poured into the measured water with a syringe. After stirring and mixing with a knife, one side is measured by visual observation. Under the change of water, a solution of methylene blue at a concentration of 1S / L (volume mole concentration; 2677. 4 // M) was injected into the water to be measured in a small amount by a syringe. The total injection volume of the same methylene blue aqueous solution up to the equivalent point was 1 mL, and the measured value of the dissolved hydrogen concentration DH obtained by substituting each value into the above formula 7 was 0.03 (mg / L). In this reference example 17, the measured values of one of the water correlation, redox potential (RPRPUV), electrical conduction, water temperature τ (0, dissolved oxygen concentration D0 (mg / L), and dissolved hydrogen concentration DH were measured. The actual measured value (mg / L) of the dissolved hydrogen concentration 讪 obtained in the above formula 7 is shown in Table 3, and the continuous measured value and actual value of DH are shown in Figure 23. In addition, on the day of measuring various physical property values The various types of instruments used in the field are the same as those described above. (Reference Example 18) The purified water that is treated with Fujisawa city water through an ion-exchange column made by Orugano Co., Ltd. is subjected to hydrogen gas. Bubbling treatment and cooling the temperature to 20 t: As the water to be measured, 1 mL of the platinum colloidal reference solution having a concentration of 40 times that of the above-mentioned atmosphere was replaced with 200 mL of the water to be measured. The cylinder was poured into the water containing chamber to be measured, and the mixture was thoroughly stirred and mixed, and the concentration of the measured water was visually observed on one side, and the concentration was 10 g / L (volume concentration; 2 6 7 7 3 · 8 μM) A solution of osmium blue is injected into the water to be measured with a small amount of syringe. The total injection amount of the solution of 6 · 2mL 'and the respective values are substituted into the actually measured value of the above formula is obtained within seven dissolved hydrogen concentration dh of 1. 66 (mg / L). This Reference Example 19 were measured for various physical properties related to water
200413503 五、發明說明(70) ' " 值表示於表3,且DH之實測值與實效值表示於第23圖。 (實施例2 0 ) ' 將上述樣本水i之基本水6 · 8 6以每分丨公升之流速下以 5A固定電流之電解條件下進行連續通水式電解處理後之電 解處理水作為被測定水,並在該被測定水2〇〇mL中,將上 述經氮氣置換過之4 0倍濃度鉑膠體基準液丨mL用針筒注入 被測定水收容室並充分攪拌混合後,在一面以目視觀察被 測定水之呈色變化下,將10g/L濃度(體積莫耳濃度; 2 6 7 7 3. 8 // Μ )之亞曱藍水溶液以針筒少量注入該被測定水 内。達到等價點為止之同亞曱藍水溶液其總注入量為 5· 9mL ’並且將各值代入上式7所求出之溶存氫濃度DH之實 測值為1 · 5 8 ( mg/ L )。本參考例2 〇被測定水相關之各種物性 值表示於表3,且DH之實測值與實效值表示於第23圖。 (實施例2 1 ) 將上述樣本水v之基本水9· 18以每分1公升之流速下以 5A固定電流之電解條件下進行連續通水式電解處理後之電 解處理水作為被測定水,並在該被測定水2〇〇mL中,將上 述經氮氣置換過之40倍濃度鉑膠體基準液imL用針筒注入 被測疋水收容室並充分授拌混合後,在一面以目視觀察被 測定水之呈色變化下,將1〇g/L濃度(體積莫耳濃度; 2 6 7 7 3 · 8 // Μ )之亞甲藍水溶液以針筒少量注入該被測定水 内。達到等價點為止之同亞甲藍水溶液其總注入量為 5· OmL ’並且將各值代入上式7所求出之溶存氫濃度DH之實 測值為1· 34(mg/L)。本參考例21被測定水相關之各種物性200413503 V. Description of the invention (70) The values are shown in Table 3, and the measured and effective values of DH are shown in Figure 23. (Example 20) 'The basic water 6 of the sample water i above was subjected to continuous water electrolysis treatment at a flow rate of 5A per minute and a fixed current of 5A under electrolytic conditions. Water, and in 200 mL of the water to be measured, the above-mentioned platinum colloidal reference solution with a concentration of 40 times replaced with nitrogen was injected into the water chamber to be measured with a syringe, and the mixture was sufficiently stirred and mixed. After observing the color change of the water to be measured, a 10 g / L concentration (volume molar concentration; 2 6 7 7 3. 8 // M) aqueous solution of osmium blue was injected into the water to be measured with a small amount of a syringe. The total injection amount of the same aqueous solution of Isatis indigotica until the equivalent point was reached was 5.9 mL ′, and the values were substituted into the measured value of the dissolved hydrogen concentration DH calculated by Equation 7 above to be 1. 5 8 (mg / L). In this reference example, various physical property values related to the measured water are shown in Table 3, and the actual measured value and actual value of DH are shown in FIG. 23. (Example 21) The basic water 9 · 18 of the sample water v described above was subjected to continuous water electrolysis treatment at a flow rate of 1 liter per minute and at a fixed current of 5 A, and the electrolytically treated water was used as the measured water. In 200 mL of the water to be measured, the above-mentioned platinum colloidal reference solution imL having a concentration of 40 times replaced with nitrogen was injected into a test water storage chamber with a syringe and thoroughly mixed, and then visually observed on one side. Under the change in color of the measurement water, a 10 g / L concentration (volume molar concentration; 2 6 7 7 · 8 // M) aqueous solution of methylene blue was injected into the measured water with a small amount of a syringe. The total injection amount of the same methylene blue aqueous solution up to the equivalent point was 5.0 mL, and the values were substituted into the dissolved hydrogen concentration DH obtained from the above Equation 7. The measured value was 1.34 (mg / L). Various properties related to water measured in Reference Example 21
2030-5943-PF(Nl);Chiumeow.ptd 第73頁 200413503 五、發明說明(71) 值一表不於表3,且卯之實測值與實效值於第23圖“ (貫施例2 2 ) =和光純藥工業(股)公司製之標準緩衝液4· 〇1 (酞 ==’奋液)用精製水稀釋1〇倍後之pH緩衝液以每分j公升 :=下以5 A固定電流之電解條件下進行連續通水式電解声 ΐ 電解處理水作為被測定水,並在該被測定水2〇〇π〇^ i將上述經氮氣置換過之4〇倍濃度鉑膠體基準液 針简注入被測定水收容室並充分攪拌混合後,在一面以 視觀察被測定水之呈色變化下,將1〇g/L濃度(體積莫耳冰 2 6 7 7 3 · 8 // Μ)之亞甲藍水溶液以針筒少量注入該被I 疋水内。達到等價點為止之同亞甲藍水溶液其總注入量 6· 3mL,並且將各值代入上式7所求出之溶存氫濃度Dh之ς 測值為1.69(mg/L)。本參考例22被測定水相關之各種物^ 值表不於表3,且DH之實測值與實效值表示於第23圖。 (實施例2 3) 將上述樣本水i之基本水6·86以每分丨公升之流速下r 5 Α固定電流之電解條件下進行連續通水循環式(循環水量乂 為0.8公升)以3分鐘電解處理後之循環電解處理水作為被 測定水,並在該被測定水2〇〇mLt,將上述經氮氣置換過 之40倍濃度鉑膠體基準液lmL用針筒注入被測定水收容室 並充分攪拌混合後,在一面以目視觀察被測定水之呈色變 化下,將10g/L濃度(體積莫耳濃度;26773· 8 “M)之亞曱 藍水溶液以針筒少量注入該被測定水内。達到等價點為止 之同亞甲藍水溶液其總注入量為9· 6mL,並且將各值代入2030-5943-PF (Nl); Chiumeow.ptd Page 73 200413503 V. Description of the invention (71) The values shown in Table 3 are not shown in Table 3, and the actual measured values and actual results are shown in Figure 23 ("Implementing Example 2 2 ) = Wako Pure Chemical Industries, Ltd. standard buffer solution 4 · 〇1 (phthalein == 'Fenye) pH buffer solution diluted 10 times with purified water to j liters per minute: = 5 A below Continuous flow-through electrolytic sonication was performed under the conditions of fixed current electrolysis. The electrolyzed treated water was used as the water to be measured, and the above-mentioned water was replaced with nitrogen at a concentration of 40 times the platinum colloidal reference solution. After the needle was poured into the water containing chamber to be measured and fully mixed, the concentration of 10 g / L (volume Morr ice 2 6 7 7 3 · 8 // Μ) was observed on one side under visual observation of the color change of the water to be measured. A small amount of methylene blue aqueous solution is injected into the beaker I water with a small syringe. The total injection amount of the same methylene blue aqueous solution up to the equivalent point is 6.3 mL, and each value is substituted into the solution obtained by the above formula 7. The measured value of hydrogen concentration Dh is 1.69 (mg / L). This reference example 22 shows various water-related substances ^ The values are not shown in Table 3, and the actual measured values and actual values of DH are shown. Fig. 23 (Example 2 3) The basic water 6.86 of the above sample water i was subjected to continuous water circulation under the electrolytic condition of a fixed current of r 5 Α per minute 丨 liter flow rate (circulating water volume 乂 0.8 liter) ) Take 3 minutes of electrolysis-treated circulating electrolyzed water as the water to be measured, and at 200 mLt of the water to be measured, inject 1 mL of the above-mentioned nitrogen colloidal platinum colloidal reference solution with a concentration of 40 times into the measured water with a syringe. After fully mixing in the storage room, and visually observing the color change of the water to be measured, inject a small amount of 10 g / L (volume concentration; 26737 · 8 "M) of osmium blue solution into the syringe with a small amount. Measured in water. The total injection volume of the same methylene blue aqueous solution up to the equivalent point is 9.6 mL, and the values are substituted into
200413503200413503
上式7所求出之溶存氫濃度DH之實測值為2. 57( 參考例23被測定水相關之各種物性值表示於表3,且DH之 實測值與實效值表示於第2 3圖。 (實施例24) 將上述樣本水v之基本水9. 18以每分1公升之流速下以 5 A固定電流之電解條件下以連續通水循環式(循環水量為 0 · 8公升)進行3分鐘電解處理後之循環電解處理 測定水,並在該被測定水2〇〇mL中,將上述經氮氣置換過 之40倍濃度鉑膠體基準液lmL用針筒注入被測定水收容室 並充分攪拌混合後,在一面以目視觀察被測定水之呈色變 化下,將10g/L濃度(體積莫耳濃度;26773. 8 “M)之亞甲 藍水溶液以針筒少量注入該被測定水内。達 之同亞曱藍水溶液其總注人量為12.3mL,並且 上式7所求出之溶存氫濃度])JJ之實測值為3· 29 (mg/L)。本 參考例24被測定水相關之各種物性值表示於表3,且⑽之 實測值與實效值表示於第2 3圖。 (實施例2 5 ) 將與實施例2 2相同之pH緩衝水溶液以每分1公升之流 速下以5 A固定電流之電解條件下以連續通水循環式(循環 水量為0 · 8公升)進行3分鐘電解處理後之循環電解處理水 作為被測定水’並在該被測定水2 〇 〇mL中,將上述經氮氣 置換過之40倍濃度鉑膠體基準液imL用針筒注入被測定水 收容室並充分攪拌混合後,在一面以目視觀察被測定水之 呈色變化下,將10g/L濃度(體積莫耳濃度;26773.8The measured value of the dissolved hydrogen concentration DH obtained by the above formula 7 is 2. 57 (Reference Example 23: Various physical property values related to the measured water are shown in Table 3, and the measured value and actual value of DH are shown in FIG. 23. (Example 24) The basic water 9.18 of the sample water v was subjected to a continuous water circulation type (circulated water amount of 0 · 8 liters) at a flow rate of 1 liter per minute and a fixed current of 5 A for 3 minutes. Circulating electrolytically treated water after electrolytic treatment, and in 200 mL of the water to be measured, 1 mL of the above-mentioned 40-fold concentration platinum colloidal reference solution replaced by nitrogen was injected into the water containing chamber to be measured with a syringe and thoroughly stirred and mixed. Then, a solution of methylene blue at a concentration of 10 g / L (volume mole concentration; 26737. 8 "M) was injected into the water to be measured with a small amount of syringe under the color change of the water to be measured visually. The same amount of indigo blue aqueous solution has a total injection amount of 12.3 mL, and the dissolved hydrogen concentration obtained from the above formula 7)] JJ The measured value is 3. 29 (mg / L). The reference example 24 is water-related. Various physical property values are shown in Table 3, and the actual measured values and effective values of ⑽ are shown in Figure 23. (Actual Example 2 5) The same pH buffered aqueous solution as in Example 22 was used at a flow rate of 1 liter per minute and at a fixed current of 5 A under electrolytic conditions in a continuous water circulation type (circulated water amount of 0 · 8 liters) for 3 minutes The circulating electrolyzed water after the electrolysis treatment was used as the water to be measured. In 200 mL of the water to be measured, the platinum colloidal reference solution imL having a concentration of 40 times replaced by nitrogen was injected into the water containing chamber for the measurement with a syringe, and After fully stirring and mixing, visually observe the color change of the water to be measured, the concentration of 10 g / L (volume molar concentration; 26773.8)
2030-5943-PF(N1);Chiumeow.ptd 第75頁 200413503 五、發明說明(73) 之亞甲藍水溶液以針筒少量注入該被測定水内。達到等價 點為止之同亞甲藍水溶液其總注入量為1 2· 4mL,並且將各 值代入上式7所求出之溶存氫濃度DH之實測值為 3 · 3 2 (m g / L )。本參考例2 5被測定水相關之各種物性值表示 於表3,且DH之實測值與實效值表示於第23圖。 表3 pH ORP[mV] EC[mS/m] 溫 Τ[ΐ] DO[mg/L] DH實測值[mg/Lj DH實效值[mg/L] 參考例17 9.8 -171 17 21.6 2.67 0.18 0.03 參考例18 7.2 -623 99 21.2 0.02 1.34 1.66 #考例20 7.0 -616 99 22.4 1.00 1.06 1.58 參考例21 9.2 -721 46 21.6 1.60 1.03 1.34 ~ #考例22 4.5 -446 64 21.7 1.53 0.81 1.69 參考例23 7.1 -650 98 22.3 0.44 1.36 2.57 9.6 -764 54 22.3 0.45 2.20 3.29 4.7 -490 67 22.3 0.39 1.69 3.32 (G)實施例之考察 依表3及第23圖,因為在溶存氫之DH實測值與實效值 間’隨實測值高時實效值也變高,故可了解具有相應之相 關性。又,參考例18及實施例20〜25之溶存氫濃度DH實效 值與參考例17之DH實效值比較,皆顯示有超過1· 3 (mg/L) 之高濃度。特別是,相對於在常溫(2 〇 °c )及大氣壓下對分 子狀氫之水的飽和溶解濃度約為1 · 6 (m g / l ),實施例2 〇〜2 5 之DH實效值顯示了2· 5〜3· 3 (mg/L)之極高濃度。 因為此處進行之溶存氫濃度之定量分析試驗皆使用事 先以活性碳處理過之水(未添加還原劑),且事先除去次亞 氣酸等氯系氧化物質,故在被測定水中所殘留之氧化劑可 認為主要是氧分子。又,氧分子因為即使以活性碳去除, 當被測定水一接觸大氣則會迅速又溶入該水内,若不特別2030-5943-PF (N1); Chiumeow.ptd Page 75 200413503 V. Description of the invention (73) The methylene blue aqueous solution is injected into the water to be measured with a small amount of syringe. The total injection volume of the same methylene blue aqueous solution up to the equivalent point is 12 · 4mL, and the values are substituted into the measured value of the dissolved hydrogen concentration DH obtained by the above formula 7 as 3 · 3 2 (mg / L) . Various physical property values related to the measured water in this Reference Example 25 are shown in Table 3, and the actual measured value and actual value of DH are shown in FIG. 23. Table 3 pH ORP [mV] EC [mS / m] Temperature T [ΐ] DO [mg / L] DH measured value [mg / Lj DH effective value [mg / L] Reference example 17 9.8 -171 17 21.6 2.67 0.18 0.03 Reference example 18 7.2 -623 99 21.2 0.02 1.34 1.66 #Examination case 20 7.0 -616 99 22.4 1.00 1.06 1.58 Reference example 21 9.2 -721 46 21.6 1.60 1.03 1.34 ~ #Examination case 22 4.5 -446 64 21.7 1.53 0.81 1.69 Reference example 23 7.1 -650 98 22.3 0.44 1.36 2.57 9.6 -764 54 22.3 0.45 2.20 3.29 4.7 -490 67 22.3 0.39 1.69 3.32 (G) The inspection of the examples is shown in Table 3 and Figure 23, because the DH measured value and effective value in dissolved hydrogen As the actual value becomes higher as the measured value becomes higher, it can be understood that there is a corresponding correlation. In addition, the DH actual value of the dissolved hydrogen concentration of Reference Example 18 and Examples 20 to 25 and the DH actual value of Reference Example 17 both showed high concentrations exceeding 1.3 (mg / L). In particular, the DH effective values for Examples 2 and 5 are shown in Example 2 with respect to the saturated dissolved concentration of molecular hydrogen water at normal temperature (20 ° C) and atmospheric pressure at about 1.6 (mg / l). Extremely high concentration of 2 · 5 ~ 3 · 3 (mg / L). Because the quantitative analysis test of dissolved hydrogen concentration used here uses water treated with activated carbon in advance (without adding reducing agent), and chlorine-based oxidizing substances such as hypochlorous acid are removed in advance, the residual in the water to be measured The oxidant can be considered to be mainly an oxygen molecule. In addition, even if the oxygen molecules are removed with activated carbon, once the measured water contacts the atmosphere, it will quickly dissolve into the water.
2030-5943-PF(Nl);Chiumeow.ptd 第76頁 五、發明說明(74) 使用還原劑而欲僅以活性 但是,在本發明所提除疋很困難的。 僅可如本案申請人所開發化方法適用前提下,不 濃度儘量提高,且可使=電位水生成裝置使溶存氫 且對期待展現以本發明之^乳4乳化物質濃度儘量降低, 氧化機能水所由來…;:存ί =劑組合而成之抗 在此,試著以對本發明之气f匕活性上是重要的。 還原色素溶存氫定量方法之風洛存水利用本發明之氧化 觀點來定義,本發^之/气=求得之溶存氫濃度Μ之實效值 為佳,進一步嘴i f〉谷存水以顯示1.3以上DH實效值 上、1.8以上、19以上 1.5以上、1·6以上、1>7以 2. 3以上、2. 4以上、2 5 . 〇以上、2. 1以上、2. 2以上、 上、2· 9以上、3· 〇以上、上、2· 6以上、2· 7以上、2· 8以 位皆為mg/L)之順序,且1以上、3· 2以上、3· 3以上(單 好。此係因可期待本發明谷存氯濃度⑽之實效值愈高愈 抗氧化機能水所由决夕、*之虱溶存水與催化劑組合而成之 平。 還原活性、抗氧化活性能展現高水 本見解為對於包含雷 量分析方法及同氫、、々广卜解處理水之氫溶存水中氫濃度定 案者。又,相對於二=^所具有顯在抗氧化力大小重新提 測時其測定步驟或處=^存氫計進行溶存氫濃度之計 被充分滿足,且成本又,,且測定精確度之點上也不能 素的溶存氫濃度定旦方常高,本發明之使用氧化還原色 若可除去被測定水ί其測定步驟或處理比較簡易,且 7 6 <氧化物質,則測定精確度之點2030-5943-PF (Nl); Chiumeow.ptd p. 76 V. Description of the invention (74) Use of reducing agents to be active only However, it is difficult to remove tritium in the present invention. Only as long as the method developed by the applicant of the present application is applicable, the concentration is not increased as much as possible, and the = potential water generation device can be used to dissolve hydrogen and reduce the concentration of the emulsified substance of the milk 4 of the present invention as much as possible, and oxidize the functional water. Origin ...;: The combination of anti-drug agents is here, and it is important to try to be active against the gas of the present invention. The method of quantifying the dissolved hydrogen in reduced pigments is defined by the oxidative viewpoint of the present invention. The effective value of the gas / gas = the obtained dissolved hydrogen concentration M is better. If the value is greater than valley water, it will show 1.3 or more DH. Effective value, 1.8 or higher, 19 or higher 1.5 or higher, 1.6 or higher, 1 > 7 to 2.3 or higher, 2.4 or higher, 2 5.0 or higher, 2.1 or higher, 2.2 or higher, upper, 2 · 9 or more, 3 · 0 or more, upper, 2 · 6 or more, 2 · 7 or more, and 2 · 8 are all mg / L), and 1 or more, 3 · 2 or more, 3 · 3 or more (single Good. This is because it can be expected that the higher the effective value of the chlorine concentration in the valley of the present invention, the higher the antioxidant function of water. The idea of high water is for the determination of the hydrogen concentration in the hydrogen-dissolved water containing the method of lightning analysis and the treatment of the same hydrogen and water. The re-measurement of the apparent antioxidant capacity with respect to the two = ^ The measurement steps or procedures are as follows: the measurement of the dissolved hydrogen concentration by the hydrogen storage meter is fully satisfied, the cost is high, and the measurement accuracy is The concentration of dissolved hydrogen that can not be primed is often high. If the redox color used in the present invention can remove the measured water, its measurement steps or treatment are relatively simple, and the accuracy of the measurement is 7 6 < oxidized substances. point
200413503200413503
上因為是用透過分子狀氫之粒子數與氧化還原色素之化學 反應直接定ϊ为析之原理’故高精密度且成本很低廉。 於X0D實驗系中使用腎上腺素氧化法之游離基消去活性評 價試驗 其次,於以下(A)說明於X〇D實驗系中使用腎上腺素氧 化法進行游離基消去活性評價試驗之方法。又,對該試驗 方法使用之本發明抗氧化機能水(Anti Oxidant functioning Water,以下有時會稱為rA〇w」)所表現之 游離基消去活性’以氫溶存水中加入貴金屬催化劑(鉑膠 體/鈀膠體/鉑鈀混合膠體)作為A〇W為例,並且下述(B)各 表示其實施例與參考例。又,X0D實驗系是指在氧溶存溶 液系中透過使生體酵素黃嘌呤氧化酶(X〇D)作用於黃嗓呤 的過私’使因κ 17示吟氧化放出的電子將氧氣之一個電子還 原以生成超乳陰離子游離基(以下有時僅以(· Q〗-)稱之)之 實驗系(以下,稱為「X0D實驗系」)。 (A)於X0D實驗系中使用腎上腺素氧化法之游離基消去活性 評價試驗方法 (A - 1 )構想之經緯 先前游離基之測定法已知例如有「游離基與藥物」廣 川書店(股)發行,ISBN 456749380X)第1 33〜141所記載之 細胞色素c還原法。 該細胞色素c還原法(參照第24圖)係利用分光光度 計’經時觀察氧化型細胞色素c之吸收極大(波長55〇nm)之 變化’以測定X0D實驗系中超氧陰離子游離基(· )使氧The reason is that the chemical reaction between the number of particles that permeate through the molecular hydrogen and the redox pigment is directly determined. Therefore, it has high precision and low cost. Evaluation Test of Free Radical Elimination Activity Using Adrenaline Oxidation Method in X0D Experimental System Next, a method for evaluating the free radical elimination activity using adrenaline oxidation method in XOD experiment system will be described below (A). In addition, the free radical elimination activity exhibited by the anti-oxidant functioning water (Anti Oxidant functioning Water (hereinafter sometimes referred to as rA0w)) used in the test method is to add a precious metal catalyst (platinum colloid / A palladium colloid / platinum palladium colloid) is taken as an example, and each of the following (B) represents an example and a reference example thereof. In addition, the X0D experiment refers to the improper use of xanthine oxidase (X〇D) to act on xanthine in an oxygen-soluble solution system, so that one of the oxygen emitted by the oxidation of kappa 17 shows that one of the oxygen is released. An experimental system (hereinafter sometimes referred to as "· Q〗-)" which is a super-emulsion anion radical by electron reduction (hereinafter referred to as "X0D experimental system"). (A) The free radical elimination activity evaluation test method using the adrenaline oxidation method in the X0D experimental system (A-1) The method for measuring free radicals of the longitude and latitude as envisaged is known, for example, "Free radicals and drugs" Guangchuan Bookstore (stock) Issue, ISBN 456749380X) Cytochrome c reduction method described in Nos. 1 33 to 141. This cytochrome c reduction method (see FIG. 24) uses a spectrophotometer to 'observe changes in the absorption maximum (wavelength of 55 nm) of oxidized cytochrome c over time' to determine the superoxide anion free radicals in the X0D experimental system (· Make oxygen
2030-5943-PF(Nl);Chiumeow.ptd 第78頁 200413503 五、發明說明(76) 化型細胞色素c(鐵細胞色素c(Fe3+)還原為氧化型細胞色素 C(亞鐵細胞色素以以2+)之反應受到S〇D或抗氧化劑等被檢 體阻^的情形,其係利用(·〇2_)之單電子還原劑反應性。 右將測定原理詳細敘述,在細胞色素c還原法中,若 (."〇2 )之氧化型細胞色素C還原反應優先(或同時)進行, =氧化劑等被檢體將(· 〇2_)還原消去了,則氧化型細胞色 之/原量即還原型細胞色素C之生成量會被抑制(上升 素cV吸緩或產生下降傾向)。這樣—來’還原型細胞色 者 七w極大(A55 0 )也會下降。若將時間的要素也加入 間還原型細胞色素C之吸收極大(A550 )會 = 1:,Ϊ ,ί量而下降。利用經時觀察吸收極大(A550 ) 文 可測疋被檢體之S〇D類活性。 系告t彳1丨f ί使用先前細胞色素c還原法之如0類活性測定 還;力之‘質:=之抗氧化機能水或抗壞血酸等具有顯著 果,、而且合右1被檢體時,不僅無法得到高精密測定結 為使用(.θ〇 -/I ΐ與原本相反的測定結果的問題。這是因 綱或抗壞i酸在的原故。也就是說,本發明之 、、占本的门原士 結果可推測是因為將(· 〇2-)全量還斥 去,,多餘的還原力將氧 二還原 此一來,不僅益生W ^ A 土、田I巴京c遏原。如 、要低的與原本相反的測定結果。 基消去活性評;:用於本發明?氧化機能水之游離 * ’ —游離基反應試藥進行專意探討研2030-5943-PF (Nl); Chiumeow.ptd Page 78 200413503 V. Description of the invention (76) Reduction of chemically modified cytochrome c (iron cytochrome c (Fe3 +) to oxidized cytochrome c (ferrous cytochrome to When the reaction of 2+) is blocked by a subject such as SOD or antioxidant, it uses the reactivity of a single electron reducing agent (· 〇2_). The measurement principle will be described in detail on the right. In the cytochrome c reduction method, In the case of (. &Quot; 〇2), the reduction reaction of oxidized cytochrome C is performed preferentially (or at the same time), = = oxidant and other subjects have eliminated (· 〇2_) reduction, then the oxidized cell color / original amount That is to say, the amount of reduced cytochrome C production will be suppressed (ascites cV slows down or tends to decrease). In this way, the reduction of cytochrome C will be reduced to a maximum of seven w (A55 0). If the element of time is also reduced The maximum absorption (A550) of the reduced-reduction type cytochrome C will be decreased by 1: 1, Ϊ, ί. The absorption maximum (A550) can be used to measure the SOD activity of the test subject. t 彳 1 丨 f ί Using the previous cytochrome c reduction method, such as class 0 activity was measured; the quality of the force: = Oxidative water, ascorbic acid, etc. have significant results, and when combined with the right subject, not only can't obtain high-precision measurement results. (.Θ〇- / I ΐ is the opposite of the original measurement results. This is the reason Or the reason why ascorbic acid is present. That is to say, the results of the present invention and the original scholars can be presumed to be because the full amount of (· 〇2-) was also repelled, and the excess reducing power reduced oxygen to two. In this way, not only the probiotic W ^ A soil, Tian I Bajing c suppress the original. For example, to lower the measurement results contrary to the original. Basic elimination activity evaluation ;: used in the present invention? Free of oxidation function water * '— Free radical reaction
200413503 五、發明說明⑺) --- 究,,到說不定可使用還原型腎上腺素之氧化的構想。 ▲還原型腎上腺素若用超氧陰離子游離基(· 〇2_ )氧化, 會變為紅色的腎上腺色素(氧化型腎上腺素),其吸收極大 (A480 )會升高。此時,(d係作為氧化劑。順帶一提, 還原型腎上腺素不易被通常的氧分子氧化,且即使被氧化 也不έ呈現紅色的呈色反應。即,以實驗確認還原型腎上 腺素即使在氧溶存溶液中其吸收極大(Α48〇)也不會升高。 這意味還,、型腎上腺素適合作為用以區分通常的氧分子 (〇2),超氧陰離子游離基(D之游離基反應試藥使用。 孩月^腺素氧化法(參照第25圖)首先係在X0D實驗系 中生成適量(·(V)。生成之(· 〇2_)會依如 還原型腎上腺變為氧化型。 ^ ^ RH3-+ · 〇2- + 2Η+ — · rh3+H202 • RH3 + 02 ~>RH2+ · 〇2-+ h+ RH2+ · 02- + H+ . RH + H2〇2 • RH + 02 — R+ · 〇2- + h+ 惟,(RH3-)為還原型腎上腺素,(幻為氧化型腎上腺 (月上腺色素)。還原型腎 ^ ’、 . 貪上腺素與(· 〇2 )在生理之pH值附 〇2—)與還原型腎上腺辛之===上腺素可以加速(. 中軔祛A蔣请;©荆&素2夂反應速度。本腎上腺素氧化法 甲孕乂佳為將還原型腎上臉I # 古、、g ^ 二上腺素之莫耳濃度設在約ImM左右之 "2 ,可觀察到還原型腎上腺素會有因例如鐵離子 _ 被氧化的傾向。為除去外在因子影 響,需要使被檢定液中共存柳TA#螯合劑。卜在因子〜 第80頁 2030-5943-PF(Nl);Chiumeow.ptd 200413503 五、發明說明(78) n 若(· 〇2 )之還原型腎上腺素氧化反應優先(或 ^ ^剂進跃行,抗氧化劑等被檢體將(· 〇厂)還原消去了,則 ,月上腺素之氧化量即氧化型腎上腺素之生成量會被 S二η的抑制。這樣一來’氧化型腎上腺素之吸收極大 扣7 j上^傾向會緩和。若將時間的要素也加入考慮,每 广二' 間氧化f腎上腺素之吸收極大(A480 )上升傾向會隨 2之,肖去1而變緩和。利用經時觀察吸收極大(A48〇) 化可測疋被檢體之S0D類活性(游離基消去活性)。 a θ,、體來虎,以經過時間為橫軸,吸光度(A480 )為縱軸 =旦則S0D類活性可以用單位時間(ΔΤ)之吸光度(A48〇) 及里(八480 )表示。也就是說,該圖之斜率(ZU/ΛΤ)可 表不S0D類活性。因此,對被檢體之s〇D類活性圖,當往正 向傾斜大(往右上斜的特性)則s〇D類活性變小,反之,往 正向傾斜小則S0D類活性變大。惟,若從游離基消去活性 高低的觀點比較正向傾斜小與負向傾斜小 游離基消去活性是較高的。 ^後者之 以上為使用腎上腺素氧化法之游離基消 活性)的測定原理。 古f生UUJ)類 (A-2)使用試藥 類活性)試驗 •和光純藥 腎上腺素氧化法之游離基消去活性(s〇D 所使用之試藥列舉如下。 ①道爾貝可磷酸緩衝生理食鹽粉末(pBS) · · 工業製 ②黃嗓吟(2,6-二氧代嘌呤)· · ·和光純藥工200413503 V. Description of the invention ⑺) --- In the end, maybe the idea of reducing the adrenaline oxidation can be used. ▲ If reduced adrenaline is oxidized with a superoxide anion (· 〇 2_), it will turn into a red adrenaline pigment (oxidized adrenaline), and its absorption (A480) will increase. At this time, (d is used as an oxidant. Incidentally, reduced adrenaline is not easily oxidized by ordinary oxygen molecules, and even if it is oxidized, it does not show a red color reaction. That is, it is experimentally confirmed that reduced adrenaline Its absorption in the oxygen-dissolved solution (A48〇) will not increase. This means that the type of epinephrine is suitable for distinguishing ordinary oxygen molecules (〇2) and superoxide anion free radicals (D radical reaction) The test drug is used. The adenosine oxidation method (refer to Figure 25) first generates an appropriate amount (· (V) in the X0D experimental system. The generated (· 〇 2_) will be reduced to the oxidized adrenal gland. ^ ^ RH3- + · 〇2- + 2Η + — · rh3 + H202 • RH3 + 02 ~> RH2 + · 〇2- + h + RH2 + · 02- + H +. RH + H2〇2 • RH + 02 — R + · 〇2- + h + However, (RH3-) is a reduced adrenaline, (an oxidized adrenal gland (adrenal pigment). Reduced adrenal ^ ',. Glutenin and (· 〇2) in the physiological pH attached 〇2—) and reduced adrenal adenine === adrenaline can accelerate (. 轫 A A Jiang please; © Jing & 夂 2 夂 reaction Speed. This adrenaline oxidation method is a good method to set the reduced adrenaline I # ancient, g ^ diadrenaline molar concentration to about ImM " 2, reducing adrenaline can be observed There is a tendency to be oxidized due to, for example, iron ions. In order to remove the influence of external factors, it is necessary to co-exist the willow TA # chelating agent in the test solution. Bu Fa factor ~ page 80 2030-5943-PF (Nl); Chiumeow. ptd 200413503 V. Description of the invention (78) n If (· 〇 2) the reduction of adrenaline oxidation reaction preferentially (or ^ ^ agent advances, antioxidants and other subjects will be eliminated (· 〇 factory) reduction, then The amount of oxidized adrenaline, that is, the amount of oxidized adrenaline produced, will be inhibited by S2η. In this way, the absorption of oxidized epinephrine is greatly reduced, and the tendency will be relaxed. If the elements of time are also reduced, Taking into account, the absorption of oxidized f-adrenaline (A480) in each Guang'er will increase with 2 and decrease with Xiao 1. It can be measured by observation of absorption over time (A48〇). SOD activity (free radical elimination activity). The horizontal axis is the horizontal axis, and the absorbance (A480) is the vertical axis. Once the SOD activity can be expressed in terms of the absorbance (A48〇) and the distance (eight 480) per unit time (ΔΤ). That is, the slope of the graph (ZU / ΔΤ) can express SOD activity. Therefore, for the SOD activity diagram of the subject, when the slope of the SOD activity is large (the characteristic of the upper right slope), the SOD activity becomes smaller, otherwise, the SOD activity is positive. The smaller the tilt, the greater the SOD activity. However, from the viewpoint of high or low radical elimination activity, the radical elimination activity is relatively high compared with a small positive slope and a small negative slope. ^ The above is the measuring principle of free radical deactivation using the adrenaline oxidation method). Gu Fsheng UUJ) (A-2) test reagent activity) test • Wako Pure Medicine's free radical elimination activity of adrenaline oxidation method (sOD) The test reagents used are listed below. ① Dolbec phosphate buffer Physiological salt powder (pBS) · · Industrial ② Huang Hou Yin (2,6-dioxopurine) · · · Wako Pure Chemical Industries
2030-5943-PF(Nl);Chiumeow.ptd 第81頁 200413503 五、發明說明(79) ③黃嘌呤氧化酶懸濁液(由奶油而來) 同仁化學研究所製·和光純 ④EDTA-2Na · 2水和物 藥工業製 ⑤1 mol/L氫氧化鈉溶液· ··和光純藥工業製 ⑥ L ( + )-抗壞血酸· ··和光純藥工業製 ⑦ (± )腎上腺素(d 1 -腎上腺素)· · ·和光純藥工 (A-3)試藥之調製方法 & 前述(A-2)所列舉之試藥調製方法如下。 ① 含EDTA之PBS緩衝原液調製 將2袋500ml用道爾貝可碟酸緩衝生理食鹽粉末(以下 稱「PBS」)溶解於蒸餾水l00mi,並等分為2。其中的“… 溶解EDTA-2NaO. 19g。以此作為EDTA原液。各取此⑽以原 液0· 5ml、無EDTA之溶液49· 5ml並混合。 、 此得到之混合溶液為含EDTA(1· 9mg)之PBS緩衝原液。 以PBS濃度而言’係10倍稀釋者。如被檢定水中有多種金 屬離子時,亦可將EDTA原液直接稀釋1〇倍使用。此情形因 E D T A濃度南’故可充分將導致測定精密下降之要因的金屬 離子去除。又,含EDTA之PBS緩衝原液調製之目的係將溶 液之pH固定在約生理液性之約7 · 4左右並預防因金屬離子 使測定精密度下降。 ② 1 · 5 Μ黃嘌呤溶液之調製 將黃嘌呤= 0·228与0.23g及l(mol/L)氫氧化納水溶液 8 0滴加入蒸镏水3 5 0 m 1,並溶解黃σ票呤。取3 5 m 1並加入含 EDTA之PBS緩衝原液配成100ml。2030-5943-PF (Nl); Chiumeow.ptd Page 81 200413503 V. Description of the invention (79) ③ Xanthine oxidase suspension (from cream) Manufactured by Tongren Chemical Research Institute · Heguang Pure ④ EDTA-2Na · 2 Manufactured by Shuwa Pharmaceutical Co., Ltd. ⑤1 mol / L Sodium Hydroxide Solution ··· Manufactured by Wako Pure Chemical Industries ⑥ L (+) -Ascorbic acid ··· produced by Wako Pure Chemical Industries ⑦ (±) adrenaline (d 1 -Adrenaline) The preparation method of the test reagents of Wako Pure Chemical (A-3) & The preparation methods of the test reagents listed in (A-2) above are as follows. ① Preparation of PBS buffered solution containing EDTA 500 ml of two bags of physiological salt powder (hereinafter referred to as "PBS") buffered with Dalbeccoic acid buffer were dissolved in 100 ml of distilled water and divided into two equal parts. "... Dissolved EDTA-2NaO. 19g. This was used as the EDTA stock solution. Take each of this solution as 0.5ml of stock solution, 49.5ml of EDTA-free solution and mix. The resulting mixed solution was EDTA-containing (1.9mg ) PBS buffer stock solution. In terms of PBS concentration, it is a 10-fold dilution. If there are multiple metal ions in the test water, the EDTA stock solution can be directly diluted 10-fold for use. In this case, the EDTA concentration is south. Removal of metal ions that cause the decrease in measurement precision. In addition, the purpose of preparing PBS buffer solution containing EDTA is to fix the pH of the solution to about 7 · 4 of physiological fluidity and prevent the measurement precision from decreasing due to metal ions. ② Preparation of 1.5 M xanthine solution Xanthine = 0.228 g and 0.23 g and 1 (mol / L) sodium hydroxide aqueous solution 80 drops was added to distilled water 3 50 m 1 and the yellow sigma was dissolved. Take 3 5 ml 1 and add EDTA-containing PBS buffer solution to make up 100ml.
2030-5943-PF(Nl);Chiumeow.ptd 第82頁 200413503 五、發明說明(80) ③ 黃嘌呤氧化酶溶液之調製 將貫°票°令氧化酶懸濁液以含EDTA之PBS缓衝原液稀釋 100倍。此試液每次實驗實施時要配製。 ④ 腎上腺素溶液之調製 ^將撥,裔用授拌子與蒸餾水10 0ml放入小瓶並塞橡皮 f ’將排=用之注射針及連通氮氣高壓筒之注射針刺入橡 皮盍。以此狀離蔣人# ^ ^ m 4, …將3蒸餾水之小瓶放在攪拌器台上,一面 p产 卜^ &乳封入蒸餾水,使蒸餾水内部完全置換 上腺素,蓋上—處理進行30分鐘。之後’投入〇·15g腎 备A娶抬ί成盖子’以攪拌器緩慢攪拌’將氮氣封入。此 氮亂置換持績進行刹每 製。重點為在添加」只驗結束。以上為腎上腺素溶液之調 後攪拌緩和下來。月上腺素前強力授掉’在添加腎上腺素 (A - 4 )試驗順序 先月ί)之XOD實驗多 加入黃嘌呤氧化酶(XOD),隨添加XOD反 序加入腔室,爭/糸係將所有試藥類與被檢定水溶液依 玉主 取後2030-5943-PF (Nl); Chiumeow.ptd Page 82 200413503 V. Description of the invention (80) ③ The preparation of xanthine oxidase solution will be carried out to make the oxidase suspension in PBS buffer solution containing EDTA Dilute 100 times. This test solution should be prepared each time an experiment is performed. ④ Preparation of epinephrine solution ^ Put the stirrup and 100 ml of distilled water into a vial and stopper the rubber f ′ pierce the injection needle used and the injection needle connected to the nitrogen high-pressure cylinder into the rubber capsule. In this way, leave the Jiangren # ^ ^ m 4,… Place the vial of 3 distilled water on the stirrer table, while pouching ^ & milk into the distilled water, so that the inside of the distilled water completely replace the epinephrine, cover-treatment is carried out 30 minutes. After that, ‘15 g of kidney preparation A was put into a lid ’and slowly stirred with a stirrer’ to seal the nitrogen gas. This nitrogen chaos replacement performance is performed every time. The emphasis is on adding "only the end of inspection. The above is the adjustment of the adrenaline solution. Before the adrenaline is given, it is strongly taught to add xanthine oxidase (XOD) in the XOD experiment of adding the adrenaline (A-4) test sequence, and then add the XOD to the chamber in reverse order. After taking all the test drugs and the tested aqueous solution
應開始的同時,R 但該先前方法i /又叫〜< (·〇2~),在該時乳在添加被檢定水溶液時尚未充分生成 存在。也就是說,(· 〇2 )之生成原料還是以氧分子的原樣 變化為(·〇2-)使(’因為氧原子會由X0D之添加時點起經時 並不會馬上2得到、/ 〇2 )生成量增大,故在添加被檢定液後 生成原料溶存氧的曰 2 ) 向旦^ a 、 的®並未被關注, $始用分光光度計測定 同量之(· 〇 -) ’因先前方法中(· 02一) 故不確定是否每次生成Should be started at the same time as R, but the previous method i / is also called ~ < (· 〇2 ~), at which time the milk is not sufficiently formed when the test solution is added. In other words, the raw material for (· 〇 2) is still changed from the oxygen molecule to (· 〇 2) so that ('because the oxygen atom will not be obtained immediately from the time when X0D is added, / 〇 2) The amount of production is increased, so after the addition of the test solution, the dissolved oxygen of the raw materials is generated. 2) Xiang Dan ^ a, of ® are not being paid attention to, and $ is measured with a spectrophotometer (· 〇-) ' In the previous method (· 02 a), I am not sure whether it is generated every time
第83頁 200413503 五、發明說明(81) f ^該等情形,希望較佳為先將含EDTA 2pBS緩衝原 液、黃嗓吟溶液、黃嘌呤氧化酶溶液與提供氧用之蒸餾水 加入腔室並混合,經過一段時間後,也就是說生成了'適量 的(·(V)後,再添加被檢定水及腎上腺素溶液並開始測 定。 故’本腎上腺素氧化法係依如下順序將各試藥溶液及 被檢定水依序投入腔室内。又,依需要設定待機時間。腔 室之容積為3ml,其中為被檢定水及供氧化蒸餾水各占約 1/3 ’其餘1/3為含EDTA之pH緩衝液等、黃嘌呤溶液、黃嗓 呤氧化酶溶液及腎上腺素溶液。 、τ ① 添加含EDTA之PBS緩衝原液30 0 // 1。 ② 添加黃嘌呤溶液3 〇 〇 # 1。 ③ 添加提供氧用之蒸餾水9 00 ^1(腔室容積之約1/3量)。 ④ 添加黃嘌呤氧化酶溶液1 0 〇 // 1。 ⑤ 為生成適量之(·〇2_),等待5分鐘。 ⑥ 添加被檢定水(液)1 m 1 (腔室容積之約1 / 3量) ⑦ 添加腎上腺素溶液4〇〇 # 1。 ⑧ 之後迅速開始以分光光度計測定吸光度(A48 0 )之經時變 化。 ⑨ 為調和腔室内試藥局部濃度分布差異,等待丨4 〇秒。也就 是說’原則上將後述游離基消去活性特性圖上從測定開始 到經過1 40秒為止之測定數據除去。經時變化之觀察時間 除去上述⑨之待機時間丨4〇秒,設定為1 5分鐘。此係因為約 5分或1 0分鐘左右由時對鉑與鈀間游離基消去活性看不出Page 83 200413503 V. Description of the invention (81) f ^ In these cases, it is preferable to add the EDTA 2pBS buffer solution, yellow throat solution, xanthine oxidase solution and distilled water for oxygen to the chamber and mix them first. After a period of time, that is, after the appropriate amount of (· (V) is generated, the test water and the adrenaline solution are added and the measurement is started. Therefore, the adrenaline oxidation method is based on the following test solution And the test water is sequentially put into the chamber. Also, the standby time is set as required. The volume of the chamber is 3ml, of which the test water and the oxidized distilled water each account for about 1/3 'The remaining 1/3 is the pH containing EDTA Buffer solution, xanthine solution, xanthosin oxidase solution and epinephrine solution, τ ① Add PBS buffer solution containing EDTA 30 0 // 1. ② Add xanthine solution 3 〇 ##. ③ Add oxygen The distilled water used is 9 00 ^ 1 (approximately 1/3 of the chamber volume). ④ Add xanthine oxidase solution 1 0 〇 // 1. ⑤ In order to generate an appropriate amount (· 〇2_), wait 5 minutes. ⑥ Add Tested water (liquid) 1 m 1 (approximately the volume of the chamber 1/3 volume) ⑦ Add epinephrine solution 4〇〇 # 1. ⑧ Quickly begin to measure the change in absorbance (A48 0) over time with a spectrophotometer. ⑨ To reconcile the difference in local concentration distribution of the test reagent in the chamber, wait 丨 4 〇 seconds. In other words, 'In principle, the measurement data from the measurement of radical elimination activity described later from the start of the measurement to the passage of 140 seconds is removed. The observation time of the change over time excludes the above-mentioned standby time ⑨ 40 seconds, set It is 15 minutes. This is because the elimination activity of free radicals between platinum and palladium cannot be seen in about 5 minutes or 10 minutes.
2030-5943-PF(Nl);Chiumeow.ptd 200413503 五、發明說明(82) 明顯的差異 又:透過實驗可以了解,即使如 起添加最後再加黃σ票呤氧化酶,並門妒 各試藥全部一 可以在某種程度上掌握游離基之消:/反應及測定,還是 者為事先在X0D實驗系中生成土了適量的^性傾向。但,較佳 被檢定液的方法,可以掌握到接近每 2 )後’再加入 傾向。又,先前的方法雖因黃嘌呤&二:基消去活性的 生成適量的(.〇2_)需要花較長時間,,不同,但因要 被檢定水等之游離基消去活性有困難。ft時間内要掌握 與纪之催化劑活性差異肖,先前方法的在要掌握始 務的因素’以上述方式進行各 ;慮實 定。 j侍機時點的設 ⑻於X0D實驗系中使用腎上腺素氧化 評價試驗方法之實施例與參考例揭示 I離基消去活性 (參考例1 9 ) 以蒸餾水(和光純藥製)作為被檢定水,以 之,序進行之游離基消去活性數據作為參考例19又 順帶一提,本參考例1 9 > y #、士丄 ^ X 151 ^ ^ ^ ^之游離基消去活性數據當使用製造 才-人不同之頁口示、虱化酶之試驗條 間之游離基消去活性特性會有4b微差里。"候1^批-(參考例2 0 ) 以氫虱置換蒸餾水(和光純藥製)作為被檢定水,以與 1 ί 同樣之試驗順序進行之游離基消去活性數據作為 ^歹·。又順帶一提,本參考例20之游離基消去活性數 第85頁 2030-5943-PF(Nl);Chiumeow.ptd 200413503 五、發明說明(83) " ' "" 據,參考例1 9同樣,當使用製造批次不同之黃嘌呤氧化酶 之试驗條件時,有時候製造批次間之游離基消去活性特性 會有些微差異。 (實施例2 6 ) 、以蒸销水(和光純藥製,以下同)中加入實施例3〜5記 載之鉑基準液使鉑膠體濃度為48 #g/1之 去活性數據作為實施例2 6。 (實施例2 7 ) 以蒸餾水(和光純藥製,以下同)中加入與實施例26同 樣之鉑,準液,使鉑膠體濃度為96 //g/l之氫氣置換A〇w作 為被檢定水,與參考例26以同樣之試驗順序進行之游離基 消去活性數據作為實施例27。 離土 (實施例28) 一曲以蒸館水中加入與實施例26同樣之鉑基準液,使鉑膠 體濃度為192 #§/1之氫氣置換A0W作為被檢定水,與實施^ 例26以同樣之試驗順序進行之游離基消去活性數據作為參 考例2 8。 夕 (實施例2 9 ) 以蒸鶴水中加入與實施例26同樣之鉑基準液, 體濃度為384 //g/i之氫氣置換A〇w作為被檢定水,與每夕 例26以同樣之試驗順序進行之游離基消去活W 考例28。 妖佩作為參 (實施例3 0 )2030-5943-PF (Nl); Chiumeow.ptd 200413503 V. Description of the invention (82) The obvious difference is again: through experiments, you can understand that even if you add yellow sigmaoxine oxidase at the end, you will be jealous of each test drug. All of them can to some extent grasp the elimination of free radicals: / reactions and determinations, or they have an appropriate tendency to generate soil in the X0D experimental system in advance. However, the method of the test solution is preferred, and it is possible to grasp the tendency of adding the solution after every 2). In addition, although the previous method takes a long time due to the generation of xanthine & di: base elimination activity, it takes a long time, and it is different, but it is difficult to verify the free radical elimination activity of water and the like. In ft time, it is necessary to grasp the difference in catalyst activity between Ji and Ji. In the previous method, it is necessary to grasp the factors of the business affairs. The example of the waiting time is set in the X0D experimental system. Examples and reference examples using the adrenaline oxidation evaluation test method are disclosed. I radical elimination activity (Reference Example 19). Distilled water (made by Wako Pure Chemical Industries, Ltd.) is used as the test water. In this regard, the sequential radical elimination activity data is referred to as Reference Example 19 and incidentally, this Reference Example 1 9 > y # 、 士 丄 ^ X 151 ^ ^ ^ ^ According to different page descriptions, the activity of free radical elimination between test strips of licease will be 4b. " Waiting 1 ^ batch- (Reference Example 20) Replace the distilled water (made by Wako Pure Chemical Industries, Ltd.) with hydrogen lice as the test water, and use the free radical elimination activity data in the same test sequence as 1 ί as ^ 歹 ·. Incidentally, the number of radical elimination activities of this Reference Example 20, page 85, 2030-5943-PF (Nl); Chiumeow.ptd 200413503 V. Description of the invention (83) " '" " According to Reference Example 1 9 Similarly, when the test conditions of xanthine oxidase from different manufacturing batches are used, sometimes the radical elimination activity characteristics between manufacturing batches may be slightly different. (Example 2 6) The deactivation data of the platinum colloid concentration of 48 # g / 1 was added to the steamed water (manufactured by Wako Pure Chemical Industries, the same below) to the platinum colloid concentration of 48 # g / 1 as Example 2 6. (Example 2 7) The same platinum as in Example 26 was added to distilled water (manufactured by Wako Pure Chemical Industries, the same below), and the platinum colloid concentration of 96 // g / l of hydrogen was used to replace Aow as the test. Water was used in Example 27 as radical elimination activity data in the same test sequence as in Reference Example 26. Isolation of soil (Example 28) The same platinum reference solution as in Example 26 was added to steamed water, and A0W was replaced by hydrogen with a platinum colloid concentration of 192 # § / 1 as the test water, which was the same as that in Example ^ Example 26. The radical elimination activity data of the test sequence was used as Reference Example 28. Evening (Example 2 9) The same platinum reference solution as in Example 26 was added to steamed crane water, and hydrogen at a concentration of 384 // g / i was used to replace Aow as the test water. The test sequence was performed with radical deactivation W. Case 28. Yao Pei as a reference (Example 30)
200413503 五、發明說明(84) 以蒸顧水中加入與實施例2 6同樣之鉑基 體濃度為768 #g/1之氫氣置換A〇w作為被檢定水夜|使^膠 例2 6以同樣之試驗順序進行之游離基消去活性摅、貝知 施例30。 蚁艨作為實 (實施例3 1 ) 以蒸餾水中加入與實施例6〜8記載之鈀基準液, 膠體濃度為48 //g/i之氫氣置換A〇w作為被檢定水,盘把 例1 9以同樣之試驗順序進行之游離基消去活性數^二考 施例3 1。 佩作為實 (實施例3 2 ) 以蒸顧水中加入與實施例31同樣之鈀基準液,使 體濃度為96 /zg/1之氫氣置換A〇w作為被檢定水,與實施^ 3 1以同樣之試驗順序進行之游離基消去活性數據作為每於 例32 。 …灵她 (實施例3 3 ) 以蒸餾水中加入與實施例3 1同樣之鈀基準液,使鈀膠 體濃度為192 /zg/1之氫氣置換A〇w作為被檢定水,與實施 例31以同樣之試驗順序進行之游離基,消去活性數據作為 施例3 3。 (實施例34) 以蒸顧水中加入與實施例3丨同樣之鈀基準液,使鈀膠 體濃度為384 //g/1之氫氣置換A〇w作為被檢定水,與實施 例3 1以同樣之試驗順序進行之游離基消去活性數據作為 施例3 4。200413503 V. Description of the invention (84) Add the same platinum matrix with a concentration of 768 # g / 1 of hydrogen as in Example 2 6 in distilled water to replace Aow as the test water. The test sequence was carried out for free radical elimination hydrazone, Example 30. The ant puppet was taken as an example (Example 31). The palladium reference solution described in Examples 6 to 8 was added to distilled water, and hydrogen at a colloidal concentration of 48 // g / i replaced Aow as the test water. 9 The number of free radical elimination activities carried out in the same test sequence. Wear it as a practical example (Example 3 2) Add the same palladium reference solution as in Example 31 to distilled water, and replace Aow with hydrogen at a body concentration of 96 / zg / 1 as the test water. The radical elimination activity data of the same test sequence were used as in Example 32. ... Ling She (Example 3 3) The same palladium reference solution as in Example 31 1 was added to distilled water, and hydrogen at a palladium colloid concentration of 192 / zg / 1 was used to replace Aow as the test water. In the same test sequence, the free radicals and elimination activity data were used as Example 33. (Example 34) The same palladium reference solution as in Example 3 丨 was added to distilled water, and A0w was replaced by hydrogen having a palladium colloid concentration of 384 // g / 1 as the test water, which was the same as that in Example 31. The test sequence of the radical elimination activity data was used as Example 34.
2030-5943-PF(Nl);Chiumeow.ptd 第87頁 2004135032030-5943-PF (Nl); Chiumeow.ptd p. 87 200413503
(實施例3 5 ) 、…餾JC中加入與實施例3 1同樣之纪 體濃度為768 //g/1之气欠罢格Anwi达、上上平,從使絶月 &丄之虱軋置換A0W作為被檢定水,盥每 例3 1以同樣之試驗川g &、故雜甘、上丄 ^ 興員施 施例35。 員序進订之游離基消去活性數據作為實 (實施例3 6 ) 以蒸餾水中加入本案申請人依前述難 「靡之製作與使用法」為根據所製造之粒:分;: 卜2nm的始膠體溶液,使翻膠體濃度為66 = A0W作為被檢定水,盥夂去办M 0丨、,门拉 ^ l乳置換 ^ 興參考例1 9以同樣之試驗順序進行 游離基消去活性數據作為實施例36。 (實施例3 7) 以蒸餾水中加入與實施例36同樣之鉑基準液,使鉬 體濃度為96 //、g/l之氫氣置換AQW作為被檢定水,與實施^ 36以同樣之試驗順序進行之游離基消去活性數據作為實施 例3 7 〇 (實施例3 8 ) 以蒸餾水中加入與實施例36同樣之鉑基準液,使鉑膠 體濃度為144 //g/1之氫氣置換A〇w作為被檢定水,與實施- 例36以同樣之試驗順序進行之游離基消去活性數據作 施例3 8。 ·只 (實施例3 9 ) 使鉑膠 與實施 以蒸餾水中加入與實施例3 6同樣之鉑基準液 體濃度為192 /zg/1之氫氣置換A〇w作為被檢定水(Example 3 5), ... JC was added with the same periodical concentration as 768 // g / 1 of the same period as in Example 31. Anwida and Shangshangping were used to reduce the absolute moon & tick A0W was replaced as the test water, and in each case 31, the same test was performed with Chuan g & The order-free radical elimination activity data is taken as an example (Example 36). The distilled water was added to the case. The applicant made the granules based on the above-mentioned difficult "producing and using method" as the basis: points; Colloidal solution, so that the colloidal concentration is 66 = A0W as the test water, and the toilet goes to M 0 丨, Menla ^ l milk replacement ^ Xing Reference Example 19 The free radical elimination activity data in the same test sequence as implementation Example 36. (Example 3 7) The same platinum reference solution as in Example 36 was added to distilled water, and the AQW was replaced by hydrogen with a molybdenum concentration of 96 //, g / l as the test water, in the same test sequence as in Example 36. The free radical elimination activity data was taken as Example 37 (Example 38). The same platinum reference solution as in Example 36 was added to distilled water, and the platinum colloid concentration was 144 // g / 1 of hydrogen to replace Aow. As the test water, the radical elimination activity data in the same test sequence as in Example 36 was used as Example 38. Only (Example 3 9) The platinum glue was used. The distilled water was added with the same platinum reference liquid concentration of 192 / zg / 1 as in Example 36 to replace Aow as the test water.
200413503200413503
例3 6以同樣之试驗川員序 施例3 9。 (實施例4 0 ) 進行之游離基消去活性數據作為實 實施例3 6同樣之鉑基準液,使翻膠 氣置換A0W作為被檢定水,與實施 進行之游離基消去活性數據作為實 以蒸餾水中加入與 體濃度為384 //g/;[之氣 例3 6以同樣之試驗順序 施例4 0。 (實施例4 1) 以蒸餾水中加入與實施 體濃度為768 //g/i之氫氣置 例3 6以同樣之試驗順序進行 施例41。 (實施例42) 例3 6同樣之鉑基準液,使鉑膠 換A0W作為被檢定水,與實施 之游離基消去活性數據作為實 以餾水中加入以與實施例2 6同之鉑 例31同樣之把基準液以莫耳比1:2混合調製之(始+纪合 膠體’,膠體濃度為96 "g/1之氣氣置換綱作為被檢定 水與/考例1 9以同樣之試驗順序進行之游離基消去活性 數據作為實施例4 2。 (實施例43) 以蒸餾水中加入與實施例42同樣之(鉑+鈀)混合膠 體,使膠體濃度為192 //g/1之氫氣置換A〇w作為被檢定 水,與實施例42以同樣之試驗順序進行之游離基消去活性 數據作為實施例43。 (實施例44)Example 36 6 uses the same test procedure as Example 39. (Example 40) The data of the radical elimination activity carried out were taken as the same platinum reference solution as in Example 36. A0W was replaced by the flip gas as the test water, and the data of the radical elimination activity carried out during the implementation was distilled water Add a gas concentration of 384 // g /; [Ziqi Example 3 6 Example 40 in the same test sequence. (Example 4 1) Example 41 was carried out in the same test sequence as adding hydrogen with distilled water at a concentration of 768 // g / i. (Example 42) Example 3 6 The same platinum reference solution was used, and platinum glue was replaced with A0W as the test water, and the free radical elimination activity data as the actual implementation was added in distilled water to be the same as in Example 26. The reference solution is prepared by mixing with a molar ratio of 1: 2 (Si + Ji colloid ', with a colloid concentration of 96 " g / 1 as a gas-gas replacement platform as the test water and / Examination Example 19 The same test Sequential free radical elimination activity data is taken as Example 4 2. (Example 43) The same (platinum + palladium) mixed colloid as in Example 42 was added to distilled water to replace the colloid concentration with 192 // g / 1 of hydrogen Aow was used as the test water, and the radical elimination activity data performed in the same test sequence as in Example 42 was used as Example 43. (Example 44)
第89頁 200413503 五、發明說明(87) 以蒸餾水中加入與實施例4 2同樣之(鉑+鈀)混合膠 體,使膠體濃度為384 /zg/1之氫氣置換a〇W作為被檢定 水,與實施例4 2以同樣之試驗順序進行之游離基消去活性 數據作為實施例44。 (實施例4 5 ) 以蒸餾水中加入與實施例42同樣之(鉑+鈀)混合膠 體,使膠體濃度為768 // g / 1之氫氣置換A〇w作為被檢定 水’與實施例4 2以同樣之試驗順序進行之游離基消去活性 數據作為實施例4 5。 (實施例46) 以蒸餾水中加入以與實施例2 6同樣之鉑基準液與實施 例31同樣之鈀基準液以莫耳比丨:5混合調製之(鉑+鈀)混合 膠體,使膠體濃度為144 /zg/1之氫氣置換A〇w作為被檢定 水,與參考例1 9以同樣之試驗順序進行之游離基消去活性 數據作為實施例4 6。 (實施例4 7 ) 之鉑基準液與實施 調製之(翻+把)混 置換A0W作為被檢 行之游離基消去活 以蒸餾水中加入以與實施例2 6同樣 例3 1同樣之鈀基準液以莫耳比丨:丨〇混合 合膠體,使膠體濃度為240 /zg/1之氫& 定水’與實施例4 6以同樣之試驗順序進 性數據作為實施例4 7。 (實施例4 8 )Page 89 200413503 V. Description of the invention (87) Add the same (platinum + palladium) mixed colloid as in Example 4 2 to distilled water, and replace the a0W with hydrogen at a colloid concentration of 384 / zg / 1 as the test water. The data of radical elimination activity performed in the same test sequence as in Example 42 were used as Example 44. (Example 4 5) The same colloid (platinum + palladium) mixed colloid as in Example 42 was added to distilled water, and hydrogen at a colloid concentration of 768 // g / 1 was used to replace Aow as the test water. Example 2 2 The data of radical elimination activity carried out in the same test sequence were taken as Examples 4 and 5. (Example 46) A platinum (palladium + palladium) mixed colloid prepared by adding a platinum reference solution similar to that in Example 26 to a palladium reference solution similar to that in Example 31 and a palladium reference solution prepared in Example 31 at a molar ratio of 5: A0w was replaced by hydrogen at 144 / zg / 1 as the test water, and the radical elimination activity data in the same test sequence as in Reference Example 19 was used as Example 46. (Example 4 7) The platinum reference solution and the prepared (turned over + put) mixed replacement A0W as the radical deactivation of the test line were added in distilled water to add the same palladium reference solution as in Example 2 6 Example 3 1 Molar ratio 丨: 丨 was used to mix the colloids so that the colloidal concentration was 240 / zg / 1 of hydrogen & fixed water 'as in Example 46. Progressive data in the same test sequence was used as Example 47. (Example 4 8)
2030-5943.PF(Nl);Chiumeow.ptd 第90頁 ZUU4U^〇3 五、發明說明(88) 2體=膠體^度為336 //g/1之氫氣置換A。*作為被檢 :ί摅;Γ: 樣之試驗順序進行之游離基消去活 性數據作為實施例48。 (實施例4 9 ) =餾水中加入以與實施例26同樣之始基準液與實施 3 =樣之纪”液以莫耳比1:20混合翻混 3體^膠體濃度為432 "g/1之氫氣置換A〇w作為被檢 以同樣之試驗順序進行之游離基消去活 性數據作為實施例4 9。 (實施例5 0 ) X蒸餾水中加入以與實施例2 6同樣之鉑基準液與實施 人^樣之把基準液以莫耳比1:25混合調製之(始+把)混 3體乂膠體濃度為528//g/1之氫氣置換A〇w作為被檢 例46以同樣之試驗順序進行之游離基消去活 性數據作為實施例5 〇。 (參考例2 1) 以使用氮氣置才奐蒸顧水時改變(A—4)中f己載順序一部 /刀之試驗順序測定之游離基消去活性數據作為參考例21。 二述試驗:序之改變部分為在試驗腔室内添加黃嗓呤溶液 300 及Π令氧化酶溶液1〇〇/U的部分,也就是說,取 代除去(.G2_)生成系’而將氧供給用蒸顧水由剛^增量 到 1 3 0 0 /z 1。 (實施例5 1) 以蒸餾水中加入以與實施例2 6同樣之鉑基準液與實施2030-5943.PF (Nl); Chiumeow.ptd Page 90 ZUU4U ^ 〇3 V. Description of the invention (88) 2 body = colloid A hydrogen with a degree of 336 // g / 1. * As the test results: ί 摅; Γ: The radical elimination activity data of the same test sequence was used as Example 48. (Example 4 9) = Add distilled water with the same reference solution as in Example 26 and implementation 3 = sample of the "liquid" solution mixed at a molar ratio of 1:20 3 body ^ colloid concentration of 432 " g / The hydrogen substitution A0w of 1 was used as the free radical elimination activity data of the test in the same test sequence as Example 4 9. (Example 50) X distilled water was added with the same platinum reference solution as in Example 26 and The reference solution was prepared by mixing the reference solution with a molar ratio of 1:25 (start + handle) and mixing with three bodies. The colloidal concentration of 528 // g / 1 of hydrogen was used to replace Aow as the test example 46. The data of the radical elimination activity carried out in the test sequence was taken as Example 5. (Reference Example 2 1) The test sequence of one f / loading sequence in (A-4) was changed when the water was distilled using nitrogen and the water was distilled. The free radical elimination activity data is used as reference example 21. The second test: the part of the sequence change is the part in which the lutein solution 300 and the Π oxidase solution 100 / U are added in the test chamber, that is, the replacement is removed (.G2_) generation system ', and the steam supply water for oxygen supply was increased from just 1 to 1 3 0 0 / z 1. (Example 5 1) Distilled water was added in Example 26 was mixed with the same embodiment of a platinum reference
2030-5943-PF(Nl);Chiumeow.ptd 第91頁 200413503 五、發明說明(89) " 例31同樣之鈀基準液以莫耳比丨:5混合調製之(鉑+鈀)混合 膠體,使膠體濃度為144 //g/l之氫氣置換A〇w作為被檢定 水’以改變(A-4)中記載順序一部分試驗順序測定之游離 基消去活性數據作為實施例5丨。上述試驗順序改變之部分 與參考例2 1相同。 (實施例52) 以蒸餾水中加入以與實施例26同樣之鉑基準液與實施 例31同樣之鈀基準液以莫耳比丨:1〇混合調製之(鉑+鈀)混 =膠體,使膠體濃度為240以g/ 1之氫氣置換A〇w作為被檢 定水,與貫施例51以同樣之試驗順序進行之游離基消去活 性數據作為實施例5 2。 (實施例5 3 ) 以蒸餾水中加入以與實施例2 6同樣之鉑基準液與實施 例31同樣之鈀基準液以莫耳比丨·· 21 5混合調製之(鉑+鈀)混 =膠體,使膠體濃度為336 #g/1之氫氣置換A〇w作為被檢 疋水,與實施例5 1以同樣之試驗順序進行之游離基消去活 性數據作為實施例5 3。 (實施例5 4 ) 以蒸餾水中加入以與實施例2 6同樣之鉑基準液與實施 同樣之鈀基準液以莫耳比丨:2〇混合調製之(鉑+鈀)混 二膠體,使膠體濃度為432" g/Ι之氫氣置換A〇w作為被檢 與實施例5 1以同樣之試驗順序進行之游離基消去活 性數據作為實施例5 4。 (實施例5 5 )2030-5943-PF (Nl); Chiumeow.ptd page 91 200413503 V. Description of the invention (89) " Example 31 The same palladium reference solution was prepared by mixing (platinum + palladium) mixed colloid with a molar ratio of 5: The hydrogen with a colloidal concentration of 144 // g / l was used to replace Aow as the test water ', and the radical elimination activity data measured in part of the test sequence described in (A-4) was changed as Example 5 丨. The above-mentioned test sequence is changed in the same manner as in Reference Example 21. (Example 52) A platinum reference solution similar to that of Example 26 and a palladium reference solution similar to Example 31 were added in distilled water to prepare a (platinum + palladium) mixture at a molar ratio of 1:10, and the colloid was formed. The concentration of 240 was replaced by g / 1 hydrogen as the test water, and the radical elimination activity data in the same test sequence as in Example 51 were used as Example 5 2. (Example 5 3) The same platinum reference solution as in Example 2 6 was added to distilled water and the palladium reference solution was the same as in Example 31. Molar ratio 丨 · 21 5 was mixed to prepare (platinum + palladium) mixed = colloid Let A0w with hydrogen at a colloidal concentration of 336 # g / 1 be used as the test water, and the data of radical elimination activity performed in the same test sequence as in Example 51 as Example 53. (Example 5 4) In a distilled water, a platinum colloid (platinum + palladium) mixed with a platinum reference solution similar to that in Example 26 and a palladium reference solution subjected to the same implementation at a molar ratio of 1:20 was added to make the colloid. The hydrogen substitution Aow at a concentration of 432 " g / 1 was used as the test and the free radical elimination activity data of Example 51 were performed in the same test sequence as Example 54. (Example 5 5)
200413503 五、發明說明(90) ' ---- 以蒸顧水中加入以與實施例26同樣之鉑基準液與實施 例31同樣之鈀基準液以莫耳比丨:25混合調製之(鉑+鈀)混 合,體,使膠體濃度為528 #g/1者之氫氣置換A〇w作為被 檢疋水,與貫施例5 1以同樣之試驗順序進行之游離基消去 活性數據作為實施例5 5。 (參考例2 2) 以將和光純藥工業(股)公司製之標準緩衝液6· 86 (磷 酉文鹽水浴液)以純水稀釋1 〇倍之pH緩衝水溶液(基本水 6· 86)作為被檢定水,將此被檢定水依(A — 4)記載之試驗順 序進行之游離基消去活性數據作為參考例22。 、 (參考例2 3 ) 將與參考例2 2同樣之基本水6 · 8 6以每分1公升之流速 下以5A固定電流之電解條件進行連續通水式電解處理後之 無添加催化劑電解處理水作為被測定水,將此被檢定水依 與參考例2 2同樣的試驗順序進行之游離基消去活性數據作 為參考例2 3。 (實施例5 6 ) 取與參考例22同樣之基本水6. 86 1公升,加入與實施 例2 6同樣之翻基準液使漢度為4 8 // g / 1以調製含鉑膠體之 基本水6· 86。將此調製好之含鉑膠體之基本水6· 86以和表 考例2 3同樣的電解條件進行連續通水式電解處理,製成催 化劑前添加1道電解處理水以作為被檢定水(A0W),將此被 檢定水依與參考例2 2同樣的試驗順序進行之游離基消去活 性數據作為實施例5 6。200413503 V. Description of the invention (90) '---- Add the same platinum reference solution as in Example 26 and the same palladium reference solution as in Example 31 in distilled water to mix with Molar ratio 丨: 25 (platinum + Palladium) was mixed, and a colloidal concentration of 528 # g / 1 of hydrogen was used to replace Aow as the test water, and the radical elimination activity data in the same test sequence as in Example 51 were used as Example 5 5. (Reference Example 2 2) A standard buffer solution 6.86 (Phosphate saline solution) manufactured by Wako Pure Chemical Industries, Ltd. was diluted with a pure water to a pH buffered aqueous solution (basic water 6.86). As the test water, the radical elimination activity data of the test water according to the test sequence described in (A-4) was taken as Reference Example 22. (Reference Example 2 3) The same basic water as in Reference Example 2 2 6 · 8 6 was subjected to continuous water electrolysis at a flow rate of 1A per minute at a fixed current of 5A, and the electrolysis treatment was performed without added catalyst. Water was used as the test water, and the radical elimination activity data of this test water in the same test procedure as in Reference Example 22 was used as Reference Example 23. (Example 5 6) Take 6.86 1 liter of the same basic water as in Reference Example 22, add the same reference solution as in Example 2 6 to make the degree of Han 4 4 // g / 1 to prepare the basic of colloid containing platinum Water 6.86. This prepared platinum colloid-containing basic water 6.86 was subjected to continuous water electrolysis treatment under the same electrolytic conditions as in Table Examination Example 2 3, and one electrolytic treatment water was added as the test water before making the catalyst (A0W ). The free radical elimination activity data of the test water in the same test sequence as in Reference Example 22 was taken as Example 56.
200413503 五、發明說明(91) (實施例5 7 ) 取與參考例2 2同樣之基本水6 · 8 6 1公升,加入與實施 例2 6同樣之鉑基準液使濃度為9 6 // g/ 1以調製含鉑膠體之 基本水6 · 8 6。將此調製好之含鉑膠體之基本水6. 8 6以和參 考例2 3同樣的電解條件進行連續通水式電解處理,製成催 化劑前添加1道電解處理水以作為被檢定水(A0W),將此被 檢定水依與實施例56同樣的試驗順序進行之游離基消去活 性數據作為實施例5 7。 (實施例5 8 )200413503 V. Description of the invention (91) (Example 5 7) Take the same basic water as Reference Example 2 2 6 · 8 6 1 liter, add the same platinum reference solution as in Example 2 6 to make the concentration 9 6 // g / 1 to prepare basic water containing platinum colloid 6 · 8 6. This prepared platinum-colloid-containing basic water 6. 8 6 was subjected to continuous water electrolysis treatment under the same electrolytic conditions as in Reference Example 2 3, and one electrolytic treatment water was added as the test water before making the catalyst (A0W ). The free radical elimination activity data of the test water in the same test sequence as in Example 56 were taken as Examples 5 and 7. (Example 5 8)
取與參考例22同樣之基本水6· 86 1公升,加入與實施 例2 6同樣之鉑基準液使濃度為丨9 2 # g/ i以調製含鉑膠體之 基本水6· 86。將此調製好之含鉑膠體之基本水6· 86以和參 考例=同樣的電解條件進行連續通水式電解處理,製成催 化劑岫添加1道電解處理水以作為被檢定水(A⑽),將此被 檢疋水依與實施例5 6同樣的試驗順序進行之游離基消去活 性數據作為實施例5 8。 (實施例5 9 )Take 6.86 1 liter of the same basic water as in Reference Example 22, and add the same platinum reference solution as in Example 2 6 to a concentration of 9 2 # g / i to prepare basic water 6.86 with platinum colloid. This prepared platinum colloid-containing basic water 6.86 was subjected to continuous water electrolysis treatment under the same electrolytic conditions as in Reference Example = to prepare a catalyst, and one electrolytic treatment water was added as the test water (A⑽). The free radical elimination activity data of this test tritium water in the same test sequence as in Example 56 were used as Example 58. (Example 5 9)
取與參考例22同樣之基本水6. 86 i公升,加入與實 ϋ6匕樣Q之鉑基準液使濃度為384 "g/1以調製含鉑膠體 二η ^ 將此凋製好之含鉑膠體之基本水6. 86以和 Γ:丨二 =Λ解條件進行連續通水式電解處理,製成 &二t二二電解處理水以作為被檢定水(a〇w),將此 施例56同樣的試驗順序進行之游離基消去 性數據作為實施例5 9。Take 6.86 i liter of the same basic water as in Reference Example 22, and add a platinum reference solution with the same quality as that of reference 6 to a concentration of 384 " g / 1 to prepare a platinum-containing colloid η ^ The basic water of platinum colloid 6.86 was subjected to continuous water electrolysis treatment under the conditions of Γ: 丨 二 = Λ solution, and made & two t two two electrolysis treated water as the test water (a〇w). In Example 56, the radical elimination data of the same test sequence were used as Examples 5-9.
2030-5943-PF(Nl);Chiumeow.ptd 第94頁 200413503 五、發明說明(92) (實施例6 0 ) 取與參考例22同樣之基本水6· 86 1公升,加入與實施 例2 6同樣之鉑基準液使濃度為7 6 8 // g / 1以調製含鉑勝體之 基本水6· 86。將此調製好之含鉑膠體之基本水6. 86以和參 考例2 3同樣的電解條件進行連續通水式電解處理,製成催 化劑前添加1道電解處理水以作為被檢定水(A0W),將此被 檢定水依與實施例5 6同樣的試驗順序進行之游離基消去活 性數據作為實施例6 〇。 (實施例6 1) 取與參考例22同樣之基本水6.86 1公升,加入與實施 例31同樣之鈀基準液使濃度為48 // g/Ι以調製含鈀膠體之 基本水6· 86。將此調製好之含鈀膠體之基本水6. 86以和參 考例23同樣的電解條件進行連續通水式電解處理,製成催 化劑前添加1道電解處理水以作為被檢定水(A0W),將此被 檢定水依與參考例22同樣的試驗順序進行之游離基消去活 性數據作為實施例6 1。 (實施例6 2 ) 取與參考例22同樣之基本水6. 86 1公升,加入與實施 例3 1同樣之鈀基準液使濃度為96 // g/ 1以調製含鈀膠體之 基本水6 · 8 6。將此調製好之含鈀膠體之基本水6 · 8 6以和參 考例2 3同樣的電解條件進行連續通水式電解處理,製成催 化劑前添加1道電解處理水以作為被檢定水(A0W),將此被 檢定水依與實施例61同樣的試驗順序進行之游離基消去活 性數據作為實施例6 2。 2030-5943-PF(Nl);Chiumeow.ptd 第95頁 200413503 五、發明說明(93) < (實施例6 3 ) ’ 取與參考例22同樣之基本水6· 86 1公升,加入與實施 · 例3 1同樣之鈀基準液使濃度為1 9 2 /z g / 1以調製含鈀膠體之 基本水6· 86。將此調製好之含鈀膠體之基本水6. 86以和參 考例2 3同樣的電解條件進行連續通水式電解處理,製成催 化劑如添加1道電解處理水以作為被檢定水(A⑽),將此被 檢定水依與實施例6 1同樣的試驗順序進行之游離基消去活 性數據作為實施例6 3。 (實施例6 4 ) 取與參考例22同樣之基本水6· 86 1公升,加入與實施 籲 例3 1同樣之纪基準液使濃度為3 8 4 # g / 1以調製含把膠體之 基本水6 · 8 6。將此調製好之含鈀膠體之基本水6 · 8 6以和參 考例2 3同樣的電解條件進行連續通水式電解處理,製成催 化,W添加1道電解處理水以作為被檢定水(A〇w),將此被 檢定水依與實施例6丨同樣的試驗順序進行之游離基消去活 性數據作為實施例6 4。 (實施例6 5 ) 取與參考例22同樣之基本水6· 86 1公升,加入與實施 例3 1同樣之鈀基準液使濃度為7 6 8 # !以調製含鈀膠體之 基本水6· 86。將此調製好之含把膠體之基本水6· 86以和參春 考例同樣的電解條件進行連續通水式電解處理,製成催 化,刖添加1道電解處理水以作為被檢定水(A〇w),將此被 檢定水依與實施例61同樣的試驗順序進行之游離基消去活 性數據作為實施例6 5。2030-5943-PF (Nl); Chiumeow.ptd Page 94 200413503 V. Description of the invention (92) (Example 60) Take the same basic water as 6.86 1 liter, and add it to Example 2 6 The same platinum reference solution was used to make the concentration 7 6 8 // g / 1 to prepare the basic water containing platinum victory body 6.86. This prepared platinum-colloid-containing basic water 6.86 was subjected to continuous water-pass electrolytic treatment under the same electrolytic conditions as in Reference Example 23, and one electrolytic treatment water was added as the test water before making the catalyst (A0W). The free radical elimination activity data of the test water in the same test sequence as in Example 56 was used as Example 60. (Example 6 1) Take 6.86 1 liter of the same basic water as in Reference Example 22, and add the same palladium reference solution as in Example 31 to a concentration of 48 // g / l to prepare basic water 6.86 with palladium-containing colloid. This prepared palladium-containing colloidal basic water 6.86 was subjected to continuous water electrolysis treatment under the same electrolytic conditions as in Reference Example 23. Before the catalyst was made, one electrolytic treatment water was added as the test water (A0W). The radical elimination activity data of the test water in the same test sequence as in Reference Example 22 was used as Example 61. (Example 6 2) 6.86 1 liter of the same basic water as in Reference Example 22 was added, and the same palladium reference solution as in Example 3 1 was added to a concentration of 96 // g / 1 to prepare a basic water 6 containing a palladium colloid. · 8 6. This prepared palladium-containing colloidal basic water 6 · 8 6 was subjected to continuous water-pass electrolytic treatment under the same electrolytic conditions as in Reference Example 2 3, and one electrolytic treatment water was added as the test water before making the catalyst (A0W ). The free radical elimination activity data of the test water in the same test sequence as in Example 61 was taken as Example 6 2. 2030-5943-PF (Nl); Chiumeow.ptd Page 95 200413503 V. Description of the Invention (93) < (Example 6 3) '' Take the same basic water as Reference Example 22 6.86 1 liter, add and implement Example 3 1 The same palladium reference solution was used to adjust the concentration to 19 2 / zg / 1 to prepare basic water 6.8 containing palladium colloid. This prepared palladium-containing colloidal basic water 6.86 was subjected to continuous water electrolysis treatment under the same electrolytic conditions as in Reference Example 23, to prepare a catalyst, such as adding 1 electrolytic treatment water as the test water (A⑽). The free radical elimination activity data of the test water in the same test sequence as in Example 61 was used as Example 63. (Example 6 4) Take 6.86 1 liter of the same basic water as in Reference Example 22, and add the same standard reference solution as in Example 3 1 to make the concentration 3 8 4 # g / 1 to prepare the basic containing colloid Water 6 · 8 6. This prepared palladium-containing colloidal basic water 6 · 8 6 was subjected to continuous water electrolysis treatment under the same electrolytic conditions as in Reference Example 2 3 to prepare a catalyst, and 1 electrolytic treatment water was added as the test water ( Aww), the data of radical elimination activity of the test water according to the same test sequence as in Example 6 丨 was taken as Example 64. (Example 6 5) Take the same basic water 6.86 1 liter as in Reference Example 22, and add the same palladium reference solution as in Example 3 1 to a concentration of 7 6 8 #! To prepare basic water containing palladium colloid 6 · 86. The prepared basic water 6.86 containing colloid was subjected to continuous water-pass electrolytic treatment under the same electrolytic conditions as in the reference example of the spring, and was made into a catalyst, and 1 electrolytic treatment water was added as the test water (A 〇w), the test water in accordance with the same test sequence as in Example 61, the radical elimination activity data as Example 65.
200413503200413503
(實施例6 6 ) 取與參考例22同樣之基本水β· 86】公升,加入與實施 例26同樣之减準液使濃度為製含歸體之 基本水6. 86。將此调製好之含鉑膠體之基本水6· 86以每分 釦1 · 5么升的流里於5 A固定電流的電解條件進行連續通水 j循環式(循環水量〇· 8公升)電解處理3分鐘,製成催化劑 前添加循環電解處理水以作為被檢定水(A〇w),將此被檢 定水依與參考例2 2同樣的試驗順序進行之游離基消去活性 數據作為實施例6 6。 (實施例6 7)(Example 6 6) Take the same basic water β · 86] as in Reference Example 22, and add the same fluid as in Example 26 to reduce the concentration to 6.86. This prepared platinum colloid-containing basic water 6.86 was subjected to continuous water circulation under the electrolysis condition of 5 A fixed current of 5 A per minute and a constant current of 5 cycles. (Circulating water amount 0.8L) Electrolytic treatment was performed for 3 minutes. Before the catalyst was prepared, circulating electrolytically treated water was added as the test water (Aow). The radical elimination activity data of this test water in the same test sequence as in Reference Example 22 was used as examples. 6 6. (Example 6 7)
取與參考例22同樣之基本水6.86 !公升,加入與實施 例2 6同樣之鉑基準液使濃度為9 6 # g/ i以調製含鉑膠體之 基本水6· 86。將此調製好之含鉑膠體之基本水6·86與實施 例66同樣的電解條件進行連續通水式循環式(循環水量 公升)電解處理3分鐘,製成催化劑前添加循環電解處理水 以作為被檢疋水(A0W),將此被檢定水依與實施例μ同樣 的試驗順序進行之游離基消去活性數據作為實施例67。 (實施例6 8 ) 取與參考例22同樣之基本水6· 86 1公升,加入與實施 例26同樣之始基準液使濃度為192 wi以調製含鉑膠 基本水6.86。將此調製好之含鉑膠體之基本水6. 86與實施 例6 6同樣的電解條件進行連續通水式循環式(循環水量〇 8 公升)電解處理3分鐘,製成催化劑前添加循環電解處理水 以作為被檢定水(A0W),將此被檢定水依與實施例66同樣7Take 6.86 liters of basic water similar to that in Reference Example 22, and add the same platinum reference solution as in Example 2 6 to a concentration of 9 6 # g / i to prepare platinum colloid-containing basic water 6.86. This prepared platinum colloid-containing basic water 6.86 was subjected to a continuous water circulation type (circulating water liter) electrolytic treatment for 3 minutes under the same electrolytic conditions as in Example 66, and the circulating electrolytically treated water was added as a catalyst before making it as a catalyst. The test mash water (A0W) was used as the example 67 for the radical elimination activity data of this test water in the same test sequence as in Example μ. (Example 6 8) The same basic water 6.86 1 liter as that of Reference Example 22 was taken, and the same reference solution as in Example 26 was added to a concentration of 192 wi to prepare a platinum gum-containing basic water 6.86. This prepared platinum-colloid-containing basic water 6.86 was subjected to a continuous water circulation type (circulated water amount of 08 liters) electrolytic treatment for 3 minutes under the same electrolytic conditions as in Example 66, and a circulating electrolytic treatment was added before the catalyst was prepared. Water is used as the test water (A0W), and this test water is the same as in Example 66. 7
200413503200413503
五、發明說明(95) (的實 =Γ行之游離基消去活性數據作為實施細。V. Description of the invention (95) (The actual value of the radical elimination activity of the Γ line is used as the implementation details.
取與參考例22同樣之基本水6.86 i公升,加入盘實施 =26同樣之#基準液使濃度為384 #g/hx調製含㈣體之 基本水6.86。將此調製好之含鉑膠體之基本水6 Μ盥奋施 例66同樣的電解條件進行連續通水式循環式(循環水量^ 8 公升)電解處理3分鐘,製成催化劑前添加循環電衣解處里理水 以作為被檢定水(A0W) ’將此被檢定水依與實施例66々同樣 的試驗順序進行之游離基消去活性數據作為實施 (實施例7 0 ) 取與參考例22同樣之基本水6.86 1公升,加入盥實施 例2 6同樣之鉑基準液使濃度為7 6 8 # g / i以調製含鈾膠體之 基本水6.86。將此調製好之含鉑膠體之基本水6 86與實施 例66同樣的電解條件進行連續通水式循環式(循環水量〇 8 公升)電解處理3分鐘,製成催化劑前添加循環電解處理水 以作為被檢定水(A0W),將此被檢定水依與實施例66同樣 的試驗順序進行之游離基消去活性數據作為實施例7〇。 (實施例7 1 )Take 6.86 i liters of the same basic water as in Reference Example 22 and add the same #reference solution to the plate to implement = 26 to make the concentration 384 # g / hx to prepare the basic water containing carcass 6.86. This prepared platinum colloid-containing basic water 6 MW was used in Example 66 under the same electrolytic conditions as the continuous water circulation type (circulating water amount ^ 8 liters) electrolytic treatment for 3 minutes. The treated water was used as the test water (A0W). The free radical elimination activity data of this test water in the same test sequence as in Example 66 was used for implementation (Example 70). The same as in Reference Example 22 was taken. Basic water 6.86 1 liter. The same platinum reference solution as in Example 2 6 was added to a concentration of 7 6 8 # g / i to prepare basic water 6.86 containing uranium colloid. This prepared platinum colloid-containing basic water 6 86 was subjected to a continuous water circulation type (circulated water amount of 8 liters) electrolytic treatment for 3 minutes under the same electrolytic conditions as in Example 66. Before the catalyst was prepared, the circulating electrolytically treated water was added to As the test water (A0W), the radical elimination activity data of this test water in the same test sequence as in Example 66 was taken as Example 70. (Example 7 1)
取與參考例22同樣之基本水6. 86 !公升,加入與實施 例3 1同樣之鈀基準液使濃度為48 # g/ }以調製含鈀膠體之 基本水6· 86。將此調製好之含鈀膠體之基本水6. 86以每分 鐘1 · 5公升的流量於5A固定電流的電解條件進行連續通水 f循環式(循環水量0.8公升)電解處理3分鐘,製成催化劑 W添加循環電解處理水以作為被檢定水(A〇w),將此被檢6.86 liters of basic water similar to Reference Example 22 was added, and the same palladium reference solution as in Example 31 1 was added to a concentration of 48 # g /} to prepare basic water 6.86 containing colloids containing palladium. This prepared palladium-containing colloidal basic water 6.86 was electrolyzed by a continuous water flow f cycle type (circulated water volume 0.8 liter) for 3 minutes at a flow rate of 1.5 liters per minute at a fixed current of 5A. Catalyst W adds circulating electrolytically treated water as the test water (Aow), and this test is performed.
2030-5943-PF(Nl);Chiumeow.ptd 第98頁 2004135032030-5943-PF (Nl); Chiumeow.ptd p. 98 200413503
進行之游離基消去活性 五、發明說明(96) 定水依與參考例22同樣的試驗順序 數據作為實施例71。 (實施例72) 取與參考例22同樣之基本水6· 86丨公升,. Γ:同基準液使浪度為96以"以調製含:入膠與體實之施 此調製好之含鈀膠體之基本水6. 86與實施 娜同樣的電㈣件進行連續通水式循環式(㈣水、旦貝= 公升)電解處理3分鐘,製成催化劑前添加循環電解%里· 8 以,為被檢定水(A0W),將此被檢定水依與實施例7 的試驗順序進行之游離基消去活性數據作為實施 ^ (實施例73) 取與參考例22同樣之基本水6·86 1公升,加入盥實施 例31同樣之鈀基準液使濃度為192 #g/1以調製含鈀膠體之 基本水6· 86。將此調製好之含鈀膠體之基本水6·86與實施 例66同樣的電解條件進行連續通水式循環式(循環水量〇 8 公升)電解處理3分鐘,製成催化劑前添加循環電解處理水 以作為被檢定水(A0W),將此被檢定水依與實施例71同樣 的試驗順序進行之游離基消去活性數據作為實施例73。 (實施例74) 取與參考例2 2同樣之基本水6 · 8 6 1公升,加入與實施 例3 1同樣之纪基準液使濃度為3 8 4 # g / 1以調製含把膠體之 基本水6· 86。將此調製好之含鈀膠體之基本水6· 86與實施 例6 6同樣的電解條件進行連續通水式循環式(循環水量〇. 8 公升)電解處理3分鐘,製成催化劑前添加循環電解處理水Radical elimination activity performed 5. V. EXPLANATION OF THE INVENTION (96) The fixed water was subjected to the same test sequence as in Reference Example 22. The data was used as Example 71. (Example 72) Take the same basic water as 6.86 丨 L, which is the same as that of Reference Example 22. Γ: Same as the reference solution so that the wave length is 96 to adjust the content: enter the gel and the body to apply this prepared content The basic water of palladium colloid is 6.86. The same electric parts as that of the implementation of Na are subjected to continuous water circulation type electrolysis treatment (water, denier = liter) for 3 minutes, and the circulating electrolysis is added before the catalyst is added. For the test water (A0W), the free radical elimination activity data of this test water in accordance with the test sequence of Example 7 was used as the implementation ^ (Example 73) Take the same basic water 6.86 1 liter as in Reference Example 22 Add the same palladium reference solution as in Example 31 to a concentration of 192 # g / 1 to prepare palladium-containing colloidal basic water 6.86. This prepared palladium-containing colloidal basic water 6.86 was subjected to a continuous water circulation type (circulating water amount of 8 liters) electrolytic treatment for 3 minutes under the same electrolytic conditions as in Example 66, and the circulating electrolytically treated water was added before the catalyst was prepared. As the test water (A0W), the radical elimination activity data of this test water in the same test sequence as in Example 71 was taken as Example 73. (Example 74) Take the same basic water 6 · 8 6 1 liter as in Reference Example 2 and add the same standard reference solution as in Example 3 1 to make the concentration 3 8 4 # g / 1 to prepare the basic Water 6.86. This prepared palladium-containing colloidal basic water 6.86 was subjected to a continuous water circulation type (circulating water amount 0.8 liter) electrolytic treatment for 3 minutes under the same electrolytic conditions as in Example 66. Cyclic electrolysis was added before the catalyst was prepared. Treated water
2030-5943-PF(Nl);Chiumeow.ptd 第99頁 200413503 五、發明說明(97) =為被檢定水(A0W),將此被檢定水依與實施例?1同樣 的试驗順序進行之游離基消去活性數據作為。 (實施例7 5 ) 取與參考例22同樣之基本水6. 86 !公升,加入盥實 例31同樣之鈀基準液使濃度為768 #g/1以 基本水U6。將此調製好之含㈣體之基本水6%6與= 例66同樣的電解條件進行連續通水式循環式(循環水量〇 = 公升)電解處理3分鐘,製成催化劑前添加循環電解處理· 以作為被檢定水(A0W),將此被檢定水依與實施例71同八 的試驗順序進行之游離基消去活性數據作為實施’ (實施例7 6 ) *以蒸餾水中加入與實施例26同樣之鉑基準液使鉑膠 浪度為384 //g/1之氫氣置換A0W作為被檢定水,與參- 21同樣以改變後之試驗順序進行之游離基消去活、/ 列 為實施例7 6。 彳康作 (實施例7 7 ) 曲以蒸德水中加入與實施例31同樣之鈀基準液使絶膠 濃度為384 //g/1之氫氣置換A〇w作為被檢定水,以採夕士體 之實施例7 6同樣試驗順序進行之游離基消去活性^日^ 實施例77。 媒作為 (參考例2 4 ) 以蒸餾水中加入與抗壞血酸(AsA)使濃度為35 5 AsA水溶液作為被檢定水,以參考例丨9同樣試驗順序5 M之 之游離基消去活性數據作為參考例24。 、 進行 2030-5943-PF(Nl);Chiumeow.ptd 第100頁 2004135032030-5943-PF (Nl); Chiumeow.ptd page 99 200413503 V. Description of the invention (97) = the water to be tested (A0W), according to the embodiment of this test water? 1 Radical elimination activity data for the same test sequence are used. (Example 7 5) 6.86 liters of the same basic water as in Reference Example 22 was taken, and the same palladium reference solution as in Example 31 was added so that the concentration was 768 # g / 1 to basic water U6. This prepared basic water containing carcass 6% 6 was subjected to a continuous water circulation type (circulating water amount = 0 liter) electrolytic treatment for 3 minutes under the same electrolytic conditions as in Example 66, and a cycle electrolytic treatment was added before the catalyst was made. As the test water (A0W), the free radical elimination activity data of this test water in the same eighth test sequence as in Example 71 was used as the implementation. (Example 7 6) * The same as in Example 26 was added in distilled water. The platinum reference solution made platinum glue with a wave length of 384 // g / 1 to replace A0W as the test water, and the same as that of reference-21, the radical deactivation performed in the changed test sequence, / is listed in Example 7 6 . Ji Kang Zuo (Example 7 7) Qu added the same palladium reference solution as in Example 31 in distilled German water to replace Aow with hydrogen at an absolute concentration of 384 // g / 1 as the test water. Example 77. The radical elimination activity in the same test sequence was performed as described in Example 77. The vehicle was used as a reference (Reference Example 24). Ascorbic acid (AsA) was added to distilled water to make a concentration of 35 5 AsA aqueous solution as the test water. Reference Example 丨 9 The free radical elimination activity data of 5 M in the same test sequence was used as Reference Example 24. . , Proceeding 2030-5943-PF (Nl); Chiumeow.ptd p. 100 200413503
五、發明說明(98) (參考例2 5 ) 以蒸餾水中加入與抗壞血酸(A s A )使濃度為71 # μ之 AsA水溶液作為被檢定水,以參考例1 9同樣試驗順序進行 之游離基消去活性數據作為參考例2 5。 (參考例2 6 ) 以蒸餾水中加入與抗壞血酸(ASA)使濃度為142 //Μ之 AsA水溶液作為被檢定水,以參考例1 9同樣試驗順序進行 之游離基消去活性數據作為參考例2 6。 (參考例2 7) 以蒸麵水中加入與抗壞血酸(AsA)使濃度為284 之 AsA水溶液作為被檢定水,以參考例1 9同樣試驗順序進行 之游離基消去活性數據作為參考例2 7。 (C )實施例之考察 /對比參考例19、20及實施例26〜30之圖26表示鉑膠體 粒徑分布2〜4nm)濃度為主參數時,含鉑膠體催化劑之畫 /谷存水(A 0 W )所展現之游離基消去活性經時變化特性。此 處,以參考例19、20兩者作為比較對照目的為掌 3ml容量試驗腔室中1/3容量之被檢定水 氣 游離基消去活性的傾向。又,以未圖示之實:::”: ^置換蒸餾水取代參考例2〇之氫置換蒸餾水以作:檢5 時,兩者的游離基消去活性經時變化二W疋7 形意味著只要氧的除去程度一致,作為比以=情 類不會對游離基消去活性的經時變 ^的广體種 樣^再者’依該圖’比較參考例19、2〇二游響離=V. Description of the invention (98) (Reference Example 25) The AsA aqueous solution with a concentration of 71 # μ was added as distilled water with ascorbic acid (A s A) as distilled water, and the free radicals in the same test sequence as in Reference Example 19 were used. The elimination activity data is referred to as Reference Examples 2 to 5. (Reference Example 2 6) Add Ascorbic acid (ASA) in distilled water to make a concentration of 142 // M AsA aqueous solution as the test water, and use the radical elimination activity data in the same test sequence as in Reference Example 19 as Reference Example 2 6 . (Reference Example 2 7) As distilled water was added Ascorbic acid (AsA) to a concentration of 284 in AsA water as the test water, and the radical elimination activity data in the same test sequence as in Reference Example 19 were used as Reference Example 27. (C) Examination / Comparison of Examples Reference Examples 19 and 20 and Examples 26 to 30. Fig. 26 shows the platinum colloid particle size distribution 2 to 4 nm.) When the concentration is the main parameter, the picture of the platinum colloid-containing catalyst / valley water (A 0 W) The characteristic of free radical elimination activity exhibited over time. Here, the two reference examples 19 and 20 are used as a comparative control object to control the tendency of the 1/3 capacity of the tested water vapor free radical in the 3 ml capacity test chamber to eliminate the activity. In addition, replace the distilled water with the distilled water in Reference Example 2 instead of the distilled water as shown in the figure: 检: When the test 5, the free radical elimination activity of the two changes with time. The degree of removal of oxygen is the same, as a broad-body species that changes over time with the fact that the type does not eliminate the radicals. ^ Furthermore, the reference example 19 and 202 are compared according to the figure.
2030-5943-PF(Nl);Chiumeow.ptd 第101頁 2004135032030-5943-PF (Nl); Chiumeow.ptd p. 101 200413503
活性的經時變化特性(以下,在比較例省略為「對照特 性」,發現自以分光光度計開始測定吸光度(A48〇 變化敎時點Ux下,省略為「敎開始時點」)起約經】 680移後實施例26〜3〇之加¥所展現之游離基消去活性(以 下在貝=例省略為「主題特性」)中任一者濃度皆較對 照特性顯著下降。也就是說,只要實施例26〜30之A0W經過 某程度經過時間,㉟能在廣範圍濃度表現良好的游離基消 去活性。又,將實施例26〜3〇之主題特性充分解析,發 鉑膠體》辰度會有濃度依存性,即濃度愈濃則消去游離基 需時間會變短。亦即,A〇w所展現的游離基消去活性會依 f鉑膠體濃度而升高。x,採用鉑膠體作為貴金屬催化劑 日寸,存在有實施例2 6〜3 0之主題特性任一者濃度皆較對照 特性顯著上升的時間帶。其理由在後述「鈀膠體對氧難 應性、催化劑活性、氫吸藏能力」之項目部分會提、, 處暫不提(以下同樣)。 曲對比參考例19、20及實施例31〜35之第27圖表示鈀膠 體濃度為主參數時,含鈀膠體催化劑之氫溶存水(A⑽)所 展現之游離基消去活性經時變化特性。依該圖,比較來 例1 9、2 0之對照特性時,發現開始測定時點起幾乎所 時間帶中,實施例31〜35之主題特性在低濃度者(實施、 31〜33)與對照特性大致同等,但高濃度者(實施例^〜^ 則總括來說對照特性有顯著較低的傾向。亦即,可以 實施例31〜35之A0W其高濃度者(實施例34〜35)可以展現良 好的游離基消去活性。又,若將實施例34〜35之主題特^Activity over time characteristics (hereinafter, omitted as "control characteristics" in the comparative example, it was found that since the absorbance was measured with a spectrophotometer (A48 ° changes at the time point Ux, it is omitted as the "time point")] 680 After the removal, the concentration of any of the radical elimination activities shown in Examples 26 to 30 plus ¥ (hereinafter abbreviated as "thematic characteristics" in the examples) is significantly lower than the control characteristics. That is, as long as the examples After a certain period of time, A0W of 26 ~ 30 can not exhibit good radical elimination activity in a wide range of concentrations. In addition, the theme characteristics of Examples 26 ~ 30 are fully analyzed, and platinum colloids will have a concentration dependence. It means that the thicker the concentration, the shorter the time required to eliminate free radicals. That is, the free radical elimination activity exhibited by Aow will increase according to the concentration of f platinum colloid. X, using platinum colloid as a precious metal catalyst, There is a time zone in which the concentration of any of the thematic characteristics of Examples 2 to 30 is significantly higher than that of the control characteristics. The reason for this is described later in the "palladium colloid to oxygen difficulty, catalyst activity, and hydrogen storage capacity" The project part will be mentioned, and will not be mentioned here (the same applies hereinafter). The comparison chart of reference examples 19 and 20 and examples 27 to 35 shows that the palladium colloid concentration is the main parameter for the hydrogen-soluble water containing palladium colloid catalyst ( A⑽) Over time, the characteristics of the radical elimination activity exhibited. According to the figure, when comparing the control characteristics of Examples 19 and 20, it was found that the subject characteristics of Examples 31 to 35 were in almost the time band from the time when the measurement was started. Those with low concentration (implementation, 31 to 33) have approximately the same characteristics as the control, but those with high concentration (example ^ ~ ^ have a tendency that the control characteristics are significantly lower. In other words, examples 31 to 35 can be used. Those with a high concentration of A0W (Examples 34 to 35) can exhibit good free radical elimination activity. Furthermore, if the subject matter of Examples 34 to 35 is special ^
200413503 五、發明說明α〇〇) " ' " 1 充分解析’發現依存鈀膠體濃度,濃度愈濃則要消去游離 基所需時間愈短。亦即,A〇w所展現的游離基消去活性會 依存把膠體漠度而升高。特別是,高濃度者(實施例 34〜35)之主題特性從測定開始時點起分別經過約44〇秒及 約230秒後’開始會顯著顯示吸光度有下降的傾向。其理 由推測可能是在高濃度(實施例34〜35)者,(· 〇2_)存在濃 度(存在濃度)的作用就像是開關一般,積極的消去游離 基。又,採用鈀膠體作為貴金屬催化劑時,實施例3丨〜3 5 之主題特性任一者濃度皆較對照特性下降。其理由在後述 「鈀膠體對氧難反應性、催化劑活性、氫吸藏能力」之 目部分會提到,此處暫不提(以下同樣)。 、 對比參考例19、20及實施例36〜41之第28圖表示鉑膠 ,(粒徑分布卜2nm)濃度為主參數時,含鉑膠體催化劑之 氫/谷存水(A0W)所展現之游離基消去活性經時變化特性。 依該圖’比較參考例19、2〇之對游離基、消去活性的對 性,發現開始測定時點起約經過92〇秒後,實施例36〜41 主題特性S -者$農纟皆較對照特性顯著為低。也就是說, :例36〜41之_經過某程度經過時間,就能在廣範 圍”表現良好的游離基消去活性…將實施例36〜41 ί 5 t充分解析,#現鉑膠體濃度會有濃度依存性, p /辰度愈》辰則消去游離基所需時間會變短。亦即,a〇w 展現的游離基消去活性會依存鉑膠體濃度而升高。 八右,9此,、ΤΙ舶膠體之粒徑參數(粒徑分布2〜4nm/粒徑 刀布1〜2·)與游離基消去活性的關係明確,試將以粒徑分200413503 V. Description of the invention α〇〇) " 1 " Fully analyzed ' It is found that the concentration of palladium colloid depends on the concentration. The thicker the concentration, the shorter the time required to eliminate free radicals. That is, the radical elimination activity exhibited by Aow will be increased depending on the degree of colloidal indifference. In particular, the subject characteristics of the high-concentration subjects (Examples 34 to 35) show that the absorbance tends to decrease significantly after about 44 seconds and about 230 seconds have elapsed from the start of the measurement. The reason is presumably that at a high concentration (Examples 34 to 35), the presence of (· 〇 2_) concentration (existing concentration) acts like a switch and actively eliminates free radicals. In addition, when a palladium colloid is used as the precious metal catalyst, the concentration of any of the subject characteristics of Examples 3 to 3 5 is lower than that of the control characteristic. The reason for this will be mentioned in the later section of "palladium colloids' poor reactivity to oxygen, catalyst activity, and hydrogen storage capacity", which will not be mentioned here (the same applies below). , Comparative reference examples 19 and 20 and examples 36 to 41 in the 28th figure show platinum gum, (particle size distribution, 2nm) concentration as the main parameter, the platinum colloidal catalyst containing hydrogen / valley water (A0W) exhibited free radicals Eliminates changes in activity over time. According to the figure 'comparing the pairs of free radicals and elimination activity of Reference Examples 19 and 20, it was found that after approximately 92 seconds have elapsed from the time of starting the measurement, Examples 36 to 41 have the subject characteristic S-or $ peacock. The characteristics are significantly low. That is to say: of examples 36 to 41, after a certain period of time, a wide range of "good radical elimination activity" can be performed ... Examples 36 to 41 will be fully analyzed, and #present platinum colloidal concentration will have Concentration-dependent, the time required to eliminate free radicals will be shorter. That is, the free radical elimination activity exhibited by aow will increase depending on the concentration of platinum colloids. The relationship between the particle size parameters of the TiBo colloid (particle size distribution 2 ~ 4nm / particle size knife cloth 1 ~ 2 ·) and the radical elimination activity is clear.
200413503 五、發明說明(101) 布2~4nm之鉑膠體濃度為主參數的第26圖與以粒徑分 1〜2nm之鉑膠體濃度為主參數的第28圖作對比。為除去 度參數的影響,例如,將鉑濃度參數相同(96#g/i)之 施例27與實施例37進行對比。實施例”從測定開始 ^約320秒左右時達到吸光度的高+,之後緩慢主題特性 有下降的傾向’到約經過44G秒吸光度__度達到幾。 相對於此,實施例37從測定開始時點經過約76〇秒左右時 J到二=的高峰,之後緩慢主體特 在測定的時間帶中並沒有吸光度達到幾乎為〇的情二仁 Ϊ行:Γ辰Ϊ 同(384 "g/1)之實施例29與實施例40 進仃對比。實施例29從測定開始時點經過約17〇秒左 特,被抑制到幾乎為〇 ’之後持續 =的:Γ40Γ開始時點經過約26°秒左右時達到】 /題特性呈現急速下降的傾向,約經過 抗乳化機能水所使用的鉑催 ^ 粒徑分布為卜2㈣者可展現/好^ ^徑分布為2〜4nm者比 吸光度抑制到幾乎為 離基消去活性(因為將 較好的。 Θ所而時間較短),以此觀點看來,是 對比參考例19、20及實施例42〜 鈀)混合膠體(粒徑分布2〜4 之第29圖表不(鉑+ 濃度為主參數時,含(鈾=混合莫耳比為η) (A0W)所展現之游離基消去活性 ::::水 比較參考例19、20之對游離其难土蹵化特性。依该圖, 土功去活性的對照特性,發为200413503 V. Description of the invention (101) The 26th graph with platinum colloidal concentration of 2 ~ 4nm as the main parameter is compared with the 28th graph with platinum colloidal concentration of 1 ~ 2nm as the main parameter. To remove the influence of the degree parameter, for example, Example 27 and Example 37 were compared with the same platinum concentration parameter (96 # g / i). Example "From the start of the measurement, the absorbance reached a high + at about 320 seconds, and then the slow theme characteristic tended to decrease." After about 44 G seconds, the absorbance __ degree reached a few. In contrast, Example 37 was from the start of the measurement. After the peak of J = II = at about 760 seconds, the slow subject did not have a light absorption of almost 0 in the measured time zone. Erren: Γ 辰 Ϊ Same (384 " g / 1) Example 29 is compared with Example 40. Example 29 passed about 170 seconds from the start of the measurement, and was suppressed to almost 0 ′ and continued to =: Γ40Γ reached at the start of about 26 ° seconds. ] / The characteristics show a tendency to decrease rapidly. After the platinum catalyst used in the anti-emulsifying water, the particle size distribution can be shown by ㈣ 2㈣ / good ^ ^ The diameter absorbance is 2 to 4 nm, and the specific absorbance is suppressed to almost radical. Elimination of activity (because it will be better. Θ and shorter time), from this point of view, it is a comparison of reference examples 19 and 20 and examples 42 to palladium) mixed colloids (particle size distribution 2 to 4) No (when platinum + concentration is the main parameter, Uranium = free radical deactivation exhibited by mixed mol ratio η) (A0W) ::: Comparison of the refractory properties of free soil with reference to water in reference examples 19 and 20. According to the figure, the control of earth work deactivation Characteristics
200413503200413503
開始測定時點起約經聊G秒後,實施例42 45之 二:辰度皆較對照特性顯著為低。也就是說,口要:Ϊ ,42〜45之A0W經過某程度經過時間, 圍以 μ基消去活性。又,將實施㈣〜45 Λ Λ ^充分=析,發現(船把)混合膠體濃度會有遭度“特 ,即派度愈濃則消去游離基所需時間會變短。 Α0Ι所展現的游離基消去活性會依存(鉑+鈀 豚 而升高。 口修體浪度 對比參考例1 9、2 0及實施例4 6〜5 0之第3 0圖表示r私+ 混合膠體(粒徑分布2〜4nm、)濃度為主參數、鉑、·鈀混 合莫耳比為為副參數時,含(鉑+鈀)混合膠體催化劑之匕 溶存水(A0W)所展現之游離基消去活性經時變化特性。^ 該圖,比較參考例丨9、20之對游離基消去活性的對照特" 性,發現開始測定時點起約經過52 0秒後,實施例46%〇之 主題特性任一者濃度皆較對照特性顯著為低。也就是說, 只要實施例46〜5 0之A0W經過某程度經過時間,就能在廣範 圍漢度表現良好的游離基消去活性。又,將實施例4 6〜5 〇 之主題特性充分解析,發現(鉑+鈀)混合膠體濃度會有濃 度依存性,即濃度愈濃則消去游離基所需時間會變"短。亦 即,A0W所展現的游離基消去活性會依存(鉑+鈀)混合膠體 濃度而升高。 ' 對比參考例2 1及實施例5 1〜5 5之第3 1圖表示(鉑+鈀)混 合膠體(粒徑分布2〜4nm、)濃度為主參數、鉑:鈀混合莫 耳比為為副參數時,含(鉑+纪)混合膠體催化劑之氫溶存After about G seconds from the time of starting the measurement, Example 42 45bis: the degrees were significantly lower than the control characteristics. In other words, the mouth should be: Ϊ, A0W of 42 ~ 45 passes a certain degree of elapsed time, and the activity is eliminated by μ base. In addition, ㈣ ~ 45 Λ Λ ^ is fully analyzed, and it is found that the concentration of the (colloid) mixed colloid will be affected, that is, the thicker the degree, the shorter the time required to eliminate free radicals. The freeness exhibited by Α0Ι The radical elimination activity will increase depending on (platinum + palladium dolphin. It will be compared with the oral body wave length of Reference Examples 19, 20 and Example 4 6 to 50. Figure 3 0 shows the r + + colloid (particle size distribution 2 ~ 4nm, when the concentration is the main parameter, and the platinum and palladium mixed mole ratios are the secondary parameters, the free radical elimination activity exhibited by the dissolved water (A0W) containing (platinum + palladium) mixed colloid catalyst changes with time. Characteristics. ^ This figure compares the control characteristics of free radical elimination activity of Reference Examples 9 and 20. It was found that the concentration of any one of the subject characteristics of Example 46% was about 46% after about 52 seconds from the start of the measurement. Both are significantly lower than the control characteristics. That is, as long as the A0W of Examples 46 to 50 has elapsed to some extent, free radical elimination activity that exhibits good performance over a wide range of degrees can be achieved. Furthermore, Examples 4 to 6 to 6 The theme characteristic of 50% is fully analyzed, and it is found that the concentration of (platinum + palladium) mixed colloid will have Concentration dependence, that is, the more concentrated the time required to eliminate radicals becomes shorter. That is, the radical elimination activity exhibited by A0W will increase depending on the concentration of (platinum + palladium) mixed colloids. 'Comparative Reference Example 21 and Example 5 The third and third figures from 1 to 5 5 show the concentration of (platinum + palladium) mixed colloid (particle size distribution 2 to 4 nm,) as the main parameter, and the platinum: palladium mixed mole ratio as the secondary parameter. Hydrogen storage with (platinum + period) mixed colloid catalyst
2030-5943-PF(Nl);Chiunieow.ptd 第 105 頁 200413503 五、發明說明(103) 水(A0W)所展現之游離基消去活性經時變化特又,夂 Γ列==6〜5" 生成系已被除去。依該’ 二與心歹"之對游離基消去活性的對照特性,發現 俭\貝她例46〜50中(.(V)生成系已被除去,還是有生成 I 〇V) t傾向。關於此點將在後述關於第37圖之說明中提 不,及’此生成(.〇2—)之傾向可依存於(翻+鈀) 此曰膠體之k度,濃度愈濃則可被抑制。 現的=基消去活性會依存⑷㈤混合膠體漠度而升斤展 二後述第37圖相關現象總合判·,可以推斷他 ,體之此s莫耳比率愈高,愈能抑制生成(.〜_)之傾向。 w Λ比Λ考例22、23及實施例56〜60之第32圖表示始膠 之、布^4nm)濃度為主參數之鉑膠體催化劑前添加 電解處理水(A0W)所展現之游離基消去活性經 二ϊ圖,實施例5"〇之主題特性在低濃度者(實 5V〜二對照特性大致等同,但高濃度者(實施例 58〜60)虽測定開始經過約74〇秒時,任—者濃度皆顯著 於對照特性。也就是說,只要實施例58〜6〇 iA〇w經 度經過時間’京尤能在廣範圍濃度表現良好的游 性二又,將實施例58〜60之主題特性充分解析,發現鉑膠 體展度會有濃度依存性,即濃度愈漠則消去游離基所^ 間會變短。亦即,A0W所展現的游離基活而$ 膠體濃度而升高。 曰依存始 對比參考例22、23及實施例61〜65之第33圖表示把膠 體(粒徑分布2〜4nm)濃度為主參數之鈀膠體催化劑前添=2030-5943-PF (Nl); Chiunieow.ptd Page 105 200413503 V. Description of the invention (103) The radical elimination activity exhibited by water (A0W) changes with time, and 夂 Γ column == 6 ~ 5 " Department has been removed. Based on the control characteristics of the radical elimination activity of the "two" and the palpitations, it was found that in the 46 to 50 cases (. (V) production system has been removed, there is still a tendency to produce I OV). This point will be mentioned in the description of FIG. 37 described later, and the tendency of 'this formation (.〇2—) may depend on (turn + palladium) the k-degree of the colloid, and the thicker the concentration, the more it can be suppressed. The current = radical elimination activity will increase depending on the mixed colloidal indifference of the ⑷㈤ mixed colloid. The second phenomenon described in Figure 37 below will be summed up. It can be inferred that the higher the s Mol ratio, the more inhibited the production (. ~ _). w Λ ratio Λ Test cases 22 and 23 and Examples 56 to 60. Figure 32 shows the starting point of the colloidal platinum colloidal catalyst whose concentration is the main parameter, and the free radicals displayed by adding electrolytically treated water (A0W) are eliminated. The activity is shown in the graph. The subject characteristics of Example 5 " 〇 are at a low concentration (actually 5V ~ 2 control characteristics are approximately the same, but the high concentration person (Examples 58 to 60) is about 740,000 seconds after the measurement starts.) -The concentrations are all significant in the control characteristics. That is, as long as the longitude elapsed time of Example 58 ~ 60iAow is used, Jingyou can perform well in a wide range of concentrations. The subject of Examples 58 ~ 60 The characteristics are fully analyzed, and it is found that the platinum colloidal spread will have a concentration dependence, that is, the more the concentration is, the shorter the interval between elimination of free radicals will be. In other words, the free radicals exhibited by A0W will increase and the colloidal concentration will increase. Comparison of Reference Examples 22 and 23 and Examples 61 to 65 in Figure 33 shows that the palladium colloidal catalyst with the colloidal (particle size distribution 2 to 4 nm) concentration as the main parameter was added before =
200413503 五、發明說明(〗〇4) 之一道電解處理水(A〇w)所展 化特性。依該圖,實施例61〜65:;=”二經時變 施例…⑻雖與對照特性大致等同主^v;在低濃f者(實 ⑺,)當測定開始經過約320秒時,任: f, 於對照特柯。; S 士、 者/辰度皆顯者低 度經過時間,就;: ί::例63〜65之4⑽經過某程 體濃产合古、曲# > 士 喊特f生充分解析,發現鈀膠 間會變紐。亦即’續所展現的游二所而時 膠體濃度而升高。特別是,最^農声」ΐ活杜會依存纪 有下二m過約830秒後,會顯著顯示吸光度 者,(Ω八理由推測可能是在高濃度(實施例65) 積極的消2去游子ΐί度(存在濃度)的作用就像是開關-般, 對比參考例2 2、2 3及實施例6 6〜7 0之第3 4圖矣千>$6跋 體(粒分布2〜4ηιη)濃度為主參數之鉑膠體催化劑添= ίΙΪ電解處理水(綱)所展現之游離基消去活性經時變 , 依δ亥圖,實施例66〜70之主題特性在低濃产者(實 於約,秒:時,任一者濃度皆顯著低 疮二士 也就疋5兄,只要實施例68〜70之ΑΟΨ經過某程 J經,’就能在廣範圍濃度表現良好的游離基消:活 n合施例68〜7〇之主題特性充分解析,發現翻膠 " ^ /辰度依存性,即濃度愈濃則消去游離基所需時 第107頁 2030-5943-PF(Nl);Chiumeow.ptd 200413503200413503 V. Description of the invention (〖〇4) The developed characteristics of one of the electrolytically treated water (Aw). According to the figure, Examples 61 to 65:; = "Two time-varying examples ..." Although approximately the same as the control characteristics ^ v; in the low-concentration f (actually,) when about 320 seconds have elapsed since the measurement started, Ren: f, in contrast to Teke .; S, Shi / Chen are all showing low elapsed time, then: ί :: Example 63 ~ 65 of 4⑽ After a certain period of concentration, Hegu, Qu # > Shihaote fully analyzed and found that the palladium gel will change. That is, the colloid concentration increased when you continued to show the second place. In particular, the most peasant sounds. After about 830 seconds at 2 m, the absorbance will be significantly displayed. (Ω eight reasons speculated that it may be at a high concentration (Example 65). The effect of the positive elimination of the 2 deuterium (existing concentration) is like a switch-, Comparative Reference Examples 2, 2, 3, and Example 6 3 to 4 of Figures 6 to 7 0 矣 1000> Platinum colloidal catalyst with a concentration of $ 6 postbody (particle distribution 2 ~ 4ηιη) as the main parameter Tim = Electrolyzed treated water ( Gang) the free radical elimination activity exhibited by time, according to the delta chart, the theme characteristics of Examples 66 to 70 are in low-concentration producers (actually about, seconds: hours, any concentration is significant) The low sore prince also has 5 brothers. As long as the ΑΟΨ of Examples 68 ~ 70 passes through a certain J-pass, it will be able to perform a good free radical elimination in a wide range of concentrations: the characteristics of the theme of Examples 68 ~ 70. Fully analyzed and found that the glue is "^ / Chen dependency", that is, when the concentration is higher, the free radicals are required to be removed. Page 1072030-5943-PF (Nl); Chiumeow.ptd 200413503
會變短。亦即,A0W所展現的游離基消去活性會依 體濃度而升高 對比參考例22、23及實施例71〜75之第35圖表示鈀膠 體(粒徑分布2〜4nm)濃度為主參數之鈀膠體催化劑前添加 之循裱電解處理水(A0W)所展現之游離基消去活性經時 化特性。依該圖,實施例71〜75之主題特性在低濃度者(者 施例71〜72)於測定開始時點經過95〇秒後’開始有些微下^ 降的傾向,但高濃度者(實施例73〜75)當測定開始經過約 650秒時,任一者濃度皆顯著低於對照特性。也就是說、, 只要實施例71〜75之A0W經過某程度經過時間,就能在廣 圍濃度表現良好的游離基消去活性。又,將實施例71〜'75 之主題特性充分解析,發現鈀膠體濃度會有濃度依存性, 即濃度愈濃則消去游離基所需時間會變短。亦即,所 展現的游離基消去活性會依存鈀膠體濃度而升高。特別 是,高濃度者(實施例73〜75)者在測定開始時點經過各約 650秒、約420秒、約230秒後’會顯著顯示吸光度有下降 的傾向。其理由推測可能是在高濃度(實施例73 75)者, (· 〇2 )存在濃度(存在濃度)的作用就像是開關一般,積極 的消去游離基。 、 ^在此為解明鉑膠體催化劑中電解條件參數(一道電解/ 循^電解)與游離基消去活性的關係,試將以鉑膠體催化 劑前添加一道電解處理水為被檢定水的第32圖與以鉑膠體 催化劑前添加循環電解處理水為被檢定水的第%圖作對 比。為除去濃度參數的影響,例如,將韵濃度參數相同Will become shorter. That is, the free radical elimination activity exhibited by A0W will increase depending on the body concentration. The 35th graphs of Reference Examples 22 and 23 and Examples 71 to 75 show that the concentration of palladium colloid (particle size distribution 2 to 4 nm) is the main parameter. Free radical elimination activity exhibited by aging of electrolysis treated water (A0W) added before the palladium colloidal catalyst over time. According to the figure, the subject characteristics of Examples 71 to 75 in the low-concentration subjects (Examples 71-72) tend to start to decrease slightly after 95 seconds have elapsed at the start of the measurement, but the high-concentration subjects (Examples 73 ~ 75) When about 650 seconds have elapsed from the start of the measurement, the concentration of any one is significantly lower than the control characteristic. That is, as long as the A0W of Examples 71 to 75 elapses to some extent, free radical elimination activity exhibiting a good range of concentrations can be achieved. In addition, the subject characteristics of Examples 71 to '75 were fully analyzed, and it was found that the concentration of palladium colloid has a concentration dependency, that is, the thicker the concentration, the shorter the time required to eliminate free radicals. That is, the radical elimination activity exhibited will increase depending on the palladium colloid concentration. In particular, those with a high concentration (Examples 73 to 75) at the start of the measurement showed that the absorbance tends to decrease after each of about 650 seconds, about 420 seconds, and about 230 seconds. The reason is presumably that at a high concentration (Examples 73 to 75), the presence of (· 〇 2) the concentration (existing concentration) acts like a switch and actively eliminates free radicals. ^ This is to clarify the relationship between the parameters of electrolysis conditions (a course of electrolysis / cycle electrolysis) and the elimination activity of free radicals in a platinum colloidal catalyst. Try to add a piece of electrolytically treated water before the platinum colloidal catalyst as the test water. The comparison is made by adding the circulating electrolytically treated water before the platinum colloidal catalyst as the% chart of the tested water. To remove the effect of the concentration parameter, for example,
200413503200413503
(1 92 # g/ i)之實施例58與實施例68進行對比。實施例 測定開始時點經過約6 8 0秒左右時達到吸光产的古 攸 後緩慢主題特性有下降的傾向,到約經過‘秒::户之 ^被抑制達到幾乎為〇。相對於此,實施例68從測ς: k點經過約620秒左右時達到吸光度的高峰,之 ], 體特性有下降的傾向’到約經過83〇秒吸光度一度^ 達到幾”0。其次’將鉑濃度參數相同(384 "g/。之· 鉍例59與實施例69行對比。實施例59 /(1 92 # g / i) Example 58 is compared with Example 68. EXAMPLES The characteristic of the slow theme tends to decrease after approximately 680 seconds has passed since the measurement started, and the characteristic of the slow theme tends to decrease. By about elapsed, the second is suppressed to almost zero. In contrast, in Example 68, the peak of the absorbance was reached after about 620 seconds passed from the measurement point k. Among them, the physical characteristics tended to decrease, 'to about 8300 seconds, the absorbance reached one degree ^ and reached several "0. Second' The platinum concentration parameters are the same (384 " g /.). Bismuth Example 59 is compared with Example 69. Example 59 /
秒左右時達到吸光度的高峰,之後緩慢’主題= I降的傾向,到約經過660秒吸光度—度被抑制達 二 。相對於此,實施例69測定開始時點經過約4〇〇成手 :達:吸光度的高,,之後主題特性呈現緩 :右 ::經過5 0 0秒左右吸光度幾乎抑制為〇。將以上二 斷,用於生成本發明抗氧化機能水所使用的電解條;“i (者准’㈣體催化劑添加前電解),循環電解者比 者可展現良好的游離基消去活性(因ϋ解 乎為〇所需時間較短),以此觀點看來/是及較先好度的抑制到幾 另外,為解龍耗催化财電解條件參數(The peak of the absorbance is reached at about 2 seconds, and then the slowness of the theme = I decreases, and the absorbance-degree is suppressed to about 2 after about 660 seconds. In contrast, in Example 69, about 400 hands were passed at the start of the measurement: up to: the absorbance was high, and then the subject characteristics became slower: right :: the absorbance was almost suppressed to 0 after about 500 seconds. The above two breaks are used to generate the electrolytic strip used in the antioxidant functional water of the present invention; "i (the electrolysis before the addition of the quasi-carbohydrate catalyst), the cycle electrolysis can exhibit a good free radical elimination activity (due to It takes a short time to solve the problem), from this point of view / yes and the suppression of the first degree of goodness to a few other, for the solution parameters of the electrolytic solution
電解)與游離基消去活性的關係,試將、電 化劑則添加一道電解處理水為被檢定 ,體催 體催化劑前添加循ί裒電解處理水為;3 5 =鈀膠 比。為除去濃度參數的影響,例=:=3*5圖作對 (192 /zg/i)之實施例63與實施例以進奋门 參考例22、23的對照特性相Λ,從測定開始The relationship between electrolysis) and free radical deactivation activity is tested. Adding an electrolysis treatment water to the electrolysis agent is the test. Adding the electrolysis treatment water before the catalyst is 3 5 = palladium gel ratio. In order to remove the influence of the concentration parameter, the example =: = 3 * 5 is shown as a pair (192 / zg / i) of Example 63 and the example is advanced. The comparison characteristic phase Λ of reference examples 22 and 23 starts from the measurement.
200413503 五、發明說明(107) 時間帶内,J: Φ日首4士 , π a α ,、主通特性雖一直較低,但呈現有緩懌井古的 傾向。相對於此,眚尬如7q + + Β 主見有級I*又升间的 約經過65 0秒左右(吸氺厣— 碭特性從測定開始時點到 是之後變為有雖有緩慢升高的傾向,但 度幾乎被抑Λ 過86G秒以後吸光 ^ t,M.I65 ^ „ m5 . ^ ^ ^ ^ m 768 , g/Ι) 點到經過約68"。〇秒左右=产:從測定開始時 Λ ^左右(及光度鬲峰)呈現緩慢的上升 在測定ϊ ί Ϊ ί有緩慢下降的傾向。相對於此,實施例75 下降的二=、點為吸光度的高峰,之後主題特性呈現緩慢 ::=,Γ經過320秒左右吸光度幾乎抑制為〇。將以 佟:二/用於生成本發明抗氧化機能水所使用的電解 條件(惟,鈀膠體催化劑添加前電解),循環電解者比一 現良好㈣離基消去活性(因為將吸光度抑制 到成乎為0所需時間較短),以此觀點看來,是較好的。 於對=參考例19、20及參考例24〜27之第36圖表示以AsA 尺’谷液/辰度為主參數之Asa水溶液(a〇W)所展現之游離基消 去活性經時變化特性。依該圖,參考例24〜27之AsA水溶液 展現的游離基消去活性任一者濃度皆低於參考例丨9、2 〇之 特性。亦即,可確認參考例24〜27iAsA水溶液如先前所 知’可在廣範圍展現游離基消去活性。且,可確認來考例 24〜27之AsA水溶液展現之游離基消去活性如先前所知,可 依存於濃度而提高。又,將該A s A水溶液展現之游離基消 去活性與本發明抗氧化機能水展現之游離基消去活性比 較’可了解例如實施例75之抗氧化機能水遠遠凌駕於參考200413503 V. Description of the invention (107) In the time zone, J: Φ the first 4 shi, π a α, although the main communication characteristics have been low, but there is a tendency to slow down the ancient well. In contrast, the awkwardness, such as 7q + + Β, shows that it takes about 65 0 seconds for the level I * to rise again. Tendency, but the degree is almost suppressed. Absorb light after 86G seconds ^ t, M.I65 ^ m5. ^ ^ ^ ^ M 768, g / Ι) point to about 68 ". 〇 or so = production: from the start of the measurement When Λ ^ (and the peak of photometric peak) showed a slow rise, there was a tendency of a slow decline in the measurement ϊ ί Ϊ ί. In contrast, the second drop of Example 75 =, the point is the peak of the absorbance, and then the theme characteristics appear slow: : =, Γ The absorbance is almost suppressed to 0 after about 320 seconds. 佟: 二 / The electrolytic conditions used to generate the antioxidant functional water of the present invention (however, electrolysis before the addition of palladium colloid catalyst), the cycle electrolyzer is better than one From the viewpoint of good ion-releasing elimination activity (because the time required to suppress the absorbance to almost zero) is short. From the viewpoint, it is better. Figure 36 shows the Asa aqueous solution (a〇W) with the AsA ruler's grain / Chen degree as the main parameter. The present characteristic of free radical elimination activity changes with time. According to the figure, the concentration of free radical elimination activity exhibited by the AsA aqueous solution of Reference Examples 24 to 27 is lower than those of Reference Examples 丨 9, 20. That is, it may be It was confirmed that the reference examples 24 to 27 of the aqueous solution of iAsA exhibited a wide range of free radical elimination activity as previously known. Moreover, it was confirmed that the free radical elimination activity exhibited by the aqueous solution of AsA from Examples 24 to 27 was previously known and could depend on the concentration. Moreover, comparing the free radical elimination activity exhibited by the A s A aqueous solution with the free radical elimination activity exhibited by the antioxidant function water of the present invention, it can be understood that, for example, the antioxidant function water of Example 75 is far superior to the reference
2030-5943-PF(Nl);Chiumeow.ptd 200413503 五、發明說明(108) 1列tiAsA水溶液,且可匹敵參考例25〜27之asa水溶液。 纪膠體之對氧難反應性、催化m氫吸藏能力 欲將本發明之抗氧化方法、抗氧化 施於例如生體等氧溶存系時,存在有會成為大障壁 ΐϋ在ί體中”氧為將營養素氧化獲得能量所需,:在 體所需各種氧添加反應需用到的關係 此處問題的本質在於溶存於抗氧化機能水二 催化劑使氧與氯反應使變回普水係=== 貴金屬膠體催化劑利用活化的氫使單電子還原,反 消去對象(.〇厂)生成,造成游離基消去活性的衰減。二 土催化劑活性愈高則會有擴大的傾向。亦, =基消去活性具有取检(trade 〇")的關 丨 活性愈高,則游離基消去活性會衰減。故’可以 :Ja 一個不易解決的根本問題。 &疋 為解決該本質問題,本發明人等努力進行社 =貴金屬催化劑中特別是纪膠體,與銘膠體比 對乳難反應性的傾向,以此發現為基礎進一步 在探討本發明可使用之責金屬催化劑時應考慮之= 素,為對氧難反應性、催化劑活性、氫吸藏能力二 考慮此三要素時,總合力的觀點看來,良好的責 催化劑為鈀膠體,並完成本發明。 ,屬夕_ 首先,對判斷鈀膠體與鉑膠體比較時之 依據作說明。 了乳難反應之2030-5943-PF (Nl); Chiumeow.ptd 200413503 V. Description of the invention (108) One column of tiAsA aqueous solution, which can match the asa aqueous solution of reference examples 25-27. The colloid is difficult to react with oxygen and catalyzes the hydrogen storage capacity. When the antioxidant method and antioxidant of the present invention are applied to an oxygen-soluble system such as a living body, there is a large barrier in the body. In order to oxidize nutrients to obtain energy, the relationship between various oxygen addition reactions required in the body is the essence of the problem here. It is dissolved in the anti-oxidant water two catalyst to react oxygen with chlorine to return to ordinary water system. = Precious metal colloidal catalyst utilizes activated hydrogen to reduce single electrons, and counter-elimination object (.〇factory) is generated, resulting in attenuation of radical elimination activity. The higher the activity of the two-earth catalyst, the more it tends to expand. Also, = radical elimination activity The higher the activity with the trade (quote), the more the radical elimination activity will be attenuated. Therefore, 'Yes: Ja, a fundamental problem that is not easy to solve. &Amp; 人 In order to solve this essential problem, the inventors and other efforts Kanasha = Precious metal catalysts, especially the colloidal colloids, tend to be less reactive with milk than the colloidal colloids. Based on this finding, further discussion of metal catalysts that can be used in the present invention should be based on this finding. Concerned = element, when considering these three elements for poor oxygen reactivity, catalyst activity, and hydrogen storage capacity, from the viewpoint of the total force, a good catalyst is a palladium colloid, and the present invention is completed. First, the basis for judging the comparison between palladium colloid and platinum colloid will be explained.
200413503 五、發明說明(109) ' 對比參考例21與實施例76、77之第37圖表示以責金屬 催化劑之種類差異作為主參鼠(濃度固定)之含催化劑氯溶 存水(A0W)所展現的游離基消去活性經時變化特性。又, 參考例21與實施例76、77中(·(V)生成系被除去。依該 圖’實施例7 6儘管(· 〇厂)生成系被除去,但其主題特j生在 測定開始時點起經過約1 4 0〜2 0 0秒,吸光值達到約〇 〇 ^ g 峰值(約經過160秒之時點)。又,自測定開始時點到約經之 過8 60秒,吸光度有緩慢上升的傾向。相對於此,實扩= 77之主題特性與參考例21之對照特性顯示約大致相^同^ 向,吸光度並沒有特別上升。該等現象推測是實施之 主題,性在測定開始時點起至經過約16〇秒間活躍的?之 u2U ΐ ΐ之(.〇2_)被本發明抗氧化機能水所展現 86 0秒,吸光度轉為緩慢上升傾向被認曰m至經過約 .b ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ t? ^ 消去(· 02-)之發生。 以致於無法抑制 其次,展開在氫與氧共存之水溶液 溶存水中溶存有氧之水溶、夜^〇 糸(在本^明之氫 膠體催化劑的作用機轉推論。 鲜膠體催化劑與鈀 第38圖表示氫氣共存水溶 機轉。 卸膠體催化劑之作用 如該圖所示,麵 氫與氧而將由活化氫 一電子還原)。此時, 胗體催化劑會隨吸附於系内所溶存之 (.H),出的一個電子轉移給氧(氧之 活化虱(.H)失去—個電子,以H+離200413503 V. Description of the invention (109) 'The 37th figure of Comparative Reference Example 21 and Examples 76 and 77 shows that the difference in the type of the metal catalyst is used as the main parameter (fixed concentration) of the catalyst-containing chlorine-soluble water (A0W). The free radical elimination activity changes over time. In addition, in Reference Example 21 and Examples 76 and 77, the (· (V) production system was removed. According to the figure, Example 7 6 Although the (· 〇) plant) production system was removed, the subject matter was born at the beginning of the measurement. After about 140 to 2000 seconds from the time point, the absorbance reached a peak value of about 〇 ^^ g (about 160 seconds). In addition, the absorbance slowly increased from the start of the measurement to about 8 to 60 seconds. In contrast, the subject characteristic of real expansion = 77 is approximately the same as the reference characteristic of Reference Example 21, and the absorbance has not particularly increased. These phenomena are presumably the subject of implementation, and the property is at the beginning of the measurement. Active until about 160 seconds elapsed? The u2U ΐ ΐ (.〇2_) was exhibited by the antioxidant functional water of the present invention for 8680 seconds, and the absorbance turned into a slowly rising tendency. It was recognized that m to about .b ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ t? ^ Eliminate the occurrence of (· 02-). So that the second cannot be suppressed, unfold the water-soluble, water-soluble, water-soluble ^ 〇 糸 (in this ^ 〇 展开) The mechanism of Ming Zhi's hydrogen colloidal catalyst is inferred. Fresh colloidal catalyst and palladium Figure 38 It shows the coexistence of hydrogen and the water dissolving machine. The effect of uncolloid catalyst is shown in the figure, the surface hydrogen and oxygen will be reduced by activated hydrogen-electron). At this time, the carcass catalyst will be adsorbed to the dissolved (.H) in the system. An electron is transferred to oxygen (oxygen-activated lice (.H) loses one electron and is separated by H +
200413503 五、發明說明(110) 子之形式放出至奉中f Γ,~ττ I、 ^ , ^ m ^ ( 下,省略關於此之重複說明)。 即’氧本身利用透過翻膜雜 ;i A 6、M I 4 # 膠催化劑因活化氫進行一電子還 原而反過末生成了原本之消去對 鉑膠體催化劑會隨吸附於备囟% W七2) :丄 返及附於糸内所溶存之氫與(.〇2-)而將由 活化鼠(· Η )放出的一個雷工击由乂々λ人/ ^ 子還原或氧之二電子请语子轉移給(·〇2—)(( .〇2-)之一電 一 子遏原)。亦即,(· 〇2-)本身利用透過 翻膠體催化劑因活化氫進行一 2 成之(〇、)會,用糸内存在之2個『離子進行離子結合,而 形成過氧化鼠(H2 02 )。之後或同時,鉬膠體催化劑會隨吸 附於系内所溶存之氫與過氧化氫(H2〇2)而將由活化氮(· H) 放出的一個電子轉移給過氧化氫(H2 02 )((H202)之一電子還 原或氧之三電子還原)。亦即,(H2〇2)本身利用透過鉑膠體 催化劑因活化氫進行一電子還原而生成了( · 〇H)。之後或 同時,鉑膠體催化劑會隨吸附於系内所溶存之氫與(·〇Η) 而將由活化氫(· Η)放出的一個電子轉移給(· 〇Η)(( · 〇Η) 之電子還原或氧之四電子還原)。亦即,(·〇ιι)本身利 用透過翻膠體催化劑因活化氫進行一電子還原而生成了 〇Η-離子。生成之0Η-會與Η+離子進行離子結合,而形成水 (4〇),並停止這一連串的反應。以上即為在氫與氧共存的 水溶液中麵膠體催化劑之作用機轉。 相對於此’鈀膠體催化劑之作用機轉如下。 第3 9圖表示氫與氧共存的水溶液中鈀膠體催化劑之作 用機轉。因說明Is膠體催化劑作用機轉時,與前述鉑膠體 催化劑作用機轉之間大的差異點為對氧難反應性由來的部 2030-5943-PF(Nl);Chiumeow.ptd 第113頁 200413503 五、發明說明(111) 分’故以此點為中心作說明,以外的重複說明則省略。 如該圖所示,鈀膠體催化劑會吸附系内溶存之氫,但 對氧不會積極的吸附,或者即使會消極的吸附(碰撞氧的 鈀膠體催化劑)也具有不易將活化氫(· H)所放出之一電子 轉移給傾向(不會還原氧分子)。故,幾乎不會生成原本的 消去對象(·(V)。之後的作用機轉與鉑膠體催化劑相同, 利用把膠體催化劑與溶存在系中之氫的共同作用,分別將 系内存在的(· 0厂)、過氧化氫(H2〇2)或(· 0H)還原,最後 生成水(H2 0 )’並停止這一連串的反應。 此處’作為對本發明較佳貴金屬膠體催化劑之鈀的特 性加以敘述,鈀原子序46、原子量1〇6·42,於18〇3年由 Wollaston所發現的過渡金屬原子。其名稱係由先前發現 的小惑星Pa 11 as (希臘神話之智慧女神)因緣命名。是一種 地球上僅有2400 0噸的珍貴元素。鈀吸取氫的能力良好, 了 =吸藏本身體積740〜938倍之氫。常用於氫化催化劑或 ^存化上。把㈣最多的領域是作為催 ,錯合物也作為由乙浠製造乙搭之催化=化 其他的用途例如作為牙醫治療用之金屬或裝飾品 再者,思考本發明抗氧化機能水之反應對 大致分類為具有不成對電子 例如Τ 具有不成對電子之具強二力=基:以及不 推測係利用本發明抗氡化機 之;二則者之例 :)狀氫而對游離基之對應作用(原子^ 基)’而展現游離基消去活性 ::游離 々耵π此便者之例可認200413503 V. Description of the invention (110) The form of the element is released to Fengzhong f Γ, ~ ττ I, ^, ^ m ^ (hereinafter, the repeated description about this is omitted). That is, the oxygen itself is used to pass through the membrane; the i A 6, MI 4 # gel catalyst is generated by the one-electron reduction of the activated hydrogen, and the original elimination is generated. The platinum colloid catalyst will be adsorbed on the prepared catalyst. W 7 2) : 丄 Return and attached to the dissolved hydrogen and (.〇2-) in the 糸, and a lightning strike released by the activated rat (· Η) will be reduced by 乂 々 λ person / ^ or oxygen two electrons. Transferred to (· 〇2-—) ((.〇2-) one electric dynamo suppressor). That is, (· 〇2-) itself uses a transcolloid catalyst to perform a 20% (0,) meeting due to activated hydrogen, and uses two "ions" present in the plutonium to ionically combine to form a peroxide rat (H2 02 ). After or at the same time, the molybdenum colloidal catalyst will transfer one electron released from activated nitrogen (· H) to hydrogen peroxide (H2 02) ((H202) as it adsorbs the dissolved hydrogen and hydrogen peroxide (H2O2) in the system. ) One electron reduction or three oxygen reduction of oxygen). That is, (H2O2) itself is generated by a one-electron reduction by activated hydrogen through a platinum colloidal catalyst (· 0H). After or at the same time, the platinum colloidal catalyst will transfer an electron released from activated hydrogen (· Η) to (· 〇Η) ((· 〇Η) electrons with the adsorption of hydrogen and (· 〇Η) dissolved in the system. Reduction or four-electron reduction of oxygen). That is, (· 〇ιι) itself uses an electron reduction through activated hydrogen through a colloidal catalyst to generate 0Η-ions. The generated 0Η- will be ionically combined with the Η + ions to form water (40) and stop this series of reactions. The above is the mechanism of the action of the surface colloidal catalyst in the aqueous solution in which hydrogen and oxygen coexist. In contrast, the mechanism of the action of the 'palladium colloid catalyst is as follows. Fig. 39 shows the mechanism of action of a palladium colloidal catalyst in an aqueous solution in which hydrogen and oxygen coexist. When explaining the mechanism of action of the Is colloidal catalyst, the point of great difference between the mechanism of action of the above-mentioned platinum colloidal catalyst and that of the aforementioned platinum colloidal catalyst is the Ministry of Origin of Reactivity to Oxygen 2030-5943-PF (Nl); Chiumeow.ptd Page 113 200413503 5 The description of the invention is divided into (111) points, so the explanation will be centered on this point, and repeated explanations other than that will be omitted. As shown in the figure, the palladium colloidal catalyst adsorbs dissolved hydrogen in the system, but does not actively adsorb oxygen, or even passive adsorption (palladium colloidal catalyst that collides with oxygen) has difficulty in activating hydrogen (· H). One of the emitted electrons is transferred to a tendency (does not reduce oxygen molecules). Therefore, the original elimination object (· (V) is hardly generated. The subsequent mechanism is the same as that of the platinum colloidal catalyst, and the coexistence of the colloidal catalyst and the hydrogen dissolved in the system is used to separately exist in the system (· (Plant 0), hydrogen peroxide (H2O2), or (· 0H) reduction, finally generating water (H2 0) 'and stop this series of reactions. Here,' as the property of the palladium of the preferred noble metal colloidal catalyst of the present invention is added Narrative, the palladium atomic number 46, atomic weight 106.42, was a transition metal atom discovered by Wollaston in 1803. Its name is named after the previously discovered little confusion star Pa 11 as (the goddess of wisdom of Greek mythology). A precious element with only 24 million tons on the earth. Palladium has a good ability to absorb hydrogen. It has a capacity of 740 to 938 times its own volume of hydrogen. It is often used in hydrogenation catalysts or storage. The most concentrated plutonium is used as a catalyst. The complex is also used as a catalyst for the production of acetamide from acetamidine. Other uses, such as metal or decoration for dentist treatment. Furthermore, the reaction of the antioxidant water of the present invention is roughly classified as having Unpaired electrons, such as T, have strong second forces of unpaired electrons = radicals: and it is not presumed that the anti-chemical machine of the present invention is used; examples of the two are :) the corresponding effect of free radicals (atomic ^ radicals) ) 'While exhibiting free radical elimination activity :: free 々 耵 π
200413503 五、發明說明(112) 為利用本發明抗氧化機能水由來之具有強還原力的原、 鼠選擇性的依對項對於氧化物質進行對應作用(有時'忙 象,會給予原子狀氫之電子),而選擇性展現還原活性對 此處,選擇性展現還原活性被認為是依原子狀氣盘\ 化物質之相性,亦即依價電子論,占據原子狀氲側^ := 占軌道之價電子流入氧化物質側最低軌道的容易度條Z 而展現選擇性的還原活性。若舉具體例作為參考^’ 物質維生素B2溶解於本發明含鈀膠體催化劑(192 ^曲 度)氫溶存水(A0W)之被檢定水,並不會有維生素B2g请辰 活性。此例推論是因為本發明抗氧化機能水由,= 還原力的原子狀氫不會將電子給予氧化物質(辛B 所以不會展現還原活性。亦即,可說原子狀氫與氧 (維生素B2)之相性不佳。再者,將氧化: 因Γ/上二亞甲藍之還原活性。此例推論是 曰肘电卞、、口予虱化物質(氧化型亞甲藍 = 原活性。亦即,可★兒肩早 斤^不曰展現還 良好。 了°兒原子狀風與氧化物質(亞甲藍)之相性 欲使本發明抗氧化機能水 提高,較佳方法可考庸你丨^ 上述反應對象之反應性 浪度之虱(以氧化還原色素之固翌力下使,合存飽和 行溶存氫濃度實效值換算),子虱;辰度定量分析方法進 之貴金屬催化劑自身吸藏 或’使氫溶存水中含有 第115頁 2030-5943-PF(Nl);Chiumeow.ptd 200413503 五、發明說明(113) 使用氧化還原色素進行之DH定量分析方法其追加實施例揭 示 以下,表示使用上述氧化還原色素進行之DH定量分析 方法其追加實施例。 (實施例78) 以與實施例7 3同樣之催化劑前添加循環電解處理水作 為被檢定水(A0W) ’將於被檢定水2〇〇mi中置換上述氮氣4〇 倍濃度翻基準液1 m 1以針筒注入被檢定水收容室並充分攪 拌混合後,並以一面以目視被檢定水呈色變化下,將 l〇g/l濃度(體積莫耳濃度26773· 8 //M)之亞甲藍水溶液少 量以針筒注入該被檢定水内。達終點時該亞甲藍水溶液之 總注入量為7 · 8 m 1,將各值代入上述式7内求出之溶存氫濃 度DH貫測值為2 · 0 9 (mg/ 1 )。本實施例78之被檢定水相關物 性表示於表4 ’溶存氫濃度dh之實效值表示於第4〇圖。 (實施例79) 將與參考例22同樣之基本水以與實施例71同樣之電解 條件進行連續通水循環式(循環水量〇 · 8公升)3分鐘之電解 處理催化劑無添加循環電解處理水作為被檢定水,將於被 檢定水20 0ml中置換上述氮氣4〇倍濃度鉑基準液lml以針筒 注入被檢定水收容室並充分攪拌混合後,並以一面以目視 被檢定水呈色變化下,將1〇g/l濃度(體積莫耳濃度26773· 8 // Μ)之亞曱藍水溶液少量以針筒注入該被檢定水内。達 終點時該亞曱藍水溶液之總注入量為8· 5mi,將各值代入 上述式7内求出之溶存氫濃度DH實測值為2· 28(mg/1 )。本200413503 V. Description of the invention (112) In order to use the strong reducing power of the original anti-oxidant function of the present invention, the mouse-selective dependent term is used to correspond to the oxidizing substance (sometimes' busy, will give atomic hydrogen Electrons), and selectively exhibit reducing activity. Here, selectively exhibiting reducing activity is considered to be based on the interphase of the atomic gas plate \ chemical substance, that is, according to the valence electron theory, occupying the atomic side ^: = orbital The valence electrons flow into the easiness bar Z of the lowest orbital side of the oxidizing substance and exhibit selective reducing activity. If a specific example is used as a reference, the substance Vitamin B2 is dissolved in the test water of the hydrogen-soluble water (A0W) of the palladium-containing colloidal catalyst (192 ^ curvature) of the present invention, and vitamin B2g will not be active. This example is inferred because the antioxidant function water of the present invention, = reducing atomic hydrogen does not donate electrons to oxidizing substances (Xin B, so it does not exhibit reducing activity. That is, it can be said that atomic hydrogen and oxygen (vitamin B2 ) The phase is not good. Furthermore, the oxidation will be: due to the reducing activity of Γ / the upper methylene blue. The inference of this example is the elbow electricity, and the oral lice substances (oxidized methylene blue = original activity. Also That is to say, it can be shown that the children's shoulders are still very good. The sexual desire of the atomic wind and the oxidizing substance (methylene blue) makes the antioxidant function water of the present invention better. The better method can test you. ^^ Reactive wave lice of the above-mentioned reaction objects (converted by the effective value of the dissolved hydrogen concentration under the co-saturation of redox pigments), lice; lice; the precious metal catalysts that have been included in the quantitative analysis method of chronometers themselves absorb or 'Make the hydrogen-soluble water contain p. 1152030-5943-PF (Nl); Chiumeow.ptd 200413503 V. Description of the invention (113) Quantitative analysis method of DH using redox pigments The following additional examples are disclosed to show the use of the above-mentioned oxidation Reduction of pigment An additional example of the DH quantitative analysis method. (Example 78) The same electrolytic catalyst treated water as the test water (A0W) was added before the same catalyst as in Example 73. 'The nitrogen gas will be replaced by the test water 200mi. The reference solution at a concentration of 40 times is turned over to 1 m 1 into a test water containing chamber with a syringe, and the mixture is thoroughly stirred and mixed. Then, under the condition that the color of the test water changes visually, 10 g / l concentration (volume mole concentration) 26773 · 8 // M) a small amount of methylene blue aqueous solution is injected into the test water with a syringe. The total injection amount of the methylene blue aqueous solution when the end point is reached is 7 · 8 m 1, and each value is substituted into the above formula 7 The calculated measured value of the dissolved hydrogen concentration DH is 2.09 (mg / 1). The tested water-related physical properties of Example 78 are shown in Table 4 and the actual value of the dissolved hydrogen concentration dh is shown in Figure 40. (Example 79) The same basic water as in Reference Example 22 was subjected to a continuous water circulation cycle (circulated water amount 0.8L) under the same electrolytic conditions as in Example 71. The electrolytic treatment catalyst was added without circulating electrolytic water for 3 minutes. The test water will replace the above in 200 ml of the test water 1 ml of a platinum reference solution with a concentration of 40 times the gas was injected into the water containing chamber of the test solution with a syringe, and the mixture was thoroughly stirred and mixed, and at the same time, the concentration of the test water was changed to 10 g / l (volume molar concentration 26737). · 8 // Μ) A small amount of aqueous solution of indigo blue was injected into the test water with a syringe. When the end point was reached, the total injected amount of the aqueous solution of indigo blue was 8.5 mi. Substituting each value into the above formula 7 The measured value of the dissolved hydrogen concentration DH is 2. 28 (mg / 1).
2030-5943-PF(Nl);Chiumeow.ptd 第116頁 200413503 五、發明說明(114) 實,例79之被檢定水相關物性表示於表4,溶存氫濃度卯 之貫效值表示於第40圖。 (實施例8 0 ) 於將藤澤市自來水以活性碳管柱處理後之活性碳處理 水加入與實施例31同樣之鈀基準液使其濃度為384i, 製含鈀膠體活性碳處理水。將此調製之含鈀膠體活性 ,處理广以與實施例71同樣之電解條件進行連續通水循環 衣水1〇. 8公升)3分鐘之電解處理催化劑無添加循環 =解處,水作為被檢定水(A0W),將於被檢定水200ml中置 二^述虱氣40倍濃度鉑基準液lml以針筒注入被檢定水收 :至並充分擾拌混合後,i以—面以目視被檢定水呈色變 卜:、’將1〇g/1濃度(體積莫耳濃度26773.8"M)之亞甲藍 =液夕里以針筒注入該被檢定水内。達終點時該亞甲玆 總注入量為9. 7ml,將各值代入上述式7内求J 度Μ實測值為2.、6G(mg/1)。本實施例8G之被檢定 40圖。性表不於表4,溶存氫濃度DH之實效值表示於第 (實施例8 1 ) 水以=藤澤市自來水以活性碳管柱處理後之活性碳處理 Gy施例79同樣^電解條件進行連續通水循環式(循 處理=柞&么升)3为鉍之電解處理催化劑無添加循環電解 ^理,作為被檢定水UOW),將於被檢定水2〇〇1111中置換上 im農度翻基準液imi以針筒注入被檢定水收容室 刀見拌混合後,並以一面以目視被檢定水呈色變化2030-5943-PF (Nl); Chiumeow.ptd Page 116 200413503 V. Description of the invention (114) It is shown in Table 4 that the tested water-related physical properties of Example 79 are shown in Table 4, and the total value of the dissolved hydrogen concentration 卯 is shown in page 40. Illustration. (Example 80) Activated carbon-treated water obtained by treating Fujisawa city tap water with an activated carbon column was added with the same palladium reference solution as in Example 31 to a concentration of 384i to prepare palladium-containing colloidal activated carbon-treated water. The palladium-containing colloid activity prepared by this treatment was treated in the same electrolytic conditions as in Example 71. Continuous water circulation was performed (10.8 liters of water). The electrolysis treatment catalyst for 3 minutes was not added. Cycle = solution. Water was used as the test water. (A0W): Put 2ml of the lice gas 40 times concentration platinum reference solution lml in 200ml of the test water and inject the test water with a syringe. After the mixture is fully stirred and mixed, i test the test water with Discoloration :, 'Pour methylene blue at a concentration of 10 g / 1 (volume concentration 26773.8 " M) into the test water with a syringe. When the end point was reached, the total injection volume of the methylene chloride was 9.7 ml, and each value was substituted into the above formula 7 to obtain the measured value of J degree M of 2, 6G (mg / 1). Fig. 40 shows the verification of 8G in this embodiment. The performance table is not shown in Table 4. The actual value of the dissolved hydrogen concentration DH is shown in (Example 8 1). Water treatment = Activated carbon treatment of Fujisawa tap water after activated carbon column treatment. Water circulation type (cycle treatment = 柞 & Mo Li) 3 is the electrolytic treatment catalyst of bismuth without added cycle electrolysis (as the test water UOW), it will be replaced in the test water 20001111 by the agricultural degree The reference solution imi is injected into the test water containing chamber with a syringe and mixed with the knife, and then the test water is visually changed on one side.
200413503 五、發明說明(115) -— 下,將10g/l濃度(體積莫耳濃度26 773·8 #M)之亞甲藍水 洛液少里以針筒注入該被檢定水内。達終點時該亞甲藍水 溶液之總注入量為10. 6ml,將各值代入上述式7内求出之 溶存氫濃度DH實測值為2.84(mg/1)。本實施例81之被檢定 水相關物性表示於表4,溶存氫濃度DH之實效值表示於第 4 0圖。 (實施例8 2 ) 於將藤澤市自來水以活性碳管柱處理後之活性碳處理 水加入與實施例31同樣之鈀基準液使其濃度為192 , 以调製含鈀膠體活性碳處理水。將此調製之含鈀膠體活性 碳處理π水以與實施例8 〇同樣之電解條件進行連續通水循環 式(循環水量〇· 8公升)3分鐘之電解處理催化劑無添加循環 電解處,水作為被檢定水(A〇w),將於被檢定水2〇〇ml中置 換上述氮氣4 0倍濃度鉑基準液丨m 1以針筒注入被檢定水收 谷室並充分攪拌混合後,並以一面以目視被檢定水呈色變 化下,將i〇g/i濃度(體積莫耳濃度26773.8 #幻之亞甲藍 水溶液y 1以針筒注入該被檢定水内。達終點時該亞甲藍 水,液,總注入量為i 2. 〇m i,將各值代入上述式7内求出 之洛存氫濃度DH實測值為3.21(mg/l)。本實施例80之被檢 定水相關物性表示於表4,溶存氫濃度M之實效值表示於 第40圖。200413503 V. Description of the invention (115)-Next, the methylene blue water with a concentration of 10 g / l (volume concentration 26 773 · 8 #M) was injected into the test water with a syringe. When the end point was reached, the total injection amount of the methylene blue water solution was 10.6 ml, and the values of the dissolved hydrogen concentration DH obtained by substituting each value into the above formula 7 were 2.84 (mg / 1). The water-related physical properties of the test in Example 81 are shown in Table 4, and the actual value of the dissolved hydrogen concentration DH is shown in Figure 40. (Example 8 2) Activated carbon treated water in which Fujitasawa tap water was treated with an activated carbon column was added with the same palladium reference solution as in Example 31 to a concentration of 192 to prepare a palladium-containing colloidal activated carbon-treated water. This prepared palladium-containing colloidal activated carbon-treated π water was subjected to a continuous water circulation cycle (circulated water amount 0.8L) for 3 minutes under the same electrolytic conditions as in Example 8.0. The electrolysis treatment catalyst was not added with a circulating electrolysis place, and water was used as a substrate. The test water (Aow) will replace the above-mentioned nitrogen 40-fold concentration platinum reference solution in 200ml of the test water, and the m 1 will be injected into the tester's harvesting chamber with a syringe and fully stirred and mixed. Under visual change of the color of the test water, inject iOg / i concentration (volume concentration 26773.8 #Magic blue methylene blue aqueous solution y 1 into the test water with a syringe. When the end point is reached, the methylene blue water , The total injection volume is i 2. 0mi, substituting each value into the above-mentioned formula 7, the measured value of the stored hydrogen concentration DH is 3.21 (mg / l). The test-related water-related physical properties of Example 80 are shown In Table 4, the actual value of the dissolved hydrogen concentration M is shown in FIG. 40.
第118頁 200413503 五、發明說明(116) 表4 pH ORP[mV] EC[mS/m] 水溫Tc] ϋΗ買效値[mg/L] 參考例17 9.8 -171 17 21.6 0.03 參考例18 7.2 -623 99 21.2 1.66 實施例78 7.1 -650 98 22.3 2.09 實施例79 7.1 -650 98 22.3 2.28 — 實施例80 7.8 -645 15 22.3 2.60 實施例8—1 8.9 -707 15 18.0 2.84 實施例82 7.4 -605 14 18.0 3.21 抗氧化機此水(A 0 W )對線蟲(C! )壽命影塑之探兮寸 屬線蟲之 Caenorhabditis eiegans (以下稱C· ei堪3仍)與果 绳、小鼠、大鼠並列在國際上廣泛使用作為多細胞生物的 老化模型。且因,C: 的全部基因體序列已被定出, 可與基因破壞或G F P融合基因等表現解析之手法組合以用 於探討人類遺傳性疾病原因基因或癌症基因等個體階層上 機能或作用機構之活試管,故受到注目。 曰 特別提出,野生型C· e&w之最常壽命為約託日乂 之短(參照「在分子階層看老化」石井直明著:講談社工 ( 20 0 1 )第102〜103頁)以C· de狗^作為實驗動物時,可 短時間内探討抗氧化機能水對動物壽命的影響。 在 本發明人等得到上述文獻「在分子階|^老化 東海大學醫學部分子生命科學助教授石井直明」t作者 幫助,實施探討以野生型C: 飼育用水作 =導與 能水(AOW)時,對壽命影響之試驗。此、产几氣「化機 育用水」是指在對淨水及抗氧化機能水各試驗群1之-飼 (A-2)試驗步驟時,在④項中把蟲靜置 适仃後述 τ ^〜0小時之操Page 118 200413503 V. Description of the invention (116) Table 4 pH ORP [mV] EC [mS / m] Water temperature Tc] ϋΗBuying effect 値 [mg / L] Reference example 17 9.8 -171 17 21.6 0.03 Reference example 18 7.2 -623 99 21.2 1.66 Example 78 7.1 -650 98 22.3 2.09 Example 79 7.1 -650 98 22.3 2.28 — Example 80 7.8 -645 15 22.3 2.60 Example 8-1 8.9 -707 15 18.0 2.84 Example 82 7.4 -605 14 18.0 3.21 Antioxidant This water (A 0 W) has a longevity effect on nematodes (C!). Caenorhabditis eiegans (hereinafter referred to as C. eikan 3 still) and fruit rope, mice, rats Juxtapose is widely used internationally as an aging model for multicellular organisms. Moreover, the entire genomic sequence of C: has been determined, and it can be combined with expression analysis methods such as gene destruction or GFP fusion gene to be used to explore the function or mechanism of the individual hierarchy such as human genetic disease cause genes or cancer genes. The live test tube attracted attention. In particular, he proposed that the most common lifespan of wild-type C · e & w is about as short as that of Yotori (see "Aging at the molecular level" by Naoto Ishii: Talking about social workers (20 0 1), 102 ~ 103). · When de dog ^ is an experimental animal, the effect of antioxidant water on animal life can be discussed in a short time. When the present inventors obtained the above-mentioned document "At the molecular level | ^ Aging of Tokai University Medical Science Assistant Professor Naoki Ishii", the author helped implement the discussion using wild-type C: feeding water as the guide and energy water (AOW), Test on the effect of life. Here, the "gas generation" "chemical water" refers to the test procedure for feed-water (A-2) of each test group 1 of purified water and antioxidant function water, and the insects are allowed to stand still in item ④. ^ ~ 0 hours of exercise
200413503 五、發明說明(117) 作所用的水’以及在⑧帛中判定蟲生死時,或瓊脂 ^秌蚪在瓊脂培養基表面上滴水的操作等各操作時所用^勺 本試驗之實驗計晝概要說明如下(A),同試驗 例與參考例說明如下(B),同試驗之結果與考察說明二下 c)。又,本試驗係依據「活性氧實驗計畫測定法、美因 病態生理模型」谷口直之監修:細胞卫程別冊土實驗 1旦糸列’秀潤社(股)發行,1 994,第288〜2 92頁「老化 模型」/中態生理模型」谷口直之監修:細胞工程別冊實驗 計畫系列’秀潤社(股)發行,1 994,第29〇〜292頁「2·各 種氧濃度下壽命之測定」)(以下,參考文獻省略為「依據 步驟」)°上述「老化模型」之記載内容引用於本說明 f °惟’因本試驗係探討飼育用水之改變對對c. elegans 壽命影響,有特殊性,故將依據步驟作了改變。對本試驗 計畫之說明係以依據步驟改變之部分為中心。 (A)试驗計晝之概要 (A -1)使用之試藥類 本試驗使用之試藥類如下。 ① (5-氟-2’-脫氧尿苷:FudR)· · ·和光純藥工業(Wako Pure Chemical)製。 ② S緩衝液(s buff er ) 氣化鈉:NaCl(0· 1M)。 碟酸钾:Potassium phosphate(pH6.0) 因為C· e/e多MS 為雌雄同體,故必需防止和子代混在一200413503 V. Description of the invention (117) The water used for operation and the operation of judging the life and death of insects in the pupa, or the operation of agar ^ dribbling water on the surface of the agar medium, etc. The description is as follows (A), the same test examples and reference examples are described as follows (B), and the results of the same tests and investigations are explained c). In addition, this test is based on "Reactive Oxygen Oxygen Project Measurement Method and Main Pathological Physiological Model" Supervised by Naoya Taniguchi: Cell Guardian's Book Soil Experiment, 1st Issue, Xiu Runsha (Stock), 1 994, 288 ~ 2 Page 92 "Aging Model" / Mid-State Physiological Model "Supervision by Naoya Taniguchi: Separate Cell Engineering Experiment Series" Shurunsha Co., Ltd. ", 1 994, pages 29〇 ~ 292" 2 · Lifetime under various oxygen concentrations "Measurement") (hereinafter, references are omitted as "based on the steps") ° The above "aging model" is cited in this note f ° However, 'this experiment is to investigate the effect of changes in feeding water on the life of c. Elegans, It is special, so it will be changed according to the steps. The description of this test plan is centered on the part that changes according to the procedure. (A) Summary of test day (A -1) Reagents used in this test The reagents used in this test are as follows. ① (5-Fluoro-2'-deoxyuridine: FudR) · · · Made by Wako Pure Chemical. ② S buffer (s buffer) Sodium vaporization: NaCl (0.1M). Potassium Dish: Potassium Phosphate (pH6.0) Because C · e / e polyMS is hermaphrodite, it is necessary to prevent mixing with progeny
2030-5943-PF(Nl);Chiumeow.ptd 第120頁 200413503 五、發明說明(118) 起。故,依依據步驟,使用試藥FudR以阻害C·以炫柳出現 子代。又,S緩衝液的使用目的為除去因ρ Η差異造成的影 響。 (A - 2 )試驗步驟 ① 依試驗步驟,收集同步培養之野生型第一期幼蟲。於含 瓊脂培養基之9公分培養孤内,放入約5 0 0〜1 0 0 0隻的蟲。 進行此操作時蟲齡約4日。 ② 以傳遞吸取器取適量S緩衝液住入於上培養皿内,再以 同傳遞吸取器把在培養JHL内之蟲和S緩衝液一起吸起來並 移到試管(徑1. 5mm)。將該試管以縱向放置的狀態靜置, 蟲會沈到試管底部。蟲沈澱後,注意不要吸到蟲,把試管 内的S緩衝液(上清)以傳遞吸取器輕輕的吸走。藉此以除 去試管内S緩衝液的狀態收集試管内的蟲。 ③ 將收集於上述試管内之蟲取出適量(1〇〇〜2〇〇隻左右), 並分配到2隻試管内(i.5mm徑,容量1〜2ml)。並在兩隻試 管中’一隻作為控制組(後述參考例28之淨水),另一隻注 入被檢水(後述實施例83之抗氧化機能水)。 ④ 將上述兩試管之開口部加蓋,並將該兩試管橫放靜置3 小時。 養 ⑤ 分別將上述橫放靜置後之兩隻試管中之蟲移到2個91^培 ^ ,並於室溫下靜置一晚。 ⑥準^備表面稍微乾燥的含瓊脂3公分培養皿(2 〇片)。在各3 A刀口養皿之、力中心各滴入一滴作為蟲_之大腸菌。如此 一來,蟲會因餌食而集中到中央,便於觀察。2030-5943-PF (Nl); Chiumeow.ptd p. 120 200413503 V. Description of invention (118). Therefore, in accordance with the steps, the test drug FudR was used to prevent C. Yixuan Liu from showing offspring. The purpose of using the S buffer is to remove the influence caused by the difference in ρ Η. (A-2) Test procedure ① According to the test procedure, collect the wild-type first-stage larvae cultured simultaneously. In a 9 cm culture orphan containing an agar medium, put about 50,000 to 10,000 worms. When this operation is performed, the worm age is about 4 days. ② Take an appropriate amount of S buffer with a transfer pipette and place it in the upper petri dish. Then use the transfer pipette to suck up the worms and S buffer in the culture JHL and transfer it to a test tube (diameter 1.5mm). The test tube is left standing in a vertical state, and the bug will sink to the bottom of the test tube. After the worms have precipitated, be careful not to suck the worms. S buffer (supernatant) in the test tube is gently sucked away with a pipette. Thereby, the worms in the test tube were collected with the S buffer in the test tube removed. ③ Take out an appropriate amount of the insects collected in the above test tube (about 100 ~ 200) and distribute it into 2 test tubes (i.e. 5mm diameter, 1 ~ 2ml capacity). One of the two test tubes was used as a control group (purified water of Reference Example 28 described later), and the other was injected with test water (antioxidant function water of Example 83 described later). ④ Cover the openings of the two test tubes, and place the two test tubes in a horizontal position for 3 hours. Cultivation ⑤ Move the worms in the two test tubes placed horizontally to two 91 ^ cultures and leave them to stand overnight at room temperature. ⑥ Prepare a 3 cm agar-containing petri dish (20 pieces) with a slightly dry surface. A drop of coliform bacteria was added to each of the 3 A knife-edge culture dishes and the force center. In this way, the insects will be concentrated in the center due to bait, which is convenient for observation.
第121頁 200413503 五、發明說明(119) ⑦ 使用後述之單離用白金線將蟲由上述⑤於室溫靜置一晚 的2個9公分培養皿移到上述⑥預備好之3公分培養孤,每一 片各=隻,總共10片。將此100隻蟲作為一個7式驗群使 用。試驗群有2個時,各試驗群都進行此操作。進行分蟲 的操作時,一併進行試藥以心之添加操作。又,單離用白 金線是一個自製工具,係將長度約3公分、直徑約5〇〇〜1〇〇 # m之白金線裝在3公分之傳遞吸取器細口部,將白金線前 端以,刀等削成銳角,並在前端約5mm左右的地方折成直 角。每次使用時,用火燄將前端(會接觸蟲或瓊脂培養基 的部分)滅菌。使用方法為將蟲由下往上勾起來。把蟲勾 Ϊ來i ’匕將白金線前端往瓊脂上輕輕接觸,蟲就會自己移 動到壤脂培養基。 ⑧ =曰(本試驗原則為隔日)檢查各群之蟲的生死(日齡)。 係利用將單離用白金線輕觸蟲頭部,或滴水 Τ二2f應ΐ判定為死亡。如果瓊脂培養基乾燥 (Β)杏扩制盥2及去取态滴卜2滴水在瓊脂培養基表面上。 C Β )貝施例與參考例之揭示 (參考例28) 以將藤澤市自來^》Page 121 200413503 V. Description of the invention (119) ⑦ Use the single-lead platinum thread described later to move the worms from the two ⑤ cm petri dishes that were left at room temperature overnight to the above ⑥ 3 cm prepared orphan , Each piece = only, a total of 10 pieces. The 100 worms were used as a type 7 colony. When there are two test groups, each test group performs this operation. When carrying out the operation of separating the worms, perform the operation of adding the drug to the heart. In addition, the single-lead platinum wire is a self-made tool. A platinum wire with a length of about 3 cm and a diameter of about 500 ~ 100 # m is installed in the narrow mouth of the transfer suction device of 3 cm. Cut to an acute angle and fold it into a right angle at about 5mm at the front end. For each use, sterilize the front end (the part that will contact the insect or agar medium) with a flame. The method of use is to hook the worm from bottom to top. Put the worm hook on it ’and touch the front end of the platinum wire gently to the agar, and the worm will move to the soil lipid medium by itself. ⑧ = Said (the principle of this test is every other day) check the life and death (day age) of each group of insects. It is determined that the single-lead platinum wire is used to lightly touch the worm's head, or the water drops T 2 2f should be judged to be dead. If the agar medium is dry (B), the apricot expansion system 2 and the dehydrated droplet 2 are dropped on the surface of the agar medium. C Β) Disclosure of Bei Shi Example and Reference Example (Reference Example 28)
(、事火〕祚A豹古K U活性故管柱處理之活性碳處理水 (淨水則飼=水時,依(a_2)記載之 X *命^料參考觸。 之活==二之?/液於1公升與參考例28同樣 尺),使鈀膠體濃度為192 #g/l,並以(, Matter of fire) 豹 A leopard ancient KU active column activated carbon-treated water (when purified water is fed = water, according to the X * life ^ material reference reference in (a_2). Live == two of them? / Liquid at 1 liter is the same size as Reference Example 28), so that the palladium colloid concentration is 192 # g / l, and
200413503 五、發明說明(120) ------------ 每分鐘1· 5公升之流量以5A固定電流的電解條件進行 通水循環式(循環水量〇 . 8公升)電解處理(相當於二道畲、只 處理)ι分鐘得到之催化劑前添加循環電解處理水解 為飼育用水,依(A-2)記載之試驗步驟得到之線蟲 & 壽命資料作為實施例8 3。 (C)試驗結果及結果之考察 對比參考例2 8 (以淨水作為飼育用水之群)與實施例 8 3 (以^几氧化機能水作為飼育用水之群)之第4丨圖、第μ圖 表示含翻膠體催化劑電解水(A〇w)對於壽命之影 # °又’本试驗以史氏T試驗(student’s t-test)檢驗獨 立2群間平均壽命差之顯著差異,結果示於表5。200413503 V. Description of the invention (120) ------------ Flow rate of 1.5 litres per minute and 5A fixed current electrolysis conditions for water circulation type (circulated water 0.8 litres) electrolytic treatment ( It is equivalent to two cycles of maggots and only treated for 1 minute. The catalyst was added to the cyclic electrolysis treatment and hydrolyzed to feed water before the catalyst was obtained. The nematode & life data obtained according to the test procedure described in (A-2) was used as Example 83. (C) Comparison and comparison of test results and results of Reference Example 2 of the reference example 2 (group of using purified water as breeding water) and Example 8 3 (group of using ^ oxidative function water as breeding water) The figure shows the effect of the colloidal catalyst-containing electrolyzed water (Aow) on the life span. ° This test uses the Student's t-test to test the significant difference in the average life difference between the two independent groups. The results are shown in table 5.
2030-5943-PF(Nl);Chiumeow.ptd 第123頁 200413503 五、發明說明(121) 表52030-5943-PF (Nl); Chiumeow.ptd Page 123 200413503 V. Description of Invention (121) Table 5
Student's t-test :假設等分散之2樣本之檢定結果(fe險率0.1%) 抗氧化機*狄 淨水 平均壽命 20.05 17.75 分散 16.66 14.98 觀惻數 99 95 集合(pool)之分散 15.84 與假設平均之差異 0 自由度 192 T 4.02961 P(T£t)單側 4.02E-05 丁邊界値單側 3.13325 P(TSt)雙側 8.05E - 05 丁邊界値雙側 3.34199 檢定結果: 因爲t=4.03>t邊界値雙側(3·34”故捨棄「以抗氧化機能水 及以淨水作爲C· e/egara之飼育用水之兩群其平均壽命相等」& 假說,因此τ以抗氧化機能水作爲C· e/egara飼育用水之群其平 均壽命(20.05曰)比起用淨水之群平均壽命(17.75曰)多出2 3 曰 τ 兩者之差有顯著性。(t(192)=4.03 τ SD:0.57 τ ρ<0·〇〇ι) 如表5所示,因危險率為0.1%時,t = 4.〇3>t邊界值替 側(3· 34),故捨棄「以抗氧化機能水及以淨水作為1 C_ 堪之飼育用水之兩群其平均壽命相等」的假士兒 此’以抗氧化機能水作為C· 飼育用水之群其平支^ 命(20· 05日)比起用淨水之群平均壽命(17. 75日)多出^可 日,兩者之差有顯著性。(t( 192)^4. 03,SD = (K 57, · 3 p<0.001)。此處 ’ 「(t(192) = 4.03)」表示自由度 192日$ t值,SD表示2群平均壽命間差異的標準偏差,n = — i日寸之 p衣不危險 罕 〇Student's t-test: Test results of hypothetical equal-dispersion 2 samples (fe risk rate 0.1%) Antioxidant machine * Di water average life 20.05 17.75 Dispersion 16.66 14.98 Observation number 99 95 Dispersion of pool 15.84 and hypothetical average Difference 0 Degrees of freedom 192 T 4.02961 P (T £ t) one side 4.02E-05 Ding boundary 値 one side 3.13325 P (TSt) two sides 8.05E-05 Ding boundary 値 both sides 3.34199 Verification result: Because t = 4.03 > t boundary 値 both sides (3 · 34), so the "average life expectancy of the two groups with antioxidant function water and clean water as C · e / egara's breeding water is the same" & hypothesis, so τ has antioxidant function The average lifespan of water as the breeding water for C · e / egara (20.05) is 2 3 longer than the average lifespan of the group using purified water (17.75). The difference between the two is significant. (T (192) = 4.03 τ SD: 0.57 τ ρ < 0 · 〇〇ι) As shown in Table 5, when the hazard rate is 0.1%, t = 4.〇3> t boundary value for the side (3.34), so the " Antioxidant functional water and purified water as 1 C_ Kanzhi's two groups of breeding water have the same average life span. "Fake children here" using antioxidant functional water as The average life expectancy (20 · 05) of C · feeding water groups was longer than the average lifespan of the group using water purification (17.75 days) ^ days, and the difference between the two was significant. (T (192 ) ^ 4. 03, SD = (K 57, · 3 p < 0.001). Here "((t (192) = 4.03)" represents the value of $ 192 degrees of freedom for t, and SD represents the difference between the average lifespan of the two groups. Standard deviation, n = — The p-shirt of i-inch is not dangerous.
2030-5943-PF(Nl);Chiumeow.ptd 第124頁 200413503 五、發明說明(122) 由此试驗結果考察,可認為是抗氧化機能水抑制了來 自活性乳類之氧化障害,使線蟲eyegayTs之壽命延長。、、舌 性氧類會透過對蛋白質及核酸等細胞内分子產生氧化障宝 而對活細胞造成毒性。亦即,來自活性氧類之氧化障害^ 老化有關的情事藉由線蟲與果蠅的研究而解明了(參照石、 井直明「線蟲中壽命決定的機制」,細胞工學v〇1. 21 N〇 7 2002;Agarwal 等,Proc· Natl· Acad· Sci· USA, 91 12332-12335, 1994; Larsen, P. L., Proc. Natl.2030-5943-PF (Nl); Chiumeow.ptd Page 124 200413503 V. Description of the invention (122) Based on the results of the test, it can be considered that the antioxidant function water inhibits the oxidation barrier from active milk, making nematode eyegayTs Extended life. Tongue oxygen can cause toxicity to living cells by generating oxidative barriers to intracellular molecules such as proteins and nucleic acids. That is, oxidative barriers from active oxygen species ^ aging-related events were clarified by the study of nematodes and fruit flies (refer to Shi and Jing Ming, "Mechanisms of Life-Span Determination in Nematodes", Cell Engineering v〇1. 21 N 〇7 2002; Agarwal et al., Proc. Natl. Acad. Sci. USA, 91 12332-12335, 1994; Larsen, PL, Proc. Natl.
Acad. Sci. U.S.A., 90, 8 90 5-89 0 9, 1 9 93; Sohal, r S·等,J. Biol· chem·, 2 70, 1 5 671 -1 5674, 1 995 等)。 本試驗與該等研究内容同樣的,確認了活性氧 化障害與老化有關的結果。 不之乳 本發明在實施形態、參考例及實施例說明中已 ί : ΐ Ϊ為氧化還原色素之例示,但本發明可使用之氧化 ^ ^素不限定於此,例如可使用接頭語為 ,3、酸性黃色素,、酸性黃色素-25、酸性黃色二 m L 撥色素_19、酸性橙色素Μ、酸性綠 —2 UK 生綠色素一25、酸性紫色素-43、酸性棕色素 性藍色素-9、酸性藍色Ϊ :n色素:31、酸性藍色素_3、酸 素-47、酸性藍色素—59 ’、、 馱性藍色素—45、酸性藍色 1 1 rj辦A主、 文性藍色素—7 4、酸性藍色辛 -113、酸性藍色素—158、 夂r王孤巴京 酸性紅色素-“、酸性紅色、酸性紅色素_2、 巴京18、酸性紅色素-27、酸性 200413503 五、發明說明(123) 紅色素-3 7、酸性紅色素—5 1、酸性紅色素_ 5 2、酸性紅色 素-87、酸性紅色素—88、酸性紅色素—91、酸性紅色素 -92、酸性紅色素—94、酸性紅色素—95、酸性紅色素 - 11 1、浴劑頁色素—2、溶劑黑色素_ 3、溶劑藍色素—7、溶 劑藍色素-11、溶劑藍色素—25、溶劑紅色素—3、溶劑紅色 素-1 9、溶劑紅色素—23、溶劑紅色素—24、溶劑紅色素 -7 3/直接黃色素—3、直接黃色素—9、直接黃色素—l2、直 接黃色素-59、直接綠色素-;[、直接綠色素_6、直接綠色 素-59、直接棕色素、直接棕色素_6、直接黑色素_4、 直接黑色素-22、直接黑色素—38、直接藍色素-丨、直接藍 色素-6、直接藍色素—53、直接藍色素—86、直接藍色素 106、直接紅色素-2、直接紅色素—28、直接紅色素—79、 分散黃色素-3、分散黃色素—5、分散黃色素-8、分散黃色 素42、为政頁色素6〇、分散黃色素64、分散橙色素3、分 散橙色素30、分散紫色素26、分散紫色素28、分散藍色素 1、分散藍色素26、分散紅色素i、分散紅色素4、分散紅 色素60、分散紅色素65、分散紅色素73、還原黃色素2、 還原綠色素1、還原綠色素3、還原棕色素1、還原掠色素 3、還原黑色素25、還原藍色素1、還原藍色素4、還原藍 色素2 0、還原紅色素1 〇、還原紅色素4丨、色料黃色素工、 色料黃色素3、色料黃色素10、色料黃色素12、色料黃色 素13、色料黃色素14、色料黃色素17、色料黃色素24、色 料黃色素55、色料黃色素81、色料黃色素83、色料黃色素 93、色料黃色素94、色料黃色素95、色料黃色素97、色料 200413503 五、發明說明(124) ^素98、色料黃色素99、色料黃色素⑽ 以=/110、色料黃色素116、色料黃二: Λ二色料黃色素151、色料黃色素154、色料 检色素5、色料橙色素12、色料撥色素14、色料橙 1二m素36、色料橙色素38、色料橙色素40、、色料 板色素43、色料綠色素4、色料綠色素7、色料綠色素&、 J料綠色素10、色料綠色素36、色料紅色素i、色料紫 :?色料紫色素19、色料紫色素23、色料紫色素33:、色 料栋色素25、色料黑色素i、色料藍色素2、色料藍色 15: J料藍色素16、色料藍色素17、色料藍色素厂8、色料 ^色素24、色料紅色素j、色料紅色素3色料紅色素$、 48 : 1、色料紅色素48 48 : 4、色料紅色素49 5 3 : 1、色料紅色素5 7 63 : 2、色料紅色素64 色料紅色素88、色料 、色料紅色素48 : 3、色料紅色素 、色料紅色素5 2 : 1、色料紅色素 、色料紅色素6 〇、色料紅色素 、色料紅色素81、色料紅色素83、 色素11 2、色料紅色素1 2 2、色料红 色素123、色料紅色素144、色料紅色素146、色料紅色素 149、色料紅色素151、色料紅色素166、色料紅色素168、、 色料紅色素170、色料紅色素丨74、色料紅色素175、色料 紅色素176、色料紅色素177、色料紅色素178、色料红色 素179、色料紅色素185、色料紅色素187、色料紅色素 208、食品黃色素3、食品綠色素3、食品紅色素6、食品紅 色素17、鹼性黃色素1、鹼性黃色素2、鹼性黃色素u、鹼 料紅色素9、色料紅色素22、色料紅色素38、色料紅色素 2030-5943-PF(Nl);Chiumeow.ptd 第127頁 (125) 200413503 性橙色素1、鹼性橙色素1 1、鹼性綠色素4、鹼性紫色素 3、鹼性紫色素4、鹼性紫色素10、鹼性紫色素14、鹼性棕 色素1、鹼性藍色素1、鹼性藍色素3、鹼性藍色素9、鹼性 藍色素2 4、驗性紅色素1、驗性紅色素5、鹼性紅色素5、 鹼性紅色素9、鹼性紅色素18、媒染黃色素】、媒染黃色素 3、媒染橙色素1、媒染紅色素26、媒染黑色素u、媒染藍 色素13、媒染藍色素29、媒染紅色素3、媒染紅色素u、 媒染紅色素1 5、反應性黃色素2、反應性黃色素3、反應性 黃色素17、反應性橙色素1、反應性橙色素2、反應性橙色 素16、反應性紫色素2、反應性黑色素5、反應性藍色素 2、反應性藍色素5、反應性藍色素7、反應性藍色素丨9、 反應性紅色素1、反應性紅色素3、反應性紅色素6、反應 性紅色素17、反應性紅色素22、反應性紅色素41等,及接 頭語無色素之吖啶黃G、茜素、陰丹明、吲哚苯胺、卩引哚 花青綠、脲硫酮、脲嘌呤、對乙氧基克里索丁鹽酸鹽、間 苯甲酚紫、鄰-苯甲酚酞、苯曱酚紅、藏花酸、葉綠素 (a、b、c、d)、氯酚紅、新亞甲藍、中性紅、凡拉明藍b ,酸鹽、曱基紫精、綠膿青素、磺化靛藍、番紅τ、酚藏 花紅、加布里藍、納魯藍、二苯胺、二曱苯青、硝基二苯 胺、試亞鐵靈、Ν-苯基蒽酸、2, 6-二氯吲哚苯酚鈉、4-二 苯基胺磺酸鈉、Ν,Ν-二苯基聯苯胺、辛那巴林(抗生物 質)、曱苯藍、核黃素(維生素Β2)、四唑藍鹽、四唑藍鹽 還原型(Di formazan)等。其中,由在本滴定中顏色變化與 亞甲藍為同程度明顯的觀點,較佳者為使用甲基紫精、凡Acad. Sci. U.S.A., 90, 8 90 5-89 0 9, 1 9 93; Sohal, r S ·, etc., J. Biol · chem ·, 2 70, 1 5 671 -1 5674, 1 995, etc.). This test is the same as these studies, confirming the results related to active oxidation barriers and aging. The present invention has been described in the embodiments, reference examples, and examples: ί Ϊ is an example of a redox pigment, but the oxidizing element that can be used in the present invention is not limited to this. For example, a linker can be used, 3. Acidic yellow pigment, acidic yellow pigment-25, acidic yellow pigment -19, acidic orange pigment M, acidic green-2 UK green pigment 25, acidic purple pigment 43, acidic brown pigment blue pigment -9, acid blue pigment: n pigment: 31, acid blue pigment_3, acid pigment-47, acid blue pigment—59 ', acid blue pigment—45, acid blue 1 1 rj Blue pigment-7, Acid blue pigment-113, Acid blue pigment-158, 王 王王孤 巴 京 酸 红 素-", Acid red, Acid red pigment_2, Bajing 18, Acid red pigment-27, Acidity 200413503 V. Description of the invention (123) Red pigment-3 7, Acid red pigment-5, Acid red pigment-5, Acid red pigment-87, Acid red pigment-88, Acid red pigment-91, Acid red pigment -92, Acid Red Pigment—94, Acid Red Pigment—95, Acid Red Pigment—11 1. Bath Pigment —2, solvent melanin_3, solvent blue pigment—7, solvent blue pigment—11, solvent blue pigment—25, solvent red pigment—3, solvent red pigment—1 9, solvent red pigment—23, solvent red pigment—24 Solvent red pigment-7 3 / direct yellow pigment-3, direct yellow pigment-9, direct yellow pigment-12, direct yellow pigment-59, direct green pigment-; [, direct green pigment-6, direct green pigment-59 , Direct brown pigment, direct brown pigment_6, direct melanin_4, direct melanin-22, direct melanin—38, direct blue pigment- 丨, direct blue pigment-6, direct blue pigment—53, direct blue pigment—86, Direct blue pigment 106, direct red pigment-2, direct red pigment-28, direct red pigment-79, disperse yellow pigment-3, disperse yellow pigment-5, disperse yellow pigment-8, disperse yellow pigment 42, as leaf pigment 60, disperse yellow pigment 64, disperse orange pigment 3, disperse orange pigment 30, disperse purple pigment 26, disperse purple pigment 28, disperse blue pigment 1, disperse blue pigment 26, disperse red pigment i, disperse red pigment 4, disperse red Pigment 60, Disperse Red Pigment 65, Disperse Red Pigment 73, Reduced Yellow 2, reduced green pigment 1, reduced green pigment 3, reduced brown pigment 1, reduced gramine pigment 3, reduced melanin 25, reduced blue pigment 1, reduced blue pigment 4, reduced blue pigment 2 0, reduced red pigment 1 0, reduced red Pigment 4 丨, pigment yellow pigment, pigment yellow pigment 3, pigment yellow pigment 10, pigment yellow pigment 12, pigment yellow pigment 13, pigment yellow pigment 14, pigment yellow pigment 17, pigment yellow pigment 24. Pigment Yellow Pigment 55, Pigment Yellow Pigment 81, Pigment Yellow Pigment 83, Pigment Yellow Pigment 93, Pigment Yellow Pigment 94, Pigment Yellow Pigment 95, Pigment Yellow Pigment 97, Pigment 200413503 V. Invention Explanation (124) ^ pigment 98, pigment yellow pigment 99, pigment yellow pigment ⑽ = / 110, pigment yellow pigment 116, pigment yellow II: Λ two pigment yellow pigment 151, pigment yellow pigment 154, color Pigment inspection pigment 5, pigment orange pigment 12, pigment pigment 14, pigment orange 1, pigment 36, pigment orange pigment 38, pigment orange pigment 40, pigment pigment 43, pigment green pigment 4 , Pigment Green Pigment 7, Pigment Green Pigment &, J Pigment Green Pigment 10, Pigment Green Pigment 36, Pigment Red Pigment i, Pigment Purple:? Pigment Purple Pigment 19, Color Purple pigment 23, pigment purple pigment 33 :, pigment pigment 25, pigment melanin i, pigment blue pigment 2, pigment blue 15: pigment blue pigment 16, pigment blue pigment 17, pigment blue pigment Factory 8, Pigment ^ Pigment 24, Pigment Red Pigment j, Pigment Red Pigment 3 Pigment Red Pigment $, 48: 1, Pigment Red Pigment 48 48: 4, Pigment Red Pigment 49 5 3: 1, Color Pigment Red Pigment 5 7 63: 2, Pigment Red Pigment 64 Pigment Red Pigment 88, Pigment Red Pigment 48: 3, Pigment Red Pigment, Pigment Red Pigment 5 2: 1, Pigment Red Pigment, Pigment Red Pigment 6 〇, Pigment Red Pigment, Pigment Red Pigment 81, Pigment Red Pigment 83, Pigment 11 2, Pigment Red Pigment 1 2 2, Pigment Red Pigment 123, Pigment Red Pigment 144, Pigment Red pigment 146, pigment red pigment 149, pigment red pigment 151, pigment red pigment 166, pigment red pigment 168, pigment red pigment 170, pigment red pigment 丨 74, pigment red pigment 175, pigment Red pigment 176, pigment red pigment 177, pigment red pigment 178, pigment red pigment 179, pigment red pigment 185, pigment red pigment 187, pigment red pigment 208, food yellow pigment 3, food green pigment 3, Magenta Pigment 6, Food Red Pigment 17, Basic Yellow Pigment 1, Basic Yellow Pigment 2, Basic Yellow Pigment u, Basic Pigment Red Pigment 9, Pigment Red Pigment 22, Pigment Red Pigment 38, Pigment Red Pigment 2030-5943-PF (Nl); Chiumeow.ptd p.127 (125) 200413503 sex orange pigment 1, basic orange pigment 1 1, basic green pigment 4, basic purple pigment 3, basic purple pigment 4, alkaline Basic purple pigment 10, basic purple pigment 14, basic brown pigment 1, basic blue pigment 1, basic blue pigment 3, basic blue pigment 9, basic blue pigment 2 Red pigment 5, Basic red pigment 5, Basic red pigment 9, Basic red pigment 18, Mordant yellow pigment], Mordant yellow pigment 3, Mordant orange pigment 1, Mordant red pigment 26, Mordant melanin u, Mordant blue pigment 13 Mordant blue pigment 29, Mordant red pigment 3, Mordant red pigment u, Mordant red pigment 1, 5, Reactive yellow pigment 2, Reactive yellow pigment 3, Reactive yellow pigment 17, Reactive orange pigment 1, Reactive orange pigment 2, reactive orange pigment 16, reactive purple pigment 2, reactive melanin 5, reactive blue pigment 2, reactive blue pigment 5, reactive blue 7. Reactive blue pigment 丨 9, reactive red pigment 1, reactive red pigment 3, reactive red pigment 6, reactive red pigment 17, reactive red pigment 22, reactive red pigment 41, and the like Acridine yellow G, alizarin, indantamine, indole aniline, indocyanine green, urethionone, uropurine, p-ethoxycristine hydrochloride, m-cresol purple, o- -Benzophenolphthalein, benzophenone red, crocetin, chlorophyll (a, b, c, d), chlorophenol red, neomethylene blue, neutral red, vanramine blue b, acid salts, fluorenyl violet Essence, pyocyanin, sulfonated indigo, saffron τ, phenol saffron, gabri blue, naru blue, diphenylamine, dibenzyl cyanide, nitrodiphenylamine, ferrospirin, N-phenylanthracene acid , 2, 6-dichloroindole sodium phenol, sodium 4-diphenylamine sulfonate, Ν, Ν-diphenylbenzidine, cinnabarin (antibiotics), toluidine blue, riboflavin (vitamin B2 ), Tetrazolium blue salt, tetrazolium blue reduced type (Di formazan) and the like. Among them, from the viewpoint that the color change in this titration is the same as that of methylene blue, it is preferable to use methyl viologen, where
2030-5943-PF(Nl);Chiumeow.ptd 第128頁 200413503 五、發明說明(126) 拉明藍B鹽酸鹽、中性紅、續化彀m、2,6_二氯·朵苯朌 鈉 /^酸鈉、N,N—二苯基聯苯胺、辛那巴林 (抗生物質)、甲苯藍等。 ☆、、々ί : ί ί 3 Ϊ實施形態、參考例及實施例中,以鉑作 、、了予Ϊ 2 2 I里分析用之貴金屬膠體催化劑舉例說明, 但疋,貝至屬膠體催化劑不限定於 Γ二、Γ銦、舒、金、銀、銖及該等貴金屬元= :物:口物、錯化合物等膠體粒子本身,或該等之混 最後,為本發明之γ g I + 療時之變形例,敘述“氫再例;J者=治 =口等=將如翻膠體;體=等=催主 ϋ、ί治療對象部位。接著q吏患者在-般用 :察ίΐ:ί:=;厂之再壓室内,-面從室内或室: 供給到再=之厂緩緩上升。此時,將 卜⑽左s。並於例如氯氣组成氧成氣分分調整到氯佔 為很微量故忽略)之分a b &虱孔(其他氣體成分因 體環境下,-面由室?或比室成外= 裡頭約1小時,之I,盥弁厭卜二察患者的樣子’使患者在 ^ ^ ^ ^ Γ, ^ λ 4 f ^ Λ 之治療對象部位(抗氧化對象) :患者生體内 吸含於生體液(氫溶存水)之氫盘者肺啤吸或皮膚呼 同對象部位相遇,並對同對象部位普;:以化 Η 2030-5943-PF(Nl);Chiumeow.ptd 第129頁 麵 200413503 五、發明說明(127) 會局部消去在同對象部位之活性氧類。依該氫再壓治療方 法,可期待該對象部位之治療效果。2030-5943-PF (Nl); Chiumeow.ptd Page 128 200413503 V. Description of the invention (126) Lamin blue B hydrochloride, neutral red, continuation 彀 m, 2,6_dichloro · benzophenone Sodium / sodium sodium, N, N-diphenylbenzidine, cinnabarin (antibiotic), toluene blue, etc. ☆, 々ί: ί ί 3 In the implementation form, reference examples, and examples, platinum is used as an example of the precious metal colloidal catalyst used in the analysis of Ϊ 2 2 I, but 疋, shellfish is not a colloidal catalyst. Limited to ΓII, Γ indium, Shu, gold, silver, baht, and other precious metal elements =: colloidal particles such as mouthpieces, compounds, etc., or a mixture of these, finally, this is the γ g I + treatment of the present invention. The modification example at that time describes the "re-example of hydrogen; J = treatment = mouth, etc. = will turn colloid; body = etc. = reminder, ί treatment target site. Then q officials use-check: ΐί: ί : =; The plant is repressurized in the room,-the surface is gradually increased from the room or the room: supply to the re == plant slowly rises. At this time, the left side is s. And, for example, the chlorine gas composition oxygen content is adjusted to chlorine account for It is negligible because it is very small, and other pores (other gas components due to the body environment,-the surface from the room? Or the outside of the room = about 1 hour inside, I, toilet disgust look at the patient's appearance. Allow patients to be treated at the site of ^ ^ ^ ^ Γ, ^ λ 4 f ^ Λ (anti-oxidation target): the patient's body absorbs hydrogen discs that are contained in biological fluids (hydrogen-soluble water) Lung beer suction or skin exhalation meets the target site, and is common to the same target site :: Η 2030-5943-PF (Nl); Chiumeow.ptd page 129 200413503 5. Description of the invention (127) will be partially eliminated in The same as the active oxygen species of the target site. According to the hydrogen repressing treatment method, the therapeutic effect of the target site can be expected.
mil 2030-5943-PF(Nl);Chiumeow.ptd 第130頁 200413503 圖式簡單說明 第1圖為表示尼倫司特式之圖。 第2圖為說明传田TFn 丄 第3圖為免燈試驗樣子的圖。 ^ ΰ ^次明本發明應用例之圖。 第4圖為顯示使用本發明 洗淨系統100之概略圖。 几乳化方法之半導體基板之 第5圖為顯示本發明半 還原電位水生成装置U盆就子^暴板洗淨糸統100中使用之 a第6圖~第了圖為顯示y亞甲構藍\之呈縱^面圖。 膠體催化劑之電解處理 ^ 色變化進行添加鉑 第8圖〜第9圖為顯示以亞還甲原二'評價試驗結^ ^ 膠體催化劑之氫溶存太A ' 色變化進行添加鉑 第10圖〜第11圖為_、還原活性評價試驗結果。 鈀膠體催化劑之氫溶存水以亞曱藍之呈色變化進行添加 第1 2圖〜第i 3圖為顯示、^原^性評價試驗結果。 貴金屬混合(鉑+鈀)膠舻拙7 T孤之呈色變化進行添加 價試驗結果。 >體催化劑之氮溶存水其還原活性評 第14圖為顯示以亞甲藍之 化劑之電解處理水(電解 、巴复化進行添加鉑膠體催 還原活性評價試驗結果。处别添加/電解處理後添加)其 第15圖〜第16圖為顯示以DppH游 添加鉑膠體催化劑之電解卢土之呈色變化進行 果。 处7〆、抗氣化活性評價試驗結 第17圖〜第18圖為顯示以DppH游 ^ 添加催化劑之氫溶存水(脫1 _ 土 色變化進行 Μ脫乳處理+風氣封入處理)其抗氧 ΙΜ 第131頁 2〇30-5943-PF(Nl);Chiumeow.ptd 200413503mil 2030-5943-PF (Nl); Chiumeow.ptd Page 130 200413503 Brief description of the diagram The first diagram is a diagram showing the Neilstein formula. Fig. 2 is a diagram illustrating Chuanda TFn 丄 Fig. 3 is a view of a lamp-free test. ^ ΰ ^ This figure illustrates an application example of the present invention. Fig. 4 is a schematic view showing a cleaning system 100 using the present invention. The fifth figure of the semiconductor substrate with several emulsification methods is a, which shows the use of the semi-reductive potential water generating device U basin of the present invention, the washing plate 100, and the sixth figure. The first figure shows the methylene blue structure. \ 之 向 长 ^ 面 图。 Electrolytic treatment of colloidal catalyst ^ Color change for adding platinum Figures 8 to 9 show the results of the evaluation test with Methylene Redox II ^ ^ Hydrogen solubility of colloidal catalyst too A 'Color change for adding platinum Figure 10 ~ Figure 11 shows the results of the reduction activity evaluation test. Hydrogen-soluble water of the palladium colloidal catalyst was added in accordance with the color change of osmium blue. Figures 12 to 3 show the results of the original evaluation test. Precious metal mixed (platinum + palladium) glue was added to the color change of 7 T solitary, and the result of valence test was performed. > Evaluation of the reducing activity of nitrogen-soluble water of a bulk catalyst for reducing activity. FIG. 14 shows the results of an evaluation test of the catalytic reduction activity of electrolyzed treated water (electrolysis, pasteurization, and addition of platinum colloids). Addition / electrolysis Addition after treatment) Figures 15 to 16 show the results of the color change of electrolytic mulch with platinum colloidal catalyst added with DppH. At 7th place, the test results of the evaluation of anti-gasification activity are shown in Figures 17 to 18, which show the anti-oxidation of hydrogen-soluble water added with DppH catalyst ^ (removal of 1 _ soil color changes and M demulsification + wind-sealed treatment). IM page 131 2030-5943-PF (Nl); Chiumeow.ptd 200413503
化活性評價試驗結果。 f之呈&變化進行添加 乳處理+氫氣封入處理) 第19圖〜第20圖為顯示以亞甲 酵素氫激酶催化劑之氫溶存水(脫 其還原活性評價試驗結果。 還原滴 第21圖〜第22圖為說明以氧化還原色素之片 定進行溶存氫濃度定量分析之方法。’、’、乳化 效值=為說明各種樣本水之溶存氫濃度dh實測值與實 第24圖為說明細胞色素c還原法的圖 第25圖為說明腎上腺素氧化法之圖 〃第26圖表示以翻膠體濃度為主參數,含鈾 之虱溶存水所表現之游離基消去活性經時變:化蜊 第27圖表示以鈀膠體濃度為主參數,含鈀 之虱溶存水所表現之游離基消去活性經時變寺::化Μ 第28圖表示以鉑膠體濃度為主參數,含鉑圖。 之氫溶存水所表現之游離基消去活性經時變化特^化劑 第29圖表示以(鉑+鈀)混合膠體濃度為主泉 "° +把)混合膠體催化劑之氫溶存水所表現之游離'(麵 經時變化特性圖。 土 4去活性 •第3〇圖表示以(鉑+鈀)混合膠體濃度為主參數,、 鉑鈀此a莫耳比為副主參數,含(鉑+鈀)混合膠座 劑之氫溶存水所表現之游離基消去活性經時變化 第31圖表示以(鉑+鈀)混合膠體濃度為主參數、,、圖 翻把此a莫耳比為副主參數,含(鉑+把)混合膠體催化Chemical activity evaluation test results. f & change and add milk treatment + hydrogen sealing treatment) Figures 19 to 20 show the results of the hydrogen-soluble water (de-reducing activity evaluation test results) using a methylene enzyme hydrogen kinase catalyst. Figure 21 of reducing drops ~ Figure 22 illustrates the method for quantitative analysis of the dissolved hydrogen concentration using the redox pigment. ',', Emulsification value = To illustrate the measured value and actual value of the dissolved hydrogen concentration dh of various sample water Figure 24 illustrates the cytochrome Figure 25 of the c reduction method. Figure 25 is a diagram illustrating the adrenaline oxidation method. Figure 26 shows the free radical elimination activity exhibited by uranium-containing lice-soluble water over time, with the concentration of the transcolloid as the main parameter. The figure shows the concentration of palladium colloid as the main parameter, and the free radical elimination activity exhibited by the palladium-containing lice in water over time. :: Μ Figure 28 shows the platinum colloid concentration as the main parameter, and the graph containing platinum. Free radical elimination activity exhibited by water as a function of time. Figure 29 shows the concentration of (platinum + palladium) mixed colloid concentration as the main spring " ° + handle) of the hydrogen dissolved water of the mixed colloid catalyst '( Time-varying Characteristic chart: Soil 4 deactivation • Figure 30 shows the concentration of (platinum + palladium) mixed colloid as the main parameter, and the platinum ratio of platinum and palladium as the secondary main parameter. Figure 31 shows the concentration of (platinum + palladium) mixed colloid as the main parameter, and the figure shows this a molar ratio as the sub-primary parameter, including (platinum + ) Mixed Colloid Catalysis
2030-5943-PF(Nl);Chiumeow.ptd 第132頁 圖式簡單說明 劑之氫溶存水所表 、 ^ 第32圖表示以之游離基消去活性經時變化特姓 添加一道電解處理,隳體濃度為主參數,鉑膠體催化二。 性圖。 处里水所表現之游離基消去活性經時:,前 τ芰化特 弟3 3圖表示以^ 添加-道電解處理水,體濃度為主參數,鈀膠體催化劑4 性圖。 k所表現之游離基消去活性經時變=ς 第34圖表示以麵 曲 、 添加循環電解處理水戶;==參數,始膠體催化劑前 性圖。 表 游離基消去活性經時變化特 第35圖表示以鈀膠體濃度為主夂 添加循環電解處理水所矣 > 鈀膠體催化劑前 性圖。 斤表現之游離基消去活性經時變化特 第36圖|示以AsA水溶液遭度為主參數,^ 表現,游離基消去活性經時變化特性圖。 / /所 =7圖表示以貴金屬催化劑種類之差異為主參數 :辦二、含催化劑氯溶存水所表現之游離基消去活性緩 時變化特性圖。 ^ 你ffl f I:圖表不虱·氧共存系水溶液系中鉑膠體催化劑之 作用機轉。 〜 弟39圖表示氮·夤j£左多t 乳,、存糸水溶液系中鈀膠體催化劑之 1乍用機轉。 第40圖表示實施例中氬溶存水濃度DH之實效值。 第41圖〜第42圖表示含鉑膠體催化劑之二段電解處理2030-5943-PF (Nl); Chiumeow.ptd Page 132 Schematic illustration of the hydrogen-soluble water of the agent, ^ Figure 32 shows the free radical elimination activity with time. Special surname added an electrolytic treatment, carcass The concentration is the main parameter, and the platinum colloid catalyzes the second. Sex illustration. The elimination activity of free radicals exhibited by the water over time: The former figure 3 shows the ^ addition-channel electrolytic treatment of water, the body concentration is the main parameter, and the palladium colloidal catalyst is a property chart. The free radical elimination activity exhibited by k changes with time = ς Figure 34 shows the surface electrolysis treatment of Mito with added surface curvature; == parameters, the former graph of the colloidal catalyst. Table 35: Changes in radical elimination activity over time. Figure 35 shows the concentration of palladium colloids as the main component, and the cyclic palladium colloidal catalyst was added. Figure 36 shows the change in free radical elimination activity over time. Figure 36 shows the main parameter of AsA solution in water. // All = 7 The graph shows the difference between the types of precious metal catalysts as the main parameter: Second, the time-dependent change of free radical elimination activity shown by catalyst-containing chlorine-soluble water. ^ You ffl f I: The mechanism of action of platinum colloidal catalyst in aqueous solution of the coexistence system of oxygen and oxygen. FIG 39 represents a nitrogen ~ Di-t plurality dead of milk left J £ ,, memory Mi based catalyst of palladium colloid aqueous solution with the machine 1 at first turn. FIG. 40 shows the actual value of the argon dissolved water concentration DH in the examples. Figures 41 to 42 show the two-stage electrolytic treatment of a platinum-containing colloidal catalyst
2030-5943-PF(Nl);Chiumeow.ptd 第133頁 200413503 圖式簡單說明 水(A0W)對線蟲壽命產生的影響。 符號說明 S〜間隙; 1 2〜直流電源; 112〜導出口; 1 1 4〜外箱; 11 6〜電極板; 2 0 1〜電極; 2 0 5〜陰極室; 2 0 9〜腔室;以及 11〜還原電位水生成裝置 111〜導入口; 113〜電解室; 115〜隔膜; 11 7〜電極板; 203〜隔膜; 2 0 7〜陽極室; 21 卜LED °2030-5943-PF (Nl); Chiumeow.ptd Page 133 200413503 Schematic illustration of the effect of water (A0W) on the lifespan of nematodes. Symbol description S ~ gap; 1 2 ~ DC power supply; 112 ~ lead outlet; 1 1 4 ~ outer box; 11 6 ~ electrode plate; 2 0 1 ~ electrode; 2 05 ~ cathode chamber; 2 0 9 ~ chamber; And 11 ~ reduction potential water generating device 111 ~ inlet; 113 ~ electrolysis chamber; 115 ~ diaphragm; 11 7 ~ electrode plate; 203 ~ diaphragm; 2 0 7 ~ anode chamber; 21 LED
2030-5943-PF(Nl);Chiumeow.ptd 第134頁2030-5943-PF (Nl); Chiumeow.ptd p.134
Claims (1)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002381774 | 2002-12-27 | ||
PCT/JP2003/005386 WO2004039735A1 (en) | 2002-04-26 | 2003-04-25 | Method of inhibiting oxidation, water capable of inhibiting oxidation and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200413503A true TW200413503A (en) | 2004-08-01 |
Family
ID=52340561
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW092128817A TW200413503A (en) | 2002-12-27 | 2003-10-17 | Method of inhibiting oxidation, water capable of inhibiting oxidation and use thereof |
Country Status (1)
Country | Link |
---|---|
TW (1) | TW200413503A (en) |
-
2003
- 2003-10-17 TW TW092128817A patent/TW200413503A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4511361B2 (en) | Method and apparatus for quantitative analysis of dissolved hydrogen concentration in test water | |
JP4653945B2 (en) | Pharmacologically functional water and its use | |
KR100726057B1 (en) | Method for antioxidation and antioxidative functional water | |
US9050278B2 (en) | Scavenger of in vivo harmful reactive oxygen species and/or free radicals | |
JP4783466B2 (en) | Pharmacologically functional water and its use | |
JP2011190276A (en) | Pharmacologically functional water and use thereof | |
CN105848624B (en) | Immersion system | |
KR20160004051A (en) | Apparatus for generating electrolysis reduction water | |
Shirahata | Reduced water for prevention of diseases | |
EA024516B1 (en) | Biologically active food additive | |
TW200413503A (en) | Method of inhibiting oxidation, water capable of inhibiting oxidation and use thereof | |
Russell | A Study into the Biological Activity and Therapeutic Potential of Molecular Hydrogen and Oxyhydrogen Gases. | |
TW200303173A (en) | Method for antioxidation and antioxidative functional water | |
JP7036324B2 (en) | Anti-blood coagulation agent, blood coagulation improving device, blood coagulation improving method, vascular endothelial cell function improving method and metabolism improving method | |
JP2001302530A (en) | Reduction type antioxidant and method for producing the same | |
Sircus | Sodium Bicarbonate: Nature's Unique First Aid Remedy | |
Fisher | Speeding up solar disinfection: Effects of hydrogen peroxide, temperature, and copper plus ascorbate on the photoinactivation of E. coli in Charles river water | |
Kinuthia | Synthesis of Meso-tetra (5-bromothiophen-2-yl) Porphyrins for Photodynamic Water Disinfection | |
WO2016149876A1 (en) | Uses of multipolar microkinetic drinking water in preparing drink, healthcare product or medicament used for weight reduction | |
Alva Garcia | Thresholds of Hypoxia for Red Sea Corals | |
WO2016149885A1 (en) | Uses of multipolar microkinetic drinking water in preparing drink, healthcare product or medicament for reducing blood urea | |
JP2007077088A (en) | Physiologic saline and method for production of the same | |
Lee et al. | Formation of Artificial Lipid Membrane and their Photolysis in Mineral Water including Germanium | |
PANICHEVA et al. | ACTIVATION | |
Prilutskiy et al. | 6.3. ANOLYTE ANK SUPER: PATH OF IMPROVEMENT |